,ticker,content
0,PRGO,putt together watch list look stock higher rs rating perrigo prgo just meet criterium new score ibd unique rs rating measure market leadership used worst best score identify stock price performance trail week match other stock history reveal stock go make biggest gain typically have rs rating north early stage move look best stock buy watch start hereperrigo break earlier have fall back prior entry flat base scenario stock break then fall more entry price consider fail happen best new base form also understand latest pattern be later stage base involve more risk top bottom line growth moved higher last quarter earning be compare prior report revenue increase company hold rank peer medical generic drug industry group ani pharmaceutical anip be rank stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
1,PRGO,teva pharmaceutical teva jump monday rival perrigo prgo say expect food drug administration delay generic version teva asthma inhaler call proair afternoon trading stock market today teva pop close near month high teva stock be consolidate buy point perrigo other hand dip delay canaccord analyst dewey steadman keep buy rating price target perrigo steadman now expect perrigo launch generic proair delay perrigo generic proair be clearly disappointing re impressed quick disclosure expect complete response letter company effort frame impact product result say note client get newsletter deliver inbox more info product service privacy policy term useon friday perrigo say fda likely delay generic proair firm didn say previously perrigo have expect launch copycat fourth quarter have expect generic proair be worth cent full year earning share have guide share overall profit quarterly earning conference call steadman note difficulty develop asthma product glaxosmithkline gsk advair also face mount competition teva launch generic mylan myl be expect launch year see delay generic proair relatively minor evidence generic advair development now proair be extremely difficult develop generic inhaled product re not certain timeline potential proair launch say teva perrigo delay mean be other potential maker generic proair credit suisse analyst vamil divan say note proair generate sale still teva be face number other issue attempt restructure new chief executive kare schultz plan unveil february cut workforce close several plant terminate slew specialty program effort save delay generic competition be benefit teva top line be obviously rather minor positive relative other challenge company be currently face divan say see proair add quarterly mid divan have outperform rating price target teva related do spot major market top easy look heavy best stock buy watch start herenew option strategy limit risk earning
2,PRGO,consider name put watch list look stock higher rs rating perrigo prgo just meet criterium new score ibd proprietary rs rating track market leadership used worst best score identify stock price performance trail week match rest market year market history show market biggest winner often have better rs rating early stage move look winning stock try simple routineperrigo be buy range climb entry flat base proper buy range extend initial entry once stock move range best set buy opportunity top bottom line growth moved higher last quarter earning be compare prior report revenue increase company earn rank peer medical generic drug industry group ani pharmaceutical anip be top rank stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
3,PRGO,perrigo prgo see positive improvement relative strength rs rating thursday upgrade ibd proprietary rating track price action worst best score grade show stock price behavior trail week compare other stock database year market history reveal top perform stock often have rs rating least early stage move see perrigo continue rebound clear threshold look winning stock try simple routineperrigo break earlier have fall back prior entry flat base case stock break then fall more entry price consider fail happen best new base take shape also keep mind latest pattern be later stage base make riskier establish new position add share exist perrigo see earning sale growth rise last quarter earning share increase revenue rise company earn rank peer medical generic drug industry group ani pharmaceutical anip mylan myl collegium pharmaceutical coll be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
4,PRGO,wednesday perrigo prgo receive positive adjustment relative strength rs rating exclusive rating investor business daily measure market leadership worst best score rating show stock price behavior last week hold other stock database history show top perform stock typically have rs rating north early stage move see perrigo continue rebound clear threshold look best stock buy watch start hereperrigo be try complete flat base entry see clear price heavy trading earning grow last quarter prior report revenue also increase company hold rank peer medical generic drug industry group ani pharmaceutical anip mylan myl collegium pharmaceutical coll be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
5,PRGO,welcome move perrigo prgo see relative strength rating rise tuesday ibd unique rating track market leadership worst best score grade show stock price movement last week compare other stock database decade market research show top perform stock often have higher rs rating launch largest price move see perrigo continue rebound hit benchmark look winning stock try simple routineperrigo be build flat base buy point see stock clear price heavy trading earning sale growth come respectively latest report show quarters improvement earning revenue company be expect release next quarterly number nov perrigo earn rank peer medical generic drug industry group ani pharmaceutical anip neos therapeutic neos akorn akrx be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
6,PRGO,tesaro tsro take swipe astrazeneca azn third quarter sale report thursday suggest revenue record ovarian cancer drug lynparza be inventory buildup not necessarily patient switch rival drug zejula xlynparza bring sale beating consensus rbc analyst kennen mackay say sequential growth timing broader label lynparza suggest astrazeneca be take share tesaro say astrazeneca tesaro clovis oncology clvs make drug treat ovarian cancer rivale drug class call parp inhibitor august lynparza gain broader label allow treat bigger population ovarian cancer patient tablet follow astrazeneca note immediate encourage uplift new patient start tesaro say thursday astrazeneca earning release datum health care tracker im imply growth demand quarter mackay say later note client equate third quarter sale lynparza believe report sale include approximately stocking lynparza capsule withdrawal market lynparza tablet prior launch be anticipate ahead transition tesaro reportedly tell mackay other analyst ibd take astrazeneca have ibd composite rating best possible make seventh medical ethical drug industry group get look better rate stock visit ibd stock checkup tesaro also believe half lynparza use be outside ovarian cancer treat breast prostate cancer have contribute majority sequential demand lynparza firm reportedly say tesaro estimate quarter ovarian cancer maintenance market have be penetrate parp inhibitor maintenance therapy help avoid slow cancer return cancer be complete remission initial treatment zejula have approximately share parp inhibitor be used ovarian cancer tesaro tell analyst more zejula use be patient ovarian fallopian primary peritoneal cancer astrazeneca press release doesn detail inventory buildup be include lynparza sale figure quarter astrazeneca representative tell investor business daily firm doesn share breakdown net sale product close bell stock market today tesaro have tank close follow own earning report wednesday sale zejula lag consensus astrazeneca fall clovis dip finish outside parp inhibitor astrazeneca total sale quarter grow top consensus firm also post cent earning share lag analyst view cent astrazeneca update full year guidance now expect core earning share be low side low midteen percentage decline constant currency basis company maintain guidance low mid single digit percentage decline sale share drugmaker perrigo prgo rocket month high firm crushed analyst expectation third quarter close perrigo jump earlier rise much perrigo sale decline top analyst forecast sale adjust income share advanced smash consensus analyst poll zack investment research adjust earning share perrigo consumer health care business decline internationally fall company credit action take last year sell nonprofitable business prescription pharmaceutical sale dip company boost guidance adjust earning share related tesaro cancer drug miss prompt rival topplenektar acadium pop street crush quarters tesaro dipsincyte rise beat raise expand deal astrazeneca
7,PRGO,perrigo prgo have relative strength rs rating upgrade wednesday welcome improvement still higher score prefer see exclusive rating investor business daily identify market leadership worst best score score show stock price performance last week hold other stock database history show market biggest winner tend have higher rs rating begin largest price move see perrigo continue rebound clear threshold see ibd help make more stocksperrigo be now consider extend buy range clear buy point first stage flat base see stock form new pattern follow buy opportunity week tight pullback day week line earning sale growth come respectively latest report mean earning have have show improvement straight quarters sale have increase company be expect report next quarterly number nov company hold rank peer medical generic drug industry group ani pharmaceutical anip mylan myl akorn akrx be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
8,PRGO,stock take early dive thursday volatile session japan ripple global market dow jone industrial average open intel intc caterpillar cat post heaviest early loss slump nasdaq composite tumble stericycle srcl ebay ebay weigh index japan tokyo market flash possible warning signal rise nearly morning trade then crash loss pare loss close nikkei have gain prior session break level first time year just reversal china market notch positive session shanghai composite thursday carry gain so far week hong kong hang seng index add week europe market trade sharply lower volatility tokyo compound uncertainty tie brexit negotiation political tax plan top corporate earning frankfurt dax be more afternoon trade cac paris fall london ftse drop intel take dow hardest early hit possibly due news late wednesday qualcomm qcom receive unsolicited takeover bid week broadcom avgo be launch chip aim compete intel market server process cloud compute datum process application qualcomm share trade open boee ba rise buoy news agreement provide single twin aisle aircraft china aviation supplier sign part president trump trade mission asia nasdaq beaten share stericycle pare loss premarket trade company earning revenue miss analyst third quarter target monster beverage shed prem arket loss rise start bell third quarter earning meet revenue slightly top consensus expectation gross margin decrease quarter year move left stock buy range buy point flat base apple aapl drop fang stock trade lower ahead open netflix nflx fall hardest possibly response roku third quarter result new issue roku roku soar open trade healthy first time report publicly trade company gain left share september high ipo price generic drug maker perrigo prgo pound early advance allegan mich base company report big beat third quarter earning line first earning gain quarters revenue slip less expect gain put share buy range buy point early alternative flat base entry base standard buy point ibd stock alarm com alrm tumble report strong third quarter performance raise fourth quarter revenue guidance loss send share diving week move average erased most stock gain clear flat base august israel base solaredge technology sedg shot higher start gate third quarter earning revenue fourth quarter revenue guidance top analyst view stock be now breaking cup base september sage therapeutic sage scorched ahead announce post partum depression treatment brexanolone show positive result late stage clinical trial gap gain send share new high putt buy range cup base buy point economic news first time unemployment claim rise week end nov labor department estimate be claim prior week economist projection new application september wholesale inventory number commerce department be expect et related nvidia lead top earning report thursday investing action plan big picture do gauge point excessive optimism
9,PRGO,perrigo prgo have relative strength rs rating upgrade wednesday ibd unique rating measure market leadership worst best score grade show stock price behavior last week stack other stock database decade market research reveal stock go make biggest gain tend have rs rating early stage move perrigo have climb more past entry first stage flat base meaning now proper buy zone look stock offer new chance get week tight pullback day week move average earning sale growth come respectively latest report marked quarters acceleration earning top line company earn rank peer medical generic drug industry group ani pharmaceutical anip be top rank stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
10,PRGO,everyone know high prescription drug price be problem pharma stockholder few person realize price cut be ripple generic side industry take look recent event tumble generic drug price wipe billion dollar market value august like teva pharmaceutical teva mylan myl dr reddy laboratory rdy compound industry wo brutal second quarter earning season relatively small contingent pharma company produce cheaper version brand name drug be get broadside player distribution chain lead wholesaler be squeeze drugmaker lower price undercut battle pharmacy contract meanwhile group purchasing organization be consolidate grab more negotiating power represent hurdle generic comprise large chunk purchase analyst say be month price stabilize ever recover mean lower price patient drugmaker be take brunt battle price have clearly deteriorate aftermath contract negotiation evercore analyst umer raffat say aug audio report question really be do mean go forward say look way mylan teva stock have behaved look way estimate have be revise clearly suggest material worsening business teva stock lose august have re-cover month drugmaker market cap be close lose status july teva market value have fall nearly half comparatively mylan trail cap teva isn only feel pain selling pressure shave mylan market capitalization august share have topple begin august particularly disheartening quarterly report whole investor business daily generic drug industry group be year date near year low august rank group track ibd underlie cause price erosion stem back drugmaker spiked price base shortage monopoly other opportunity credit suisse analyst vamil divan tell ibd something be day see day re only make be competition say else produce have more flexibility price drug now card be go say ibd take teva have ibd composite rating best possible meaning perform bottom stock term key growth metric top rank generic drugmaker be ani pharmaceutical have middling cr visit ibd stock checkup look stock not only competition be more fierce also generic face adversary heavy scrutiny medium washington january then president elect donald trump accuse drugmaker get away murder pricing now aim use competition undercut price complicate matter drugmaker teva mylan perrigo prgo include be investigation department justice allege generic drug price fix last month member congress send letter maker multiple sclerosis drug probe rise drug price yet wrench generic story divan say investor be look cleaner story say too much unknown here teva mylan second quarter earning call project price erosion high single digit rest mylan specify erosion take place north american generic unit follow lackluster quarterly report mylan north american sale decline teva number be help acquisition actavis generic teva mylan cut forecast call executive company acknowledge increase generic approval food drug administration be champ sale new fda commissioner scott gottlieb be look speed generic approval even more help ease drug price be line trump vision quarter see increase competition result fda focus accelerate approval third fourth fifth generic mylan president rajiv malik say unfortunately have not see same first generic more complex niche product result mylan say delay launch generic version glaxosmithkline gsk asthma drug advair teva multiple sclerosis drug copaxone uncertain regulatory environment teva former interim chief executive yitzhak peterburg cite customer consolidation increase fda generic drug approval product be delay subject more competition accelerate price erosion decrease volume second quarter fda approval complication be cite second quarter report mizuho analyst irina koffler say aug report client generic approval be catch wind fda new goal complex generic molecular copy also have complex active ingredient formulation route device combination have be subject administrative delay koffler see mylan best position rebound tie challenged generic sector firm have pipeline complex generic biosimilar guidance be now more realistic less lever peer meaning pursue acquisition company stock have drop risk be pricing pressure not abate overall profitability company be decline expand lower margin international market now comprise greater percentage revenue say few drugmaker seemingly escap second quarter malaise report be somewhat mislead cfra analyst jeffrey loo tell ibd perrigo issue beat raise help stock fly day perrigo generic drug sale topple year year separate consumer health segment have smaller decline internationally respectively valeant pharmaceutical vrx crushed second quarter profit view sale come hair light firm also cut revenue target keep earning interest taxe depreciation amortization forecast lot person consider valeant generic play bulk business be now bausch lomb eye care product loo say quarter revenue bausch lomb well salix drug division represent total sale smaller generic unit other hand fall exclude valeant generic space perrigo none generic drugmaker really buck trend second quarter loo say think pressure group likely continue go forward next quarters teva lead generic drug sector also most pressure steven schoenfeld chief information officer bluestar index tell ibd bluestar index track israeli equity cybersecurity play check point software technology chkp be now bigger teva term market cap former teva chief executive erez vigodman step february bribery investigation then management have be shaky firm strategy have be kilter schoenfeld say follow loss several key patent protect ms drug copaxone january september teva name former lundbeck nordisk nvo veteran kare schultz new chief executive officer still teva be splitting focus generic brand drug schoenfeld say need strategy say need see want expand continue invest blockbuster drug ve now get early stage alzheimer asset other drug have decide re go be percentage generic so do profit go innovation meanwhile debt have rocket investor be longer sure teva paid acquire actavis generic allergan agn be good price say june teva have debt rise end march schultz teva recently avoid covenant violation debt teva say amend several term loan revolve credit facility provide teva greater flexibility financial leverage ratio covenant question forefront now be generic drug sector have hit bottom recent history mylan have come scrutiny pricing emergency allergy injection epipen turing pharmaceutical former chief executive martin shkreli draw criticism spiking price decade old hiv drug teva be be look ms drug price popular culture have turn bluestar schoenfeld say secular trend aren go go away market see pricing pressure have stock price worst teva be trading have major support time frame wouldn recommend anyone plunge teva most firm be now trading time earning cfra loo say continue price erosion see stock trading sideway next month note aren many drug go patent future cause somewhat roadblock new generic hope ve hit bottom say be not many catalyst go forward see buyer step buy share company time earning be awfully attractive valuation related biogen teva slip democrat launch ms drug pricing topple generic drugmaker be poise rebound fall generic drugmaker get analyst upgradegeneric drug be rebound teva mylan free fallperrigo beat raise lift generic drug buck teva mylan trend
11,PRGO,mylan myl teva pharmaceutical teva stock diverged wednesday analyst reportedly upgrade mylan differentiate durable generic drug portfolio issue teva downgrade morning trade stock market today mylan pop much settle back gain close teva topple finish accord various news account citigroup analyst liav abraham see mylan have more favorable balance sheet relative peer teva endo international endp upgrade mylan buy rating neutral boost price target accord fly company be best position outperform challenge market generic drugmaker abraham reportedly say note client citigroup didn immediately return request copy report investor business daily abraham also downgrade teva neutral rating buy cut price target have neutral rating endo ibd take mylan have ibd composite rating meaning outperform third stock term key growth metric best possible head ibd stock checkup look better rate drug stock teva biggest obstacle be debt june be need finance acquisition actavis generic teva debt be nearly double market cap mylan teva cut guidance second half issue quarterly result lag consensus perrigo prgo beat trend soon report wall street top metric boost guidance related generic drug be rebound teva mylan free fallperrigo beat raise lift generic drug buck teva mylan trendcan generic drug stock catch break mylan crash
12,PRGO,perrigo prgo shot month high thursday buck weakness generic drug business industry overall top second quarter expectation raise guidance xin morning trading stock market today perrigo pop earlier spiking much touch high last see late february meanwhile generic drug stock collectively rebound generic drug stock have be pressure month teva pharmaceutical teva mylan myl lead group report lackluster quarterly result cut guidance entire group trade straight day begin recover wednesday early thursday perrigo report sale adjust earning share top consensus cent respectively canaccord analyst dewey steadman write note client generic unit be become less important steadman say perrigo beat arrived back consumer business generic decline year year part lower sale crohn disease drug entocort ibd take biotechs be better rate generic drug stock perrigo have ibd composite rating best possible meaning underperform most stock term key growth metric celgene celg lead biotech group cr head ibd stock checkup look top rate stock year year basis consumer sale americas internationally decline respective perrigo sell unprofitable business last year exclude impact sale revenue grow respectively be stark contrast perrigo current large generic peer set face significant pricing challenge existential growth issue recent quarterly announcement steadman say consumer unit behave materially different generic steadman note expect perrigo shift further consumer drive business time significant opportunity keep buy rating price target perrigo perrigo also raise guidance adjust income share vs earlier view top consensus view steadman say related generic drug stock catch break mylan crash teva crash day be hurt generic drugmakersteva crash year low very tough quarter
13,PRGO,generic drug maker mylan myl continue free fall friday rival teva pharmaceutical teva manage briefly arrest slide broader generic lead eagle pharmaceutical egrx defy trend spiked higher third straight day xin afternoon trading stock market today ibd company generic drug industry group pop highest point aug day teva report second quarter earning sale miss cut guidance generic drug stock broadly trade consecutive day begin recover earlier week eagle aclaris therapeutic acrs lead group midday friday rise respective perrigo prgo offer quarterly beat raise week pop analyst expect perrigo generic drug business topple quarter follow disappointment teva mylan generic business do decline strength consumer drive business be enough help perrigo top expectation perrigo shot thursday second quarter report amazing good quarter do ub analyst marc goodman write research report have buy rating price target perrigo goodman note perrigo do unexpected increase net sale guidance generic drug unit perrigo bump expect generic sale earlier view due earlier expect launch new product significant move stock be also due solid upside consumer business combination cost cut execution be drive margin improvement appear be sustainable goodman say ibd take inflation have have part play earning miss head ibd economy page see teva other have be impact perrigo boost generic guide call year year erosion generic drug price second half year separate report goodman nearly halved price target teva keep neutral rating expect teva see generic competition multiple sclerosis drug copaxone first quarter lose several key patent earlier year more importantly have significantly lower generic number topline margin base management see new generic landscape write analysis suggest be not buy opportunity hence remain neutral stock goodman assume teva generic business likely decline average decrease be drive base erosion be partially offset new product launch say teva expect generic revenue decline look save money close manufacturing facility well synergy allergan agn generic deal teva acquire allergan generic business last august related perrigo beat raise lift generic drug buck teva mylan trendhow teva crash day be hurt generic pop report ceo win jump ship teva pharma
14,PRGO,nasdaq composite lead major average lower undercut day move average president trump fiery rhetoric north korea negative reaction earning other corporate news xwalt disney announce split netflix nflx priceline pcln give weak guidance macy other department store crash snap snap miss everything send share lower nvidia nvda have blowout number price perfection share fall top rate china internet generally retreat slew earning government crackdown social medium nasdaq composite tumble sank move day move average dow industrial dip set record high tuesday number lead stock undercut recent buy point key support level cboe volatility index market fear gauge near month high sink time low late july trump threat wreck fire fury north korea continue make nuclear missile advance unnerved investor earning corporate news have have bigger effect related nasdaq break support step take nowbig picture market uptrend be pressurewalt disney end movie distribution deal netflix nflx say ll create own video demand subscription service disney win pull tv show netflix ongoing marvel netflix collaboration continue still move force netflix spend more own content notably big ticket film netflix fall nearly return july buy point friday bounce meanwhile disney report mixed result say plan espn stream service start early not end disney sank hit month low related netflix fall continue end disney movie deal key fact disney rogue move mean netflix nvda earn cent share year year sale quarter end july analyst expect cent current quarter graphic chip maker expect sale rise vs consensus nvidia cite strong chip sale video game device datum center artificial intelligence application analyst say datum center revenue be little light share fall friday sink thursday ahead result related nvidia earning crush view guidance bullish stock snapchat operator report wider expect adjust share loss revenue user growth average revenue user be weaker forecast snap snap crash friday hit record lows snap add just user facebook fb successfully clone snapchat offering notably instagram story snap fall short just metric stock crashesmacy kohl kss jwn report stronger expect earning sale tumble thursday regular session longer term concern midtier mall base big box retailer face amazon amzn discounter macy crash worst level september dd report surprise loss send stock plunge just edge higher friday solid late thursday result jcpenney jcp already fall sharply thursday crash friday record lows report wider expect loss weaker expect same store sale related beat rival chain plunge sale keep fallingj penney stock sink second quarter loss missespriceline pcln earning beat view revenue match online travel book site see ep vs wall street estimate booking growth estimate be also light tripadvisor trip earning also beat analyst expectation revenue be line hotel revenue climb airline traffic growth continue outpace gdp hotel revenue fall room rental company airbnb gain ground priceline fall tumble buy point day line tripadvisor rise related priceline share drop earning outlook fall shortsina sina weibo wb netease nte yy yy athm report better expect earning june quarter netease crash day line yy dip thursday wild session be nicely so far week auto info site soar result sina own control stake weibo reversed lower undercut monday weibo also retreat hold own entry china crack social medium hit twitter service well sina tencent tcehy baidu bidu trade desk ttd say second quarter adjust earning be cent share year revenue rise analyst expect trade desk report earning cent sale provider automate advertising technology compete facebook fb alphabet googl guide full year revenue estimate higher trade desk ipo september see first day pop peaked late july trade desk soar friday tumble day line thursday related trade desk earning blow past estimate sale outlook hikedlumentum holding lite fall september quarter guidance miss view ramp sensor device new customer assume analyst be apple aapl optical device maker report line profit revenue be light weakness company north america business well china lumentum management say have order device calendar manufacturing yield have be solid question be much apple business lumentum potentially share germany am finisar fnsr ii vi iivi lumentum say china inventory correction last december quarter drug biotech earning be mixed bag perrigo prgo horizon pharma hznp kite pharma kite valeant pharmaceutical vrx top view mylan myl jazz pharmaceutical jazz nektar therapeutic nktr alnylam pharmaceutical alny lag second quarter expectation valeant mylan cut guidance perrigo horizon ionis ion boost piece full year outlook meanwhile tesaro tsro beat top line report wider expect loss other news esperion therapeutic espr hit year high bump timeline file application cholesterol lower treatment wendy wen second quarter result top street estimate stephen analyst attribute strong show value meal marketing fresh never frozen beef hamburger jack box jack same store sale come better expect analyst hope chain reclaim customer bigger push cheap combo offering other deal company also continue weigh sell do something else qdoba chain red robin gourmet burger rrgb beat top bottom line mcdonald mcd set sight china form partnership aim expand number location norwegian cruise line nclh report second quarter ep growth revenue better expect cruise line operator stock pop record intraday tuesday fall week plan stock offer behalf exist shareholder tesla tsla say develop self drive semi truck platooning ability long haul trip tesla say prior week issue new debt fund model rollout say sell debt tesla share rise blue apron aprn lose cent share expect first quarterly report go public revenue rise beating view show slow growth meal kit provider customer base fall quarter quarter competitor expand amazon amzn loom blue apron be cut market spending be not great sign attract customer share crash week hit record low planet fitness plnt report ep rise cent beating cent revenue gain view systemwide same store sale grow gym operator also raise guidance full year earning revenue comp sale planet fitness break past buy point thursday pull back modestly friday share zillow group fall online real estate portal swung adjust profit traffic slow company forecast september quarter sale expectation
15,PRGO,stock skid lower thursday open pressure overseas market bleed stock second day dow jone industrial average drop send index back mark slump nasdaq composite tumble most influential tech name apple aapl shed heavyweight fang stock trade loss dow boee ba lead early action gain goldman sachs gs unite technology utx take downside respectively earning front heaviest early loss chicago bridge iron cbi tumble exone xone take dive drugmaker perrigo prgo plow higher lead early action michigan base company second quarter earning revenue fall less forecast management boost full year earning guidance well consensus view gain haul stock back week move average remain april high coca cola european partner cce advanced follow strong second quarter result share be extend breaking flat base mid july blue apron aprn dive loss investor take mixed second quarter result earning be expect revenue top view new order customer rise respectively year year fall sequentially company backed marketing expenditure blue apron share trade late june ipo price ibd name yy yy fall netease nte drop report quarterly result yy share remain extend flat base july netease loss cut support stock week line support heavy trade flash sell signal department store come heavy early pressure report second quarter result wisconsin base kohl kss drop beating second quarter earning estimate report slowdown same store sale decline loss end stock attempt retake support week move average macy slough just open report strong second quarter result dd tank surprise quarterly loss price paid producer slip july labor department report june advance expectation gain core price energy food also dip view rise first time unemployment claim remain roughly steady week end aug labor department revise slightly prior week estimate new claim economist have project application week new york federal reserve bank president william dudley speak et benchmark oil rise top barrel gold add ounce silver jump dollar be mixed vs euro rise yen bond gain send year yield basis point take only mild hit wednesday decline china accelerate thursday send shanghai composite hong kong hang seng index loss opposite be true japan investor pile safe haven yen help tokyo nikkei trim loss less vs slide wednesday europe seller continue drive market london ftse afternoon trade frankfurt dax be cac paris show decline related big picture apple get extend stock break wednesdayfang loom large earning report investing action planstock buy watch top ipos big small cap growth stock
16,PRGO,mylan myl hit year low take generic drug stock report second quarter metric lag wall street cut guidance next year then re-cover post slight gain wednesday xon stock market today mylan end trading day earlier fall much hit low last see june be sixth consecutive day mylan have spend red follow disappointing report fellow generic drugmaker teva pharmaceutical teva crash initially send ibd company generic drug industry group much sector re-cover recent trade rise nearly close still taro pharmaceutical taro collegium pharmaceutical coll perrigo prgo remain respectively second quarter end june mylan report sale year year miss consensus adjust earning share lag cent fall revenue north america be hit hardest sale europe rest world grow respectively vs year earlier period sale epipen injection allergic reaction decline due increase competition ibd take mylan have ibd composite rating meaning perform bottom half stock term key growth metric get look better rate stock ibd stock checkup mylan also cut guidance sale adjust profit share now see adjust earning least earlier view new target be expectation midpoint give region ongoing challenge uncertain regulatory environment have elect defer major launch full year financial guidance include generic advair copaxone mylan say news release advair be used prevent asthma attack flare up chronic obstructive pulmonary disease brand glaxosmithkline gsk mylan other be work generic version food drug administration delay mylan application drug mylan other be also work generic version teva multiple sclerosis drug copaxone lose key patent earlier year medicine company mdco pop lag second quarter revenue loss beat expectation promising clinical update include ldl cholesterol lower drug rival amgen amgn regeneron pharmaceutical regn sanofi sny medicine co note second quarter come agreement regulator europe drug inclisiran cholesterol buster total expect enroll patient phase trial design support submission application approval inclisiran be know pcsk synthesis inhibitor have slightly different mechanism psck inhibitor amgen regeneron sanofi medicine co be also work study patient determine cardiovascular benefit inclisiran second quarter end june medicine co report sale miss consensus analyst poll zack investment research revenue adjust loss share widen cent loss year earlier period top consensus view adjust loss share medicine co lift close related tesaro beat sale view loss nektar miss teva crash day be hurt generic drugmakersmylan fda limbo generic multiple sclerosis drug
17,PRGO,stock stick very close home thursday mixed economic datum earning report frayed attempt build momentum better expect weekly jobless claim june consumer confidence number be positive sharp drop manufacturing growth report philadelphia fed open help stoke investor concern investor response earning report cut sharply direction mostly soft trade session result give nasdaq technical new high straight gain increase be less weak trade mean feat check point software chkp tripadvisor trip qualcomm qcom turn broad loss apple aapl netflix nflx google parent alphabet googl end minor loss day drugmaker mylan myl regeneron pharmaceutical regn lead nasdaq mylan jump positive phase trial result report late wednesday ibd stock regeneron also swung weak trade work new consolidation slip fraction back away new high notch intraday drugmaker be key leader also perrigo prgo mallinckrodt mnk post gain trade be weak dow jone industrial average close valiant effort nike nke buck more day stock have fall buy point entry remain play home depot hd fall ratchete drag dow catalyst appear be agreement sear holding shld sell respect kenmore brand home appliance amazon com amzn news send sear share nearly gain amazon sketch advance macom technology solution mtsi lead ibd more average trade be sufficient take new high share be already extend early july rebound week move average chipmaker plan report fiscal third quarter result aug side floor decor fnd tumble fast trade fall back week move average company price share follow offer just wednesday close price stock remain april ipo price related financial be buy range earning tonightamazon team sear new retail group tumblespaypal stock record high jpmorgan deal online payment sizzle
18,PRGO,major market average edge lower late morning trade crude oil price continue recent trek lower nasdaq composite lose dow jone industrial average dip dow industrial microsoft msft pace advancer pop american express axp follow gain early trading blue chip index laggard be apple aapl cisco system csco apple be downgrade sector weight gross margin risk analyst call likelihood decline post iphone advanced micro device amd lead way rise micron mu nvidia nvda follow gain respectively downside medical stock find bottom pack perrigo prgo mallinckrodt mnk drop nearly respectively generic drug maker perrigo be downgrade sector perform underperform rbc capital analyst action stock market today snapchat parent snap snap ibd member veeva system veev be downgrade social medium company see price target lower jpmorgan veeva be cut sector weight morgan stanley share fall lead stock workday wday decline electric automaker tesla tsla fall record high fang stock google parent alphabet googl jump cross first time netflix nflx fall action ibd be mostly positive early monday upside ichor holding ichr jump recent ipo floor decor holding fnd moved china base stock momo momo netease nte moved respectively downside athm drop private mortgage insurer essent group esnt trade related apple cut post iphone risk snap price target croppeddow jone industrial average dow stock news stock news quote facebook amazon netflix google
19,PRGO,teva pharmaceutical teva say thursday increase price multiple sclerosis drug copaxone partially offset dip global first quarter sale share fall total revenue miss wall street view stock market today teva stock rise earlier fall much share be year antitrust probe generic include teva mylan myl perrigo prgo first quarter end march teva report adjust income share sale profit top cent decline year year sale miss view grow vs last year generic medicine sale grow comprise total sale chunk represent year earlier period teva note acquisition actavis help boost segment quarter revenue teva specialty drug unit decline teva blame lower sale central nervous system respiratory drug decrease specialty medicine help offset teva receive payment takeda subsidiary buy royalty right multiple myeloma drug ninlaro copaxone see fewer sale quarter revenue multiple sclerosis drug fall partially offset price increase copaxone product january teva say teva sell milligram milligram dose copaxone ibd take generic drug stock topple last week federal official search perrigo office part widespread price fix investigation head ibd industry theme deeper look company face department justice scrutiny outside copaxone revenue grow teva face loom copaxone competition february delaware court rule invalid key patent protect drug siding mylan pfizer pfe momenta pharmaceutical mnta be work copaxone copy respiratory product also topple first quarter bring revenue sale asthma inhaler proair qvar decline respectively teva note wholesaler retailer inventory reduction well net pricing effect play dip teva also say michael mcclellan serve interim chief financial officer effective july follow plan departure eyal desheh join teva mcclellan have year career sanofi sny related mylan revenue fall short view epipen sale declineteva downgrade lose ms drug patent doj probe
20,PRGO,market end dull thud run loss nasdaq dow jone industrial average be nasdaq seventh straight monthly advance end manage gain dow industrial eke only thinnest fractional advance datum play key role wednesday action dow industrial nasdaq open higher then reverse sharply release chicago purchasing manager index et correct version pmi show much stronger report first release chicago pmi show read hard prior month tally consensus view correct version show read highest mark year well forecast overnight datum china show better expect manufacturing growth steel equipment mining stock normally react positively such news come pressure early session addition claim libya production have re-cover long term ceiling barrel help send crude price almost barrel leave month stock fall then gradually regain ground release federal reserve beige book show continue modest growth increase sign optimism be flagging report be closely watch last beige book report ahead fed meeting interest rate june majority investor expect increase rate pfizer pfe lead dow industrial announce food drug administration european medicine agency have accept submission expand approve use sutent include treatment recurrent renal cell carcinoma patient follow kidney surgery pfizer share be work first weekly advance late april pressure come michael kor kor tenet healthcare thc southwestern energy swn goldman sachs gs goldman jpmorgan jpm drive downside dow stock goldman tumble jpmorgan follow revelation jpmorgan cfo marianne lake speaking investor conference firm trading revenue be year year loss be more subdue nasdaq reilly automotive orly baidu bidu hardest hit apiece top nasdaq vertex pharmaceutical vrtx rise take new high analog device adi thrash higher open then backtrack close higher big trade norwood mass company report big fiscal earning deliver revenue earning guidance analyst expectation share end buy range buy point flat base ibd stock control ctrl roar higher big trade needham upgrade connect home software developer buy price target stock be extend april rebound week move average drugmaker perrigo prgo lead strong first quarter report stock remain deep month consolidation related tech leader high earning loom investing action plan here look semtech broadcom earning
21,PRGO,generic drug stock crash wednesday news department justice have conduct search perrigo prgo office related widespread price fix investigation be also look teva pharmaceutical teva mylan myl early trading stock market today ibd company medical generic drug industry group fall collective week low lannett company lci perrigo stock lose most respectively lannett miss third quarter earning estimate late tuesday perrigo decline comment press release confirm authority execute search warrant perrigo corporate office have be previously disclose number company justice department antitrust division have be look industrywide pricing practice perrigo release say company be take investigation seriously be cooperate appropriate authority investigation center potential price collusion dozen company illegal company agree set price corporate discount perrigo case justice department be look price skin drug bloomberg report other drugmaker investigation be allergan agn impax laboratory impx covis pharma sun pharmaceutical mayne pharma taro pharmaceutical taro endo international endp subsidiary par pharmaceutical ibd take keep pharma news visit ibd biotech pharma industry stock news page mylan tell investor business daily last year receive subpoena regard doxycycline antibiotic hadn be ask information pricing tactic digoxin blood pressure drug be also search january jeffrey glazer jason malek former executive generic drug maker heritage pharmaceutical plead guilty price fix agreement other drugmaker related teva ceo step patent loss bribery settlement stock ionis outplay med sector perrigo tenet valeant diveperrigo share plunge plan sell ms drug royalty stream
22,PRGO,share perrigo co prgo plunge hour trading monday ireland base drugmaker announce plan divest right royalty stream multiple sclerosis drug tysabri rpi finance trust press release perrigo say deal come cash receive milestone payment base future tysabri net sale share perrigo be nearly hour trading close fraction regular session perrigo stock have fall april hit time high perrigo also announce preliminary unaudited figure net sale come top analyst view loss share item be expect hit primarily due goodwill intangible asset impairment charge perrigo say perrigo guide earning share item lag consensus view net sale guidance be light miss wall street view ibd take perrigo stock have low ibd composite rating meaning underperform more stock sector term key growth metric get look better stock idea ibd stock checkup company also announce ron winowiecki succeed judy brown act chief financial officer effective april brown be leave perrigo run global business service global internal audit unit biotech amgen accord wall street journal winowiecki be perrigo senior vice president business finance extensive search permanent cfo include winowiecki perrigo say related mylan glaukos supernus live growth view next week
23,PRGO,kite pharma kite outperformed med stock tuesday gapping lymphoma trial result even perrigo prgo tenet healthcare thc make double digit plunge lead similar decline valeant pharmaceutical vrx akorn akrx close bell stock market today kite stock have rocket share trade buy zone hit entry point consolidation period begin august biotech stock be broadly almost tuesday juno therapeutic juno too jump more kite news be work drug treat diffuse large cell lymphoma month kite drug know kte show complete response rate cell lymphoma patient continue response rate report month kte achieve best overall response rate response rate patient group leerink analyst michael schmidt note result be durable also set bar juno drug know jcar juno plan begin trial used jcar same type lymphoma patient biotech ionis pharmaceutical ion see share charge higher well day move average consensus crush fourth quarter metric ionis post cent earning share exclude certain item analyst expect cent loss sale top nearly ibd take want more biotech pharma industry be sure stop ibd biotech pharma stock page best idea sector upward stock motion tuesday be largely limit kite ionis exelixis exel stock re-cover earlier beating follow stifel nicolaus analyst stephen willey downgrade hold rating buy willey cite exelixis inflate valuation lack input support downgrade everything be go right exelixis write note monday exelixis post strong fourth quarter result announce immuno oncology partnership bristol myer squibb bmy roche rhhby share fall tuesday close tenet stock topple report cent earning share certain item sale miss consensus analyst poll thomson reuter cent respectively perrigo continue downward stock path tuesday share end day late monday announcement sell royalty stream multiple sclerosis drug tysabri rpi finance trust guidance be also light valeant report strong fourth quarter consensus top metric share dove close earning guidance lag view valeant guide earning interest taxe amortization miss estimate akorn stock be wallop fall close related valeant plunge earning outlook unrealistic brand salesexelixis rocket bristol roche ty follow merck incyte teamperrigo share plunge plan sell ms drug royalty stream
24,PRGO,generic drugmaker mylan myl be expect late wednesday report third consecutive quarter sale growth well earning re accelerate company dip red mylan report come week chock full health sector earning include biotech supernus pharmaceutical supn tuesday eye care firm glaukos gkos wednesday horizon pharma hznp perrigo prgo be slate report earning monday analyst poll thomson reuter expect mylan see earning share item sale respectively vs year earlier quarter ep fall quarters growth part investor day new york mylan also issue guidance analyst currently view sale grow ep item mylan stock be year well day move average rough see stock tumble ceo heather bresch be force defend bump price epipen pack share fall friday ibd take glaukos file initial public offer august be several stock outperform head ibd ipo analysis deep dive glaukos fellow outperform stock year end mylan introduce generic epipen half cost brand pack also late wednesday glaucoma cataract surgery firm glaukos be slate report sale break even ep ex item sale be expect grow year year company lose cent share year earlier quarter glaukos stock hit record high tuesday share rise friday late tuesday analyst expect supernus report cent ep ex item revenue rise supernus stock fall friday touch time high start month related momenta pfizer give teva breathe room generic ms drugacorda stave mylan teva generic protect ampyra rbcteva dife year low copaxone patent invalidate
25,PRGO,already trouble valeant pharmaceutical vrx see stock crash year low early tuesday company slash guidance report sale earning topple vs year earlier quarter stock market today valeant stock tumble earlier fall share have plunge more year ibd company medical ethical drug industry group have fall more valeant report sale earning share ex item respectively year year metric miss consensus analyst poll thomson reuter valeant have miss ep past quarters sale last quarters valeant blame sale miss decline product sale revenue exist business ibd take valeant have low composite rating meaning underperform stock term key growth metric none drugmaker have high cr depome be rank highest group cr get stock checkup more company trouble begin late last year scandal erupt involve valeant relationship now defunct pharmacy call philidor turn valeant secretly have option acquire thing have go downhill bloomberg report tuesday regulator be try build fraud case former valeant ceo michael pearson former cfo howard schiller new ceo joseph papa come perrigo prgo april executive team be strive right ship decline be primarily due lower realize price related ophthalmology product result implementation rebate other price adjustment versus prior year valeant say press release valeant brand rx segment see sale plunge diversify product unit fall latter segment valeant experience generic competition neurology product sale valeant bausch lamb international segment rise new acquisition higher volume product sale help offset decline exist business valeant now see sale earlier guidance firm cut ep item guidance related aerie pharma dip minor glaucoma setback missvaleant share sell plan sell stomach disorder business
26,PRGO,growth stock fund have outperformed blend value counterpart past year reverse be true year average value fund nearly average blend fund nearly average growth fund growth fund have keep pace value fund year be parnassus endeavor fund parwx large cap growth fund be year recent top holding include apply material amat year qualcomm qcom micron technology mu holding haven do well include gilead science gild year generic drug maker perrigo prgo fund have be manage jerome dodson fund seek buy high quality company hold long term seek keep company portfolio give significant weighting most have turnover rate parnassus endeavor have environmental social governance esg component holding offer outstanding workplace not be involved oil other fossil fuel fund commentary written early october dodson say market look fairly value decline number attractive stock help explain cash fund have build way average stock fund also way goal cash put cash work win invest just sake reduce cash position say have be good idea inspire investment mean good company trading very attractive price strategy have serve well year evidence strong return so not tempt change policy lower fund standard just reduce cash balance strong inflow fund investor attract strong performance have contribute cash build dodson encourage investor stay course keep investment come point ll figure do money say dodson profess lack deep concern likely path interest rate immediate reaction interest rate increase probably be drop stock market longer term gradual reasonable increase rate probably not depress market very long say commentary rise interest rate usually mean economy be do better so corporation be do better stock find way move higher continue interest rate move higher late year early next year initial reaction be stock market swoon happen stock go more attractive valuation provide opportunity put idle cash work related parnassus dodson win hot tech stock pass esg be fidelity trend like apple amazon alphabetwhy top columbia fund like stock leaderschinese other foreign stock drive top mutual fund performance
27,PRGO,share generic drugmaker perrigo prgo have fall half past year jump monday activist hedge fund investor starboard value announce have take ownership stake be ask change company believe perrigo be deeply undervalue significant opportunity exist create value benefit shareholder base action be control management board starboard write letter address perrigo ceo john hendrickson believe change be need reverse trajectory poor operate financial performance reposition perrigo future success believe significant opportunity exist improve performance perrigo core business perrigo share rise stock market today have be downtrend go back more year ibd take generic drug sector have be ibd medical biom biotech industry group rank solid group recent coverage offer advice look earning report spot sale volume growth vs price hike growth identify biotechs keep eye month perrigo elevated hendrickson president ceo april company former ceo joseph papa resign take top job valeant pharmaceutical vrx generic drugmaker have be pressure continue price competition ibd company medical generic drug group have fall more year teva pharmaceutical teva friday give update product include competitor mylan myl epipen say be market late next year huge overall issue high drug price sprang again last month lawmaker democratic presidential candidate hillary clinton sharply criticize cost emergency allergy treatment research note late sunday rbc capital market analyst randall stanicky be unimpressed teva update outlook sector overall teva update write research note do not think be enough assuage pre exist investor concern overall generic outlook drive street number higher continue see teva best position generic sector visibility be still challenge november perrigo shareholder recommend perrigo management turn propose buyout mylan value share letter monday starboard sharply criticize move perrigo management unfortunately time result have go decidedly wrong direction management promise have be woefully unfulfilled starboard write specifically company have severely mismanage omega pharma invest omega now perrigo brand consumer healthcare business integration commit numerous execution error significantly lower financial guidance past earning call perrigo form brand consumer health care business bch acquire omega pharma last year perrigo have say bch have be perform weaker expect lower expectation new product launch related mylan make own generic own epipenis epipen price fda fault hold competition
28,PRGO,stock turn higher open mixed lower trading well pre market lows dow industrial rise less climb more nasdaq gain market suffer heaviest loss third quarter friday comment federal reserve official amp concern fed raise benchmark interest rate stock market today face significant economic release more fed commentary be expect morning atlanta federal reserve bank president dennis lockhart be schedule speak et minneapoli fed president neel kashkari fed governor lael brainard be due speak et ripple effect rate hike fear overseas commodity factor powerfully premarket trade monday market asia drop hard mirror friday action europe hong kong hang seng outpaced other lead index sell europe market be hard have come partially lows early afternoon trade london ftse cac paris frankfurt dax apiece crude oil trim early loss less west texas intermediate hang barrel oil price rise last week mark first advance week gold shave fraction trade ounce early monday dollar be mixed vs euro hong kong dollar yen bond ease add basis point year treasury dow unitedhealth group unh fall wal mart wmt climb more upgrade outperform cowen co fertilizer giant potash corp saskatchewan pot agrium agu agree merge create combine operation value potash rise fractionally agrium fall praxair px fall fraction german industrial gase outfit linde call preliminary talk perrigo prgo offer bright spot premarket trade jump nearly hedge fund starboard value announce have establish almost stake michigan base generic drug maker ibd stock china base netease nte jump fall sharply premarket action related potash corp agrium merge create fertilizer giantlinde praxair end talk industrial gase mergerperrigo jump starboard reveal big stake demand changeswal mart upgrade target downgrade
29,PRGO,month filibuster gold miner industry group be knock rank perch not quite week fiber optic industry group be just number recent change industry group track ibd have top industry leadership look more diversify healthy have
30,PRGO,stock open nearly flat wednesday dow industrial fraction nasdaq less walt disney drag dow result report late tuesday generally beat analyst expectation cable sale weaker forecast china base stock be front center early stock market action yirendai yrd surge open online consumer finance facilitator ibd stock report late tuesday ep rise revenue gain far analyst target yirendai end wednesday session december ipo price be extend july rebound support week move average online retail giant jd com jd open report surprise profit wider expect gross margin increase annual active customer fashion brand ralph lauren rl jump fiscal earning revenue slip less expect online business review site yelp yelp scream higher san francisco base outfit squeak analyst ep forecast gain revenue rise easily top view management hoist revenue guidance well consensus forecast sunpower spwr crumble report wider expect loss warning challenge affect result management also say cut job workforce generic drug maker perrigo prgo tumble early trading allegan mich base company revenue slip less expect earning decline more project company cut full year guidance base competition price erosion rx business cyberark software cybr drop open security software play report revenue earning analyst projection raise revenue guidance view investor appear have be disappoint soft ep guidance wednesday thin economic calendar include labor department job opening labor turnover survey set et release energy information administration also report weekly oil inventory datum et oil future trim early loss fraction leave west texas intermediate just barrel gold add rise ounce dollar weaken bond inched trimming basis point year treasury yield china japan market close narrowly mixed europe market be steady carry minor loss afternoon trade
31,PRGO,stock open higher wednesday overseas market climb new report give mixed reading manufacturing activity nasdaq dow jone industrial rise climb stock early motion include american express axp cisco system csco perrigo prgo stock market today face busy morning economic news lead federal reserve policy announcement due et industrial production fall view drop manufacturing activity also sank biggest drop auto related output january however new york federal reserve empire state manufacturing survey show solid improvement regional business activity june index jump read tally well forecast result new order shipment rise employment remain steady inventory decrease report say producer price rise labor department report increase april expectation gain core price food energy rise vs april gain view increase federal open market committee wrapped day meeting policy announcement afternoon energy information administration weekly oil inventory report be expect dow stock american express rise tumble tuesday concern credit card charge off cisco system fall nearly receive downgrade healthy be cisco system do stack vs other networking stock find ibd stock checkupminer freeport mcmoran fcx jump more endo pharmaceutical endp rise nearly perrigo slide back day line spiking tuesday takeover chatter whole food market wfm fall more lose tuesday news report tuesday say food drug administration have issue chain letter warning regard health safety practice company food preparation site massachusett company say early correction make order satisfy fda warning february be not reflect more recent letter date june whole food stock have climb straight week attempt start right side month consolidation ibd nvidia nvda be universal display oled trade broadcom avgo rise fractionally universal display end tuesday session buy point week tight mxl rise stumbling early premarket trade chip developer pull back buy range past session end tuesday bit more cup base buy point oil future dip nearly send west texas intermediate barrel gold pull back fraction ounce dollar rise yen ease vs euro year treasury yield climb basis point overseas china shanghai composite bounce higher retake piece monday dive hong kong hang seng index edge japan tokyo nikkei also add european market pressed higher afternoon trade paris cac lead major index
32,PRGO,here investing action plan need know investor come week federal reserve chair janet yellen take center stage again just week policymaker meet weigh rate hike series key economic indicator flow china report valeant vrx lululemon lulu highlight earning
33,PRGO,drugmaker endo international endp plunge friday deliver hefty guidance cut drive weakness generic business drag nearly other generic drug stock endo actually beat analyst consensus cut full year earning guidance now share trim revenue outlook range company earning release ceo rajiv silva blame new competitive entrant include voltaren gel greater expect price erosion generic sector delay regulatory action related certain endo product ibd take healthy be share endo teva do stack vs rival find ibd stock checkupit be second factor rattle rest generic industry teva pharmaceutical industry teva stock fall hit month low allergan agn already staggering cancellation buyout pfizer pfe hit year low end day even selling generic business teva perrigo prgo cut own guidance last month fall smaller drugmaker akorn akrx much end day akorn have fall way accounting due internal issue late friday finally set date earning release respectively leerink analyst joseph schwartz write research note endo problem read most directly teva akorn perrigo more moderately allergan essentially do most price hike product represent more generic sale lately be most trouble refer industrywide datum im schwartz write base analysis akorn have take price increase match criterium im generic sale perrigo generic im sale endo take generic im sale teva meanwhile be due report own earning guidance monday morning allergan be due open follow day endo get least downgrade wall street analyst friday mostly neutral underweight end day year close low
34,PRGO,have be widely rumore drugmaker perrigo prgo lose ceo valeant pharmaceutical vrx monday also report preliminary earning guidance miss expectation perrigo stock plummet early trading valeant stock rise modestly valeant say perrigo ceo joseph papa take helm chairman chief executive early replace robert ingram former role michael pearson latter anonymous source have leak papa appointment press late last week be still unclear time perrigo let contract papa have strong shareholder orientation background science unmatched track record accomplishment highlighted ability lead company time transition drive excellence commercial manufacturing platform ingram say statement addition foster ethical culture create opportunity professional development have always be high priority joe look forward joe arrival valeant valeant rise afternoon trading stock market today perrigo tumble hit year low just much be perrigo hurt valeant take ceo get idea ibd stock checkup perrigo meanwhile name president john hendrickson new ceo align succession plan process accord chairman laurie brla company also say sale be miss analyst consensus accord thomson reuter earning be share wall street have expect perrigo also cut more dollar full year ep guidance now majority change guidance provide feb be result reduction pricing expectation rx segment due industry competitive pressure sector perrigo say statement remainder reduction be primarily due weaker expect performance bch brand consumer health care segment next quarters lower expectation consolidated new product launch perrigo also say be assess possible impairment charge associate bch business be form perrigo acquire omega pharma last year say be prepared report extent charge issue official report
35,PRGO,stock market show modest loss afternoon trading monday wall street braced start day federal reserve meeting nasdaq dow jone industrial average lose small cap lag russell volume nyse nasdaq be tracking lower friday level stock market today decline stock outnumber advancer nyse more ratio nasdaq oil gas related group underperform oil reversed lower west texas intermediate crude june delivery be barrel steel transport solar stock also lag economic news homebuilding stock shift generally lower commerce department report new home sale march decline annualize rate department revise february estimate upward economist consensus have expect uptick home march janet yellen lead federal open market committee meet tuesday wednesday announcement interest rate policy schedule wednesday et fed fund future trader give chance fed raise rate week meeting only chance rate be raise june meeting upside small cap fabrinet fn add hasn look back reclaim buy point late january also break flat base march earning be due close fabrinet be top rate stock electronic contract manufacturing group see other leader be ibd stock checkup share embattled drugmaker valeant vrx add company tap former perrigo prgo ceo joseph papa lead company share perrigo plunge ibd pra health science prah be top performer nearly still well buy range conventional entry be low volume so far meanwhile dave buster play picked hold level set possible new high just handle entry alternate handle buy point be also legitimate news gannett gci jump offer buy tribune publish tpub owner los angele time include good chunk debt tribune soar
36,PRGO,system ddd be handed downgrade tuesday general electric ge perrigo prgo get price target cut walt disney receive price target raise system be now hold needham book buy earlier month citigroup deem highly unlikely hp inc hpq acquire printing company downgrade system sell share system close stock market today general electric get price target haircut stifel buy rating day get pt bump rbc ge be transition become digital industrial company come ahead street forecast report friday ge share edge nomura up price target disney medium conglomerate have top perform movie theater lead jungle book spot past week zootopia spot weekend accord box office mojo disney share add rbc slash perrigo price target sector perform rating preliminary result miss ceo be leave valeant perrigo share finished higher sink monday boost palo alto network panw buy hold less week morgan stanley bump price target stock overweight rating cybersecurity vendor be outperform peer reseller distributor accord recent piper jaffray survey palo alto rise
37,PRGO,stock pare loss close well session lows monday ahead federal reserve day monetary policy meeting begin tuesday nasdaq give dow jone industrial average edge lower volume be lighter board vs friday accord preliminary figure loser swamp winner more nyse margin nasdaq generic drugmaker steel oil stock lead decline stock market today west texas intermediate crude slide more barrel perrigo prgo gap sank massive turnover lowest level year generic counter drugmaker cut full year earning guidance range share earlier outlook valeant phamaceutical vrx name new ceo joseph papa resign same post perrigo valeant share fall caterpillar cat average trade be dow biggest loser stock reversed lower rating upgrade goldman sachs neutral sell base recovery china share have rally jan intraday low gainer include newspaper telecom food stock gannett gci share surge news usa today publisher have offer buy los angele time owner tribune publish tpub deal value tribune gap soar month high heavy volume ibd stock decline advanced lendingtree tree show biggest loss more stamp com stmp score biggest gain economic news new home sale dip annualize rate economist forecast uptick february estimate be revise upward
38,PRGO,share valeant pharmaceutical international vrx rise sharply fellow specialty drugmaker perrigo prgo fall friday report former be hire away latter ceo late thursday wall street journal quote anonymous source say valeant be hire joseph papa get perrigo board void noncompete clause contract friday morning perrigo issue brief statement say not comment speculation be only official word company so far valeant have be hunting new ceo march activist investor william ackman moved board try order company grow chaos stock lose more value scandal related pharmacy partner break last september force valeant strike new distribution deal boot alliance wba be accompany board price cut disastrous report guidance cut internal investigation accuse former cfo current board member howard schiller misconduct eventually turn even bullish analyst valeant management papa meanwhile have run perrigo year have largely successful track record watch company revenue have more triple stock have climb eightfold inversion deal moved headquarters low tax dublin mylan myl attempt hostile takeover perrigo successfully fought ibd take perrigo be once hot stock not lately learn ibd stock checkupperrigo once steady profit growth have get uneven last couple year however stock have decline more mylan induced high last april currently hold mediocre ibd composite rating change have lead analyst worry implication papa departure perrigo papa have become face perrigo long tenure ceo write jeffery analyst david steinberg research note however exception cfo judy brown company other executive include john hendrickson be appoint president oct be largely unfamiliar investment community further timing couldn have be more inopportune mr papa be potentially depart prior announcement result follow string difficult quarterly financial particularly company flagship consumer business guggenheim analyst louise chen agree note perrigo be widely expect miss estimate lower guidance have be debate senior management change perrigo don think street be think actually happen be soon chen write perrigo stock be late afternoon trading stock market today hit lowest level intraday august valeant stock be
39,PRGO,stock be lower go noon hour monday trader stand sideline meeting federal reserve week nasdaq fall drop dow jone industrial average lose stock market today volume be tracking significantly lower nyse nasdaq exchange compare same time friday janet yellen lead federal open market committee meet tuesday wednesday announcement schedule wednesday fed fund future trader give chance fed raise rate meeting month chance rate be raise june meeting chance july meeting fed post meeting statement be carefully parsed clue regard fed think ibd stock advance issue decline issue be evenly split best performer be sprout farmer market sfm appear have find support day move average worst performer be universal display oled nearly attempt consolidate sharp run lendingtree tree ibd name fall lose support day line drugmaker perrigo prgo gap be trading lower company announce be slash guidance ceo joseph papa be leave head valeant pharmaceutical vrx perrigo forecast earning year be share lower earlier forecast
40,PRGO,stock nip further early loss monday morning earning news soft housing sale report do little bolster investor confidence dow drop fall nasdaq slip volume be weak stock market today nyse lower nasdaq compare action same time friday homebuilding stock shift generally lower commerce department report new home sale march decline annualize rate department revise february estimate upward economist consensus have expect uptick sale pace home march ibd stock michael kor kor lead bit less luxury apparel designer be week move average week possible base pattern get technical fundamental vital sign kor ibd stock checkup ibd share los angele time owner tribune publish tpub surge open company disclose gannett gci offer buy company deal value include debt gannett share trade dow stock open almost unanimously lower unite technology utx drop hardest oil energy stock be weigh worst performer be perrigo prgo very heavy trade michigan base drugmaker warn earning miss consensus target lower full year ep guidance analyst projection addition chief executive joseph papa announce immediate departure company further north quebec valeant phamarceutical vrx confirm morning have name papa new chairman chief executive officer papa become valeant second ceo third chairman just month valeant share rise more china base internet portal sohu com sohu slide lower revenue earning narrowly top analyst expectation management guide expectation top bottom line consensus view sohu have be slide support month base effort past week image provide shutterstock
41,PRGO,major market index close small loss monday ahead federal reserve day monetary policy meeting nasdaq give dow jone industrial average edge lower volume be lighter board vs friday accord preliminary figure loser swamp winner more nyse margin nasdaq generic drug maker steel maker oil stock lead decline stock market today west texas intermediate crude slide more barrel perrigo prgo gap sank massive turnover lowest level year generic counter drug company cut full year earning guidance range share earlier outlook valeant phamaceutical vrx name new ceo joseph papa resign same post perrigo valeant share fall caterpillar cat average trade be dow biggest loser stock reversed lower rating upgrade goldman sachs neutral sell base recovery china share have rally jan intraday low gainer include newspaper telecom food stock gannett gci share surge news usa today publisher have offer buy los angele time owner tribune publish tpub deal value tribune gap soar month high heavy volume ibd stock decline advanced lendingtree tree show biggest loss more stamp com stmp score biggest gain economic news new home sale dip annualize rate economist forecast uptick february estimate be revise upward tuesday march durable good order case shiller home price index february consumer confidence april busy earning slate tuesday include apple aapl ebay ebay procter gamble pg twitter twtr apple shed monday light trade sixth decline past session stock be near test day move average meeting resistance level analyst expect fiscal ep fall sale dip iphone maker report tuesday close expect decline iphone sale unit
42,PRGO,walt disney macy gap gps kohl kss fossil fosl other report weak earning guidance trigger broad sell retail other consumer stock not share amazon amzn meanwhile apple aapl tumble year low fresh evidence iphone demand remain weak major index ultimately close modestly lower dow industrial fall key support major average fall third straight week most loss come friday dow fall close day move average first time feb nasdaq already key line retreat market uptrend remain pressure retail consumer group be big loser raft weak earning report guidance like walt disney macy oil price rise month high week retail sale rise april best gain more year couldn shake gloom surround retail consumer stock macy kohl jwn jcpenney jcp dd tumble dismal first quarter report guidance macy upscale slash outlook sharp ep decline kohl post same store sale drop be worst height great recession accord retail metric macy stock fall year low kohl fall nearly set year worst jcpenney lose respectively meanwhile watchmaker seller fossil collapse miss view slash guidance fossil hint competition apple watch other wearable gap say same store sale sank april comp ahead full result share plunge nearly worst late wal mart wmt home depot hd ross store rost also continue flood retail earning next week medium conglomerate deliver first earning miss year share profit grow revenue grow short consensus espn lose subscriber once again medium network segment didn appear disappoint wall street too badly studio revenue shot star war force awaken zootopia fanfare captain america civil war keep movie box office receipt high disney share tumble fall cup handle base well buy range disney close just day line apple stock fall last week new evidence apple supplier be see weak order upcoming iphone suggest apple sale wo continue quite time separately apple invest didi chux chinese ride hail service app apple stock fall lowest level june lose market cap crown barely google parent alphabet googl amazon intensified rivalry alphabet google launch new video stream service comparable youtube sanford bernstein analyst carlos kirjner tuesday raise price target amazon whopping wal mart wmt announce subscription service offer day free delivery vs day brick mortar retailer struggle amazon rise investor bet share consumer spending keep expand facebook release guideline reveal social medium giant rely far more person trend news topic contradict earlier company claim be largely drive computer algorithms earlier gizmodo suggest facebook be suppress news story conservative medium outlet facebook strongly deny allegation say have rigorous guideline place review team seek ensure consistency neutrality facebook ceo mark zuckerberg say meet conservative discuss facebook policy facebook stock rise week extend recent still buy range staple spls office depot odp call propose merger late tuesday federal judge agree federal trade commission deal have limit office supply competition big corporate customer staple crash office depot drop obama administration have block several megamerger recently include halliburton hal baker hughe bhi analyst say health insurance consolidation get hard look aetna aet seek buy humana hum anthem antm set acquire cigna ci treasury department tuesday call greater oversight nascent industry quick easy online payment lend solution threaten upend traditional banking have raise question safeguard potential abuse come day lend club lc say ceo renaud laplanche be step company find misconduct online lend platform relate loan sale lack financial oversight several large small bank halter work lend club share shed hit record low peer peer lend firm prosper recently announce large round layoff disappointing quarterly result ondeck ondk have prompt worry insufficient loan volume growth online gaming platform netease nte more double revenue beating estimate boost mobile game such fantasy westward journey newer release such kung fu panda ep also top share rise week move day line weibo wb twitter twtr social medium platform majority own sina sina fared well help mobile user growth strong ad revenue expansion major city share rise week online medium company sina also top view better sale narrower net loss expect strong weibo performance be key help ad revenue web portal segment lag share lose plunge day line close just day online retailer jd com jd report loss line expectation sale surge be just expectation revenue guidance be just shy analyst consensus share tumble lgi home lgih tuesday report surprisingly strong surge first quarter adjust earning share entry level homebuilder revenue fall short gross profit margin decline lgi home briefly flirted buy point fall trex trex world largest maker wood alternative decking railing product top view trex guide revenue consensus share reversed hard week gypsum wallboard related product maker continental build product cbpx profit climb share rise breaking base month high topbuild bld install build insulation also best wall street earning revenue estimate share july ipo rise prior week several housing report include housing start exist home sale april be tap next week solarcity scty torch wall street sale view late monday loss swell residential installer cut installation guidance booking fall short nevada cut net meter payment solar customer also monday rival vivint solar vslr report revenue rise still miss view loss widen installer sunrun run late thursday report surprise profit ex item revenue nearly double solarcity fall week vivint be nearly hit record lows sunrun be nearly even friday pop israeli giant teva pharmaceutical industry teva beat earning sale estimate guide slightly consensus teva say buyout allergan agn generic business be track close june earlier delay teva stock rise cent week allergan report mixed result earning beat sale miss drugmaker say ll buy stock allergan fresh fail takeover pfizer pfe signale ll focus more improve operation make big buyout future share rise third generic giant perrigo prgo hit year low report thursday issue guidance last month be few surprise perrigo fall week work fifth straight weekly loss smaller player jazz pharmaceutical jazz miss estimate stock rise news deal generic drugmaker not sell knock off lead drug xyrem end jazz share close meanwhile akorn akrx finally report number long accounting overhaul lift share more set report jab beech add krispy kreme doughnut kkd coffee empire pay share krispy kreme shot slightly offer price jab beech subsidiary jab hold own peet coffee tea stumptown coffee roaster caribou coffee einstein noah restaurant group intelligentsia coffee lead investor group buy keurig green mountain
43,PRGO,stock market open lower monday stop short loss drag europe market dow jone industrial average nasdaq lose nasdaq ease earning economic news get quiet start stock market today focal point earning calendar week be apple aapl report due tuesday close eye be nasdaq week last week soft performance small cap also be interest outpace market last week small cap russell end week ahead vs gain decline nasdaq top economic event be federal open market committee rate policy decision wednesday afternoon few expect substantive change be pending hint fed go upcoming increase be plenty enough move market today commerce department report march new home sale et oil price be once again likely be focus week wti crude oil june delivery add rise gasoline demand help drive oil more last week be crude ninth gain past week largest climb early march oil energy industry have lead much market advance past week turn top gain industry last week handful heavyweight oil report be due week begin bp bp tuesday wind friday report exxon mobil xom check ibd investing action plan broader view week most important event early trading dow stock be mostly lower gain loss hold less xerox xrx slump nearly just open report slightly expect drop earning revenue fall less forecast management lower full year adjust ep guidance well analyst consensus xerox end friday back cross week move average february low biggest move stock be slide perrigo prgo chief executive joseph papa monday morning announce sudden exit company same time perrigo have warn result miss analyst target full year guidance receive healthy trim unconfirmed news report last week say papa be candidate ceo seat valeant pharmaceutical vrx share valeant jump early trade overseas market trade lower lead index china japan close loss just short market europe trade afternoon trading image provide shutterstock
44,PRGO,generic drugmaker perrigo prgo dip morning trading thursday earning miss estimate guidance also low side exclude time item perrigo make share quarter year earlier quarter miss analyst consensus cent accord thomson reuter revenue rise consensus
45,PRGO,valeant pharmaceutical vrx share climb much tuesday drug maker say expect restate earning not much overall help clear air congressional investigation raise question company former relationship distributor philidor rx service question pricing practice specialty drugmaker valeant say written statement late monday evening internal review additional analysis identify certain sale philidor have be recognize product be dispense patient rather delivery philidor valeant say currently believe net revenue be include second half have be book later correct misstatement be expect reduce report gaap earning share cent valeant say increase gaap ep roughly cent base analyst consensus lift ep roughly valeant share close stock market today share have fall friday monday well fargo warn unanswered question company accounting strategic direction stock fall hour monday wall street journal say earning restatement be likely stock plunge aug intraday high questionable number come light low nov statement valeant note sale occur prior earlier bid acquire philidor specialty pharmacy philidor be suspect fill prescription valeant alter doctor order raise insurer reimbursement bloomberg say oct report cite former employee internal document oct valeant say be sever ty philidor subsequently begin wind operation interim chief executive howard schiller say statement company also expect delay filing complete review related accounting matter ad committee determination need delay filing be very disappointing necessary schiller say add remain commit improve report procedure internal control transparency investor schiller be name post interim basis jan fill ailing ceo michael pearson be be treat severe pneumonia complication valeant release unaudited result feb private label counter prescription generic drugmaker perrigo prgo share have be batter too fall lowest point year monday perrigo lose session report weak fourth quarter earning last thursday be downgrade analyst earning perrigo close big pharma allergan agn report hike ep jump revenue monday rise monday finished tuesday allergan agree november be acquire pfizer pfe deal be expect close year
46,PRGO,valeant pharmaceutical vrx perrigo prgo share continue tumble monday generally pull drug sector allergan agn be exception rise strong earning valeant late monday tumble low be lowest march dow jone report valeant pharmaceutical likely restate earning hour later valeant say restatement earning be expect related sale drug ex distributor philidor valeant say sale late have be recognize later valeant expect earning be lower cent share ep lift cent regular session valeant share close stock market today extend loss bearish report well fargo friday valeant share dive nearly day well fargo initiate coverage maker brand drug treat eye disease acne depression other ailment underperform say be unanswered question accounting method strategic direction earlier monday drugstore giant cvs health cvs say plan restrict use valeant jublia toenail fungus drug part initiative cut cost dermatology treatment jublia retail milliliter bottle accord goodrx valeant stock price have plunge intraday high double digit quarterly earning revenue growth nearly year bill ackman persh square hedge fund be significantly year partly fund large stake valeant valeant have already be batter series event include absence ceo michael pearson be be treat severe pneumonia complication jan valeant board name board member former chief financial officer howard schiller interim ceo earlier month valeant interim ceo schiller be call congress explain company decide increase price cardiac drug schiller promise end era sharp price hike perrigo business model be divide private label counter prescription generic drug fall monday lowest level late stock have lose session perrigo report weak fourth quarter result thursday subsequently have negative report jeffery friday goldman sachs monday jeffery cut price target maintain buy rating goldman sachs however downgrade stock neutral sell price target report say perrigo report ep time item cent estimate be company first earning miss quarters revenue grow analyst expect mylan myl last year make offer perrigo perrigo shareholder mid november reject mylan rise monday big pharma allergan agn report expect be final full earning report independent drug maker agree november be buy pfizer pfe allergan ep ex item rise hike revenue wall street expect ep revenue allergan share climb pfizer rise ibd generic drug ethical brand drug group be rare loser otherwise strong day stock
47,PRGO,stock wrestle narrowly mixed territory early thursday rise oil mixed economic datum earning news factor open trade dow hash back forth narrow gain nasdaq slip discovery communication disca dish network dish garmin grmn drag index shed volume moved lower nasdaq nyse relative trade same time wednesday lighter volume signal institutional investor be not significantly active stock market today feel early push overseas market benchmark index hong kong tokyo close more higher europe market backed away early gain turn mixed afternoon trade follow start market positive read weekly jobless claim also aid open action continue contraction mid atlantic manufacturing gauge philly fed index stir concern state economy conference board report january lead indicator index slip line expectation also revise december decline upward oil price push more lift west texas intermediate barrel brent crude well american petroleum institute datum wednesday show oil inventory decline barrel week end feb energy information administration plan release weekly inventory report et ibm ibm buck lead dow company announce be buy health care software provider truven health analytic wal mart wmt drop almost dow worst loss earning narrowly beat fourth quarter revenue full year revenue guidance miss consensus projection nvidia nvda charge head nasdaq index spiking nvidia fourth quarter earning revenue guidance easily outpaced analyst expectation report follow wednesday close generic drug maker perrigo prgo tumble more lower earning revenue miss analyst consensus estimate management significantly pare top end full year ep guidance stock have be correct rise briefly week line august ibd stock universal display oled rumble almost strong trade work seventh straight advance move position share test resistance day move average retake support day line wednesday turf tend equipment maker toro ttc bolt higher heavy action send share buy range buy point cup handle base low end list drop pull back light trade day rally slip put share back buy point cup handle base
48,PRGO,perrigo shareholder reject hostile takeover bid fellow generic drug maker mylan friday morning send perrigo stock mylan long acrimonious battle end
49,PRGO,mylan myl say press release et deadline perrigo prgo share have be validly tender miss require takeover succeed
50,PRGO,grow alone
51,PRGO,mylan management maintain statement be fine perrigo
52,PRGO,mylan focuse approach organic inorganic growth have deliver compound annual growth rate adjust diluted earning share ep shareholder strategically consistently expand business say mylan ceo heather bresch recent financial result continue demonstrate power stand alone platform double digit growth legacy business well enhance double digit growth epd business
53,PRGO,mylan shareholder seem agree stock rise close perrigo stock fall management claim victory
54,PRGO,have say offer mylan be bad deal shareholder significantly undervalue durable business model industry lead future growth prospect perrigo ceo joseph papa say statement strong organic growth discipline approach transparent accessible corporate governance policy be foundation successful business strategy
55,PRGO,mylan first propose buy perrigo back april cash mylan share perrigo share later lift share mylan share time
56,PRGO,time mylan launch tender offer stock portion offer have lose considerable value result teva pharmaceutical industry teva abandon own hostile bid mylan buy generic business allergan agn also general drug stock sell perrigo stock have fall also however lead mylan argue perrigo shareholder still make money deal
57,PRGO,perrigo leadership have steadfastly opposed mylan overture criticize offer mylan business mylan corporate governance same time ve seek mollify shareholder operational improvement share buyback plan latter papa say friday go ahead now vote be
58,PRGO,accord anonymously source report perrigo buyout prospect be also hold mylan issue be resolve wall street journal report wednesday summer perrigo be talk endo international endp possible combination
59,PRGO,not do deal
60,PRGO,capital iq analyst jeffrey loo write expect more perrigo future
61,PRGO,do not see many synergistic fit company now mylan issue be believe perrigo begin pursue acquisition likely consumer health care unit loo write research note maintain buy rating perrigo mylan
62,PRGO,morningstar analyst michael also write see mylan stay hunt
63,PRGO,generic drug industry still remain relatively fragmented view possible asset sale pfizer pfe sanofi sny provide mylan other opportunity merger acquisition especially asset have greater cost synergy potential perrigo mostly counter business write research note perrigo shareholder reject hostile takeover bid fellow generic drug maker mylan friday morning send perrigo stock mylan long acrimonious battle end mylan myl say press release et deadline perrigo prgo share have be validly tender miss require takeover succeed grow alonemylan management maintain statement be fine perrigo mylan focuse approach organic inorganic growth have deliver compound annual growth rate adjust diluted earning share ep shareholder strategically consistently expand business say mylan ceo heather bresch recent financial result continue demonstrate power stand alone platform double digit growth legacy business well enhance double digit growth epd business mylan shareholder seem agree stock rise close perrigo stock fall management claim victory have say offer mylan be bad deal shareholder significantly undervalue durable business model industry lead future growth prospect perrigo ceo joseph papa say statement strong organic growth discipline approach transparent accessible corporate governance policy be foundation successful business strategy mylan first propose buy perrigo back april cash mylan share perrigo share later lift share mylan share time time mylan launch tender offer stock portion offer have lose considerable value result teva pharmaceutical industry teva abandon own hostile bid mylan buy generic business allergan agn also general drug stock sell perrigo stock have fall also however lead mylan argue perrigo shareholder still make money deal perrigo leadership have steadfastly opposed mylan overture criticize offer mylan business mylan corporate governance same time ve seek mollify shareholder operational improvement share buyback plan latter papa say friday go ahead now vote be accord anonymously source report perrigo buyout prospect be also hold mylan issue be resolve wall street journal report wednesday summer perrigo be talk endo international endp possible combination not do deal capital iq analyst jeffrey loo write expect more perrigo future do not see many synergistic fit company now mylan issue be believe perrigo begin pursue acquisition likely consumer health care unit loo write research note maintain buy rating perrigo mylan morningstar analyst michael also write see mylan stay hunt generic drug industry still remain relatively fragmented view possible asset sale pfizer pfe sanofi sny provide mylan other opportunity merger acquisition especially asset have greater cost synergy potential perrigo mostly counter business write research note
64,PRGO,war word heated generic drug maker mylan myl perrigo prgo week company strive shareholder vote set friday mylan hostile takeover attempt mylan first propose buy perrigo back april cash mylan share perrigo share later lift
65,PRGO,stock again open narrow loss friday retail sector stock experience unusually heavy selling nasdaq hurt worst dow jone industrial average carved decline fall
66,PRGO,trade be mixed nasdaq lower nyse compare action same time thursday
67,PRGO,stock market today feel early drag company report compound raft weaker forecast producer price retail sale datum
68,PRGO,business inventory expand commerce department say vs consensus view change
69,PRGO,consumer sentiment offer bright spot university michigan november consumer sentiment index jump september view improvement be index best read july
70,PRGO,stock number heavy premarket move hold regular session
71,PRGO,generic drug maker mylan myl surge perrigo prgo slump mylan fail attempt hostile takeover michigan base perrigo wall street journal report mylan cash stock tender offer garner only perrigo share mylan need least successful takeover offer expire friday
72,PRGO,switzerland base seed strain herbicide giant syngenta syt leap bloomberg report company reject takeover offer state own china national chemical corp syngenta refuse offer earlier year
73,PRGO,retail group show market worst loss industry first half hour trade fossil group fosl collapse jwn crumble report weak quarterly result late thursday
74,PRGO,video game retailer gamestop gme drop grilled chicken chain el pollo unraveled
75,PRGO,chip equipment maker apply material amat climb santa clara cal outfit report line fiscal result thursday close management say quarterly conference call company be open possibility merger apply material have be climb september low remain deep month consolidation
76,PRGO,lead stock open session lousy mood more stock ibd list lose ground early action
77,PRGO,china base tal education xrs post best move group almost peck new high provider kindergarten grade school tutor service be now nearly past buy point cup handle base
78,PRGO,low end list paycom software payc lop oklahoma city base provider online human capital management program price share offer discount thursday close price loss drag share back buy point left stock day line support
79,PRGO,follow alan elliott twitter ibd_aelliott facebookstock again open narrow loss friday retail sector stock experience unusually heavy selling nasdaq hurt worst dow jone industrial average carved decline fall trade be mixed nasdaq lower nyse compare action same time stock market today feel early drag company report compound raft weaker forecast producer price retail sale datum business inventory expand commerce department say vs consensus view change consumer sentiment offer bright spot university michigan november consumer sentiment index jump september view improvement be index best read july stock number heavy premarket move hold regular session generic drug maker mylan myl surge perrigo prgo slump mylan fail attempt hostile takeover michigan base perrigo wall street journal report mylan cash stock tender offer garner only perrigo share mylan need least successful takeover offer expire friday switzerland base seed strain herbicide giant syngenta syt leap bloomberg report company reject takeover offer state own china national chemical corp syngenta refuse offer earlier year retail group show market worst loss industry first half hour trade fossil group fosl collapse jwn crumble report weak quarterly result late thursday video game retailer gamestop gme drop grilled chicken chain el pollo unraveled chip equipment maker apply material amat climb santa clara cal outfit report line fiscal result thursday close management say quarterly conference call company be open possibility merger apply material have be climb september low remain deep month consolidation lead stock open session lousy mood more stock ibd list lose ground early action china base tal education xrs post best move group almost peck new high provider kindergarten grade school tutor service be now nearly past buy point cup handle base low end list paycom software payc lop oklahoma city base provider online human capital management program price share offer discount thursday close price loss drag share back buy point left stock day line support follow alan elliott twitter ibd_aelliott facebook
80,PRGO,sell retail stock weigh major average midday friday october retail sale datum miss expectation big drop oil price didn help matter
81,PRGO,dow jone industrial average nasdaq lose give small cap hold relatively well russell only nasdaq volume be tracking higher thursday level stock market today volume nyse be tracking close thursday level
82,PRGO,retail sale rise october consensus estimate exclude auto sale rise also expectation worst perform group market friday hailed retail sector
83,PRGO,new york mercantile exchange december crude oil future slump barrel thursday government report seventh straight weekly increase crude supply
84,PRGO,downside ulta beauty ulta be need makeover share slump heavy volume earning be due dec
85,PRGO,other lead retail stock be pressured include signet jeweler sig restoration hardware rh
86,PRGO,meanwhile perrigo prgo slump shareholder reject hostile takeover bid fellow generic drug maker mylan lab myl share mylan soar
87,PRGO,paycom software payc slump nearly company price share offer
88,PRGO,day gainer recent new issue planet fitness plnt jump report earning late thursday share be recently trading slightly august ipo price planet fitness still have lot work do complete proper ipo base still high
89,PRGO,follow ken shreve twitter ibd_kshreve facebook sell retail stock weigh major average midday friday october retail sale datum miss expectation big drop oil price didn help matter dow jone industrial average nasdaq lose give small cap hold relatively well russell only nasdaq volume be tracking higher thursday level stock market today volume nyse be tracking close thursday level retail sale rise october consensus estimate exclude auto sale rise also expectation worst perform group market friday hailed retail sector new york mercantile exchange december crude oil future slump barrel thursday government report seventh straight weekly increase crude supply downside ulta beauty ulta be need makeover share slump heavy volume earning be due dec other lead retail stock be pressured include signet jeweler sig restoration hardware rh meanwhile perrigo prgo slump shareholder reject hostile takeover bid fellow generic drug maker mylan lab myl share mylan soar paycom software payc slump nearly company price share offer day gainer recent new issue planet fitness plnt jump report earning late thursday share be recently trading slightly august ipo price planet fitness still have lot work do complete proper ipo base still high follow ken shreve twitter ibd_kshreve facebook
90,PRGO,stock future narrow early loss abruptly approach start bell friday overseas market continue trade lower dow future show point decline vs point tumble hour earlier
91,PRGO,nasdaq future halved hour earlier loss trade point fair market value future be point lower improve point loss small cap remain pressure russell future ease early loss point decline
92,PRGO,stock market today get roll converge day move average nasdaq day line only market post day healthy gain wednesday also include federal reserve launch interest rate tighten cycle big news big hurdle market clear
93,PRGO,friday premarket action be not encourage nasdaq do open session gain week be ahead index have gain past week
94,PRGO,economic calendar close week quiet note only preliminary read service due researcher markit et regional survey expect atlanta federal reserve bank kansa city federal reserve baker hughe bhi release weekly rig count datum pm
95,PRGO,half dow stock moved lower other half remain flat premarket trade johnson johnson jnj boee ba chevron cvx dip more dupont dd be sole gainer
96,PRGO,several late season earning report whip action bell
97,PRGO,carmax kmx dive open report third quarter sale earning stop short analyst estimate same store sale rise vs expectation increase stock have be scoop consolidation tight trade june
98,PRGO,homebuilder lennar len rise more fiscal earning easily beat consensus view revenue growth stop just short forecast new home delivery rise order even newer home jump lennar share have be gradually weaken consolidation august
99,PRGO,handheld device maker blackberry bbry grab gain ontario canada firm report not bad expect sale loss
100,PRGO,leader open source software developer red hat rht jump more lead ibd list raleigh company late thursday deliver revenue earning consensus forecast management revenue guidance be earning guidance be analyst consensus view stock have be work retake day move average end thursday cup base buy point
101,PRGO,qihoo technology qihu climb almost finally inking deal be take private group investor lead company chairman zhou hongyi zhou have propose deal earlier year market china slump serious correction
102,PRGO,oil price slip west texas intermediate crude shed more barrel just week brent crude be fraction lower just almost week gold rise fraction still standing tight ounce level copper future pop leave price effectively level week
103,PRGO,overseas market be broadly lower friday trading higher week japan nikkei tokyo topple leave index loss week shanghai composite end flat friday week hong kong hang seng end friday weekly gain
104,PRGO,europe stock be pressure midday cac paris be frankfurt dax dip london ftse show decline week ftse track gain cac be dax show gain stock future narrow early loss abruptly approach start bell friday overseas market continue trade lower dow future show point decline vs point tumble hour earlier nasdaq future halved hour earlier loss trade point fair market value future be point lower improve point loss small cap remain pressure russell future ease early loss point decline stock market today get roll converge day move average nasdaq day line only market post day healthy gain wednesday also include federal reserve launch interest rate tighten cycle big news big hurdle market clear friday premarket action be not encourage nasdaq do open session gain week be ahead index have gain past week economic calendar close week quiet note only preliminary read service due researcher markit et regional survey expect atlanta federal reserve bank kansa city federal reserve baker hughe bhi release weekly rig count datum pm half dow stock moved lower other half remain flat premarket trade johnson johnson jnj boee ba chevron cvx dip more dupont dd be sole gainer several late season earning report whip action bell carmax kmx dive open report third quarter sale earning stop short analyst estimate same store sale rise vs expectation increase stock have be scoop consolidation tight trade june homebuilder lennar len rise more fiscal earning easily beat consensus view revenue growth stop just short forecast new home delivery rise order even newer home jump lennar share have be gradually weaken consolidation august handheld device maker blackberry bbry grab gain ontario canada firm report not bad expect sale loss leader open source software developer red hat rht jump more lead ibd list raleigh company late thursday deliver revenue earning consensus forecast management revenue guidance be earning guidance be analyst consensus view stock have be work retake day move average end thursday cup base buy point qihoo technology qihu climb almost finally inking deal be take private group investor lead company chairman zhou hongyi zhou have propose deal earlier year market china slump serious correction oil price slip west texas intermediate crude shed more barrel just week brent crude be fraction lower just almost week gold rise fraction still standing tight ounce level copper future pop leave price effectively level week overseas market be broadly lower friday trading higher week japan nikkei tokyo topple leave index loss week shanghai composite end flat friday week hong kong hang seng end friday weekly gain europe stock be pressure midday cac paris be frankfurt dax dip london ftse show decline week ftse track gain cac be dax show gain
105,PRGO,shareholder generic drug giant mylan myl friday vote favor continue firm hostile bid perrigo prgo launch be protracted battle mylan say third shareholder have approve transaction issuance share perrigo shareholder cash stock bid mylan last formal proposal april be worth
106,PRGO,be sell not be sell be course question lie generic drug maker perrigo prgo regardless answer analyst say be plenty reason investor take interest dublin base company owing ability capitalize trend generic prescription drug counter sale first thing first friday stockholder drugmaker mylan myl be schedule vote approve hostile takeover bid perrigo move ahead tender offer perrigo ceo joseph papa speaking month analyst company latest quarterly earning call reiterate own opposition offer unanimous rejection perrigo board make prediction mylan shareholder vote want remind everyone include mylan shareholder proceed tender offer perrigo not be easy path be painting be papa say express confidence perrigo investor support stand alone ambition mylan begin pursue perrigo earlier year follow several refusal mylan recently offer share cash share perrigo share mylan need approval own shareholder support perrigo investor more share seal deal mylan insist new decisionin letter shareholder public statement most recent earning call papa have say mylan have undervalue perrigo mylan do shareholder vote initiate tender process ll make strategic decision board right thing do company say expect close vote analyst observer say deal ever get do not talk surround perrigo have attract positive attention be sticking buy rating perrigo see path upside share stand alone basis hopefully supplement acquisition large scale context sale mylan party deutsche bank analyst write perhaps deal talk lead even stronger bid mylan suitor potential investor sam pappas ceo mystic asset management veteran health care industry investor tell ibd many pharma company be hunting acquisition so not surprise more buyer show serious interest perrigo build pipeline say be efficient way do other hand mylan takeover attempt falter other suitor do not immediately enter fray perrigo be freed month long distraction focus anew organic growth acquisition own lawrence white economist new york university stern school business long time observer market tell ibd pharma industry bigger player often capitalize scale more efficiently distribute medication manufacture takeout target be not always case add say fast growth company have such robust pipeline proven growth sale simply interfere already solid expansion path perrigo establish be indeed case own shareholder back vote mylan takeover add important dose confidence investor feed biggest isn always best be lot move part address come distribute pharmaceutical tend favor larger company white say be not be biggest be always best rule here analyst say perrigo be indeed well position growth remain stand alone entity company be lead maker distributor private label counter generic prescription drug analyst say frugal consumer be increasingly move away national brand store brand away expensive prescription otc alternative outcome aside continue fundamental perrigo story give global leadership position store brand otc ability capitalize rx otc switch william blair analyst say august report perrigo spend absorb own acquisition dublin base elan sell treatment everything smoking cessation pain relief stock have ibd composite rating ibd medical general drug industry group rank st industry group perrigo be rank allergan agn quarter end june perrigo report earning cent share exclude time item generate ep revenue firm cite strength new brand consumer health care line include recent acquisition omega pharma expansion pharmaceutical revenue brand consumer health care generate sale sale perrigo prescription pharmaceutical segment increase more bolt on company also recently inked deal buy patheon operation mexico well portfolio otc drug glaxosmithkline gsk analyst anticipate perrigo pursue more such bolt deal remain stand alone operation post quarterly result earlier august perrigo executive project ep increase midpoint sale ahead midpoint executive say addition company specific trend perrigo also stand benefit general ongoing demographic health care development give megatrend have talk many year include age population increase use medication individual get older rise health care cost perrigo be well position meet future need global health care community papa chief executive say earning call
107,PRGO,market go rocky phase pay close attention stock icon iclr weather storm better most drugmaker allergan agn perrigo prgo contract research organization cro icon be base ireland provide phase phase clinical trial service help pharmaceutical biotech medical device company bring product
108,PRGO,teva pharmaceutical teva confirm report monday buy allergan agn generic drug business drop hostile takeover bid mylan pharmaceutical myl deal teva pay cash share deal be expect close teva say buyout boost adjust earning share double digit deal allow allergan focus brand drug business give teva revenue source face competition multiple sclerosis drug copaxone acquisition allergan generic establish strong foundation long term sustainable growth anchor lead generic capability world class late stage pipeline accelerate ability build exceptional portfolio product generic specialty well intersection say teva ceo erez vigodman teva share jump premarket trading stock market today allergan climb mylan share plunge hostile bid mylan mylan say continue pursue perrigo prgo mylan shareholder vote acquisition next several week accord company perrigo share rally premarket global health care have hit july vs year accord datum cite reuter teva also report strong preliminary result raise full year ep outlook analyst poll thomson reuter be expect teva announce official result thursday follow gillian rich twitter ibd_grich
109,PRGO,volatile market tuesday weak economic datum china several ipos have be hold own planet fitness plnt share close ahead result wednesday first report go public aug gym operator have ibd composite rating receive slew positive
110,PRGO,israeli drug giant teva pharmaceutical industry drop hostile bid mylan instead agree buy global generic drug business allergan monday teva allergan stock jump new high mylan drop teva teva agree pay cash stock allergan agn actavis business
111,PRGO,stock future change tune point slightly weaker start stock market today nasdaq future fall point vs fair value future lose point future dow jone industrial average give point
112,PRGO,stock market end week winning streak last week pickup distribution day prompt downgrade market outlook
113,PRGO,stock market overseas be mixed europe france cac slip friday series attack islamic state left more dead germany dax rise london ftse climb
114,PRGO,asia hong kong hang seng fall japan nikkei slump shanghai composite reversed higher gain
115,PRGO,crude oil jump more barrel potential supply disruption oil price hit lowest level month last week
116,PRGO,safe haven instrument such bond dollar be trading higher gold be also higher ounce
117,PRGO,economic news empire state index november come vs consensus estimate econoday
118,PRGO,number central bank official be speaking week start tuesday fed governor jerome powell minute fed october meeting be due wednesday
119,PRGO,stock starwood hotel resort hot fall premarket trading news be buy marriott international mar cash stock deal create world biggest hotel chain
120,PRGO,dd slump premarket trading post disappointing quarterly result department store operator say earn share include tax credit cent share sale slip view be ep revenue rival macy plunge last week disappointing quarterly sale weak outlook
121,PRGO,airline stock be lower premaket activity concern friday attack tourism share american airline group aal delta air line dal unite continental ual ryanair ryaay be more
122,PRGO,nyse nasdaq observe minute silence et victim paris terrorist attack friday
123,PRGO,follow vincent mao twitter ibd_vmao stock future change tune point slightly weaker start stock market today nasdaq future fall point vs fair value future lose point future dow jone industrial average give point stock market end week winning streak last week pickup distribution day prompt downgrade market outlook stock market overseas be mixed europe france cac slip friday series attack islamic state left more dead germany dax rise london ftse climb asia hong kong hang seng fall japan nikkei slump shanghai composite reversed higher gain crude oil jump more barrel potential supply disruption oil price hit lowest level month last week safe haven instrument such bond dollar be trading higher gold be also higher ounce economic news empire state index november come vs consensus estimate econoday number central bank official be speaking week start tuesday fed governor jerome powell minute fed october meeting be due wednesday stock starwood hotel resort hot fall premarket trading news be buy marriott international mar cash stock deal create world biggest hotel chain dd slump premarket trading post disappointing quarterly result department store operator say earn share include tax credit cent share sale slip view be ep revenue rival macy plunge last week disappointing quarterly sale weak outlook airline stock be lower premaket activity concern friday attack tourism share american airline group aal delta air line dal unite continental ual ryanair ryaay be more nyse nasdaq observe minute silence et victim paris terrorist attack friday follow vincent mao twitter ibd_vmao
124,PRGO,midcap stock mutual fund past year have leapfrog small cap fund year performance contribute factor midcap fund fall less small cap third quarter
125,PRGO,tell investment average midcap mutual fund march have grow june year accord morningstar inc datum
126,PRGO,same investment have grow small cap fund large cap fund average proxy broad stock market
127,PRGO,buffalo discovery fund have return average annual past year vs year date fund have handed investor gain vs fund have be manage clay dave carlsen elizabeth jone trio be kornitzer capital management buffalo fund hire subadvisor fund
128,PRGO,fund recent holding include iphone maker apple aapl drugmaker perrigo prgo midcap stock mutual fund past year have leapfrog small cap fund year performance contribute factor midcap fund fall less small cap third quarter tell investment average midcap mutual fund march have grow june year accord morningstar inc datum same investment have grow small cap fund large cap fund average proxy broad stock market buffalo discovery fund have return average annual past year vs year date fund have handed investor gain vs fund have be manage clay dave carlsen elizabeth jone trio be kornitzer capital management buffalo fund hire subadvisor fund fund recent holding include iphone maker apple aapl drugmaker perrigo prgo
129,PRGO,barely hatch independent company drugmaker baxalta bxlt get unsolicited buyout proposal shire shpg send stock sharply early trading tuesday shire say july propose stock transaction exchange shire adr share baxalta imply value share base
130,PRGO,share generic drug maker perrigo prgo rise much tuesday bmo capital market launch coverage outperform rating say perrigo stock be undervalue regardless mylan myl succeed acquire company
131,PRGO,analyst david maris write trend favor perrigo business model be divide private label counter prescription generic drug
132,PRGO,continue movement consumer national brand store brand product prescription otc switch combine increase health care cost age population drive global demand store brand otc medication write
133,PRGO,maris also say perrigo be try resist unsolicited bid mylan be likely especially careful guidance give perrigo miss estimate unsolicited bid period defense unwanted deal have think perrigo guidance be conservative side write
134,PRGO,maris admit mylan bid fail perrigo stock fall short term say fundamental growth eventually make loss
135,PRGO,add also potential upside biogen biib report positive result trial tysabri multiple sclerosis drug biogen be pay perrigo royalty thank perrigo acquisition elan
136,PRGO,trial be due readout later year be testing tysabri secondary progressive ms stroke prevention wall street be not give great odd success so add revenue indication be not consensus expectation write
137,PRGO,maris set price target stock midday trading stock market today perrigo stock be nearly
138,PRGO,follow amy reeve twitter ibd_areeve
139,PRGO,related
140,PRGO,perrigo glaxo buy make too pricey share generic drug maker perrigo prgo rise much tuesday bmo capital market launch coverage outperform rating say perrigo stock be undervalue regardless mylan myl succeed acquire company analyst david maris write trend favor perrigo business model be divide private label counter prescription generic drug continue movement consumer national brand store brand product prescription otc switch combine increase health care cost age population drive global demand store brand otc medication write maris also say perrigo be try resist unsolicited bid mylan be likely especially careful guidance give perrigo miss estimate unsolicited bid period defense unwanted deal have think perrigo guidance be conservative side write maris admit mylan bid fail perrigo stock fall short term say fundamental growth eventually make loss add also potential upside biogen biib report positive result trial tysabri multiple sclerosis drug biogen be pay perrigo royalty thank perrigo acquisition elan trial be due readout later year be testing tysabri secondary progressive ms stroke prevention wall street be not give great odd success so add revenue indication be not consensus expectation write maris set price target stock midday trading stock market today perrigo stock be nearly follow amy reeve twitter ibd_areeve related perrigo glaxo buy make too pricey
141,PRGO,israeli drug giant teva pharmaceutical industry teva report positive result recently acquire drug tuesday teva stock be fraction however company also face new roadblock effort take mylan myl
142,PRGO,teva say sd drug have gain buyout auspex pharmaceutical last month hit primary endpoint pivotal trial dyskinesia movement disorder sometimes afflict person take psychotic medication news follow successful trial sd huntington disease teva say dyskinesia be larger market potentially pass year peak sale
143,PRGO,importantly study also show favorable safety tolerability profile include low rate depression somnolence insomnia akathisia movement disorder be differentiate factor competitive landscape maxim group analyst jason kolbert write research note tuesday
144,PRGO,evercore isi analyst umer raffat note efficacy seem broadly similar neurocrine bioscience nbix candidate nbi agree email safety tolerability continue look excellent teva drug be very important commercial differentiator
145,PRGO,also tuesday abbott laboratory own stake mylan say vote support mylan attempt acquire perrigo prgo mylan have be pursue april support acquisition be problem teva pursuit mylan teva offer company late april same time make clear not interested perrigo business
146,PRGO,neither perrigo mylan want be buy investor not care company want perrigo stock be nearly afternoon trading stock market today mylan stock be
147,PRGO,follow amy reeve twitter ibd_areeve israeli drug giant teva pharmaceutical industry teva report positive result recently acquire drug tuesday teva stock be fraction however company also face new roadblock effort take mylan myl teva say sd drug have gain buyout auspex pharmaceutical last month hit primary endpoint pivotal trial dyskinesia movement disorder sometimes afflict person take psychotic medication news follow successful trial sd huntington disease teva say dyskinesia be larger market potentially pass year peak sale importantly study also show favorable safety tolerability profile include low rate depression somnolence insomnia akathisia movement disorder be differentiate factor competitive landscape maxim group analyst jason kolbert write research note tuesday evercore isi analyst umer raffat note efficacy seem broadly similar neurocrine bioscience nbix candidate nbi agree email safety tolerability continue look excellent teva drug be very important commercial differentiator also tuesday abbott laboratory own stake mylan say vote support mylan attempt acquire perrigo prgo mylan have be pursue april support acquisition be problem teva pursuit mylan teva offer company late april same time make clear not interested perrigo business neither perrigo mylan want be buy investor not care company want perrigo stock be nearly afternoon trading stock market today mylan stock be follow amy reeve twitter ibd_areeve
148,PRGO,stock pare gain midday wednesday expectation federal reserve raise interest rate later day nasdaq be dow jone industrial average edge
149,PRGO,volume nasdaq nyse be tracking tuesday level
150,PRGO,fed policymaker be expect raise interest rate basis point mark first increase central bank drop rate financial crisis
151,PRGO,stock market today drugmaker valeant pharmaceutical vrx jump heavy volume issue weaker expect earning forecast
152,PRGO,stock jump tuesday announce distribution agreement walgreen boot alliance wba canada base drugmaker say help rebuild business cut ty philidor rx service allegation wrongdoing however valeant forecast jump profit fall short analyst expectation
153,PRGO,solar stock be day best performer lead first solar fslr jump new high heavy volume
154,PRGO,maker solar panel component have get lift negotiator nearly other country reach deal last weekend cut greenhouse gas emission agreement lead greater investment energy efficient solar technology solar
155,PRGO,downside global payment gpn plunge heavy volume slice day line credit card payment processor say buy rival heartland payment system hpy
156,PRGO,meanwhile homebuider rise housing start build permit rise much more expect november accord datum commerce department send homebuilder pulte group phm toll bro tol horton dhi lennar len rise stock pare gain midday wednesday expectation federal reserve raise interest rate later day nasdaq be dow jone industrial average edge volume nasdaq nyse be tracking tuesday level fed policymaker be expect raise interest rate basis point mark first increase central bank drop rate financial crisis stock market today drugmaker valeant pharmaceutical vrx jump heavy volume issue weaker expect earning forecast stock jump tuesday announce distribution agreement walgreen boot alliance wba canada base drugmaker say help rebuild business cut ty philidor rx service allegation wrongdoing however valeant forecast jump profit fall short analyst expectation solar stock be day best performer lead first solar fslr jump new high heavy volume maker solar panel component have get lift negotiator nearly other country reach deal last weekend cut greenhouse gas emission agreement lead greater investment energy efficient solar technology solar downside global payment gpn plunge heavy volume slice day line credit card payment processor say buy rival heartland payment system hpy meanwhile homebuider rise housing start build permit rise much more expect november accord datum commerce department send homebuilder pulte group phm toll bro tol horton dhi lennar len rise
157,PRGO,acquisition product approval actavis act continue grow size sale rapid pace dublin base drugmaker tuesday follow last week fda approval viberzi irritable bowel syndrome treatment green light guaifenesin pseudoephedrine tablet actavis partner perrigo prgo start shipping store brand equivalent rb inc mucinex
158,PRGO,embattled generic drugmaker perrigo prgo agree buy portfolio counter drug glaxosmithkline gsk tuesday move interpreted help fend advance mylan myl
159,PRGO,undisclosed sum perrigo agree acquire variety product include cold flu medicine nicotine patch cold sore treatment sale totale last year largely european market glaxo part sell product meet antitrust requirement allow form consumer health joint venture novartis nvs
160,PRGO,acquisition demonstrate perrigo ability execute base strategy make selective accretive transaction expand durable base business perrigo ceo joseph papa say statement be build global platform establish omega pharma acquisition capture even greater share european otc market opportunity several well establish complementary brand bolster otc product portfolio
161,PRGO,perrigo hold short conference call deal tuesday morning say expect new brand perform consistently perrigo annual revenue growth profile lack price tag make calculation difficult leerink analyst jason gerberry see economic favorable
162,PRGO,expect deal be accretive ep potential upside prgo re accelerate growth brand gerberry write research note tuesday add buyout be also strategically sound prgo leverage omega ex commercial infrastructure continue look further deal maximize platform
163,PRGO,hold conference call deal size be unusual rbc capital market analyst randall stanicky theorize have be drive mylan unsolicited pursuit perrigo
164,PRGO,give myl bid assume want use announcement highlight value omega platform perceive value be able discuss deal broadly give irish law constraint stanicky write research note tuesday
165,PRGO,stanicky say glaxo deal make perrigo more expensive acquire therefore decrease odd mylan acquisition happen
166,PRGO,view turn increase odd teva pharmaceutical industry teva succeed unsolicited pursuit mylan fact mylan ceo accuse teva violate antitrust law latter reveal late monday
167,PRGO,perrigo stock be more midday trading glaxo stock be flat mylan stock be fraction
168,PRGO,follow amy reeve twitter ibd_areeve embattled generic drugmaker perrigo prgo agree buy portfolio counter drug glaxosmithkline gsk tuesday move interpreted help fend advance mylan myl undisclosed sum perrigo agree acquire variety product include cold flu medicine nicotine patch cold sore treatment sale totale last year largely european market glaxo part sell product meet antitrust requirement allow form consumer health joint venture novartis nvs acquisition demonstrate perrigo ability execute base strategy make selective accretive transaction expand durable base business perrigo ceo joseph papa say statement be build global platform establish omega pharma acquisition capture even greater share european otc market opportunity several well establish complementary brand bolster otc product portfolio perrigo hold short conference call deal tuesday morning say expect new brand perform consistently perrigo annual revenue growth profile lack price tag make calculation difficult leerink analyst jason gerberry see economic favorable expect deal be accretive ep potential upside prgo re accelerate growth brand gerberry write research note tuesday add buyout be also strategically sound prgo leverage omega ex commercial infrastructure continue look further deal maximize platform hold conference call deal size be unusual rbc capital market analyst randall stanicky theorize have be drive mylan unsolicited pursuit perrigo give myl bid assume want use announcement highlight value omega platform perceive value be able discuss deal broadly give irish law constraint stanicky write research note tuesday stanicky say glaxo deal make perrigo more expensive acquire therefore decrease odd mylan acquisition happen view turn increase odd teva pharmaceutical industry teva succeed unsolicited pursuit mylan fact mylan ceo accuse teva violate antitrust law latter reveal late monday perrigo stock be more midday trading glaxo stock be flat mylan stock be fraction follow amy reeve twitter ibd_areeve
169,PRGO,top rate specialty drugmaker horizon pharma beat first quarter sale estimate settle patent suit stock fall friday horizon hznp earning exclude time item rise vs year earlier cent share line analyst consensus accord thomson reuter sale leap view
170,PRGO,horizon also boost guidance reflect just close buyout rare disease specialist hyperion therapeutic see full year sale well analyst do not offer ep guidance say ebitda earning interest taxe depreciation amortization be net royalty range beat consensus
171,PRGO,hyperion buyout be quite popular investor horizon stock jump day be announce company look supplement best seller vimovo revenue shrank quarter
172,PRGO,friday call analyst chief business officer robert carey say horizon still have spend acquisition ve get sufficient capacity execute plan right now hope continue be active marketplace
173,PRGO,ub analyst marc goodman write note friday bottom line miss target
174,PRGO,look management be guide higher spending thought write think focus story be top line give prescription trend believe top line be head right direction
175,PRGO,guggenheim analyst louise chen raise price target base new guidance hznp be commit do more deal have infrastructure close several deal year view say note
176,PRGO,horizon also settle patent suit generic drug maker perrigo prgo arthritis ointment pennsaid perrigo be able start selling generic pennsaid jan earlier certain circumstantop rate specialty drugmaker horizon pharma beat first quarter sale estimate settle patent suit stock fall friday horizon hznp earning exclude time item rise vs year earlier cent share line analyst consensus accord thomson reuter sale leap view horizon also boost guidance reflect just close buyout rare disease specialist hyperion therapeutic see full year sale well analyst do not offer ep guidance say ebitda earning interest taxe depreciation amortization be net royalty range beat consensus hyperion buyout be quite popular investor horizon stock jump day be announce company look supplement best seller vimovo revenue shrank quarter friday call analyst chief business officer robert carey say horizon still have spend acquisition ve get sufficient capacity execute plan right now hope continue be active marketplace ub analyst marc goodman write note friday bottom line miss target look management be guide higher spending thought write think focus story be top line give prescription trend believe top line be head right direction guggenheim analyst louise chen raise price target base new guidance hznp be commit do more deal have infrastructure close several deal year view say note horizon also settle patent suit generic drug maker perrigo prgo arthritis ointment pennsaid perrigo be able start selling generic pennsaid jan earlier certain circumstan
177,PRGO,aspiring specialty drug giant endo international agree buy major generic drug maker par pharmaceutical holding monday deal endo say make top generic drug maker world investor be less enthusiastic however endo stock fall close endo endp agree shell
178,PRGO,specialty drug giant ibd stock actavis act beat wall street estimate monday first time offer guidance include newly acquire allergan be line expectation actavis stock be early trading monday moved week move average company say earning quarter rise
179,PRGO,big health insurer want get bigger cut cost fatten profit course seem be move faster now consolidate response merger elsewhere health care system
180,PRGO,bigger pharmaceutical company merge hospital require larger more powerful insurer represent patient
181,PRGO,so eager perhaps prove determination investor anthem antm last week take unusual step publicize detail takeover talk cigna ci lead bloomfield conn base cigna publicly admit deeply disappoint anthem disclose latest offer
182,PRGO,meanwhile humana hum have offer sale be be pursue aetna aet reportedly be be court unitedhealth group unh nation largest health insurer
183,PRGO,possible post merger scenario include anthem aetna unitedhealth lord health insurance sector be just anthem unitedhealth dust settle
184,PRGO,now big insurer also be feel more pressure merge soon possible know subsequent proposal invite greater antitrust scrutiny
185,PRGO,big health insurer be too big too late avoid critic
186,PRGO,lack competition clearly exist today speak loudly further consolidation health insurance industry chairman american academy family physician write federal trade commission month
187,PRGO,address rise cost
188,PRGO,still reason cut cost gain leverage merger
189,PRGO,last year prescription drug spending rise record accord im institute healthcare informatic hepatitis treatment most expensive new blockbuster
190,PRGO,consolidation give insurer more leverage negotiate price doctor hospital drugmaker other sector health care industry have consolidated rapidly lately
191,PRGO,re try scale order get more leverage contract drug manufacturer other health care provider say jeffrey loo analyst capital iq
192,PRGO,insurer be feel more pressure grow now have just absorb new patient
193,PRGO,obamacare creation federally subsidize insurance exchange used state have provide new option million newly insure consumer only last year
194,PRGO,health care be busiest industry consolidation year rite aid rad agree buy envision pharmaceutical service february next month unitedhealth buy pharmacy benefit manager catamaran ctrx cvs health cvs agree month pay buy target tgt pharmacy state
195,PRGO,tenet healthcare thc hca hca other major hospital operator have gobble smaller player recent year
196,PRGO,drugmaker be slouch department april teva pharmaceutical industry teva bid mylan myl perrigo prgo reject mylan bid march dublin base actavis complete acquisition allergan create world top pharmaceutical company sale estimate june actavis change name allergan agn
197,PRGO,nonprofit such kaiser permanente blue cross blue shield be seek grow exchange morningstar vishnu lekraj say
198,PRGO,medicaid expansion federal government be ripple rest market
199,PRGO,big health insurer revenue have be grow high single digit margin have be relatively flat loo say
200,PRGO,striking hot iron
201,PRGO,merger mania have strike health insurance sector big time stock be best performer market anthem cigna aetna share hit record high again tuesday unitedhealth gain so far year record tuesday jan humana share flattened tuesday ibd medical manage care industry group have rise past year compare gain
202,PRGO,kind consolidation big company say gerald kominski director ucla center health policy research really only way grow faster organic growth big health insurer want get bigger cut cost fatten profit course seem be move faster now consolidate response merger elsewhere health care system bigger pharmaceutical company merge hospital require larger more powerful insurer represent patient so eager perhaps prove determination investor anthem antm last week take unusual step publicize detail takeover talk cigna ci lead bloomfield conn base cigna publicly admit deeply disappoint anthem disclose latest offer meanwhile humana hum have offer sale be be pursue aetna aet reportedly be be court unitedhealth group unh nation largest health insurer possible post merger scenario include anthem aetna unitedhealth lord health insurance sector be just anthem unitedhealth dust settle now big insurer also be feel more pressure merge soon possible know subsequent proposal invite greater antitrust scrutiny big health insurer be too big too late avoid critic lack competition clearly exist today speak loudly further consolidation health insurance industry chairman american academy family physician write federal trade commission month address rise reason cut cost gain leverage merger last year prescription drug spending rise record accord im institute healthcare informatic hepatitis treatment most expensive new blockbuster consolidation give insurer more leverage negotiate price doctor hospital drugmaker other sector health care industry have consolidated rapidly lately re try scale order get more leverage contract drug manufacturer other health care provider say jeffrey loo analyst capital iq insurer be feel more pressure grow now have just absorb new patient obamacare creation federally subsidize insurance exchange used state have provide new option million newly insure consumer only last year health care be busiest industry consolidation year rite aid rad agree buy envision pharmaceutical service february next month unitedhealth buy pharmacy benefit manager catamaran ctrx cvs health cvs agree month pay buy target tgt pharmacy state tenet healthcare thc hca hca other major hospital operator have gobble smaller player recent year drugmaker be slouch department april teva pharmaceutical industry teva bid mylan myl perrigo prgo reject mylan bid march dublin base actavis complete acquisition allergan create world top pharmaceutical company sale estimate june actavis change name allergan agn nonprofit such kaiser permanente blue cross blue shield be seek grow exchange morningstar vishnu lekraj say medicaid expansion federal government be ripple rest market big health insurer revenue have be grow high single digit margin have be relatively flat loo say striking hot ironsmerger mania have strike health insurance sector big time stock be best performer market anthem cigna aetna share hit record high again tuesday unitedhealth gain so far year record tuesday jan humana share flattened tuesday ibd medical manage care industry group have rise past year compare gain kind consolidation big company say gerald kominski director ucla center health policy research really only way grow faster organic growth
203,PRGO,generic drug giant mylan deliver mixed first quarter report late tuesday other top rate medical stock issue more positive report earlier day share slip fraction hour trading mylan myl profit rise year earlier quarter cent share beating analyst consensus penny accord thomson reuter sale increase
204,PRGO,cross border merger boom be boost etfs hold catamaran ctrx dresser rand drc other pharma energy company be hot takeover target merger arbitrage exchange trade fund profit difference stock price deal be announce final purchase price typically upward move cross border merger acquisition have totale roughly
205,PRGO,specialty drug giant ibd stock actavis beat wall street first quarter estimate monday first time offer earning guidance include newly acquire allergan highly rate ligand pharmaceutical lgnd endo international endp also top ep target actavis act earning rise vs year earlier share cent analyst consensus accord
206,PRGO,generic drug maker mylan myl raise offer drugstore supplier perrigo wednesday get reject again
207,PRGO,mylan offer share cash mylan share perrigo prgo share significant increase april bid cash mylan share
208,PRGO,base mylan share price april first propose buy perrigo most recent offer come perrigo share
209,PRGO,perrigo however have be argue mylan stock price have be drive speculation be buy teva pharmaceutical industry teva eventual bid mylan reject monday
210,PRGO,teva have make clear not interested perrigo outside mylan perrigo consider real mylan stock price be be close teva acquisition rumor start march
211,PRGO,today announcement mylan continue propose price lower previously reject proposal perrigo say
212,PRGO,research note wednesday leerink analyst jason gerberry write likely herald raise teva bid
213,PRGO,morning catch teva ir recap company recent investor meeting myl shareholder write come away convince teva be commit get myl deal do have room sweeten offer
214,PRGO,midday trading stock market today mylan stock be perrigo stock be fraction teva stock be fraction
215,PRGO,follow amy reeve twitter ibd_areeve generic drug maker mylan myl raise offer drugstore supplier perrigo wednesday get reject again mylan offer share cash mylan share perrigo prgo share significant increase april bid cash mylan share base mylan share price april first propose buy perrigo most recent offer come perrigo share perrigo however have be argue mylan stock price have be drive speculation be buy teva pharmaceutical industry teva eventual bid mylan reject monday teva have make clear not interested perrigo outside mylan perrigo consider real mylan stock price be be close teva acquisition rumor start march today announcement mylan continue propose price lower previously reject proposal perrigo say research note wednesday leerink analyst jason gerberry write likely herald raise teva bid morning catch teva ir recap company recent investor meeting myl shareholder write come away convince teva be commit get myl deal do have room sweeten offer midday trading stock market today mylan stock be perrigo stock be fraction teva stock be fraction follow amy reeve twitter ibd_areeve
216,PRGO,mylan myl reject takeover bid teva pharmaceutical teva monday say be still be commit offer perrigo prgo generic pharmaceutical company say offer undervalue company require mylan shareholder believe be low quality teva share exchange high quality mylan share many analyst
217,PRGO,teva pharmaceutical industry teva make long rumore bid smaller generic rival mylan myl tuesday share stock rise pre market trading counter product maker perrigo prgo have offer mylan fall early trading
218,PRGO,israeli base teva offer buy mylan share equal part cash stock
219,PRGO,propose combination teva mylan create lead company pharmaceutical industry well position transform global generic space teva say statement combine company leverage significantly more efficient advanced infrastructure enhance scale production network end end product portfolio capability geographic reach
220,PRGO,mylan share rise open stock market today teva climb
221,PRGO,mylan last week various teva buzz say plan remain standalone company april offer share perrigo many analyst speculate be effort prevent mylan be takeover target perrigo fall pre market trading
222,PRGO,teva proposal also provide mylan stockholder more attractive alternative mylan propose acquisition perrigo company plc announce april well mylan standalone basis teva say teva pharmaceutical industry teva make long rumore bid smaller generic rival mylan myl tuesday share stock rise pre market trading counter product maker perrigo prgo have offer mylan fall early trading israeli base teva offer buy mylan share equal part cash stock propose combination teva mylan create lead company pharmaceutical industry well position transform global generic space teva say statement combine company leverage significantly more efficient advanced infrastructure enhance scale production network end end product portfolio capability geographic reach mylan share rise open stock market today teva climb mylan last week various teva buzz say plan remain standalone company april offer share perrigo many analyst speculate be effort prevent mylan be takeover target perrigo fall pre market trading teva proposal also provide mylan stockholder more attractive alternative mylan propose acquisition perrigo company plc announce april well mylan standalone basis teva say
223,PRGO,pharmaceutical company search new market energy business seek growth have fuel rate company buy overseas asset year high
224,PRGO,cross border merger acquisition worldwide year totale thursday year biggest year date total accord thomson reuter
225,PRGO,announce cross border deal comprise total so far largest annual share cross border transaction amount so far year have be announce transaction also most not deal have yet close
226,PRGO,megadeal have be full force deal value more make nearly half cross border total so far year
227,PRGO,company be lead charge have keen eye european target so far overseas deal have take place europe point last year company switzerland be most popular target value
228,PRGO,more attractive european
229,PRGO,europe rise popularity come continental value be damage great recession eurozone lurch crisis next persistent strength dollar make euro property more affordable american hope stronger economic growth indeed europe economy have grow faster recent month
230,PRGO,last year person begin feel more comfortable business model european company be solidify little bit say matthew toole thomson reuter director deal intelligence
231,PRGO,energy sector have be batter depress crude oil price translate fall earning revenue have be most active sector cross border year energy company have value deal year total more double year date energy sector value deal total
232,PRGO,royal dutch shell rdsa announce deal acquire read england base bg group be biggest announce cross border energy deal so far
233,PRGO,health care sector lead big pharma have generate deal ytd total year
234,PRGO,include reject megadeal offer st loui base agribusiness giant offer buy switzerland base syngenta syt offer reject purportedly undervalue company underestimate regulatory issue generic drug maker mylan myl reject offer rival teva pharmaceutical teva canonsburg pa base mylan currently be engineering hostile takeover bid irish drugmaker perrigo prgo
235,PRGO,obama administration last year crack tax inversion company buy foreign business relocate headquarters lower corporate tax rate hasn slow health care company desire expand new market
236,PRGO,pretty obvious inversion cross border piece have business rationale toole say be look new area business
237,PRGO,pfizer pfe valeant vrx abbvie abbv abandon attempt acquisition foreign target include astrazeneca azn have turn eye acquire domestic company just thursday pfizer say be ask federal trade commission more information propose merger hospira hsp pharmaceutical company search new market energy business seek growth have fuel rate company buy overseas asset year high cross border merger acquisition worldwide year totale thursday year biggest year date total accord thomson reuter announce cross border deal comprise total so far largest annual share cross border transaction amount so far year have be announce transaction also most not deal have yet close megadeal have be full force deal value more make nearly half cross border total so far year company be lead charge have keen eye european target so far overseas deal have take place europe point last year company switzerland be most popular target value more attractive europeanseurope rise popularity come continental value be damage great recession eurozone lurch crisis next persistent strength dollar make euro property more affordable american hope stronger economic growth indeed europe economy have grow faster recent month last year person begin feel more comfortable business model european company be solidify little bit say matthew toole thomson reuter director deal intelligence energy sector have be batter depress crude oil price translate fall earning revenue have be most active sector cross border year energy company have value deal year total more double year date energy sector value deal total royal dutch shell rdsa announce deal acquire read england base bg group be biggest announce cross border energy deal so far health care sector lead big pharma have generate deal ytd total year include reject megadeal offer st loui base agribusiness giant offer buy switzerland base syngenta syt offer reject purportedly undervalue company underestimate regulatory issue generic drug maker mylan myl reject offer rival teva pharmaceutical teva canonsburg pa base mylan currently be engineering hostile takeover bid irish drugmaker perrigo prgo obama administration last year crack tax inversion company buy foreign business relocate headquarters lower corporate tax rate hasn slow health care company desire expand new market pretty obvious inversion cross border piece have business rationale toole say be look new area business pfizer pfe valeant vrx abbvie abbv abandon attempt acquisition foreign target include astrazeneca azn have turn eye acquire domestic company just thursday pfizer say be ask federal trade commission more information propose merger hospira hsp
238,PRGO,merger acquisition be nothing new generic specialty drug space latest round have take quality romantic farce everybody chasing someone chasing somebody else grow number investor analyst be wonder actual wedding season be nearly do past month teva pharmaceutical industry ticker
239,PRGO,ibd big cap leader screen filter highly liquid large cap stock strong record earning growth top notch medical stock make screen cut be valeant pharmaceutical vrx gilead science gild celgene celg actavis act biogen biib regeneron regn shire shpg illumina ilmn
240,PRGO,valeant pharmaceutical have highest possible ibd composite rating meaning share outperform stock market measure fundamental technical factor factor be earning sale growth profit margin return equity relative price performance
241,PRGO,valeant complete acquisition salix pharmaceutical april salix partner pharm group come monday good interim datum phase clinical trial conestat alfa drug ruconest develop treatment angioedema attack allergy related swell
242,PRGO,valeant share ease tuesday be extend past cup handle base buy point initially clear last december
243,PRGO,actavis partner perrigo prgo announce tuesday new drug application guaifenesin pseudoephedrine tablet mucinex alternative be give fda approval
244,PRGO,last week eluxadoline drug viberzi treatment irritable bowel syndrome also receive fda approval
245,PRGO,actavis be try stay cup handle base buy point initially clear last wednesday close tuesday actavis have composite rating best
246,PRGO,gilead have ibd composite rating biotech announce sunday phase trial result idelalisib drug zydelig combination ofatumumab show improvement progression free survival previously treat patient chronic lymphocytic leukemia cll
247,PRGO,last week european medicine agency validate gilead marketing application emtricitabine tenofovir alafenamide combination hiv treatment investigational combination be now evaluation european medicine agency
248,PRGO,share barely close tuesday be buy point month long price consolidation
249,PRGO,celgene be biotech composite rating bmo capital last week reiterate outperform rating celgene part future prospect pleiotropic modulator cc
250,PRGO,stock be form price consolidation buy point
251,PRGO,biogen biotech earn composite rating be now trading march peak price be reach nearly month long run price consolidation
252,PRGO,regeneron break cup handle base buy point mid gain much level tuesday session biotech share dip back buy range regeneron boast composite rating
253,PRGO,shire clear buy point flat base ethical drug maker stock be now trading back level shire have composite rating
254,PRGO,illumina make gene sequence system be work price consolidation buy point last week share get pivot be now trading level
255,PRGO,follow alissa william twitter ibd_awilliam ibd big cap leader screen filter highly liquid large cap stock strong record earning growth top notch medical stock make screen cut be valeant pharmaceutical vrx gilead science gild celgene celg actavis act biogen biib regeneron regn shire shpg illumina ilmn valeant pharmaceutical have highest possible ibd composite rating meaning share outperform stock market measure fundamental technical factor factor be earning sale growth profit margin return equity relative price performance valeant complete acquisition salix pharmaceutical april salix partner pharm group come monday good interim datum phase clinical trial conestat alfa drug ruconest develop treatment angioedema attack allergy related swell valeant share ease tuesday be extend past cup handle base buy point initially clear last december actavis partner perrigo prgo announce tuesday new drug application guaifenesin pseudoephedrine tablet mucinex alternative be give fda approval last week eluxadoline drug viberzi treatment irritable bowel syndrome also receive fda approval actavis be try stay cup handle base buy point initially clear last wednesday close tuesday actavis have composite rating best gilead have ibd composite rating biotech announce sunday phase trial result idelalisib drug zydelig combination ofatumumab show improvement progression free survival previously treat patient chronic lymphocytic leukemia cll last week european medicine agency validate gilead marketing application emtricitabine tenofovir alafenamide combination hiv treatment investigational combination be now evaluation european medicine agency share barely close tuesday be buy point month long price consolidation celgene be biotech composite rating bmo capital last week reiterate outperform rating celgene part future prospect pleiotropic modulator cc stock be form price consolidation buy point biogen biotech earn composite rating be now trading march peak price be reach nearly month long run price consolidation regeneron break cup handle base buy point mid gain much level tuesday session biotech share dip back buy range regeneron boast composite rating shire clear buy point flat base ethical drug maker stock be now trading back level shire have composite rating illumina make gene sequence system be work price consolidation buy point last week share get pivot be now trading level follow alissa william twitter ibd_awilliam
256,PRGO,share teva pharmaceutical industry teva abruptly rebound friday afternoon report drugmaker be think seriously bidding mylan anonymous source say teva not make offer be evaluate idea have approach adviser subject bloomberg report most wall street have be assume teva be think
257,PRGO,israeli drug giant teva pharmaceutical industry teva make long await bid competitor mylan tuesday offer share stock rise news
258,PRGO,teva proposal half cash half stock be unsolicited mylan myl adopt poison pill provision month initial report teva interest emerge
259,PRGO,april mylan make own unsolicited bid fellow generic drug maker perrigo prgo tune observer say be do least partly fend teva bid
260,PRGO,mylan reiterate stance last friday fresh rumor teva interest emerge say not only combination doesn make strategic sense run antitrust issue due product overlap
261,PRGO,evercore isi analyst umer raffat say webinar tuesday morning team analysis estimate teva have divest worth product satisfy federal trade commission requirement still only total annual revenue combine company teva spokesman have tell number be bit lower raffat say
262,PRGO,product divest be mylan generic version teva blockbuster multiple sclerosis drug copaxone just last week fda approve first generic copaxone make team momenta pharmaceutical mnta novartis nvs generic unit sandoz mylan have own version be expect also be approve sometime soon
263,PRGO,also hit list be epipen injectable emergency anaphylaxis be mylan single biggest selling product
264,PRGO,raffat also say teva current bid have rise whisper number go street mylan worth be share capital iq analyst jeffrey loo agree
265,PRGO,teva current offer value myl ep estimate slightly peer think teva need raise bid lower stock portion myl loo write note tuesday
266,PRGO,mylan stock hit new high early stock market today late morning be more teva stock be perrigo stock be nearly
267,PRGO,follow amy reeve twitter ibd_areeve israeli drug giant teva pharmaceutical industry teva make long await bid competitor mylan tuesday offer share stock rise news teva proposal half cash half stock be unsolicited mylan myl adopt poison pill provision month initial report teva interest emerge april mylan make own unsolicited bid fellow generic drug maker perrigo prgo tune observer say be do least partly fend teva bid mylan reiterate stance last friday fresh rumor teva interest emerge say not only combination doesn make strategic sense run antitrust issue due product overlap evercore isi analyst umer raffat say webinar tuesday morning team analysis estimate teva have divest worth product satisfy federal trade commission requirement still only total annual revenue combine company teva spokesman have tell number be bit lower raffat say product divest be mylan generic version teva blockbuster multiple sclerosis drug copaxone just last week fda approve first generic copaxone make team momenta pharmaceutical mnta novartis nvs generic unit sandoz mylan have own version be expect also be approve sometime soon also hit list be epipen injectable emergency anaphylaxis be mylan single biggest selling product raffat also say teva current bid have rise whisper number go street mylan worth be share capital iq analyst jeffrey loo agree teva current offer value myl ep estimate slightly peer think teva need raise bid lower stock portion myl loo write note tuesday mylan stock hit new high early stock market today late morning be more teva stock be perrigo stock be nearly follow amy reeve twitter ibd_areeve
268,PRGO,israeli drug giant teva pharmaceutical industry make long await bid competitor mylan tuesday offer share consensus wall street say price have go higher teva teva proposal half cash half stock create giant generic specialty drug space annual
269,PRGO,stock jab higher open then quickly turn mixed rise volume tuesday morning
270,PRGO,nasdaq tick respectively dow jone industrial average shed
271,PRGO,volume rise stock market today nasdaq nyse compare same time monday
272,PRGO,chemical maker dupont dd dive more follow mixed first quarter result weigh heavily dow software giant sap sap pop report continue advance january low harley davidson hog dive nearly report mixed take worst early hit stock
273,PRGO,chip equipment maker lam research lrcx spiked bell fremont calif base maker wafer fabrication tool report late monday fiscal third quarter sale earning clear consensus estimate revenue guidance be also view gain put share back critical level support month consolidation
274,PRGO,mylan myl rumble start trade teva pharmaceutical teva bid acquire pennsylvania base drugmaker teva share proposal project annual cost saving teva say deal be more advantageous mylan effort acquire perrigo prgo
275,PRGO,mylan last week say combination teva be sound industrial logic cultural fit be significant overlap company teva share rise start bell tuesday gain put mylan flat base buy point
276,PRGO,noah holding noah surge new high china base financial adviser be month clear buy point april stock jab higher open then quickly turn mixed rise volume tuesday morning nasdaq tick respectively dow jone industrial average shed volume rise stock market today nasdaq nyse compare same time monday chemical maker dupont dd dive more follow mixed first quarter result weigh heavily dow software giant sap sap pop report continue advance january low harley davidson hog dive nearly report mixed take worst early hit stock chip equipment maker lam research lrcx spiked bell fremont calif base maker wafer fabrication tool report late monday fiscal third quarter sale earning clear consensus estimate revenue guidance be also view gain put share back critical level support month consolidation mylan myl rumble start trade teva pharmaceutical teva bid acquire pennsylvania base drugmaker teva share proposal project annual cost saving teva say deal be more advantageous mylan effort acquire perrigo prgo mylan last week say combination teva be sound industrial logic cultural fit be significant overlap company teva share rise start bell tuesday gain put mylan flat base buy point noah holding noah surge new high china base financial adviser be month clear buy point april
277,PRGO,seek avoid be takeover mylan myl raise offer perrigo prgo promptly reject bid say proposal be generic drugmaker mylan bid cash mylan share share perrigo be worth friday close higher informal offer unspecified cash
278,PRGO,stock rise tuesday ahead highly anticipate day meeting federal reserve apparent bet fed only mildly tinker interest rate
279,PRGO,nasdaq rise gain dow jone industrial average advanced stock market today volume be higher major exchange accord preliminary datum
280,PRGO,close hewlett packard hpq announce restructure send stock lower company say deliver annual cost reduction person leave company
281,PRGO,unite natural food unfi be volatile close report adjust ep cent share guidance be line estimate company say michael zechmeister replace mark shamber cfo mid october
282,PRGO,open wednesday bureau labor statistic report consumer price index august economist forecast change open weekly crude oil inventory be report energy information administration recent report have cause volatility energy market
283,PRGO,federal open market committee begin day meeting end thursday announcement fed raise interest rate current fed fund target be cme group fedwatch be forecasting chance raise rate
284,PRGO,also open fedex fdx report first quarter fiscal result analyst be expect share be increase year earlier
285,PRGO,also cracker barrel old country store cbrl report result analyst be expect earning share increase year earlier stock rise tuesday ahead highly anticipate day meeting federal reserve apparent bet fed only mildly tinker interest rate nasdaq rise gain dow jone industrial average advanced stock market today volume be higher major exchange accord preliminary datum close hewlett packard hpq announce restructure send stock lower company say deliver annual cost reduction person leave company unite natural food unfi be volatile close report adjust ep cent share guidance be line estimate company say michael zechmeister replace mark shamber cfo mid october open wednesday bureau labor statistic report consumer price index august economist forecast change open weekly crude oil inventory be report energy information administration recent report have cause volatility energy market federal open market committee begin day meeting end thursday announcement fed raise interest rate current fed fund target be cme group fedwatch be forecasting chance raise rate also open fedex fdx report first quarter fiscal result analyst be expect share be increase year earlier also cracker barrel old country store cbrl report result analyst be expect earning share increase year earlier
286,PRGO,generic drug giant mylan myl announce wednesday have bid share cash stock sizable peer perrigo send stock soar
287,PRGO,perrigo prgo apparently hadn agree deal mylan statement indicated be talk
288,PRGO,proposal be culmination number prior discussion mylan perrigo compelling strategic financial logic combination mylan ceo robert coury say press release combination result meaningful immediate long term value creation proposal be design deliver value shareholder other stakeholder company
289,PRGO,mylan note company combine revenue be say combination increase earning operate profit margin total value offer be nearly time late morning announcement equity component be set increase mylan stock be more midday trading stock market today new high perrigo stock also hit new high cruise nearly past be less midday trading
290,PRGO,wall street analyst have be speculate mylan be involved major most popular idea have be combination teva pharmaceutical industry teva fact just hour news break jpmorgan analyst chris schott theorize research note mylan go upward share such deal however add believe mylan look own larger transaction
291,PRGO,mylan be highest rate stock large drugmaker sporting ibd composite rating perrigo be formerly top rating stock profit growth have recently flattened leave cr
292,PRGO,follow amy reeve twitter ibd_areeve generic drug giant mylan myl announce wednesday have bid share cash stock sizable peer perrigo send stock soar perrigo prgo apparently hadn agree deal mylan statement indicated be talk proposal be culmination number prior discussion mylan perrigo compelling strategic financial logic combination mylan ceo robert coury say press release combination result meaningful immediate long term value creation proposal be design deliver value shareholder other stakeholder company mylan note company combine revenue be say combination increase earning operate profit margin total value offer be nearly time late morning announcement equity component be set increase mylan stock be more midday trading stock market today new high perrigo stock also hit new high cruise nearly past be less midday trading wall street analyst have be speculate mylan be involved major most popular idea have be combination teva pharmaceutical industry teva fact just hour news break jpmorgan analyst chris schott theorize research note mylan go upward share such deal however add believe mylan look own larger transaction mylan be highest rate stock large drugmaker sporting ibd composite rating perrigo be formerly top rating stock profit growth have recently flattened leave cr follow amy reeve twitter ibd_areeve
293,PRGO,mylan myl perrigo continue climb stock market thursday wall street analyze speculate possible combination day mylan unsolicited proposal leerink analyst jason gerberry write research note mylan come ahead land perrigo prgo not doesn say teva
294,PRGO,stock close strong rise trade wednesday nasdaq lead healthy advance add dow jone industrial average weigh weakness oil still dow manage find support day move average retake line monday
295,PRGO,russell snap short streak advance preliminary number show volume higher board stock market today
296,PRGO,generic drug group be day top performer news potential industry consolidation mylan myl soar time high announce bid buy rival generic drug maker perrigo prgo
297,PRGO,airline biotech security software stock also outperformed
298,PRGO,oil gas stock be hurt sharp drop crude price
299,PRGO,elsewhere nike nke visa home depot hd climb lead dow stock be highly rate well composite rating
300,PRGO,global payment gpn gap new high reaction third quarter result top analyst earning expectation company also raise full year guidance announce accelerate share buyback program share rise volume surge more average stock close strong rise trade wednesday nasdaq lead healthy advance add dow jone industrial average weigh weakness oil still dow manage find support day move average retake line monday russell snap short streak advance preliminary number show volume higher board stock market today generic drug group be day top performer news potential industry consolidation mylan myl soar time high announce bid buy rival generic drug maker perrigo prgo airline biotech security software stock also outperformed oil gas stock be hurt sharp drop crude price elsewhere nike nke visa home depot hd climb lead dow stock be highly rate well composite rating global payment gpn gap new high reaction third quarter result top analyst earning expectation company also raise full year guidance announce accelerate share buyback program share rise volume surge more average
301,PRGO,wall street rise second day tuesday leave major index just record high higher oil price boost energy stock dow jone industrial average rise nasdaq climb end latter finishing just time peak volume be higher nyse nasdaq compare monday accord preliminary datum
302,PRGO,stock market today oil producer pioneer natural resource pxd driller diamond offshore do rise lead oil price jump more just barrel strike oil worker brazil port shutdown libya
303,PRGO,noah holding noah lead ibd jump heavy volume climb right side deep base provider wealth management service china be due report result nov profit period be see rise cent share be biggest gain quarters
304,PRGO,medical product stock cambrex cbm rise more better expect earning report also climb right side new base
305,PRGO,post session trading luxury electric vehicle maker tesla motor tsla rise sharply narrower expect loss stock fall more regular session end week high
306,PRGO,share real estate zillow be hour follow result
307,PRGO,also close groupon gpn edge higher report provider discount retailer also announce coo rich william replace eric lefkofsky ceo lefkofsky become chairman
308,PRGO,lgi home lgih facebook fb epam system epam cognizant technology solution ctsh be company report quarterly earning wednesday
309,PRGO,economic report due wednesday include institute supply management index service sector activity october adp private sector payroll november crude oil inventory week end oct mortgage banker association index mortgage application week end oct wall street rise second day tuesday leave major index just record high higher oil price boost energy stock dow jone industrial average rise nasdaq climb end latter finishing just time peak volume be higher nyse nasdaq compare monday accord preliminary datum stock market today oil producer pioneer natural resource pxd driller diamond offshore do rise lead oil price jump more just barrel strike oil worker brazil port shutdown libya noah holding noah lead ibd jump heavy volume climb right side deep base provider wealth management service china be due report result nov profit period be see rise cent share be biggest gain quarters medical product stock cambrex cbm rise more better expect earning report also climb right side new base post session trading luxury electric vehicle maker tesla motor tsla rise sharply narrower expect loss stock fall more regular session end week high share real estate zillow be hour follow result also close groupon gpn edge higher report provider discount retailer also announce coo rich william replace eric lefkofsky ceo lefkofsky become chairman lgi home lgih facebook fb epam system epam cognizant technology solution ctsh be company report quarterly earning wednesday economic report due wednesday include institute supply management index service sector activity october adp private sector payroll november crude oil inventory week end oct mortgage banker association index mortgage application week end oct
310,PRGO,generic drug giant mylan announce wednesday have bid share cash stock sizable peer perrigo send stock soar perrigo prgo hadn agree deal mylan myl indicated have be talk proposal be culmination number prior discussion mylan perrigo compelling strategic
311,PRGO,stock be mixed just hour left tuesday session dow jone industrial average give back early gain nasdaq hung buoy strength security software stock
312,PRGO,dow lose weigh soft result dupont dd ease less nasdaq add nyse nasdaq volume be tracking slightly higher monday level
313,PRGO,stock market today security software stock help fuel nasdaq outperformance fortinet ftnt gap new high strong earning biggest quarterly billing growth ipo share rise nearly
314,PRGO,barracuda network cuda cyberark software cybr palo alto network panw be other strong performer group rise cyberark gap reclaim cup handle buy point
315,PRGO,elsewhere signature bank sbny surge yearlong consolidation rise strong earning be catalyst new york base bank clear buy point
316,PRGO,news mylan myl jump teva teva offer value mylan share earlier month mylan make unsolicited bid generic drugmaker perrigo prgo say offer be make fend teva bid
317,PRGO,meanwhile armour ua report quarter strong top line growth share fall fast trade profit cent share be line expectation year sale rise forecast sale tad consensus estimate
318,PRGO,chipotle cmg rally ahead earning report set be release close quarterly profit be expect rise year share chipotle gap day move average april heavy volume strengthen chart stock be mixed just hour left tuesday session dow jone industrial average give back early gain nasdaq hung buoy strength security software stock dow lose weigh soft result dupont dd ease less nasdaq add nyse nasdaq volume be tracking slightly higher monday level stock market today security software stock help fuel nasdaq outperformance fortinet ftnt gap new high strong earning biggest quarterly billing growth ipo share rise nearly barracuda network cuda cyberark software cybr palo alto network panw be other strong performer group rise cyberark gap reclaim cup handle buy point elsewhere signature bank sbny surge yearlong consolidation rise strong earning be catalyst new york base bank clear buy point news mylan myl jump teva teva offer value mylan share earlier month mylan make unsolicited bid generic drugmaker perrigo prgo say offer be make fend teva bid meanwhile armour ua report quarter strong top line growth share fall fast trade profit cent share be line expectation year sale rise forecast sale tad consensus estimate chipotle cmg rally ahead earning report set be release close quarterly profit be expect rise year share chipotle gap day move average april heavy volume strengthen chart
319,PRGO,stock future tuesday advanced open second straight day show bit more strength monday premarket session
320,PRGO,dow future be ahead point well monday premarket level rise nasdaq future climb point fair market value future show healthy point gain small cap also look good shape russell future point
321,PRGO,stock market today roll december automaker release november sale number session fiat chrysler fcau report gain sale best level november year jeep sale drive result rise vs decline chrysler product slip dodge fall fiat auto
322,PRGO,auto researcher edmund forecast total light vehicle sell month year accurate make best november automaker
323,PRGO,institute supply management release november ism index commerce department report october construction spending
324,PRGO,retailer strong online presence get bump datum release adobe system adbe show shopper spend total cyber monday monday follow black friday launch holiday shopping season be designate day technology online shopping special amount be record last year cyber monday sale adobe say adobe also estimate thanksgiving cyber monday receipt top year year also record
325,PRGO,third dow issue be positive premarket action rest be flat best gain come home depot hd add
326,PRGO,adobe system rise lead nasdaq baidu bidu post nasdaq largest decline nearly
327,PRGO,automate network control specialist infoblox blox rocket higher open santa clara calif base company report late monday fiscal first quarter earning revenue guidance expectation management announce share buyback initiative
328,PRGO,mattress firm hold mfrm bounce higher announce late monday buy hmk mattress hold owner sleepy retail chain deal company say expect year cost saving mattress firm also announce fiscal sale rise say expect ep gain line consensus view
329,PRGO,china base qihoo technology qihu add wall street journal report investor group be prepared offer take internet security content provider market american depositary receipt deal be complete come week report say plan then call relisting company china domestic exchange
330,PRGO,qihoo be most recent wave privatization china base company trading china base issue ikang healthcare kang announce monday be be take private group investor adr
331,PRGO,leader stock ibd list be quiet ahead open most group remain flat few gain loss hold less same be true stock ibd weekly review list
332,PRGO,overseas market asia gain pmi gauge tracking china manufacturing service sector show further divergence month european market be narrowly mixed midday
333,PRGO,follow alan elliott twitter ibd_aelliott stock future tuesday advanced open second straight day show bit more strength monday premarket session dow future be ahead point well monday premarket level rise nasdaq future climb point fair market value future show healthy point gain small cap also look good shape russell future point stock market today roll december automaker release november sale number session fiat chrysler fcau report gain sale best level november year jeep sale drive result rise vs decline chrysler product slip dodge fall fiat auto auto researcher edmund forecast total light vehicle sell month year accurate make best november automaker institute supply management release november ism index commerce department report october construction spending retailer strong online presence get bump datum release adobe system adbe show shopper spend total cyber monday monday follow black friday launch holiday shopping season be designate day technology online shopping special amount be record last year cyber monday sale adobe say adobe also estimate thanksgiving cyber monday receipt top year year also record third dow issue be positive premarket action rest be flat best gain come home depot hd add adobe system rise lead nasdaq baidu bidu post nasdaq largest decline nearly automate network control specialist infoblox blox rocket higher open santa clara calif base company report late monday fiscal first quarter earning revenue guidance expectation management announce share buyback initiative mattress firm hold mfrm bounce higher announce late monday buy hmk mattress hold owner sleepy retail chain deal company say expect year cost saving mattress firm also announce fiscal sale rise say expect ep gain line consensus view china base qihoo technology qihu add wall street journal report investor group be prepared offer take internet security content provider market american depositary receipt deal be complete come week report say plan then call relisting company china domestic exchange qihoo be most recent wave privatization china base company trading china base issue ikang healthcare kang announce monday be be take private group investor adr leader stock ibd list be quiet ahead open most group remain flat few gain loss hold less same be true stock ibd weekly review list overseas market asia gain pmi gauge tracking china manufacturing service sector show further divergence month european market be narrowly mixed midday follow alan elliott twitter ibd_aelliott
334,PRGO,tech stock lead mixed show wall street tuesday earning report activity dominate headline early gain turn loss close dow also reversed lower fall weigh sluggish result dupont dd nasdaq trade tight range day end
335,PRGO,ibd composite rating stock price trading time high recent run robust financial growth generic drug maker akorn akrx be already top stock show even more strength future quarters thank several trend work favor report last month ibd lake forest ill base company have
336,PRGO,generic drug maker be top perform industry group thursday easy see pfizer pfe announce be buy stock group hospira hsp share purchase price be premium wednesday close alone account much group gain even announcement generic
337,PRGO,mylan myl stock break wednesday rumor circulate twitter generic brand drugmaker be sale possibly teva announce drug launch mylan stock rise wednesday briefly pass buy point ease teva pharmaceutical industry teva gain analyst be divide logic
338,PRGO,stock pare gain midday wednesday expectation federal reserve raise interest rate later day nasdaq be dow jone industrial average edge
339,PRGO,volume nasdaq nyse be tracking tuesday level
340,PRGO,fed policymaker be expect raise interest rate basis point mark first increase central bank drop rate financial crisis
341,PRGO,stock market today drugmaker valeant pharmaceutical vrx jump heavy volume issue weaker expect earning forecast
342,PRGO,stock jump tuesday announce distribution agreement walgreen boot alliance wba canada base drugmaker say help rebuild business cut ty philidor rx service allegation wrongdoing however valeant forecast jump profit fall short analyst expectation
343,PRGO,solar stock be day best performer lead first solar fslr jump new high heavy volume
344,PRGO,maker solar panel component have get lift negotiator nearly other country reach deal last weekend cut greenhouse gas emission agreement lead greater investment energy efficient solar technology solar
345,PRGO,downside global payment gpn plunge heavy volume slice day line credit card payment processor say buy rival heartland payment system hpy
346,PRGO,meanwhile homebuider rise housing start build permit rise much more expect november accord datum commerce department send homebuilder pulte group phm toll bro tol horton dhi lennar len rise stock pare gain midday wednesday expectation federal reserve raise interest rate later day nasdaq be dow jone industrial average edge volume nasdaq nyse be tracking tuesday level fed policymaker be expect raise interest rate basis point mark first increase central bank drop rate financial crisis stock market today drugmaker valeant pharmaceutical vrx jump heavy volume issue weaker expect earning forecast stock jump tuesday announce distribution agreement walgreen boot alliance wba canada base drugmaker say help rebuild business cut ty philidor rx service allegation wrongdoing however valeant forecast jump profit fall short analyst expectation solar stock be day best performer lead first solar fslr jump new high heavy volume maker solar panel component have get lift negotiator nearly other country reach deal last weekend cut greenhouse gas emission agreement lead greater investment energy efficient solar technology solar downside global payment gpn plunge heavy volume slice day line credit card payment processor say buy rival heartland payment system hpy meanwhile homebuider rise housing start build permit rise much more expect november accord datum commerce department send homebuilder pulte group phm toll bro tol horton dhi lennar len rise
347,PRGO,stock close flourish thursday volume dwindle exchange accord preliminary datum
348,PRGO,nasdaq rise dow jone industrial average gain stock market today
349,PRGO,generic drugmaker be top perform group more
350,PRGO,dow component pfizer pfe agree buy hospira hsp member member group premium wednesday close favorable reaction earning report lannett lci teva pharmaceutical teva perrigo prgo also boost group
351,PRGO,akorn akrx generic drugmaker specialty injectable vault base new time high
352,PRGO,oil stock be also strong price barrel west texas intermediate crude finished nearly increase
353,PRGO,ibd stock rise fall best performer be reilly automotive orly auto part retailer report better expect earning morning roar flat base heavy volume
354,PRGO,worst performer be synchronoss technology sncr stock initially jump reaction earning report then finished more heavy volume move put serious crimp right side potential base
355,PRGO,good gain dupont dd pfizer visa help boost dow
356,PRGO,gopro gpro twitter twtr linkedin lnkd buffalo wild wing bwld expedia expe be company report earning hour stock close flourish thursday volume dwindle exchange accord preliminary datum nasdaq rise dow jone industrial average gain stock market today generic drugmaker be top perform group more dow component pfizer pfe agree buy hospira hsp member member group premium wednesday close favorable reaction earning report lannett lci teva pharmaceutical teva perrigo prgo also boost group akorn akrx generic drugmaker specialty injectable vault base new time high oil stock be also strong price barrel west texas intermediate crude finished nearly increase ibd stock rise fall best performer be reilly automotive orly auto part retailer report better expect earning morning roar flat base heavy volume worst performer be synchronoss technology sncr stock initially jump reaction earning report then finished more heavy volume move put serious crimp right side potential base good gain dupont dd pfizer visa help boost dow gopro gpro twitter twtr linkedin lnkd buffalo wild wing bwld expedia expe be company report earning hour
357,PRGO,stock stay positive be session high friday afternoon
358,PRGO,nasdaq be add dow dip volume be tracking higher stock market today quadruple witching option future
359,PRGO,major index be hold time multiyear high offer mixed picture market health lead stock have have trouble advance breakout stock come repeat heavy volume selling recent week bounce back furiously wednesday thursday
360,PRGO,nike nke be drag dow fall heavy volume late thursday company report fiscal second quarter earning sale ahead analyst estimate investor be spook drop future order
361,PRGO,lead stock be mixed just half ibd trading lower
362,PRGO,gilead science gild lead premier growth list climb active trading stock be climb right side cup shape base buy point
363,PRGO,cinta cta jump huge trade follow thursday past flat base buy point fiscal second quarter result report thursday close show increase earning flat revenue corporate uniform supply company hit new time high friday
364,PRGO,generic drugmaker perrigo prgo hit new high active trading add gain thursday past flat base buy point stock have composite rating have report earning decline past quarters stock stay positive be session high friday afternoon nasdaq be add dow dip volume be tracking higher stock market today quadruple witching option future major index be hold time multiyear high offer mixed picture market health lead stock have have trouble advance breakout stock come repeat heavy volume selling recent week bounce back furiously wednesday thursday nike nke be drag dow fall heavy volume late thursday company report fiscal second quarter earning sale ahead analyst estimate investor be spook drop future order lead stock be mixed just half ibd trading lower gilead science gild lead premier growth list climb active trading stock be climb right side cup shape base buy point cinta cta jump huge trade follow thursday past flat base buy point fiscal second quarter result report thursday close show increase earning flat revenue corporate uniform supply company hit new time high friday generic drugmaker perrigo prgo hit new high active trading add gain thursday past flat base buy point stock have composite rating have report earning decline past quarters
365,PRGO,trained pharmacist joseph papa learn scrutinize science make decision earn bachelor degree pharmacy taught use socratic question dig answer
366,PRGO,pharmaceutical business come be go do product say papa chairman president chief executive perrigo prgo come science feel ask right question force person get root cause issue
367,PRGO,base dublin ireland perrigo be global manufacturer counter pharmaceutical nutritional product store brand market store brand product be sell food drug dollar club store own label
368,PRGO,soon papa arrival perrigo ceo late introduce workforce emphasize driver future success month package concept pillar
369,PRGO,be skepticism first then person say get thing right ll be successful papa recall
370,PRGO,juggle ceo
371,PRGO,papa pillar be quality customer service innovation cost structure person want company employee focus area daily
372,PRGO,reinforce theme often lead staffer ask question such be go do increase quality contribute low cost structure
373,PRGO,papa compare do ceo job juggle ball ball be metal so make lot noise hit ground other be rubber bounce back harmlessly fall glass ball be fragile break drop
374,PRGO,glass one do lot damage say have try differentiate metal one make big noise life go conclude leader rivet everyone attention really important avoid costly mistake
375,PRGO,ensure quality production be particularly crucial company embrace papa call lean sigma continuous improvement process reduce cost improve speed efficiency
376,PRGO,second day person world be take product say tell person next tablet make be consume family friend
377,PRGO,papa view perrigo ideally suit capitalize health care reform say be winner current environment company such gilead science gild make sovaldi treatment hepatitis opposite side perrigo commitment quality affordable health care product
378,PRGO,barbell ll be growth extreme papa say think be even more growth end barbell trained pharmacist joseph papa learn scrutinize science make decision earn bachelor degree pharmacy taught use socratic question dig answer pharmaceutical business come be go do product say papa chairman president chief executive perrigo prgo come science feel ask right question force person get root cause issue base dublin ireland perrigo be global manufacturer counter pharmaceutical nutritional product store brand market store brand product be sell food drug dollar club store own label soon papa arrival perrigo ceo late introduce workforce emphasize driver future success month package concept pillar be skepticism first then person say get thing right ll be successful papa recall juggle ceopapa pillar be quality customer service innovation cost structure person want company employee focus area daily reinforce theme often lead staffer ask question such be go do increase quality contribute low cost structure papa compare do ceo job juggle ball ball be metal so make lot noise hit ground other be rubber bounce back harmlessly fall glass ball be fragile break drop glass one do lot damage say have try differentiate metal one make big noise life go conclude leader rivet everyone attention really important avoid costly mistake ensure quality production be particularly crucial company embrace papa call lean sigma continuous improvement process reduce cost improve speed efficiency second day person world be take product say tell person next tablet make be consume family friend papa view perrigo ideally suit capitalize health care reform say be winner current environment company such gilead science gild make sovaldi treatment hepatitis opposite side perrigo commitment quality affordable health care product barbell ll be growth extreme papa say think be even more growth end barbell
379,PRGO,generic drug maker lannett co boast robust pipeline have sight grow revenue substantially next several year philadelphia base company be already solid foot late august report fiscal fourth quarter earning cent share more year earlier sale double lannett lci develop manufacture medication treat array malady cite particular strength sale largest product category thyroid deficiency cardiovascular pain management ahead fiscal first quarter report due nov company oct preannounce expect report net sale approximately quarter more double year earlier diluted earning share cent cent lannett have be able raise price key product category window temper competition fiscal say margin be improve substantially help explain lannett stock have rebound rough patch july company receive subpoena connecticut attorney general price fix investigation heart medicine digoxin be now more start august get past price company say september review conduct outside legal expert find do not violate connecticut law analyst say investor have turn attention back company favorable sale earning trajectory don think do anything wrong management have reiterate same oppenheimer co analyst rohit vanjani tell ibd so think pricing be pretty solid needham co analyst elliot wilbur say interview operate environment lannett look quite favorable say consolidation prescription drug industry have minimize competition era demand medication age population continue grow provide company such lannett leverage legally boost price same time add substantial new competition lannett size generic space have yet materialize highly rate lannett be smaller firm ibd medical generic drug industry group be dominate size actavis act teva pharmaceutical teva perrigo prgo group be strong performer rank group track ibd lannett hold best possible composite rating do fellow group member actavis akorn akrx lannett spokesman robert jaffe say company have enter customary quiet period ahead november earning release executive not comment article speaking conference september company ceo say lannett have be able raise price product say favorable pricing environment extend be opportunistic company ceo arthur bedrosian say see opportunity raise price competitor drop product be shortage marketplace sometimes drive cfo marty galvan speaking same conference say lannett total have product pipeline include be currently review food drug administration say company generate nearly revenue fiscal top fiscal galvan say product lannett current pipeline view have highest probability success fda commercial perspective average say drug produce annual revenue so growth see come pipeline market fiscal new niche company pipeline be swell expand controlled drug arena executive view ripe growth lannett be only company hold dea license require import raw material need produce controlled substance pain management also be only few company have ability then manufacture ingredient need medication well final dosage same time age population lannett expect demand controlled pain medication mount come year so limit competition space increase demand view reliable segment favorable profit margin most recently september lannett win fda approval oxycodone hydrochloride oral solution pain management marked fourth lannett product approve fda shift controlled drug be important analyst say lannett be currently have success boost price broadly win be able do so indefinitely win last forever never do say wilbur needham analyst competition inevitably come back ceo bedrosian share view say conference end anticipate competition re emerge industry be generally do lower price try grab customer away competitor say reason migrate controlled drug eventual return competition also help explain lannett be look acquisition help drive revenue even further meantime industry have already consolidated notably recent year remove many potential take target still significant value creation potential acquisition front wilbur say certainly look acquire smaller company bedrosian say almost go animal kingdom larger one gobble smaller one be hopefully do gobble say company have recently pursue target success continue prowl more opportunity be hope acquire kind stave eventuality be acquire bedrosian say happen ve get offer shareholder be go figure be best offer have receive happy assign share acquirer latter possibility lannett eventually selling appear be year away bedrosian emphasize company be not market be grow rapidly own nevertheless add long term appeal stock analyst say wilbur say lannett acquire multiple smaller competitor next few year build target reach mark term annual sale near level say become increasingly appeal array much larger pharmaceutical company include foreign operation look get foothold wilbur say drug firm sell much not company current plan bedrosian say do see eventually someone acquire company lannett want get controlled drug space be reason make offer acquire get favorable premium be space have make commitment grow area
380,PRGO,rbc capital market upgrade generic drugmaker akorn akrx outperform sector perform monday send stock morning trading stock market today
381,PRGO,analyst randall stanicky cite good environment generic drug general accelerate approval rate strong pricing trend
382,PRGO,akrx pipeline set well fda action anda file earlier least month old ripe approval say research note
383,PRGO,stanicky also cite sagent pharmaceutical sgnt good play trend
384,PRGO,also like akorn prospect buyer seller akorn have unusually high corporate tax rate so say inversion deal be possible treasury department recent move disincentivize deal let base company move headquarters lower tax country such ireland
385,PRGO,stanicky assessed possibility perrigo prgo acquire akorn say be good strategic fit
386,PRGO,worth note believe perrigo be currently focuse omega possible acquisition other eu opportunity write however higher barrier generic portfolio growth profile fit well perrigo overall business believe be strategic interest least degree akorn
387,PRGO,akorn be latest ibd highest possible composite rating akorn stock be more year touch time high aug
388,PRGO,follow amy reeve twitter ibd_areeve rbc capital market upgrade generic drugmaker akorn akrx outperform sector perform monday send stock morning trading stock market today analyst randall stanicky cite good environment generic drug general accelerate approval rate strong pricing trend akrx pipeline set well fda action anda file earlier least month old ripe approval say research note stanicky also cite sagent pharmaceutical sgnt good play trend also like akorn prospect buyer seller akorn have unusually high corporate tax rate so say inversion deal be possible treasury department recent move disincentivize deal let base company move headquarters lower tax country such ireland stanicky assessed possibility perrigo prgo acquire akorn say be good strategic fit worth note believe perrigo be currently focuse omega possible acquisition other eu opportunity write however higher barrier generic portfolio growth profile fit well perrigo overall business believe be strategic interest least degree akorn akorn be latest ibd highest possible composite rating akorn stock be more year touch time high aug follow amy reeve twitter ibd_areeve
389,PRGO,last year life multiple sclerosis patient have change better new generation powerful oral drug have moved market dominate injectable thing aren do change yet september conference boston show meeting hold jointly american european committee treatment research ms
390,PRGO,drugmaker perrigo prgo beat wall street expectation thursday morning send stock stock market today even guidance miss estimate sale quarter end june rise year earlier quarter beating analyst consensus profit jump share exclude time item top
391,PRGO,stock stay hesitant mode thursday nasdaq show stall action nasdaq close rise morning add less ibd fall volume rise board action nasdaq amount stall point distribution day count
392,PRGO,specialty drugmaker salix pharmaceutical announce oct be do something unusual back merger close back july salix slxp have agree acquire cosmo technology irish subsidiary italian drugmaker cosmo pharmaceutical stock swap value deal have allow salix so many
393,PRGO,stock turn respectable performance thursday end modest gain session high day nasdaq confirm new uptrend gain higher volume
394,PRGO,close nasdaq dow jone industrial rise preliminary datum show nyse nasdaq volume come slightly lower wednesday level stock market today
395,PRGO,news omnivision technology ovti surge get buyout offer chinese investment group lead hua capital management offer be share cash premium wednesday close omnivision clear buy point short cup handle base aug
396,PRGO,earning news drugmaker perrigo prgo gap day move average rise report strong earning stock be work first stage cup handle base
397,PRGO,elsewhere air method airm close high still little less stock have be trading tightly bullish move last week share soar better expect earning company be mostly know provider air ambulance service new tourism segment include helicopter tour charter flight be show strong growth
398,PRGO,amgen amgn rise nearly extend gain recent cup handle news fail drug trial recall cancer drug krypoli fail improve survival rate phase iii trial amgen say result announce earlier month be sufficient support regulatory submission company also recall pre filled syringe anemia drug aranesp
399,PRGO,economic datum due friday include july producer price index empire manufacturing august confidence datum august university michigan stock turn respectable performance thursday end modest gain session high day nasdaq confirm new uptrend gain higher volume close nasdaq dow jone industrial rise preliminary datum show nyse nasdaq volume come slightly lower wednesday level stock market today news omnivision technology ovti surge get buyout offer chinese investment group lead hua capital management offer be share cash premium wednesday close omnivision clear buy point short cup handle base aug earning news drugmaker perrigo prgo gap day move average rise report strong earning stock be work first stage cup handle base elsewhere air method airm close high still little less stock have be trading tightly bullish move last week share soar better expect earning company be mostly know provider air ambulance service new tourism segment include helicopter tour charter flight be show strong growth amgen amgn rise nearly extend gain recent cup handle news fail drug trial recall cancer drug krypoli fail improve survival rate phase iii trial amgen say result announce earlier month be sufficient support regulatory submission company also recall pre filled syringe anemia drug aranesp economic datum due friday include july producer price index empire manufacturing august confidence datum august university michigan
400,PRGO,british big pharma astrazeneca azn turn second takeover bid counterpart pfizer pfe friday say offer be still too low pfizer stock drop nearly astrazeneca hold steady stock market today pfizer first bid astrazeneca board objected large proportion stock share offer
401,PRGO,conflict israel palestinian cause federal aviation administration tuesday temporarily ban american flight tel aviv ben gurion international airport rocket land facility
402,PRGO,airport be same distance tiny territory know gaza strip tel aviv stock exchange tase
403,PRGO,israel launch ground operation gaza july respond missile fire israel area
404,PRGO,authority report palestinian israeli have die fight
405,PRGO,israel market have show little reaction
406,PRGO,hostility begin shekel have strengthen vs dollar index trade broadly higher tel aviv exchange tuesday have show little shakiness start israel offensive vs gaza
407,PRGO,israel etfs stay strong
408,PRGO,israel focuse etfs ishare msci israel eis market vector israel isra have react rise respectively past week year be
409,PRGO,lead israel base trade stock check point software technology chkp be try rebound key week move average
410,PRGO,teva pharmaceutical teva largest name israel ta index nose year high tuesday
411,PRGO,chipmaker mellanox technology mlnx climb tuesday stock jump more last week upgrade jeffery
412,PRGO,other israel base stock shrug war include tower semiconductor tsem various thinly trade play include taro pharmaceutical taro caesarstone cste
413,PRGO,maybe greater concern israeli investor be possible loss perrigo prgo tel aviv exchange
414,PRGO,michigan base dublin domicile drugmaker dual list tase buy agis announce last week be explore option possible sale
415,PRGO,recent acquisition include give imaging retalix list tase follow deal
416,PRGO,perrigo be second largest stock measure market capital israel ta index conflict israel palestinian cause federal aviation administration tuesday temporarily ban american flight tel aviv ben gurion international airport rocket land facility airport be same distance tiny territory know gaza strip tel aviv stock exchange tase israel launch ground operation gaza july respond missile fire israel area authority report palestinian israeli have die fight israel market have show little reaction hostility begin shekel have strengthen vs dollar index trade broadly higher tel aviv exchange tuesday have show little shakiness start israel offensive vs gaza israel etfs stay strongin israel focuse etfs ishare msci israel eis market vector israel isra have react rise respectively past week year be lead israel base trade stock check point software technology chkp be try rebound key week move average teva pharmaceutical teva largest name israel ta index nose year high tuesday chipmaker mellanox technology mlnx climb tuesday stock jump more last week upgrade jeffery other israel base stock shrug war include tower semiconductor tsem various thinly trade play include taro pharmaceutical taro caesarstone cste maybe greater concern israeli investor be possible loss perrigo prgo tel aviv exchange michigan base dublin domicile drugmaker dual list tase buy agis announce last week be explore option possible sale recent acquisition include give imaging retalix list tase follow deal perrigo be second largest stock measure market capital israel ta index
417,PRGO,actavis have make acquisition transform generic focuse drugmaker bigger player prescription drug now find enviable position thrive home base ireland expect generate revenue be now large diverse enough forge ahead international power pharmaceutical industry yet
418,PRGO,specialty drugmaker ibd stock salix pharmaceutical slxp be more morning trading stock market today announce tax inversion merger late tuesday analyst be underwhelm term benefit deal stock swap salix agree merge cosmo technology irish subsidiary italian drugmaker cosmo pharmaceutical
419,PRGO,stock be hold session high pace second straight gain recent rocky market action
420,PRGO,blue chip dow jone industrial outperformed gain meanwhile broader nasdaq be respectively turnover be tracking higher major exchange stock market today trade be barely higher nyse
421,PRGO,kandi technology kndi stretched gain chinese automaker announce kandi electric vehicle group joint venture shanghai maple guorun automobile sell electric vehicle first quarter kandi lose money past quarters sale growth accelerate straight period kandi be quickly build right side new base
422,PRGO,perrigo prgo be session high still hefty trading drugmaker be say be seek buyer accord theflyonthewall com cite globe hebrew financial newspaper
423,PRGO,shire shpg add fresh record high stock be now past buy point cup base clear last month stock have trigger ibd week rule handle fast mover late last week suitor abbvie abbv raise buyoutoffer irish drugmaker fourth time
424,PRGO,leader volume be few michael kor kor extend loss slice day move average long term support level stock have be trading line april stock be hold session high pace second straight gain recent rocky market action blue chip dow jone industrial outperformed gain meanwhile broader nasdaq be respectively turnover be tracking higher major exchange stock market today trade be barely higher nyse kandi technology kndi stretched gain chinese automaker announce kandi electric vehicle group joint venture shanghai maple guorun automobile sell electric vehicle first quarter kandi lose money past quarters sale growth accelerate straight period kandi be quickly build right side new base perrigo prgo be session high still hefty trading drugmaker be say be seek buyer accord theflyonthewall com cite globe hebrew financial newspaper shire shpg add fresh record high stock be now past buy point cup base clear last month stock have trigger ibd week rule handle fast mover late last week suitor abbvie abbv raise buyoutoffer irish drugmaker fourth time leader volume be few michael kor kor extend loss slice day move average long term support level stock have be trading line april
425,PRGO,horizon pharma hznp follow many fellow drugmaker ireland wednesday agree buy dublin base vidara therapeutic deal worth horizon share jump stock market today hit time high
426,PRGO,reverse merger horizon pharma inc turn horizon pharma plc locate low tax haven emerald isle many specialty drugmaker have similarly buy way include actavis act perrigo prgo jazz pharmaceutical jazz other be be ask investor ll do same
427,PRGO,tax benefit horizon gain vidara bioengineer form interferon call actimmune treat rare disease call severe malignant osteopetrosis chronic granulomatous disease vidara acquire actimmune intermune itmn intermune abandon effort develop pulmonary fibrosis
428,PRGO,drug help diversify horizon portfolio most recent quarter arthritis drug duexis account sale ibd report recent new america profile
429,PRGO,press release wednesday horizon say addition bring revenue ebitda earning interest taxe depreciation amortization analyst consensus currently predict sale ebitda accord thomson reuter
430,PRGO,horizon stock have already be run news drive ibd composite rating even company have yet record profit early trading wednesday stock hit highest point go public july midmorning stock be more
431,PRGO,follow amy reeve twitter ibd_areeve
432,PRGO,related jazz pharmaceutical guidance get mixed reaction horizon pharma hznp follow many fellow drugmaker ireland wednesday agree buy dublin base vidara therapeutic deal worth horizon share jump stock market today hit time high reverse merger horizon pharma inc turn horizon pharma plc locate low tax haven emerald isle many specialty drugmaker have similarly buy way include actavis act perrigo prgo jazz pharmaceutical jazz other be be ask investor ll do same tax benefit horizon gain vidara bioengineer form interferon call actimmune treat rare disease call severe malignant osteopetrosis chronic granulomatous disease vidara acquire actimmune intermune itmn intermune abandon effort develop pulmonary fibrosis drug help diversify horizon portfolio most recent quarter arthritis drug duexis account sale ibd report recent new america profile press release wednesday horizon say addition bring revenue ebitda earning interest taxe depreciation amortization analyst consensus currently predict sale ebitda accord thomson reuter horizon stock have already be run news drive ibd composite rating even company have yet record profit early trading wednesday stock hit highest point go public july midmorning stock be more follow amy reeve twitter ibd_areeve related jazz pharmaceutical guidance get mixed reaction
433,PRGO,many big cap stock be well extend basis participate fully month long rally few be hang buy point few other be hit new high perrigo prgo maker generic drug nutritional product be buy point cup base stock break feb volume
434,PRGO,perennial growth stock perrigo prgo break flat base wednesday volume be subpar share rise stock close session high entry week base perrigo maker drug other health care product have make huge advance market bottom cup handle
435,PRGO,stock market close higher thursday index pare gain
436,PRGO,nasdaq climb dow jone industrial average add
437,PRGO,volume rise nyse fall nasdaq accord early figure advance stock lead decliner nasdaq winner barely edge loser nyse
438,PRGO,computer trucking financial rank day top perform sector retail metal energy stock lag
439,PRGO,weak forecast send homebuilding stock stock market today
440,PRGO,meritage home mth cut forecast earning cite rise labor cost delay closing slower expect business company newer market southeast stock fall heavy trading lowest level early february
441,PRGO,be shortage skilled labor many market subcontractor struggle catch increase demand continue recovery homebuilding say chairman ceo steven hilton competition labor be raise cost lengthen construction time statement add bad weather part texas colorado further hurt company
442,PRGO,homebuilder industry group have be market leader be worst group thursday ibd track
443,PRGO,day biggest loser be lululemon athletica lulu plunge yoga style apparel chain guide full year earning expectation share fall lowest level december
444,PRGO,google googl rise share continue rise support day move average volume google be light
445,PRGO,close share action sport retailer zumiez zumz slide company announce quarterly result stock close regular trading week low
446,PRGO,follow juan carlos arancibia twitter ibd_jarancibia stock market close higher thursday index pare gain nasdaq climb dow jone industrial average add volume rise nyse fall nasdaq accord early figure advance stock lead decliner nasdaq winner barely edge loser nyse computer trucking financial rank day top perform sector retail metal energy stock lag weak forecast send homebuilding stock stock market today meritage home mth cut forecast earning cite rise labor cost delay closing slower expect business company newer market southeast stock fall heavy trading lowest level early february be shortage skilled labor many market subcontractor struggle catch increase demand continue recovery homebuilding say chairman ceo steven hilton competition labor be raise cost lengthen construction time statement add bad weather part texas colorado further hurt company homebuilder industry group have be market leader be worst group thursday ibd track day biggest loser be lululemon athletica lulu plunge yoga style apparel chain guide full year earning expectation share fall lowest level december google googl rise share continue rise support day move average volume google be light close share action sport retailer zumiez zumz slide company announce quarterly result stock close regular trading week low follow juan carlos arancibia twitter ibd_jarancibia
447,PRGO,biotech pharmaceutical company be rise life save promise add hope stock also be healthy investment industry be friday general market weakness concern growth stock continue dominate week ibd list company base superior earning strong price performance leadership industry here
448,PRGO,joseph papa have be ceo generic drug maker perrigo co just few week learn potential tiny metal fragment batch pill be november well oversaw triple revenue year sprint perrigo prgo
449,PRGO,biogen idec finished high note highly tout oral multiple sclerosis drug tecfidera produce nearly sale fourth quarter company be pace generate more first year market tecfidera performance helpedbiogen biib deliver record overall revenue be
450,PRGO,earning result have be mixed so far many retailer post weaker expect result tough holiday season tech financial giant have lead earning growth ibd company manhattan associate manh web com wwww green mountain coffee roaster gmcr michael kor kor perrigo prgo be expect post strong result announce earning week
451,PRGO,many medical stock be picture health several segment post rosy checkup medical biom biotech industry group rank first group track ibd group second straight week list medical ethical drug medical generic be no medical system equipment medical research equipment service rank no mutual fund be throw
452,PRGO,buy store brand counter drug save money re probably perrigo customer firm say make counter pharmaceutical product be sell retailer name usually get saving national brand store brand product say joseph papa chairman president chief executive
453,PRGO,generic drugmaker perrigo prgo beat wall street quarterly profit estimate miss badly revenue predict more same rest year stock fall morning trade company mostly make store brand version counter drug say sale fiscal third quarter rise year
454,PRGO,drugmaker perrigo prgo have make second pullback week move average january time tougher go perrigo break cup handle base jan base be part base base pattern begin form year share make good progress pull back week line
455,PRGO,stock end modestly lower wednesday federal reserve chief janet yellen say be live possibility interest rate hike next month fall dow jone industrial average edge nasdaq dip volume be mixed dip nyse rise nasdaq compare tuesday accord preliminary datum maker consumer stock be biggest loser stock market today motorola solution msi make way radio other communication product plunge more better expect profit sale result stock have be work flat base crash day move average finally steadying just day line tesla motor tsla lead share automaker higher soar electric vehicle maker delivery outlook trump weaker expect quarterly earning report stock be testing resistance day line remain week higher homeaway away rocket post session trading expedia expe agree buy online marketplace vacation rental deal be expect close first quarter next year pending regulatory approval be expect help expedia compete home rental business such airbnb meanwhile facebook fb rise hour trading follow earning report profit period rise cent share gain revenue top wall street estimate company say number daily active user rise year average september mobile daily active user jump average month facebook rise regular session buy range buy point qualcomm qcom be sharply hour outlook fiscal first quarter end december trail analyst estimate outweighed better expect result latest period disney celgene celg cyberark software cybr nvidia nvda be company schedule report quarterly earning thursday economic report due thursday include initial jobless claim week end oct productivity datum
456,PRGO,oftentimes pullback week move average become base case perrigo prgo rather bounce week line drugmaker have continue trade line have be consolidate week trading have be fairly orderly controlled consolidation tight weekly close indicate
457,PRGO,share perrigo prgo tumble more early trading thursday company report fiscal fourth quarter sale miss analyst expectation generic drugmaker say revenue quarter end june rise vs year earlier quarter miss analyst consensus more profit nonetheless beat expectation rise
458,PRGO,major average be little change friday weak post holiday trading nasdaq be edge dow jone industrial be flat volume friday half day session be run sharply lower same time wednesday last trading session thanksgiving universal display oled maker light emit flat panel display jump heavy volume new report product be used apple aapl iphone model due stock be approach buy point deep cup base fall oil price hurt energy stock help airline stock market today coal producer consol energy cnx oil stock southwestern energy swn longtime laggard drop weigh other hand american airline aal unite continental ual rise line decline oil price ibd stock hawaiian rise meanwhile walt disney drop heavy volume drag medium stock announce late wednesday espn sport network have lose subscriber past year stock drop cup handle buy point clear nov viacom viab fall time warner twx be
459,PRGO,biotech advance new investment merger activity have help lift drugmaker alexion pharmaceutical alxn celgene celg biogen idec biib past rest market have see up down recently
460,PRGO,company well perrigo prgo actavis act be ibd big cap screen day feature large stock strong earning price performance
461,PRGO,several also appear ibd leaderboard premium service lead stock annotate chart
462,PRGO,alexion develop treatment rare immune disorder currently have only drug market soliris company be look expand product offering give moderna therapeutic upfront cash payment
463,PRGO,investment give alexion right develop messenger rna therapy come moderna research
464,PRGO,alexion share shot new high stock market tuesday medical biom biotech group be industry group ibd track best perform group so far
465,PRGO,perrigo make generic store brand drug be expansion mode december company complete buyout irish drugmaker elan give access more european market
466,PRGO,late tuesday perrigo announce receive final approval abbreviated new drug application fluocinonide cream generic version valeant pharma vrx vano cream
467,PRGO,celgene develop therapy treat cancer jan biotech announce drug abraxane be approve treat metastatic pancreatic cancer combine eli lilly lly gemzar europe drug be originally approve use only treat breast cancer celgene continue gain additional approval drug buy abraxis bioscience
468,PRGO,monday celgene announce preliminary ep figure miss view cent biotech speaking jpmorgan healthcare conference san francisco cite collaboration cost cent share preliminary revenue be just forecast
469,PRGO,celgene see ep analyst estimate outlook be more bullish
470,PRGO,biogen make treatment multiple sclerosis cancer autoimmune disease tuesday joel sendek analyst stifel nicolaus say see strong sale biogen new drug
471,PRGO,project revenue avonex more prior estimate see sale tecfidera biogen ms drug
472,PRGO,sendek also expect fda approve drug plegridy more drug summer
473,PRGO,also big cap screen be actavis have see improve sale buy irish drugmaker warner chilcott october debut lidoderm pain patch
474,PRGO,actavis say tuesday morning expect earning come modestly high end prior estimate share cite gain warner chilcott deal analyst have expect share
475,PRGO,follow gillian rich twitter ibd_grich biotech advance new investment merger activity have help lift drugmaker alexion pharmaceutical alxn celgene celg biogen idec biib past rest market have see up down recently company well perrigo prgo actavis act be ibd big cap screen day feature large stock strong earning price performance several also appear ibd leaderboard premium service lead stock annotate chart alexion develop treatment rare immune disorder currently have only drug market soliris company be look expand product offering give moderna therapeutic upfront cash payment investment give alexion right develop messenger rna therapy come moderna research alexion share shot new high stock market tuesday medical biom biotech group be industry group ibd track best perform group so far perrigo make generic store brand drug be expansion mode december company complete buyout irish drugmaker elan give access more european market late tuesday perrigo announce receive final approval abbreviated new drug application fluocinonide cream generic version valeant pharma vrx vano cream celgene develop therapy treat cancer jan biotech announce drug abraxane be approve treat metastatic pancreatic cancer combine eli lilly lly gemzar europe drug be originally approve use only treat breast cancer celgene continue gain additional approval drug buy abraxis bioscience monday celgene announce preliminary ep figure miss view cent biotech speaking jpmorgan healthcare conference san francisco cite collaboration cost cent share preliminary revenue be just forecast celgene see ep analyst estimate outlook be more bullish biogen make treatment multiple sclerosis cancer autoimmune disease tuesday joel sendek analyst stifel nicolaus say see strong sale biogen new drug project revenue avonex more prior estimate see sale tecfidera biogen ms drug sendek also expect fda approve drug plegridy more drug summer also big cap screen be actavis have see improve sale buy irish drugmaker warner chilcott october debut lidoderm pain patch actavis say tuesday morning expect earning come modestly high end prior estimate share cite gain warner chilcott deal analyst have expect share follow gillian rich twitter ibd_grich
476,PRGO,major index close mixed wednesday money clearly continue flow medical technology sector give birth new breakout nasdaq composite benefit most rise add tuesday handsome lift sport best accumulation distribution rating index chart page nasdaq also rise fall less
477,PRGO,generic drugmaker perrigo prgo gap early trading tuesday report fiscal profit guidance beat analyst expectation perrigo fiscal second quarter end dec sale rise year earlier quarter thomson reuter analyst poll profit rise share cent
478,PRGO,stock market close lower thursday index erased early gain nasdaq have be nearly trip loss shed dow jone industrial average less selling intensified final minute trading index close session lows volume increase nyse fall nasdaq accord preliminary figure close loser lead winner more earlier be just opposite winner lead breakout hanesbrand hbi methode electronic hold spansion code close buy point market rally early news european central bank have adopt new stimulus strategy move be expect wall street have just elect sell news cleveland fed president loretta mester make comment support back away fed considerable period guidance raise interest rate index be lower comment crossed wire market also have be jittery ahead friday employment report maker apparel auto steel lead market retail do fairly well too energy number health care industry group lag most bell el pollo report first result go public share rise early extend trading
479,PRGO,last month otherwise hum conference call financial guidance valeant pharmaceutical vrx ceo michael pearson electrify stock market make audacious promise today re introduce sixth strategic initiative be become top most valuable pharmaceutical company measure market cap end say
480,PRGO,specialty drugmaker endo health solution endp tuesday announce major acquisition further plan transform also soundly beat expectation stock jump time high eventually close nearly endo say buy canadian drugmaker paladin lab paladin have more
481,PRGO,generic drug maker perrigo prgo announce new quarterly dividend cent share wednesday prepared report fiscal result early thursday analyst expect bring uptick profit growth accord thomson reuter analyst average expect earning share year earlier quarter sale be see rise
482,PRGO,drugmaker celgene celg biogen idec biib be big cap drugmaker deep pocket proven product line process today screen day be big cap leader top rate large cap stock price drugmaker big cap leader list include biotechs celgene biogen idec well generic drugmaker actavis act perrigo ticker
483,PRGO,generic drugmaker perrigo prgo beat analyst fiscal guidance top bottom line thursday send stock time high perrigo sale rise year earlier quarter beating analyst consensus profit climb share beating consensus cent segment experience double digit organic
484,PRGO,even market condition be rocky thursday few lead stock pound new high strong volume harman international industry har trim gain final hour still surge point nearly more time average trade share be much thursday high still harman be
485,PRGO,acquisition have long be staple drug industry drive force investment decision big pharmas blockbuster drug have go patent ve filled pipeline buy smaller firm new drug smaller player buyout be usually investor chief hope healthy return investment little biotechs be
486,PRGO,perrigo co actively play acquisition game target buy build strong position generic prescription store brand counter drugmaker recent buyout include last year purchase sergeant pet care product focuse otc animal health care acquisition fera pharmaceutical product portfolio prescription ophthalmic ointment solution acquisition fit
487,PRGO,drugmaker gunmaker top list stock hit new high friday sturm ruger rgr biogen biib clear buy point ruger clear cup base entry intraday end volume be just average however short jump see ruger still possess accumulation distribution rating
488,PRGO,stock open higher thursday limp close still action didn stop several top perform name variety sector hit new week high ibd aerospace defense group precision castpart pcp extend gain recent flat base share rally close buy point group peer boee ba meanwhile
489,PRGO,stock again improve late trading thursday major index now green equity be also pace end october big monthly gain nasdaq climb be pace end october gain respectively dow jone industrial average edge
490,PRGO,stock open modest loss thursday company report job datum oil price figured early trade dow drop nasdaq narrow early loss hung red
491,PRGO,volume climb nasdaq be higher nyse relative trade same time wednesday
492,PRGO,stock market today get start weak foot labor department report jobless claim hold steady week end nov follow unexpected surge prior week investor be also take early comment make separate speech federal reserve chair janet yellen st loui federal reserve president james bullard jeffrey lacker president richmond federal reserve bank
493,PRGO,employer claim position go unfilled labor department september job opening labor turnover survey number be unfilled opening august
494,PRGO,oil price be sharply west texas intermediate more barrel ahead energy information administration weekly inventory report due et
495,PRGO,stock goldman sachs gs boee ba weigh dow cisco system csco hold dow high ground half percent fiscal first quarter report due close seller be pile mining issue freeport mcmoran fcx consol energy cnx early action
496,PRGO,advance auto part aap peel loss roanoke va base chain third quarter earning revenue miss estimate guidance be weak chief executive darren jackson announce retire jan gap loss drive share well day move average very heavy trade
497,PRGO,ibd list netease nte climb almost strong trade just optional cup base buy point china base provider online game content report strong third quarterly result late wednesday
498,PRGO,downside operation management consultant maximus mms buckled fall reston va base operation report fiscal fourth quarter earning penny consensus view revenue stop shy forecast management trim full year ep guidance loss end stock effort rise cup base buy point stock open modest loss thursday company report job datum oil price figured early trade dow drop nasdaq narrow early loss hung red volume climb nasdaq be higher nyse relative trade same time wednesday stock market today get start weak foot labor department report jobless claim hold steady week end nov follow unexpected surge prior week investor be also take early comment make separate speech federal reserve chair janet yellen st loui federal reserve president james bullard jeffrey lacker president richmond federal reserve bank employer claim position go unfilled labor department september job opening labor turnover survey number be unfilled opening august oil price be sharply west texas intermediate more barrel ahead energy information administration weekly inventory report due et stock goldman sachs gs boee ba weigh dow cisco system csco hold dow high ground half percent fiscal first quarter report due close seller be pile mining issue freeport mcmoran fcx consol energy cnx early action advance auto part aap peel loss roanoke va base chain third quarter earning revenue miss estimate guidance be weak chief executive darren jackson announce retire jan gap loss drive share well day move average very heavy trade ibd list netease nte climb almost strong trade just optional cup base buy point china base provider online game content report strong third quarterly result late wednesday downside operation management consultant maximus mms buckled fall reston va base operation report fiscal fourth quarter earning penny consensus view revenue stop shy forecast management trim full year ep guidance loss end stock effort rise cup base buy point
499,PRGO,choppy condition again dictate friday session top rate stock be able muster new high especially medical stock perrigo prgo add more twice average volume stock follow thursday past buy point cup handle base drugmaker give gain hour trading
500,PRGO,stock market erased midday loss close modestly higher friday
501,PRGO,nasdaq rise less climb dow jone industrial average volume rise nyse fall nasdaq early figure show
502,PRGO,several medical stock climb heavy trading biotechs pharmaceutical be leader stock market today
503,PRGO,valeant pharmaceutical vrx rally double usual volume find support day move average thursday valeant close day line report disappointing sale
504,PRGO,perrigo prgo add heavy trading generic drug company be now extend buy point company announce recall infant pain reliever bottle have be ship syringe not properly marked
505,PRGO,gentium gent rise new high earning easily top expectation thinly trade italy base biotech have more triple july
506,PRGO,shire shpg inched pharmaceutical company be hold most last week surge follow strong earning report
507,PRGO,wellcare health plan wcg plunge company surprise move replace ceo alec cunningham also warn profit miss estimate
508,PRGO,stock gap nearly time average volume erase gain past aug stock market erased midday loss close modestly higher friday nasdaq rise less climb dow jone industrial average volume rise nyse fall nasdaq early figure show several medical stock climb heavy trading biotechs pharmaceutical be leader stock market today valeant pharmaceutical vrx rally double usual volume find support day move average thursday valeant close day line report disappointing sale perrigo prgo add heavy trading generic drug company be now extend buy point company announce recall infant pain reliever bottle have be ship syringe not properly marked gentium gent rise new high earning easily top expectation thinly trade italy base biotech have more triple july shire shpg inched pharmaceutical company be hold most last week surge follow strong earning report wellcare health plan wcg plunge company surprise move replace ceo alec cunningham also warn profit miss estimate stock gap nearly time average volume erase gain past aug
509,PRGO,early gain deteriorate narrowly mixed trade early friday investor wade welter mixed earning report economic news
510,PRGO,nasdaq inched dow jone industrial average dip backed
511,PRGO,volume be soft nasdaq lower nyse compare trade same time thursday
512,PRGO,stock market today launch october final trading session nasdaq month be lean first monthly advance july gain be track be best month index october
513,PRGO,market take add confidence weaker expect september personal income spending number speculate datum add fed reason further delay normalize interest rate
514,PRGO,labor department labor cost index tick third quarter line expectation cost accelerate growth
515,PRGO,midwest manufacturing return expansion mode october send kingsbury international chicago purchasing manager index well forecast read indicate sector growth
516,PRGO,consumer sentiment ease october accord university michigan place consumer sentiment index month be september level disappointing expectation uptick
517,PRGO,oil price trade fraction higher lift west texas intermediate barrel cent week baker hughe bhi release weekly rig count report
518,PRGO,stock action be brisk mixed
519,PRGO,linkedin lnkd vault higher baidu bidu leap quarterly result deliver thursday close genworth financial gnw drop electronic art ea shed disappointing result
520,PRGO,cvs health cvs fall pharmacy giant earning meet expectation revenue rise better forecast full year profit guidance meet consensus view ep outlook be shy projection big volume dip drag share week move average stock be climb right side month consolidation
521,PRGO,cleveland base bank keycorp key drop open announce acquire first niagara financial group fnfg deal value first niagara rise less
522,PRGO,gain ibd stock be modest early trade cavium cavm starbucks sbux technology avgo rise more downside egg man cal maine food calm see deepest decline
523,PRGO,ibd big cap list priceline pcln be early leader online travel deal site pulse more possibly feel updraft peer expedia expe spiked report result late thursday expedia result be mixed gross booking rise drive hotel booking air ticket gain easily push priceline new high buy point cup base priceline report result nov
524,PRGO,comfort system usa fix jetted ahead lead ibd weekly review list heating ventilation air conditioning contractor report late thursday third quarter earning revenue clobber consensus forecast stock have be buy range face resistance just buy point double bottom base be now extend buy mark
525,PRGO,low end weekly review list electronic retail chain aaron aan fall more mixed third quarter report earning miss revenue top consensus forecast management lower full year guidance well expectation move pull stock day move average early gain deteriorate narrowly mixed trade early friday investor wade welter mixed earning report economic news nasdaq inched dow jone industrial average dip backed volume be soft nasdaq lower nyse compare trade same time thursday stock market today launch october final trading session nasdaq month be lean first monthly advance july gain be track be best month index october market take add confidence weaker expect september personal income spending number speculate datum add fed reason further delay normalize interest rate labor department labor cost index tick third quarter line expectation cost accelerate growth midwest manufacturing return expansion mode october send kingsbury international chicago purchasing manager index well forecast read indicate sector growth consumer sentiment ease october accord university michigan place consumer sentiment index month be september level disappointing expectation uptick oil price trade fraction higher lift west texas intermediate barrel cent week baker hughe bhi release weekly rig count report stock action be brisk mixed linkedin lnkd vault higher baidu bidu leap quarterly result deliver thursday close genworth financial gnw drop electronic art ea shed disappointing result cvs health cvs fall pharmacy giant earning meet expectation revenue rise better forecast full year profit guidance meet consensus view ep outlook be shy projection big volume dip drag share week move average stock be climb right side month consolidation cleveland base bank keycorp key drop open announce acquire first niagara financial group fnfg deal value first niagara rise less gain ibd stock be modest early trade cavium cavm starbucks sbux technology avgo rise more downside egg man cal maine food calm see deepest decline ibd big cap list priceline pcln be early leader online travel deal site pulse more possibly feel updraft peer expedia expe spiked report result late thursday expedia result be mixed gross booking rise drive hotel booking air ticket gain easily push priceline new high buy point cup base priceline report result nov comfort system usa fix jetted ahead lead ibd weekly review list heating ventilation air conditioning contractor report late thursday third quarter earning revenue clobber consensus forecast stock have be buy range face resistance just buy point double bottom base be now extend buy mark low end weekly review list electronic retail chain aaron aan fall more mixed third quarter report earning miss revenue top consensus forecast management lower full year guidance well expectation move pull stock day move average
526,PRGO,stock slightly improve late trading friday be again mixed equity be also pace end narrowly mixed week dow jone industrial average push gain edge nasdaq be still big cap techs such apple aapl amazon com amzn google goog be
527,PRGO,few large cap medicine consumer good business service tech sector show decent action wednesday cognizant technology solution ctsh rise add tuesday earning inspire gain close past buy point cup handle base clear also extend rebound week move average cognizant be
528,PRGO,share jazz pharmaceutical jazz be time high afternoon trading stock market monday drugmaker prepared earning report close tuesday bullish analyst sentiment analyst poll thomson reuter expect jazz report earning share year earlier quarter sale be see
529,PRGO,shareholder have bad reaction drugmaker perrigo prgo announce buyout irish biotech firm elan eln send stock more monday morning
530,PRGO,elan shareholder cheer news send share sharply elan have earlier reject lower bid royalty pharma hostile takeover bid
531,PRGO,perrigo transaction value elan share premium base friday close price
532,PRGO,michigan base perrigo say move headquarters ireland elan be incorporate save more annual operate expense taxe ireland corporate tax rate be vs
533,PRGO,perrigo be leader counter store brand drug common remedy such headache heartburn also make generic prescription drug sell pet care product
534,PRGO,elan ll get royalty multiple sclerosis drug tysabri market distribute biogen idec biib ms drug generate sale last year have be grow year average
535,PRGO,believe transaction be compelling elan shareholder fully take account value elan asset include large cash balance double digit royalty claim tysabri perrigo chairman ceo joseph papa say statement
536,PRGO,perrigo say merger establish premier global health care company serve springboard further international expansion
537,PRGO,perrigo have long be acquisitive company paid more pbm holding lead store brand infant formula maker more recently acquire sergeant pet care product shareholder have bad reaction drugmaker perrigo prgo announce buyout irish biotech firm elan eln send stock more monday morning elan shareholder cheer news send share sharply elan have earlier reject lower bid royalty pharma hostile takeover bid perrigo transaction value elan share premium base friday close price michigan base perrigo say move headquarters ireland elan be incorporate save more annual operate expense taxe ireland corporate tax rate be vs perrigo be leader counter store brand drug common remedy such headache heartburn also make generic prescription drug sell pet care product elan ll get royalty multiple sclerosis drug tysabri market distribute biogen idec biib ms drug generate sale last year have be grow year average believe transaction be compelling elan shareholder fully take account value elan asset include large cash balance double digit royalty claim tysabri perrigo chairman ceo joseph papa say statement perrigo say merger establish premier global health care company serve springboard further international expansion perrigo have long be acquisitive company paid more pbm holding lead store brand infant formula maker more recently acquire sergeant pet care product
538,PRGO,stock hold quiet loss midday monday merger earning news fuel most major move nasdaq dow jone industrial average dip board volume remain quiet sign stock market today just stick hold pattern ahead news follow federal reserve day meeting end wednesday
539,PRGO,generic drug maker perrigo miss analyst expectation fourth quarter sale guidance thursday send stock close perrigo prgo say adjust profit quarter end june rise year earlier quarter share beating estimate penny sale rise fall more
540,PRGO,share generic drugmaker perrigo prgo be more midday trading stock market thursday company post fiscal result guidance miss analyst consensus perrigo say adjust profit quarter end june rise year earlier quarter share beating estimate penny sale rise
541,PRGO,stock kick shorten week trading mixed performance tuesday friday year high nasdaq outperformed rise health care name especially biotech ethical drug do heavy lift once again add dow jone industrial average fall weigh coca cola ko share fall disappointing
542,PRGO,stock future be moderately lower ahead monday open investor look heavy week economic policy news break market week stalemate
543,PRGO,dow future be point future show point loss nasdaq future dip point
544,PRGO,stock market today open eye dollar be early pressure straight weekly decline buck be likely be key factor week action preliminary read gdp due federal open market committee begin day meeting tuesday raft payroll job datum be due later week strategy decision be also expect central bank europe
545,PRGO,news just be enough bump nasdaq recent stupor have stall mumble trade past week dow have edge slightly higher
546,PRGO,merger acquisition news share ireland base elan eln pop drug maker perrigo prgo say buy company reuter report deal ireland tax policy cut perrigo overall tax rate high teen also give perrigo royalty right elan blockbuster multiple sclerosis drug tysbari have sale last year
547,PRGO,perrigo rise fraction
548,PRGO,global leader advertising trade new york base omnicom omc france publicis groupe say sunday merge deal value combine company hope better compete increasingly powerful online ad leader such google goog facebook fb management say deal close omnicom share trade
549,PRGO,monday open light earning calendar schedule pick hour herbalife hlf denny denn anadarko petroleum apc many company schedule report
550,PRGO,wynn resort wynn slip just second quarter earning miss revenue just meet analyst forecast revenue macau property rise vs rise la vegas revenue macau earning slip earning la vegas surge quarter wynn have be correct late battle retake support week line past week
551,PRGO,ibd list herbalife gain ahead open bell ahead hour earning report stock be extend clear buy point sloppy cup base july
552,PRGO,overseas japan nikkei tokyo dive putt index more past session china market be mixed shanghai composite
553,PRGO,europe stock ignore asia volatility hold narrow gain end morning trade
554,PRGO,dollar slump euro yen oil be steady just barrel gold rise ounce
555,PRGO,pending home sale number june be expect national association realtor et stock future be moderately lower ahead monday open investor look heavy week economic policy news break market week stalemate dow future be point future show point loss nasdaq future dip point stock market today open eye dollar be early pressure straight weekly decline buck be likely be key factor week action preliminary read gdp due federal open market committee begin day meeting tuesday raft payroll job datum be due later week strategy decision be also expect central bank europe news just be enough bump nasdaq recent stupor have stall mumble trade past week dow have edge slightly higher merger acquisition news share ireland base elan eln pop drug maker perrigo prgo say buy company reuter report deal ireland tax policy cut perrigo overall tax rate high teen also give perrigo royalty right elan blockbuster multiple sclerosis drug tysbari have sale last year perrigo rise fraction global leader advertising trade new york base omnicom omc france publicis groupe say sunday merge deal value combine company hope better compete increasingly powerful online ad leader such google goog facebook fb management say deal close omnicom share trade monday open light earning calendar schedule pick hour herbalife hlf denny denn anadarko petroleum apc many company schedule report wynn resort wynn slip just second quarter earning miss revenue just meet analyst forecast revenue macau property rise vs rise la vegas revenue macau earning slip earning la vegas surge quarter wynn have be correct late battle retake support week line past week ibd list herbalife gain ahead open bell ahead hour earning report stock be extend clear buy point sloppy cup base july overseas japan nikkei tokyo dive putt index more past session china market be mixed shanghai composite europe stock ignore asia volatility hold narrow gain end morning trade dollar slump euro yen oil be steady just barrel gold rise ounce pending home sale number june be expect national association realtor et
556,PRGO,stock slump start gate monday home sale black friday return chicago manufacturing datum put pressure open trade
557,PRGO,nasdaq slip furthest dow jone industrial average dip apiece small cap run slightly grain russell rise small cap index nearly early trade
558,PRGO,volume be well friday morning level surprise lame duck trading session thanksgiving day break
559,PRGO,stock market today receive break early economic news
560,PRGO,chicago purchasing manager index drop november kingsbury international report be sharply october read well economist consensus expectation gauge be generally take precursor more closely watch institute supply management pmi index be due tuesday morning
561,PRGO,pending home sale tick feeble october national association realtor say gain be improvement month decline well forecast increase pending home sale have flattened fall nar say release consumer face rise price dwindle inventory home
562,PRGO,stock computer science csc jump company divide separate publicly trade operation csra csra combine csc government contractor business operation sra international csc announce august acquire begin trading monday csra ticker csc commercial operation continue trade csc nyse csra share trade early action
563,PRGO,retailer be take notable hit early tally begin roll black friday launch holiday shopping season armour ua urban outfitter urbn drop ugg maker decker outdoor deck dive fashion designer steve madden shoo dump
564,PRGO,ibd stock tal education xrs jump nearly bump new high china base chain school tutor clinic have gain recent session process clear buy point cup handle base share be now extend almost
565,PRGO,china base issue noah noah climb nearly group second best gain asset management firm have fail decisively clear buy point flaw cup handle base
566,PRGO,nike nke slip more take ibd worst early decline also largest decline dow stock dip left share just buy point flat base stock slump start gate monday home sale black friday return chicago manufacturing datum put pressure open trade nasdaq slip furthest dow jone industrial average dip apiece small cap run slightly grain russell rise small cap index nearly early trade volume be well friday morning level surprise lame duck trading session thanksgiving day break stock market today receive break early economic news chicago purchasing manager index drop november kingsbury international report be sharply october read well economist consensus expectation gauge be generally take precursor more closely watch institute supply management pmi index be due tuesday morning pending home sale tick feeble october national association realtor say gain be improvement month decline well forecast increase pending home sale have flattened fall nar say release consumer face rise price dwindle inventory home stock computer science csc jump company divide separate publicly trade operation csra csra combine csc government contractor business operation sra international csc announce august acquire begin trading monday csra ticker csc commercial operation continue trade csc nyse csra share trade early action retailer be take notable hit early tally begin roll black friday launch holiday shopping season armour ua urban outfitter urbn drop ugg maker decker outdoor deck dive fashion designer steve madden shoo dump ibd stock tal education xrs jump nearly bump new high china base chain school tutor clinic have gain recent session process clear buy point cup handle base share be now extend almost china base issue noah noah climb nearly group second best gain asset management firm have fail decisively clear buy point flaw cup handle base nike nke slip more take ibd worst early decline also largest decline dow stock dip left share just buy point flat base
567,PRGO,irish drugmaker elan eln lengthy drama come close early monday announce have agree takeover michigan base perrigo prgo
568,PRGO,perrigo agree pay share elan amount get cash elan be gathering divestment asset most recently april elan land cool ownership share tysabri blockbuster multiple sclerosis drug have be splitting biogen idec biib biogen still pay royalty sale drug percentage increase sale pass
569,PRGO,tysabri be only market drug elan have left sell most other asset previous transaction have product pipeline design treat aggression patient alzheimer disease failure potentially much bigger alzheimer treatment bapineuzumab be co develop johnson johnson jnj pfizer pfe company basically become royalty engine
570,PRGO,elan ceo kelly martin say have big plan company last month face shareholder revolt extraordinary meeting stockholder turn deal pay portion theravance thrx royalty set pulmonary drug be develop glaxosmithkline gsk also pressured management putt elan sale fend hostile takeover attempt royalty pharma martin have abandon plan prove correct say elan get better price royalty offer share
571,PRGO,perrigo be odd match elan main business be generic counter drug be sell house brand various drugstore have product comparable elan neurological drug fact early consensus street seem be perrigo be mainly chance relocate ireland tax benefit
572,PRGO,acquisition follow familiar strategy used other specialty pharmaceutical company include valeant pharmaceutical vrx actavis act lower tax liability tax restructure deal write morningstar analyst michael research note monday expect perrigo eventually divest royalty stream receive elan generic pharmaceutical manufacturer doubt perrigo utilize elan asset launch pad future biotech drug development
573,PRGO,conference call analyst company executive estimate perrigo tax rate fall high teen now
574,PRGO,perrigo ceo joseph papa also say deal create meaningful synergy opportunity be accretive company earning brushed question make sense hang tysabri
575,PRGO,re excited tysabri asset say think clearly always continue look maximize shareholder value right now think great asset think be important future
576,PRGO,nonetheless add don want anyone think re go start spending billion dollar say company decide deal elan product pipeline elnd next clinical trial milestone
577,PRGO,rbc capital market analyst michael yee estimate elan royalty contribute annually perrigo revenue last month totale nonetheless investor have feel perrigo overpay stock drop monday close hit time high friday
578,PRGO,view deal favorably long term opportunity enhance international expansion platform irish domicile time ev ebitda estimate acquisition look expensive write leerink swann analyst jason gerberry research note monday ratio enterprise value earning interest taxe depreciation amortization be popular measure value company gerberry call elan top line growth prospect questionable
579,PRGO,takeover speculation already have drive elan stock week high rise monday irish drugmaker elan eln lengthy drama come close early monday announce have agree takeover michigan base perrigo prgo perrigo agree pay share elan amount get cash elan be gathering divestment asset most recently april elan land cool ownership share tysabri blockbuster multiple sclerosis drug have be splitting biogen idec biib biogen still pay royalty sale drug percentage increase sale pass tysabri be only market drug elan have left sell most other asset previous transaction have product pipeline design treat aggression patient alzheimer disease failure potentially much bigger alzheimer treatment bapineuzumab be co develop johnson johnson jnj pfizer pfe company basically become royalty engine elan ceo kelly martin say have big plan company last month face shareholder revolt extraordinary meeting stockholder turn deal pay portion theravance thrx royalty set pulmonary drug be develop glaxosmithkline gsk also pressured management putt elan sale fend hostile takeover attempt royalty pharma martin have abandon plan prove correct say elan get better price royalty offer share perrigo be odd match elan main business be generic counter drug be sell house brand various drugstore have product comparable elan neurological drug fact early consensus street seem be perrigo be mainly chance relocate ireland tax benefit acquisition follow familiar strategy used other specialty pharmaceutical company include valeant pharmaceutical vrx actavis act lower tax liability tax restructure deal write morningstar analyst michael research note monday expect perrigo eventually divest royalty stream receive elan generic pharmaceutical manufacturer doubt perrigo utilize elan asset launch pad future biotech drug development conference call analyst company executive estimate perrigo tax rate fall high teen now perrigo ceo joseph papa also say deal create meaningful synergy opportunity be accretive company earning brushed question make sense hang tysabri re excited tysabri asset say think clearly always continue look maximize shareholder value right now think great asset think be important future nonetheless add don want anyone think re go start spending billion dollar say company decide deal elan product pipeline elnd next clinical trial milestone rbc capital market analyst michael yee estimate elan royalty contribute annually perrigo revenue last month totale nonetheless investor have feel perrigo overpay stock drop monday close hit time high friday view deal favorably long term opportunity enhance international expansion platform irish domicile time ev ebitda estimate acquisition look expensive write leerink swann analyst jason gerberry research note monday ratio enterprise value earning interest taxe depreciation amortization be popular measure value company gerberry call elan top line growth prospect questionable takeover speculation already have drive elan stock week high rise monday
580,PRGO,valeant pharmaceutical international vrx trim earning guidance thursday generic rival come market earlier expect wednesday afternoon mylan myl win fda approval generic version herpes ointment zovirax provide sale last year news cause mylan stock bounce
581,PRGO,perrigo prgo narrowly miss quarterly sale forecast tuesday share re-cover optimism position top supplier store brand drug allegan mich base company make counter store brand drug compete pricier brand name medicine perrigo have enjoy steady sale earning growth more consumer switch store brand product trend continue perrigo fiscal fourth quarter
582,PRGO,several technology stock hit new high strong volume wednesday lead russian web portal yandex yndx nasdaq rise time session day biggest winner be consumer stock nu skin enterprise nus soar massive volume network marketer personal care product hike full year earning
583,PRGO,perrigo prgo celgene celg drugmaker have be show healthy share gain august suffer setback thursday former report sale lag analyst view latter sale barely beat perrigo celgene beat profit view however perrigo world largest provider counter store brand drug sank celgene specialist blood cancer drug see
584,PRGO,stock take breather recent gain monday end modest loss nasdaq fall close just level round number become key support resistance level also lose dow jone industrial average slip small cap fared worst russell give erase friday move
585,PRGO,stock fought mixed ground thursday rock sock open follow datum show surprise fall mid atlantic manufacturing activity nasdaq cling gain dow jone industrial average be apiece volume be also mixed higher nasdaq nyse compare
586,PRGO,share perrigo prgo slide more early trading wednesday drugmaker report fiscal sale badly miss analyst estimate company say revenue quarter end rise year earlier quarter be more short wall street consensus profit rise share cent consensus include tax benefit cent share perrigo guide full fiscal ep midpoint ahead analyst forecast company see modest growth largest division consumer health care sell mostly store brand version drugstore product cold medicine painkiller prescription drug grow sharply mostly due july acquisition paddock laboratory other division nutritional active pharmaceutical ingredient shrank due increase competition pricing pressure nutritional business focus mostly infant child have heavy hit rival such mead johnson mjn abbott laboratory nestle nsrgy perrigo stock hit time high early october be trading early wednesday month low monday barrington research upgrade stock outperform investor consider likelihood management be able deliver long term growth target revenue growth earning growth believe management team have proven be better bet write analyst charley jone majority analyst however rate stock hold related major drug recall perrigo put quality first
587,PRGO,drugmaker perrigo prgo tech giant google goog be high rate stock hit new high friday perrigo produce generic counter medicine rise nearly morning action touch time high move level first time joined general market stage negative reversal end fraction
588,PRGO,perrigo prgo be expand generic pharmaceutical business include man best friend generic counter drug firm announce thursday purchase sergeant pet care product privately hold company cash share be midday trading sergeant market health care product pet atlantis fur so fresh geisler gourmet
589,PRGO,stock stay worst level still deeply red late wednesday major average be pace biggest day percentage loss june
590,PRGO,nasdaq be dow jone industrial average lose turnover continue track sharply higher board
591,PRGO,perrigo prgo shave large chunk loss be still blister trade open drugmaker post disappointing fiscal sale perrigo report revenue year first single digit gain quarters miss more
592,PRGO,regeneron pharmaceutical regn fall lowest level more month now buy point flat base clear late august biotech lose money number year be expect turn profit share year
593,PRGO,whole food market wfm lose breach day line ahead fiscal result close analyst see high end grocer earning rise cent share mark second straight period acceleration sale be slate climb
594,PRGO,upside middleby midd reversed higher rise bounce support day line late tuesday maker commercial cook equipment beat expectation earning grow share sale rise edge view upside reversal also put thinly trade stock back buy point flat base stock stay worst level still deeply red late wednesday major average be pace biggest day percentage loss june nasdaq be dow jone industrial average lose turnover continue track sharply higher board perrigo prgo shave large chunk loss be still blister trade open drugmaker post disappointing fiscal sale perrigo report revenue year first single digit gain quarters miss more regeneron pharmaceutical regn fall lowest level more month now buy point flat base clear late august biotech lose money number year be expect turn profit share year whole food market wfm lose breach day line ahead fiscal result close analyst see high end grocer earning rise cent share mark second straight period acceleration sale be slate climb upside middleby midd reversed higher rise bounce support day line late tuesday maker commercial cook equipment beat expectation earning grow share sale rise edge view upside reversal also put thinly trade stock back buy point flat base
595,PRGO,stock climb thursday mostly bad news be good news sort rally volume moved dow jone industrial average moved nasdaq volume rise nasdaq nyse accord preliminary datum release weak economic datum initial jobless claim unexpectedly rise last week
596,PRGO,stock future slip narrowly mixed trade thin loss ahead thursday open mixed job housing news preface intensely watch fed policy announcement later day
597,PRGO,dow future slump point fair market value nasdaq future be narrow point future slip point
598,PRGO,stock market today be fed policy decision be announce et market have be notch positive move ahead decision nasdaq open today session week ahead uptrend launch follow session week tuesday be pressure still intact
599,PRGO,unemployment news be positive labor department report initial jobless claim fall week end economist have estimate hold steady outcome claim week move average dip continue recent downtrend
600,PRGO,real estate market housing start slow annualize rate august accord commerce department be well july rate undercut consensus projection more mild slowdown
601,PRGO,build permit picked however pace narrowly best estimate department also revise july permit rate upward
602,PRGO,philadelphia federal reserve release regional manufacturing survey
603,PRGO,nasdaq stock stick close home only chip maker move more open nvidia nvda add micron technology mu slip dow be bracket wal mart wmt goldman sachs gs
604,PRGO,aerie pharmaceutical aeri rocket higher premarket action irvine calif base biotech report late wednesday rhopressa eye drop treatment show positive result clinical phase trial
605,PRGO,drug aim ease intraocular pressure related glaucoma ocular hypertension aerie have be climb sharp sell late april end wednesday early april high october ipo price
606,PRGO,oracle orcl slump more report mixed fiscal first quarter result late wednesday earning slip less expect revenue fall more forecast management say software service company be quickly close gap leader salesforce com crm oracle share have be deepen consolidation january
607,PRGO,office furniture manufacturer herman miller mlhr scramble higher ahead open mich base outfit report wednesday close fiscal earning revenue easily clear consensus forecast management lift ep guidance analyst expectation stock have trade flat fading consolidation june high
608,PRGO,rite aid rad tumble report disappoint analyst earning fall vs consensus view drop revenue rise better expect management trim full year earning guidance stock have be struggle resistance april
609,PRGO,leader ibd stock be generally quiet ahead open bulk group be flat motion be sticking gain loss less
610,PRGO,euro inched dollar dollar post bigger gain yen bond edge oil continue bob more west texas intermediate firmly barrel more week stock future slip narrowly mixed trade thin loss ahead thursday open mixed job housing news preface intensely watch fed policy announcement later day dow future slump point fair market value nasdaq future be narrow point future slip point stock market today be fed policy decision be announce et market have be notch positive move ahead decision nasdaq open today session week ahead uptrend launch follow session week tuesday be pressure still intact unemployment news be positive labor department report initial jobless claim fall week end economist have estimate hold steady outcome claim week move average dip continue recent downtrend real estate market housing start slow annualize rate august accord commerce department be well july rate undercut consensus projection more mild slowdown build permit picked however pace narrowly best estimate department also revise july permit rate upward philadelphia federal reserve release regional manufacturing survey nasdaq stock stick close home only chip maker move more open nvidia nvda add micron technology mu slip dow be bracket wal mart wmt goldman sachs gs aerie pharmaceutical aeri rocket higher premarket action irvine calif base biotech report late wednesday rhopressa eye drop treatment show positive result clinical phase trial drug aim ease intraocular pressure related glaucoma ocular hypertension aerie have be climb sharp sell late april end wednesday early april high october ipo price oracle orcl slump more report mixed fiscal first quarter result late wednesday earning slip less expect revenue fall more forecast management say software service company be quickly close gap leader salesforce com crm oracle share have be deepen consolidation january office furniture manufacturer herman miller mlhr scramble higher ahead open mich base outfit report wednesday close fiscal earning revenue easily clear consensus forecast management lift ep guidance analyst expectation stock have trade flat fading consolidation june high rite aid rad tumble report disappoint analyst earning fall vs consensus view drop revenue rise better expect management trim full year earning guidance stock have be struggle resistance april leader ibd stock be generally quiet ahead open bulk group be flat motion be sticking gain loss less euro inched dollar dollar post bigger gain yen bond edge oil continue bob more west texas intermediate firmly barrel more week
611,PRGO,stock open mixed quickly slip red friday major index try defend narrow gain week be nasdaq dow jone industrial average slip apiece volume be soft nasdaq lower nyse compare same time thursday best
612,PRGO,stock be higher midday tuesday reverse earlier loss follow strong earning report sign greece be make progress plan avoid disorderly default
613,PRGO,nasdaq rise sank earlier dow jone industrial average be also rebound earlier decline volume index be slightly positive compare same time monday
614,PRGO,greek official be draft proposal european union bailout need avoid default upset credit market damage global economy plan be approve parliament be scene protest tuesday austerity measure aim pare government debt
615,PRGO,boee ba caterpillar cat pare earlier loss coca cola ko shot more sale profit top wall street view
616,PRGO,generic drug maker perrigo prgo ibd stock gap profit rise vs year rise sale beat wall street estimate do company forecast
617,PRGO,company say release generic version popular counter drug mucinex allegra prevacid next month
618,PRGO,perrigo share have retreat hit time high dec relative strength rating be modest earning share rating be putt top stock
619,PRGO,coinstar cstr blast higher massive volume company own kiosk base movie rental operation redbox report late monday earning rise share more expectation revenue jump also clobber estimate
620,PRGO,bellevue wash base company also say acquire ncr entertainment operation include blockbuster express rental kiosk
621,PRGO,coinstar gap past buy point
622,PRGO,management software provider solarwind swi rocked report earning cent share expectation cent revenue surge vs forecast company offer line earning guidance first quarter raise revenue guidance expectation
623,PRGO,ibd leaderboard stock clear buy point base feb be now buy point
624,PRGO,casual restaurant chain buffalo wild wing bwld panera bread pnra other leaderboard stock be due report earning close tuesday stock be higher midday tuesday reverse earlier loss follow strong earning report sign greece be make progress plan avoid disorderly default nasdaq rise sank earlier dow jone industrial average be also rebound earlier decline volume index be slightly positive compare same time monday greek official be draft proposal european union bailout need avoid default upset credit market damage global economy plan be approve parliament be scene protest tuesday austerity measure aim pare government debt boee ba caterpillar cat pare earlier loss coca cola ko shot more sale profit top wall street view generic drug maker perrigo prgo ibd stock gap profit rise vs year rise sale beat wall street estimate do company forecast company say release generic version popular counter drug mucinex allegra prevacid next month perrigo share have retreat hit time high dec relative strength rating be modest earning share rating be putt top stock coinstar cstr blast higher massive volume company own kiosk base movie rental operation redbox report late monday earning rise share more expectation revenue jump also clobber estimate bellevue wash base company also say acquire ncr entertainment operation include blockbuster express rental kiosk coinstar gap past buy point management software provider solarwind swi rocked report earning cent share expectation cent revenue surge vs forecast company offer line earning guidance first quarter raise revenue guidance expectation ibd leaderboard stock clear buy point base feb be now buy point casual restaurant chain buffalo wild wing bwld panera bread pnra other leaderboard stock be due report earning close tuesday
625,PRGO,stock give back more ground tuesday add already ambiguous picture market nasdaq drop just trimming loss buyer prop market final hour trading fall close level have be support beam past session index
626,PRGO,stock tack gain slow volume thursday afternoon keep market message mixed tuesday big gain signale uptrend be way nasdaq advanced dow jone industrial average volume be sharply major exchange ibd proxy lead stock be evenly split winner loser cloud compute play network ffiv add faster volume stock appear be find support day move average have be work long consolidation january pattern be see giant double bottom base handle correction run deep potential buy point be stock have mildly bullish volume ratio accumulation distribution rating be neutral read downside drug provider perrigo prgo clear entry flat base early trade stock reversed lower be back buy point base be first stage first second stage be more likely work later stage however perrigo have be try break recently hasn be able get job do top rate stock be mixed advancer lead ratio blue chip dow jone industrial average general electric ge rise faster action retook day move average stock be laggard carry ep rank mean half market be grow earning faster ibm ibm edge modestly average volume stock gap day line wednesday heavy volume ibm chart action have be wider looser july follow month tight action wide loose trade be consider bearish
627,PRGO,stock buoy encourage sign euro zone crisis climb heel overseas market rally rise lead allegheny technology atus joy global joyg dow jone industrial average rise nasdaq volume be higher nasdaq nyse compare same time yesterday consumer confidence eke higher september lift conference board consumer confidence index vs read august read be analyst forecast far july number case shiller report home price city index decline year year july number be better decline june better analyst expectation decline lead stock apparel retailer genesco gco jump open report late monday second quarter earning sale easily top expectation owner journey journey kidz underground station chain also lift earning guidance fiscal analyst view stock be shape handle base drop more buy point prior handle genesco carry composite rating ibd perrigo prgo spiked heavy trade hit new high stock have be rise rebound nice volume week move average
628,PRGO,major index hold session high midday wednesday boost fed chief ben bernanke tell congress central bank be ready provide more economic stimulus need market also be get lift news china gdp grow healthy clip last quarter nyse composite nasdaq composite be
629,PRGO,stock maintain mixed performance late afternoon action today warning fitch rating continue weigh market nasdaq be edge dow jone industrial average slip volume remain higher board boost quadruple witching expiration index option index future stock option
630,PRGO,stock market close modestly tuesday seesaw day slow big gain prior session want hear ibd analysis today market emerge stock click here watch market wrap video turnover increase exchange monday anemic pace remain average ahead labor day holiday weekend
631,PRGO,major index padded morning gain trade intraday high hour trading remain thursday session nasdaq rise wednesday advanced trade highest level march gain nearly nyse composite lag volume remain higher major exchange opentable open jump post new high clear base buy point decline base be just maximum decline allow square box base online reservation system provider restaurant industry be showcased new america today ibd accord article opentable earn dollar diner seat reservation make namesake cent reservation make eatery site ii vi iivi rally heavy trade maker optical component laser be try reclaim day move average breaking key support line earlier month company grow earning jump sale latest quarter be expect grow earning fiscal sport composite rating ii vi have office chiba japan locate less mile area ravage most march earthquake downside generic drug maker perrigo prgo cut loss be mere stock have close rise day move average breaking january
632,PRGO,stock future pare loss tuesday solid earning news ease pain weak housing datum uptick price inflation
633,PRGO,dow future fall point bell dip point earlier trade future be point nasdaq future lose point earlier lows
634,PRGO,housing market receive more bad news housing start july fall prior month result be expectation start new build permit fall july june analyst have expect permit july
635,PRGO,inflation datum also raise red flag export price agricultural good eke june rise import price oil rise same amount follow decrease july
636,PRGO,wal mart wmt rise pre market trade top second quarter sale earning expectation retail chain offer earning revenue guidance line estimate
637,PRGO,home depot hd share climb ahead bell home improvement chain beat earning revenue view boost fiscal earning revenue guidance expectation
638,PRGO,leader drug maker perrigo prgo slump allegan mich base company report better expect earning gain revenue fall just short consensus forecast move put stock well week move average keep mind premarket move be often erased start regular trading
639,PRGO,china shanghai composite slip hong kong hang seng index lose japan tokyo nikkei climb
640,PRGO,market moved abruptly lower europe datum show germany economic growth slow second quarter afternoon trade frankfurt dax be london ftse lose paris cac fall stock future pare loss tuesday solid earning news ease pain weak housing datum uptick price inflation dow future fall point bell dip point earlier trade future be point nasdaq future lose point earlier lows housing market receive more bad news housing start july fall prior month result be expectation start new build permit fall july june analyst have expect permit july inflation datum also raise red flag export price agricultural good eke june rise import price oil rise same amount follow decrease july wal mart wmt rise pre market trade top second quarter sale earning expectation retail chain offer earning revenue guidance line estimate home depot hd share climb ahead bell home improvement chain beat earning revenue view boost fiscal earning revenue guidance expectation leader drug maker perrigo prgo slump allegan mich base company report better expect earning gain revenue fall just short consensus forecast move put stock well week move average keep mind premarket move be often erased start regular trading china shanghai composite slip hong kong hang seng index lose japan tokyo nikkei climb market moved abruptly lower europe datum show germany economic growth slow second quarter afternoon trade frankfurt dax be london ftse lose paris cac fall
641,PRGO,stock continue hold session high day move average be act resistance
642,PRGO,nyse composite be nasdaq dow industrial meanwhile add index slice day line june have be volume be again tracking lower board
643,PRGO,align technology algn climb heavy trading stock regain day move average friday be build new base accumulation distribution rating have improve early june orthodontic product maker have deliver straight quarters triple digit profit growth
644,PRGO,rovi rovi climb near year high stock clear buy point flat base july have gain formerly know macrovision rovi provide digital entertainment service
645,PRGO,perrigo prgo shed early morning loss rise stock be try climb back day move average earlier monday drugmaker say have receive fda approval cetirizine cherry syrup treat allergy
646,PRGO,cavium network cavm reversed earlier loss rise month high stock clear buy point cup handle base friday cavium make semiconductor product report earning thursday analyst see earn cent share vs cent shortfall year earlier period sale growth have accelerate past quarters stock continue hold session high day move average be act resistance nyse composite be nasdaq dow industrial meanwhile add index slice day line june have be volume be again tracking lower board align technology algn climb heavy trading stock regain day move average friday be build new base accumulation distribution rating have improve early june orthodontic product maker have deliver straight quarters triple digit profit growth rovi rovi climb near year high stock clear buy point flat base july have gain formerly know macrovision rovi provide digital entertainment service perrigo prgo shed early morning loss rise stock be try climb back day move average earlier monday drugmaker say have receive fda approval cetirizine cherry syrup treat allergy cavium network cavm reversed earlier loss rise month high stock clear buy point cup handle base friday cavium make semiconductor product report earning thursday analyst see earn cent share vs cent shortfall year earlier period sale growth have accelerate past quarters
647,PRGO,last decade more american consumer have show willingness substitute store brand product brand original have play right imitative hand perrigo corp prgo leader produce distribute store brand version popular counter medication sell wal mart target cvs other major retailer problem be heartburn seasonal
648,PRGO,stock struggle mixed terrain thursday morning nasdaq inched early loss nasdaq strained hold fractional gain be less line dow jone industrial average hold loss volume reversed be nyse trade nasdaq be
649,PRGO,major index have shed gain midday fed chief ben bernanke appear backtrack issue further economic stimulus tell lawmaker thursday central bank doesn plan third round quantitative ease comment come day bernanke raise hope further stimulus say fed be
650,PRGO,stock future slip early high still point higher open investor assessed euro zone progress amend treaty dow future be point point advance early trade nasdaq future be point higher future hold point gain trade deficit narrow fourth
651,PRGO,major index be lackluster early trading thursday mixed job durable good datum nasdaq eke add fraction nyse composite be less volume be sharply nasdaq lower nyse compare same time wednesday toyota motor tm put north american manufacturing plant notice possible shutdown news report say due supply chain issue link march earthquake tsunami japan lead stock smartphone tablet compute chipmaker atmel atml surge early trade stock be try rebound straight week selling aruba network arun bump stopping just short recent high maker network security software have pause past week remain extend latest buy point perrigo prgo gap loss heavy trade michigan base generic drug maker slide day line first time early january perrigo be shape most recent base
652,PRGO,stock hold stout gain hour go tuesday trading session chip farm equipment mining internet content industry group lead way nasdaq rally add monday rebound nyse composite be not far large cap gain volume jump major exchange be likely finish average cummin cmi re-cover early decline edge less higher volume be track be highest oct stock be fight hold day move average take pound day late january jan cummin notch new high low volume suggest demand share be cool diesel natural gas engine giant report increase earning share sale rise sizable ep jump meet ibd minimum requirement select outstanding growth stock also represent material slowdown growth increase prior quarters sale rise growth prior period cummin official say news release sale engine component distribution segment hit record full year sale climb weak north american truck engine market company also forecast sale baidu bidu featured noon market update reach higher new ground gain volume be already run more double day average turnover share hour go session google goog also member internet content industry group gain slightly average volume search engine titan break narrow cup handle gain backtracking base google relative price strength rating tuesday ibd seriously underperform baidu rs other recent breakout get lift market broad rally generic drug maker perrigo prgo edge higher be now past buy point acme packet apkt broadcom brcm be slate report earning tuesday market close
653,PRGO,much legislation health care package be dog breakfast incentive disincentive nobody know unintended consequence be market early sort be already do market doesn always follow simple logic generic drug maker originally hope be big winner bill want year exclusivity new drug reduce year ve allow generic enter game earlier lose still year generic medical stock rise anyhow logic say thing market do trust trust market impax laboratory ipxl develop specialty generic drug break flat base day president obama convene health care summit now roughly extend sale jump past quarters earning be cent share cent share vs year loss perrigo prgo provide generic drug counter medicine nutritional product clear buy point week tight pattern session health bill pass analyst expect earning growth fiscal end june only growth fiscal par pharmaceutical prx have foot camp develop generic brand pharmaceutical appear be work base need shape right side earning soar sale expand past quarters second half analyst expect least straight quarters decline earning sale
654,PRGO,elite list company featured table be launch point research
655,PRGO,here be stock be make move deserve be noticed
656,PRGO,spectra energy partner sep start strong be identify top master limit partnership wall street transcript market research group spectra have healthy dividend yield
657,PRGO,company earning accelerate past quarters profit last quarter rise sale be even stronger growth sixth quarter accelerate growth
658,PRGO,share be time high company initial public offer june
659,PRGO,thinly trade loral space communication lorl be find support day move average
660,PRGO,maker satellite space system commercial government market be earning uptrend big loss earning turn positive past quarters analyst expect continue
661,PRGO,fund hold share top holder be rate rowe price high yield fund blackrock high yield bond portfolio
662,PRGO,perrigo prgo snap day streak generic drugmaker hit time high begin week wednesday pull back volume ease
663,PRGO,fundamentally stock have few flaw composite rating ep score put elite class perrigo also have rise profit margin great amount cash flow growth stock
664,PRGO,sale growth be expect drop single digit come quarters elite list company featured table be launch point research here be stock be make move deserve be noticed spectra energy partner sep start strong be identify top master limit partnership wall street transcript market research group spectra have healthy dividend yield company earning accelerate past quarters profit last quarter rise sale be even stronger growth sixth quarter accelerate growth share be time high company initial public offer june thinly trade loral space communication lorl be find support day move average maker satellite space system commercial government market be earning uptrend big loss earning turn positive past quarters analyst expect continue fund hold share top holder be rate rowe price high yield fund blackrock high yield bond portfolio perrigo prgo snap day streak generic drugmaker hit time high begin week wednesday pull back volume ease fundamentally stock have few flaw composite rating ep score put elite class perrigo also have rise profit margin great amount cash flow growth stock sale growth be expect drop single digit come quarters
665,PRGO,stock future point higher monday dollar softened european market notch significant gain dow future rise point ahead bell future be point nasdaq future climb lead stock be busy rebound take hard hit friday new oriental education technology edu jump ahead open bell
666,PRGO,major index trade lower midday tuesday many lead stock come pressure nasdaq composite be nyse composite shed lose dow fared best trading volume continue track higher board longtime leader baidu bidu shed strong turnover chinese web search
667,PRGO,software tool maker solarwind say thursday earn cent share third quarter easily beating forecast push share higher solarwind swi third quarter revenue rise analyst poll thomson reuter have expect profit climb cent share cent year earlier period analyst expect cent
668,PRGO,stock ease early afternoon trading wednesday try establish new session high major index remain positive territory
669,PRGO,nyse composite be higher have be much also add dow nasdaq gain volume be tracking higher nasdaq tad lower nyse
670,PRGO,cree cree rise fast trade company sign cross licensing pact help increase growth led light used cree be rebound correction april peak
671,PRGO,str holding stri erased earlier loss gain stock nearly touch resistance day move average company make material used production solar module str earning grow triple digit past quarters analyst see triple digit gain current period
672,PRGO,downside perrigo prgo shave earlier loss just stock ease early afternoon trading wednesday try establish new session high major index remain positive territory nyse composite be higher have be much also add dow nasdaq gain volume be tracking higher nasdaq tad lower nyse cree cree rise fast trade company sign cross licensing pact help increase growth led light used cree be rebound correction april peak str holding stri erased earlier loss gain stock nearly touch resistance day move average company make material used production solar module str earning grow triple digit past quarters analyst see triple digit gain current period downside perrigo prgo shave earlier loss just
673,PRGO,stock open mixed thursday earning report drive early trading mixed economic datum take back seat
674,PRGO,nasdaq claim gain be fraction dow jone industrial average be lower trading be higher nasdaq nyse compare same time wednesday
675,PRGO,philadelphia federal reserve manufacturing index fall better june read forecast gauge have be negative
676,PRGO,stock seem little moved report housing start slip new permit jump july weekly initial jobless claim rise slightly ongoing claim decline
677,PRGO,earning report other hand send wal mart wmt perrigo prgo gapping day move average
678,PRGO,dollar tree dltr plunge much trimming loss early thursday stock trade day line recover have spoil flat base be form dollar tree meet earning estimate give weak outlook
679,PRGO,cisco system csco climb early trade networking equipment giant fiscal fourth quarter revenue earning squeak past consensus estimate company raise dividend yielding better wednesday close stock be climb right side deep correction
680,PRGO,netease nte swoon open second quarter sale earning miss view late wednesday company cite slowdown subscriber online game advertising revenue rise vs gaming revenue slip
681,PRGO,ibd stock have just reclaim day line work base start early june stock open mixed thursday earning report drive early trading mixed economic datum take back seat nasdaq claim gain be fraction dow jone industrial average be lower trading be higher nasdaq nyse compare same time wednesday philadelphia federal reserve manufacturing index fall better june read forecast gauge have be negative stock seem little moved report housing start slip new permit jump july weekly initial jobless claim rise slightly ongoing claim decline earning report other hand send wal mart wmt perrigo prgo gapping day move average dollar tree dltr plunge much trimming loss early thursday stock trade day line recover have spoil flat base be form dollar tree meet earning estimate give weak outlook cisco system csco climb early trade networking equipment giant fiscal fourth quarter revenue earning squeak past consensus estimate company raise dividend yielding better wednesday close stock be climb right side deep correction netease nte swoon open second quarter sale earning miss view late wednesday company cite slowdown subscriber online game advertising revenue rise vs gaming revenue slip ibd stock have just reclaim day line work base start early june
682,PRGO,stock future pare loss be hit hard sell ripple global market dow jone industrial average future be point earlier lows nasdaq future be point future fall point also morning lows official greece announce sunday euro worth budget cut
683,PRGO,stock market drop fresh session lows early afternoon trading lose ground news conference leader france germany nasdaq composite shed dow jone industrial average volume be tracking higher board news conference noon et major index have pare
684,PRGO,market show little life tuesday broad rally few top rate stock manage break week
685,PRGO,stock sell convince fashion wednesday major index finished session high thursday still mostly lower ibd current outlook continue be market correction
686,PRGO,best not buy stock correction ibd style investor be look stock be consolidate calm fashion uncertain environment
687,PRGO,number stock make weekly review be camp include genetic analysis tool developer illumina ilmn atvs maker polaris industry pii generic drug producer perrigo prgo
688,PRGO,illumina appear be etching base base structure possible buy point whole pattern qualify second stage base such early stage basis be preferable later stage structure
689,PRGO,polaris seem be work right side base pattern be interpreted double bottom base potential entry point
690,PRGO,perrigo look be shape right side third stage base possible buy point be stock end tack handle
691,PRGO,breakout
692,PRGO,manage care provider healthspr hs athletic clothing seller lululemon athletica lulu farm gear retailer tractor supply tsco be weekly review stock clear basis tuesday
693,PRGO,healthspr clear buy point late stage flat base
694,PRGO,part bunch defensive health stock claim spot top weekly review list area concern be drop ep expect current quarter
695,PRGO,lululemon be new high move buy point odd shape base also late stage structure exceptional leader make good gain third stage breakout
696,PRGO,tractor supply top base somewhat light trade market show little life tuesday broad rally few top rate stock manage break week stock sell convince fashion wednesday major index finished session high thursday still mostly lower ibd current outlook continue be market correction best not buy stock correction ibd style investor be look stock be consolidate calm fashion uncertain environment number stock make weekly review be camp include genetic analysis tool developer illumina ilmn atvs maker polaris industry pii generic drug producer perrigo prgo illumina appear be etching base base structure possible buy point whole pattern qualify second stage base such early stage basis be preferable later stage structure polaris seem be work right side base pattern be interpreted double bottom base potential entry point perrigo look be shape right side third stage base possible buy point be stock end tack handle breakout manage care provider healthspr hs athletic clothing seller lululemon athletica lulu farm gear retailer tractor supply tsco be weekly review stock clear basis tuesday healthspr clear buy point late stage flat base part bunch defensive health stock claim spot top weekly review list area concern be drop ep expect current quarter lululemon be new high move buy point odd shape base also late stage structure exceptional leader make good gain third stage breakout tractor supply top base somewhat light trade
697,PRGO,be rough week broad market lead stock be act well consolidate correction continue ibd style investor be take least profit table not establish new position also be work watch list weekly review help fossil fosl
698,PRGO,major index be poise higher start tuesday investor look ahead mid term election eye fresh batch corporate earning report nasdaq dow future gain ground ahead open bell steven madden shoo report third quarter earning cent share top view cent shoe maker revenue rise beating estimate company say see full year ep vs street view perrigo prgo deliver fiscal profit cent share cent consensus drug maker revenue rise miss view perrigo do issue bullish full year earning projection share vs view other highly rate stock slate report earning later today include synchronoss technology sncr radiant system rad
699,PRGO,general market be choppy expect lead stock show mixed result be falter soon be carve new basis even major index whip be just fine add polish uptrend generac holding gnrc be excellent example difficulty
700,PRGO,recently stock news chart mainly haven be top rank industry group
701,PRGO,average group ranking stock monday edition be group fact stock highest rank industry list be perrigo prgo medical generic drug rank monday ibd just week be fourth
702,PRGO,drugmaker have notch week winning streak begin jan week come average volume chart show latest quarter earning grow sale rise
703,PRGO,ranking be good characteristic be exception lately
704,PRGO,arlington asset investment ai be member low rank group rd rank finance investment management industry
705,PRGO,arlington industry have horrid ranking be recover stock be rise find support week move average
706,PRGO,fundamentally wreck investment company have see sale slip straight quarters wall street analyst don expect firm see earning growth
707,PRGO,be monday maker chip set athero communication athr pass buy point end level cup handle pattern
708,PRGO,heaviest volume base be week jan stock fall negative feature chart
709,PRGO,athero be rank electronic semiconductor industry group recently stock news chart mainly haven be top rank industry group average group ranking stock monday edition be group fact stock highest rank industry list be perrigo prgo medical generic drug rank monday ibd just week be fourth drugmaker have notch week winning streak begin jan week come average volume chart show latest quarter earning grow sale rise ranking be good characteristic be exception lately arlington asset investment ai be member low rank group rd rank finance investment management industry arlington industry have horrid ranking be recover stock be rise find support week move average fundamentally wreck investment company have see sale slip straight quarters wall street analyst don expect firm see earning growth be monday maker chip set athero communication athr pass buy point end level cup handle pattern heaviest volume base be week jan stock fall negative feature chart athero be rank electronic semiconductor industry group
710,PRGO,stock bolt higher friday most index hit multiyear high market view much await job report friendly way
711,PRGO,nasdaq jump dow jone industrial average rise gain volume climb nyse dip nasdaq accord preliminary datum
712,PRGO,hasn see level december dow end time peak see october nasdaq end shy term peak see september turn be highest november
713,PRGO,strongest news have be government revise higher nonfarm payroll result prior month addition worker economy january be expect take together economist see reason hope labor market be heal new consumer power appear month ahead
714,PRGO,big disappointment come unemployment rate tick even stat be see positively sense new life labor market long term unemployed be million be re enter search job
715,PRGO,google goog add fast trade new time high tech giant account nasdaq be trading upper limit buy range establish cup handle buy point stock have strong ibd composite rating lift support day move average last week follow better expect quarterly earning report search king be generate headline friday due move resolve eu antitrust investigation
716,PRGO,commvault system cvlt climb grab new high datum backup recovery specialist be past buy point ascend base
717,PRGO,generic drugmaker perrigo prgo gap fly triple pace trade michigan base company say fiscal earning rise share nickel consensus revenue rise clear expectation wide margin company also announce acquisition velcera maker flea tick treatment petarmor
718,PRGO,eastman chemical emn jump big turnover also touch fresh time high late thursday chemical producer report fourth quarter ep match forecast revenue miss view hike ep guidance expectation stock stand past buy point week tight pattern be wednesday ibd
719,PRGO,ingredion ingr slump heavy turnover undercut support day line maker starch sweetener other food ingredient be monday ibd have fall lineup wednesday
720,PRGO,bonanza creek energy bcei drop base oil producer price offer share sell shareholder project black bear lp share also increase size offer share
721,PRGO,netsuite stage ugly downside reversal move gain loss time average appear better expect earning report enterprise software maker end flat base entry stock bolt higher friday most index hit multiyear high market view much await job report friendly way nasdaq jump dow jone industrial average rise gain volume climb nyse dip nasdaq accord preliminary datum hasn see level december dow end time peak see october nasdaq end shy term peak see september turn be highest november strongest news have be government revise higher nonfarm payroll result prior month addition worker economy january be expect take together economist see reason hope labor market be heal new consumer power appear month ahead big disappointment come unemployment rate tick even stat be see positively sense new life labor market long term unemployed be million be re enter search job google goog add fast trade new time high tech giant account nasdaq be trading upper limit buy range establish cup handle buy point stock have strong ibd composite rating lift support day move average last week follow better expect quarterly earning report search king be generate headline friday due move resolve eu antitrust investigation commvault system cvlt climb grab new high datum backup recovery specialist be past buy point ascend base generic drugmaker perrigo prgo gap fly triple pace trade michigan base company say fiscal earning rise share nickel consensus revenue rise clear expectation wide margin company also announce acquisition velcera maker flea tick treatment petarmor eastman chemical emn jump big turnover also touch fresh time high late thursday chemical producer report fourth quarter ep match forecast revenue miss view hike ep guidance expectation stock stand past buy point week tight pattern be wednesday ibd ingredion ingr slump heavy turnover undercut support day line maker starch sweetener other food ingredient be monday ibd have fall lineup wednesday bonanza creek energy bcei drop base oil producer price offer share sell shareholder project black bear lp share also increase size offer share netsuite stage ugly downside reversal move gain loss time average appear better expect earning report enterprise software maker end flat base entry
722,PRGO,stock shake early wobble squeeze scant gain friday volume end mixed
723,PRGO,dow jone industrial average nasdaq nose cede small change
724,PRGO,volume be mixed slightly higher nasdaq lower nyse accord preliminary datum
725,PRGO,china inflation rise year year december highest month more expect bloomberg survey predict gain report stoke fear beij pull back easy money policy stimulus plan shanghai composite have be improve sank
726,PRGO,best buy bby soar heavy trade struggle electronic retailer holiday season sale come flat better expect
727,PRGO,cognizant technology ctsh gap average volume move have be sympathy gain peer infosys infy surge december quarter result cognizant plan report fourth quarter result feb stock clear cup handle base buy point december be now buy point
728,PRGO,sodastream international soda climb citigroup start coverage buy rating stock be bounce back reverse multiyear high heavy trading monday stock be still past buy point cup handle base
729,PRGO,perrigo prgo gap loss heavy trade drug maker correct november have be climb right side possible base stock drop back day move average
730,PRGO,watson pharmaceutical wpi gap day move average lose fast trade be cut neutral buy goldman sachs watson have just regain day line thursday stock have be bounce back fall handle buy point jan stock shake early wobble squeeze scant gain friday volume end mixed dow jone industrial average nasdaq nose cede small change volume be mixed slightly higher nasdaq lower nyse accord preliminary datum china inflation rise year year december highest month more expect bloomberg survey predict gain report stoke fear beij pull back easy money policy stimulus plan shanghai composite have be improve sank best buy bby soar heavy trade struggle electronic retailer holiday season sale come flat better expect cognizant technology ctsh gap average volume move have be sympathy gain peer infosys infy surge december quarter result cognizant plan report fourth quarter result feb stock clear cup handle base buy point december be now buy point sodastream international soda climb citigroup start coverage buy rating stock be bounce back reverse multiyear high heavy trading monday stock be still past buy point cup handle base perrigo prgo gap loss heavy trade drug maker correct november have be climb right side possible base stock drop back day move average watson pharmaceutical wpi gap day move average lose fast trade be cut neutral buy goldman sachs watson have just regain day line thursday stock have be bounce back fall handle buy point jan
731,PRGO,now be week july follow day confirm current market uptrend so surprise many highly rate stock be well extend breaking move proper buy range generally expect lead stock win too long follow make big move latest weekly review lineup hospital operator hca holding hca paint retailer sherwin william shw be stock have be hit new week high lift further buy range stock re not current shareholder want new buy opportunity uptrending market lead stock often provide second chance briefly drop week move average then rebound weekly review name mellanox technology mlnx appear be display type action israeli tech stock sell last week news longtime cfo plan retire now try lift support week line so far volume hasn come strongly do last week retreat mellanox have earn strong ibd rating nearly category lately accumulation distribution rating have slip reflect recent sell be still lead stock be buy zone consider dick sporting good dks have be reach new time high sporting good retailer have top buy point week flat base part larger base base pattern stock be trading less so still possible buy zone dick strength include big gain ep past quarters revenue growth have be modest weekly review stock dick retail leisure product industry group be cabela cab be well extend
732,PRGO,quite few stock respectable ibd rating touch new high tuesday broad market re-cover monday downside reversal allot communication allt advanced average volume reach fresh peak israeli networking gear maker break base march run nicely early then consolidated week
733,PRGO,worry eurozone crisis concern slow growth have make volatile market condition recent week leader be show more constructive action be trading basis apple aapl be close buy point cup handle base stock have quickly rebound selling disappointing quarterly result nearly week
734,PRGO,stock hold most gain late thursday weak job consumer price datum boost hope federal reserve take action stimulate economy dow jone industrial average be climb nasdaq rise volume be slightly nasdaq nyse compare
735,PRGO,lead stock show mixed action past week stage breakout other struggle
736,PRGO,questcor pharmaceutical qcor jump past buy point cup handle base strong turnover
737,PRGO,questcor get lift upbeat note ladenburg thalman analyst raise price target stock
738,PRGO,highly rate drug maker perrigo prgo top buy point flat base
739,PRGO,mellanox technology mlnx be lead stock have show discourage action try break
740,PRGO,israeli maker interconnect product computer network climb cup entry different session
741,PRGO,mellanox couldn close level instead finishing session lows day negative price reversal be not want see attempt friday mellanox do manage close buy point volume be average
742,PRGO,discount clothing retailer ross store rost manage close buy point flat base daily volume be light side most week finally nudge average friday
743,PRGO,prefer see huge turnover stock climb consolidation
744,PRGO,ibd current outlook turn confirm uptrend so now time check watch list leader breaking basis
745,PRGO,sxc health solution sxci pharmacy benefit manager have form flat base buy point sxc also have be find support week move average
746,PRGO,gnc holding gnc be etching new base still need more time nutritional product retailer hit new low pattern friday
747,PRGO,gnc appear be find support level also see regain week move average find support key line
748,PRGO,alexion pharmaceutical alxn be shape flat base conventional buy point
749,PRGO,drugmaker joined last month also appear have tack handle provide lower buy point
750,PRGO,week ibd index gain
751,PRGO,meanwhile nasdaq rise nyse composite lead stock show mixed action past week stage breakout other struggle questcor pharmaceutical qcor jump past buy point cup handle base strong turnover questcor get lift upbeat note ladenburg thalman analyst raise price target stock highly rate drug maker perrigo prgo top buy point flat base mellanox technology mlnx be lead stock have show discourage action try break israeli maker interconnect product computer network climb cup entry different session mellanox couldn close level instead finishing session lows day negative price reversal be not want see attempt friday mellanox do manage close buy point volume be average discount clothing retailer ross store rost manage close buy point flat base daily volume be light side most week finally nudge average friday prefer see huge turnover stock climb consolidation ibd current outlook turn confirm uptrend so now time check watch list leader breaking basis sxc health solution sxci pharmacy benefit manager have form flat base buy point sxc also have be find support week move average gnc holding gnc be etching new base still need more time nutritional product retailer hit new low pattern friday gnc appear be find support level also see regain week move average find support key line alexion pharmaceutical alxn be shape flat base conventional buy point drugmaker joined last month also appear have tack handle provide lower buy point week ibd index gain meanwhile nasdaq rise nyse composite
752,PRGO,stock rushed ahead wednesday big volume be miss nasdaq leap nyse composite add small cap lead surge median gain ibd be want hear ibd analysis today market emerge stock click here watch market wrap video
753,PRGO,stock rebound morning lows nudge nasdaq positive territory turn other major index flat nasdaq be earlier fall much dow jone industrial average rise less slip less volume be major exchange blue chip microsoft msft
754,PRGO,stock be session lows midday thursday early rally give way dow jone industrial average nasdaq be volume be tracking higher board perrigo prgo drop erased wednesday advance stock reset base count earlier month be nearly week new base perrigo be week high relative strength line be already new high hansen natural han fall fast trading stock remain past buy point lopsided cup handle base clear tuesday hansen base be third stage structure autozone azo reversed fresh record high lose fast trade fall buy point clear wednesday come lighter ideal volume upside dollar tree dltr add be pace fourth straight gain deep discount retailer announce accelerate share buyback program be part repurchase announce june bank remain day top perform group warren buffett announce plan invest bank america bac bofa have trim gain morgan stanley ms well fargo wfc be respectively
755,PRGO,stock relinquish gain be still poise finish higher first time session nyse composite pare gain nasdaq be respectively be comfortably session peak volume be tracking lower board open text otex rise brisk trading putt back buy point double bottom base break july lack volume earlier wednesday maker content management software say buy case management software firm global perrigo prgo trim gain volume have also tone earlier stock clear left side week saucer base rival shire pharmaceutical shpgy rally brand new high heavy trading take buy point week flat base shire be irish drugmaker develop treatment attention deficit hyperactivity genetic disorder downside adtran adtn be session low still huge volume late tuesday communication gear maker deliver earning view give weak third quarter sale outlook company expect revenue be flat mid single digit sequential basis currently estimate call sale second quarter close restaurant giant yum brand yum unveil result operator pizza hut taco bell chain be expect earn cent share year sale be slate rise share be ahead report
756,PRGO,year patent expiration price crash drugmaker lose much market share generic rival chill prospect pfizer pfe cholesterol fighter lipitor world best selling drug go patent later year
757,PRGO,pfizer other holder expire blockbuster patent do have hope ask fda approval sell drug counter otc
758,PRGO,price be much lower still face generic rival selling script store brand copy better nothing prescription otc switch drugmaker ac cess more customer fda grant year otc exclusivity discourage generic prescription rival
759,PRGO,regulator concern safety oversight block drugmaker otc ambition expect flood application put now prescription drug pharmacy shelve
760,PRGO,believe next year product represent brand prescription sale move counter say joseph papa ceo perrigo prgo leader store brand otc drug
761,PRGO,counter drug don ring multibillion dollar sale patented hit lipitor several boast annual sale note laura mahecha industry manager health care practice kline co otc winner include allergy drug claritin zyrtec well heartburn treatment prevacid prilo sec
762,PRGO,counter table
763,PRGO,still otc option isn always so simple
764,PRGO,drugmaker don talk switch application pfizer do not respond interview request ibd industry watcher believe have be try unsuccessfully year gain otc approval lipitor viagra pfizer be also seek extend impotence drug patent
765,PRGO,don think question ve be push switch several year say steve francesco consultant specialize otc switch head eponymous francesco international
766,PRGO,fda typically raise question wisdom otc sale script drug pfizer fda have likely be go back forth safety otc lipitor viagra say
767,PRGO,ve get make sure population used used properly say dose example be issue viagra be good be better drugstore cowboy reason accord francesco high cholesterol require periodic testing do doctor be not involved
768,PRGO,prescription full counter access be third way
769,PRGO,expire patent holder seek counter status consumer need pharmacist approval such nonprescription medication more common europe well know example here be plan drug used woman fear contraception effort have fail be available only counter
770,PRGO,be dramatic growth rx counter switch francesco add top candidate include cholesterol incontinence insomnia treatment
771,PRGO,currently just few smaller insurer reimburse otc drug francesco expect greater reimbursement time
772,PRGO,eventually otc brand face generic imitation store brand make like cvs cvs wal mart wmt wag
773,PRGO,store brand hold otc market grow
774,PRGO,believe store brand ultimately get share say perrigo ceo papa
775,PRGO,even store brand rival pricing pressure be not great otc note suntrust robinson humphrey analyst frank pinkerton year patent expiration price crash drugmaker lose much market share generic rival chill prospect pfizer pfe cholesterol fighter lipitor world best selling drug go patent later year pfizer other holder expire blockbuster patent do have hope ask fda approval sell drug counter otc price be much lower still face generic rival selling script store brand copy better nothing prescription otc switch drugmaker ac cess more customer fda grant year otc exclusivity discourage generic prescription rival regulator concern safety oversight block drugmaker otc ambition expect flood application put now prescription drug pharmacy shelve believe next year product represent brand prescription sale move counter say joseph papa ceo perrigo prgo leader store brand otc drug counter drug don ring multibillion dollar sale patented hit lipitor several boast annual sale note laura mahecha industry manager health care practice kline co otc winner include allergy drug claritin zyrtec well heartburn treatment prevacid prilo sec counter table still otc option isn always so simple drugmaker don talk switch application pfizer do not respond interview request ibd industry watcher believe have be try unsuccessfully year gain otc approval lipitor viagra pfizer be also seek extend impotence drug patent don think question ve be push switch several year say steve francesco consultant specialize otc switch head eponymous francesco international fda typically raise question wisdom otc sale script drug pfizer fda have likely be go back forth safety otc lipitor viagra say ve get make sure population used used properly say dose example be issue viagra be good be better drugstore cowboy reason accord francesco high cholesterol require periodic testing do doctor be not involved prescription full counter access be third way expire patent holder seek counter status consumer need pharmacist approval such nonprescription medication more common europe well know example here be plan drug used woman fear contraception effort have fail be available only counter be dramatic growth rx counter switch francesco add top candidate include cholesterol incontinence insomnia treatment currently just few smaller insurer reimburse otc drug francesco expect greater reimbursement time eventually otc brand face generic imitation store brand make like cvs cvs wal mart wmt wag store brand hold otc market grow believe store brand ultimately get share say perrigo ceo papa even store brand rival pricing pressure be not great otc note suntrust robinson humphrey analyst frank pinkerton
776,PRGO,major stock average extend gain midday friday have regain more third thursday loss positive headline europe upbeat sentiment datum fuel friday gain nasdaq climb dow jone industrial average rise volume be tracking roughly even nyse touch lower nasdaq
777,PRGO,stock lose more ground thursday fear combination tax hike spending cut set take effect end year continue weigh market nasdaq swoon slump dow jone industrial average fall volume fall nyse nasdaq compare
778,PRGO,stock drop increase volume tuesday snap day winning streak come decline trade want hear ibd analysis today market emerge stock click here watch market wrap video nasdaq nyse lose shed volume rise moderately monday level be slightly average market
779,PRGO,stock reversed lower dollar rally tuesday
780,PRGO,stock reversed lower dollar rally tuesday
781,PRGO,want hear ibd analysis today market emerge stock click here watch latest market wrap video
782,PRGO,nyse composite slump nasdaq dow volume jump board give major index distribution day distribution day few week derail rally
783,PRGO,distribution day involve sizable loss major index rise volume point institutional selling
784,PRGO,number leader sell heavy volume tuesday
785,PRGO,china new borun born reversed open gain dive heavy trading reversal erased nearly monday work stock be still trading week move average
786,PRGO,alcohol producer announce board member resign china new borun report earning nov analyst see profit rise cent share china new borun have previously deliver straight quarters triple digit growth
787,PRGO,zhongpin hog gap tumble nearly triple average volume chinese pork producer report earning sale view get hit downgrade zhongpin now sit record high reach thursday
788,PRGO,perrigo prgo reversed lower drop slice day move average stock trim loss nearly hit day line maker generic drug fall sympathy teva pharmaceutical teva
789,PRGO,court block teva selling generic version brain cancer treatment temodar be make merck mrk teva lose fraction
790,PRGO,silver wheaton slw reversed new high shed volume swell nearly share busiest year silver price reversed year high chicago mercantile exchange be raise margin silver future contract
791,PRGO,ebix ebix turn gain loss share turn tail software provider beating view jump earning rise sale
792,PRGO,upside priceline pcln gap gain nearly triple average volume stock close session lows late monday online travel service provider smash expectation rise earning rise sale stock have gain clear buy point rare short stroke pattern aug
793,PRGO,close job job fall deliver result view
794,PRGO,top rate stock report earning wednesday include advance auto part aap home inn hotel management hmin macy maidenform brand mfb
795,PRGO,want hear ibd analysis today market emerge stock click here watch latest market wrap video
796,PRGO,nyse composite slump nasdaq dow volume jump board give major index distribution day distribution day few week derail rally
797,PRGO,distribution day involve sizable loss major index rise volume point institutional selling
798,PRGO,number leader sell heavy volume tuesday
799,PRGO,china new borun born reversed open gain dive heavy trading reversal erased nearly monday work stock be still trading week move average
800,PRGO,alcohol producer announce board member resign china new borun report earning nov analyst see profit rise cent share china new borun have previously deliver straight quarters triple digit growth
801,PRGO,zhongpin hog gap tumble nearly triple average volume chinese pork producer report earning sale view get hit downgrade zhongpin now sit record high reach thursday
802,PRGO,perrigo prgo reversed lower drop slice day move average stock trim loss nearly hit day line maker generic drug fall sympathy teva pharmaceutical teva
803,PRGO,court block teva selling generic version brain cancer treatment temodar be make merck mrk teva lose fraction
804,PRGO,silver wheaton slw reversed new high shed volume swell nearly share busiest year silver price reversed year high chicago mercantile exchange be raise margin silver future contract
805,PRGO,ebix ebix turn gain loss share turn tail software provider beating view jump earning rise sale
806,PRGO,upside priceline pcln gap gain nearly triple average volume stock close session lows late monday online travel service provider smash expectation rise earning rise sale stock have gain clear buy point rare short stroke pattern aug
807,PRGO,close job job fall deliver result view
808,PRGO,top rate stock report earning wednesday include advance auto part aap home inn hotel management hmin macy maidenform brand mfb nyse composite slump nasdaq dow volume jump board give major index distribution day distribution day few week derail rally distribution day involve sizable loss major index rise volume point institutional selling number leader sell heavy volume tuesday china new borun born reversed open gain dive heavy trading reversal erased nearly monday work stock be still trading week move average alcohol producer announce board member resign china new borun report earning nov analyst see profit rise cent share china new borun have previously deliver straight quarters triple digit growth zhongpin hog gap tumble nearly triple average volume chinese pork producer report earning sale view get hit downgrade zhongpin now sit record high reach thursday perrigo prgo reversed lower drop slice day move average stock trim loss nearly hit day line maker generic drug fall sympathy teva pharmaceutical teva court block teva selling generic version brain cancer treatment temodar be make merck mrk teva lose fraction silver wheaton slw reversed new high shed volume swell nearly share busiest year silver price reversed year high chicago mercantile exchange be raise margin silver future contract ebix ebix turn gain loss share turn tail software provider beating view jump earning rise sale upside priceline pcln gap gain nearly triple average volume stock close session lows late monday online travel service provider smash expectation rise earning rise sale stock have gain clear buy point rare short stroke pattern aug close job job fall deliver result view top rate stock report earning wednesday include advance auto part aap home inn hotel management hmin macy maidenform brand mfb
809,PRGO,major index win back lose ground early action monday follow big sell end last week
810,PRGO,nasdaq rise dow nyse composite dow volume tumble board compare friday option expiration inflate level
811,PRGO,chip stock notch early gain cirrus logic crus xilinx xlnx gain altera altr add philadelphia semiconductor index jump early trading
812,PRGO,downside baidu bidu fall brisk trade chinese internet search engine provider stock slash day move average china cctv report baidu other search engine have profit promotion web site sell counterfeit drug
813,PRGO,perrigo prgo skid heavy volume drugmaker stock gap hit resistance day move average past several week major index win back lose ground early action monday follow big sell end last week nasdaq rise dow nyse composite dow volume tumble board compare friday option expiration inflate level chip stock notch early gain cirrus logic crus xilinx xlnx gain altera altr add philadelphia semiconductor index jump early trading downside baidu bidu fall brisk trade chinese internet search engine provider stock slash day move average china cctv report baidu other search engine have profit promotion web site sell counterfeit drug perrigo prgo skid heavy volume drugmaker stock gap hit resistance day move average past several week
814,PRGO,stock continue drift modestly lower territory thursday afternoon dow nyse composite fall nasdaq dip volume be tracking lower board perrigo prgo lose erase wednesday gain breach day move average stock relative price strength rating have drop weak leader tend have rs rating greater steven madden shoo fall putt further south day line clear week consolidation nov now buy point shoe designer profit growth slow past quarters upside anadarko petroleum apc buck weakness oil producer gap gain heavy trading takeover chatter daily mail report mining titan bhp billiton bhp make bid oil gas producer anadarko be more session peak check point software technology chkp be session peak still active trading earlier stock touch highest level nearly year check point have gain more clear handle buy point security software maker earning grow past quarters sale growth range same period
815,PRGO,stock have pare loss remain modestly lower early afternoon trading thursday nyse composite fall drag homebuilder build related group earlier realtytrac report record foreclosure august meanwhile lose nasdaq dow major index be session lows turnover continue track lower board chang china bistro pfcb drop huge trade company news stock have already trade nearly time average volume chang fall buy point handle double bottom base stock have be isn top rate stock earning share rank be meaning market be grow earning faster dress barn dbrn drop heavy trading late wednesday apparel retailer report fiscal earning view stock appear be find support day move average too be not top stock due mediocre price performance perrigo prgo reversed new record high fall fast trade earlier stock clear buy point month cup base upside osi system osis bolt new record high heavy trading earlier diversify manufacturer say win contract worth transportation security administration ray inspection system figure be more half osi sale fiscal sina sina rally year high heavy trading put past buy point cup handle base clear wednesday accord bloomberg stock jump prospect weibo blog service elsewhere gold pull back hit record high december contract climb ounce earlier hit new high ounce
816,PRGO,stock be higher early tuesday afternoon reverse earlier loss improvement labor market sign greece be make progress plan avoid disorderly default nasdaq rise have be early trading dow jone industrial average be rebound earlier decline volume index be slightly positive compare same time monday greek official be draft proposal european union bailout need avoid default upset credit market damage global economy plan be approve parliament be scene protest tuesday austerity measure aim pare government debt meanwhile number job opening rise nearly year high december raise hope hire continue pick boee ba caterpillar cat pare earlier loss coca cola ko rise heavy trade sale profit top wall street view generic drug maker perrigo prgo ibd stock gap more profit climb vs year rise sale beat wall street estimate do company forecast company say release generic version popular counter drug mucinex allegra prevacid next month perrigo share have retreat hit time high dec relative strength rating be modest earning share rating be putt top stock coinstar cstr blast higher massive volume soar buy point company own kiosk base movie rental operation redbox report late monday earning rise share more expectation revenue jump also clobber estimate bellevue wash base company also say acquire ncr entertainment operation include blockbuster express rental kiosk management software provider solarwind swi rocket more report earning cent share expectation cent revenue surge vs forecast company earning guidance be line expectation revenue guidance top analyst forecast ibd leaderboard stock clear buy point base feb be now buy point sport bar grill chain buffalo wild wing bwld panera bread pnra other leaderboard stock be due report earning close tuesday buffalo wild wing profit be expect climb sale gain analyst downgrade company monday advance report rise food cost share close heavy volume be tuesday strong volume stock be range buy point support day line week tight pattern have also form potential buy point panera be strong volume tuesday ahead earning report be expect show rise profit gain revenue stock be extend past buy point flat base buy stock be more entry point be risky also tuesday yum brand yum rise record high day profit beat view strong sale china overall revenue operator kfc pizza hut fast food restaurant rise third straight quarter accelerate sale growth biggest gain year meanwhile credit card giant visa be expect report wednesday profit rise increase sale stock pop new high thursday rival mastercard report strong quarterly result mastercard also be ibd visa share be slightly early afternoon trading be buy range buy point flat base
817,PRGO,major stock index improve most back session high midday wednesday dow climb thank gain traveler trv ibm ibm weakness chip sector nasdaq edge earlier goldman sachs downgrade micron technology mu maxim integrate mxim philadelphia semiconductor index drop meanwhile be flat nyse composite dip volume turn lower exchange perrigo prgo climb fast trade near buy point cup base stock accumulation distribution rating have improve perrigo be generic drugmaker note firm profit growth have slow recent quarters sina sina be session peak still heavy trading earlier stock clear buy point cup handle base sina have already trade more share vs average daily volume share last year chinese internet portal operator earning fall analyst see jump year green mountain coffee roaster gmcr reversed open loss gain tuesday coffee distributor slip agree buy canadian rival van houtte deal value green mountain clear buy point high handle have gain also ve identify lower buy range find support day move average
818,PRGO,major index thursday notch gain least first time week nasdaq show way gain nyse composite add respectively dow tack volume be nasdaq nyse heavy volume
819,PRGO,lead stock earning report appear be winning combination tuesday top stock haul market temporary gain open nasdaq give early gain be ease less dow jone industrial average be fraction early trade volume be trace higher
820,PRGO,slew drug company insurer other medical related stock healthy ibd list be deck report third quarter earning next week first tuesday be impax laboratory ipxl develop drug treat migraine parkinson davita dva provide kidney dialysis service analyst forecast impax morning post earning be
821,PRGO,doubt re tough market even aug follow day condition be rocky due worry global economy
822,PRGO,many breakout have occur short basis big winner have be few be struggle have return gain tough time follow rule be crucial sell stock fall purchase price
823,PRGO,arco dorado arco be rare winner april ipo be new high extend past buy point cup base too have experience volatility arco dorado initially clear entry aug trigger sell rule session later clear buy point again aug
824,PRGO,company be world biggest mcdonald mcd franchisee more restaurant latin america last year deliver gain earning analyst poll thomson reuter see profit rise year
825,PRGO,hansen natural han rebound bounce day move average now extend past buy point cup handle base last month distributor monster energy drink beat view rise earning total revenue climb monster drink sale jump account more hansen gross sale
826,PRGO,perrigo prgo have trigger sell rule clear short shape base aug
827,PRGO,ambev abv be close be buy point stock appear be find support day line
828,PRGO,athenahealth athn clear own short consolidation stock come right back next day market sell be now back new high
829,PRGO,mastercard fizzle breaking square box stock have regain vigor rally straight day thursday surpass buy point heavy volume
830,PRGO,nu skin enterprise nus dollar tree dltr dollar general dg be back slightly recent buy point
831,PRGO,more half ibd stock fall week
832,PRGO,average change be skewer ulta salon cosmetic fragrance ulta surge week doubt re tough market even aug follow day condition be rocky due worry global economy many breakout have occur short basis big winner have be few be struggle have return gain tough time follow rule be crucial sell stock fall purchase price arco dorado arco be rare winner april ipo be new high extend past buy point cup base too have experience volatility arco dorado initially clear entry aug trigger sell rule session later clear buy point again aug company be world biggest mcdonald mcd franchisee more restaurant latin america last year deliver gain earning analyst poll thomson reuter see profit rise year hansen natural han rebound bounce day move average now extend past buy point cup handle base last month distributor monster energy drink beat view rise earning total revenue climb monster drink sale jump account more hansen gross sale perrigo prgo have trigger sell rule clear short shape base aug ambev abv be close be buy point stock appear be find support day line athenahealth athn clear own short consolidation stock come right back next day market sell be now back new high mastercard fizzle breaking square box stock have regain vigor rally straight day thursday surpass buy point heavy volume nu skin enterprise nus dollar tree dltr dollar general dg be back slightly recent buy point more half ibd stock fall week average change be skewer ulta salon cosmetic fragrance ulta surge week
833,PRGO,most ibd stock have add gain last week relief rally market condition remain challenge new breakout also leader be well extend buy point
834,PRGO,nevertheless number elite stock keep work basis have moved closer possible entry point such ancestry com acom catalyst health solution chsi priceline com pcln
835,PRGO,ancestry be form right side new base part larger base base structure family history come public have draw increase institutional sponsorship stock tack handle potential buy point be
836,PRGO,catalyst pharmacy benefit manager regain week move average last week keep consolidate still high
837,PRGO,priceline longtime leader be etching third stage base possible entry volume have be light online travel broker have shape consolidation right side priceline manage clear want see strong turnover move
838,PRGO,other base ibd name be chip designer altera altr medical waste handler stericycle srcl former however have fall sharply week accumulation distribution rating have dive worst possible
839,PRGO,generic drug producer perrigo prgo break past new buy point solid volume wednesday close slightly price add gain thursday buck market decline close slightly proper entry point
840,PRGO,leader try break last week quickly run trouble vmware vmw stand trigger top wednesday july accretive health provide financial service health care organization surge base wednesday quickly make bearish reversal
841,PRGO,ugg boot maker decker outdoor deck carbo ceramic crr provide key product oil gas firm top buy point volume be unconvincing
842,PRGO,illumina ilmn jump past entry point tuesday july finished week level still developer genetic analysis tool hasn trigger sell rule
843,PRGO,week end july ibd stock rise average nasdaq rise advanced nyse dip most ibd stock have add gain last week relief rally market condition remain challenge new breakout also leader be well extend buy point nevertheless number elite stock keep work basis have moved closer possible entry point such ancestry com acom catalyst health solution chsi priceline com pcln ancestry be form right side new base part larger base base structure family history come public have draw increase institutional sponsorship stock tack handle potential buy point be catalyst pharmacy benefit manager regain week move average last week keep consolidate still high priceline longtime leader be etching third stage base possible entry volume have be light online travel broker have shape consolidation right side priceline manage clear want see strong turnover move other base ibd name be chip designer altera altr medical waste handler stericycle srcl former however have fall sharply week accumulation distribution rating have dive worst possible generic drug producer perrigo prgo break past new buy point solid volume wednesday close slightly price add gain thursday buck market decline close slightly proper entry point leader try break last week quickly run trouble vmware vmw stand trigger top wednesday july accretive health provide financial service health care organization surge base wednesday quickly make bearish reversal ugg boot maker decker outdoor deck carbo ceramic crr provide key product oil gas firm top buy point volume be unconvincing illumina ilmn jump past entry point tuesday july finished week level still developer genetic analysis tool hasn trigger sell rule week end july ibd stock rise average nasdaq rise advanced nyse dip
844,PRGO,stock market remain broadly weak early afternoon trading monday many lead stock gap nasdaq nyse composite be volume be lower nyse slightly higher nasdaq technology health care metal industrial stock be market poorest area nearly ibd
845,PRGO,stock remain modestly lower late trading monday pace third straight loss
846,PRGO,nasdaq nyse composite drop slip nasdaq volume be tracking sharply higher nyse trade be now tracking tad higher
847,PRGO,silver wheaton slw fall heavy trading stock pop week consolidation april have fail make much headway silvercorp metal svm also lose silver price re-trace bulk intraday gain monday push further year high earlier
848,PRGO,alcoa aa erased earlier gain fall nearly ahead first quarter result close analyst poll thomson reuter see aluminum product company earning surge cent share sale be slate climb
849,PRGO,upside perrigo prgo gap gain record high stock break jan recently springboard week move average perrigo make drug well diagnostic nutritional product
850,PRGO,retailer limit brand ltd rise more heavy trading put stock past buy point cup handle base break april last week operator bath body work victorium secret report surge march same store sale smash estimate increase stock remain modestly lower late trading monday pace third straight loss nasdaq nyse composite drop slip nasdaq volume be tracking sharply higher nyse trade be now tracking tad higher silver wheaton slw fall heavy trading stock pop week consolidation april have fail make much headway silvercorp metal svm also lose silver price re-trace bulk intraday gain monday push further year high earlier alcoa aa erased earlier gain fall nearly ahead first quarter result close analyst poll thomson reuter see aluminum product company earning surge cent share sale be slate climb upside perrigo prgo gap gain record high stock break jan recently springboard week move average perrigo make drug well diagnostic nutritional product retailer limit brand ltd rise more heavy trading put stock past buy point cup handle base break april last week operator bath body work victorium secret report surge march same store sale smash estimate increase
851,PRGO,ibd market outlook downshift uptrend pressure past week behavior lead stock reflect more challenge environment side few ibd stock still manage break week oracle orcl clear buy point week tight pattern thursday business software giant come
852,PRGO,stock stumble mixed volume wednesday portugal debt situation unnerved market nyse composite slide nasdaq dow step back volume be nyse nasdaq be second distribution day past session nyse link index lighter trade
853,PRGO,stock future be have pull back early high ahead thursday open surprise jump mid atlantic region manufacturing
854,PRGO,dow future trade point fair market value point gain hour earlier nasdaq future hold point gain sticking close earlier high future pull back point gain
855,PRGO,stock market today carry bit less weight shoulder decisively punch past day move average nasdaq gain more altitude important line support wednesday
856,PRGO,investor draw confidence minute fed oct meeting show majority federal open market committee favor rate hike december apple aapl also factor day gain gapping better gain upgrade goldman sachs
857,PRGO,current uptrend still bear heavy load distribution day nasdaq be good cause keep cautious stance new purchase stock flash sell signal
858,PRGO,relatively light economic calendar open labor department report weekly jobless claim ease week end nov prior week economist consensus have forecast pullback claim week move average continue higher mark third straight advance
859,PRGO,philadelphia federal reserve regional manufacturing survey firm november rise beat consensus expectation flat outcome index fall read october follow tally september
860,PRGO,conference board be set release lead economic indicator index october et
861,PRGO,dow unitedhealth unh drop premarket action minnetonka minn base manage care provider trim full year ep guidance consensus view company say claim activity deteriorate individual participation insurance exchange lag
862,PRGO,seller keep pressure retail apparel maker send best buy bby perry ellis pery loss mixed quarterly report buckle bke ton store bont report earning miss stock remain unchanged premarket trade
863,PRGO,keurig green mountain gmcr ahead top premarket action owner cup coffee franchise trounce analyst earning expectation revenue fall less forecast management boost quarterly dividend cent keurig share end wednesday november high
864,PRGO,salesforce com crm jab bell ep leap gain revenue narrowly clear analyst consensus projection revenue earning projection be line analyst view management hoist full year ep guidance just consensus software service leader end wednesday buy range bit more cup base buy point
865,PRGO,china base play chalk strong premarket move
866,PRGO,ctrip com international ctrp soar higher deliver result online travel site end wednesday buy point double bottom base
867,PRGO,china base micro blog site weibo wb shot premarket trade report ep cent cent share loss year view cent revenue surge better forecast stock finished wednesday deep cup base stock future be have pull back early high ahead thursday open surprise jump mid atlantic region manufacturing dow future trade point fair market value point gain hour earlier nasdaq future hold point gain sticking close earlier high future pull back point gain stock market today carry bit less weight shoulder decisively punch past day move average nasdaq gain more altitude important line support wednesday investor draw confidence minute fed oct meeting show majority federal open market committee favor rate hike december apple aapl also factor day gain gapping better gain upgrade goldman sachs current uptrend still bear heavy load distribution day nasdaq be good cause keep cautious stance new purchase stock flash sell signal relatively light economic calendar open labor department report weekly jobless claim ease week end nov prior week economist consensus have forecast pullback claim week move average continue higher mark third straight advance philadelphia federal reserve regional manufacturing survey firm november rise beat consensus expectation flat outcome index fall read october follow tally september conference board be set release lead economic indicator index october et dow unitedhealth unh drop premarket action minnetonka minn base manage care provider trim full year ep guidance consensus view company say claim activity deteriorate individual participation insurance exchange lag seller keep pressure retail apparel maker send best buy bby perry ellis pery loss mixed quarterly report buckle bke ton store bont report earning miss stock remain unchanged premarket trade keurig green mountain gmcr ahead top premarket action owner cup coffee franchise trounce analyst earning expectation revenue fall less forecast management boost quarterly dividend cent keurig share end wednesday november high salesforce com crm jab bell ep leap gain revenue narrowly clear analyst consensus projection revenue earning projection be line analyst view management hoist full year ep guidance just consensus software service leader end wednesday buy range bit more cup base buy point china base play chalk strong premarket move ctrip com international ctrp soar higher deliver result online travel site end wednesday buy point double bottom base china base micro blog site weibo wb shot premarket trade report ep cent cent share loss year view cent revenue surge better forecast stock finished wednesday deep cup base
868,PRGO,stock deliver best performance almost week automaker gold miner specialty steel housing stock lead pack nasdaq rise nyse composite ibd edge however loss perrigo prgo netease nte weigh index volume rise major exchange
869,PRGO,stock start upside thursday reversed lower mount worry fiscal deal remain elusive nasdaq have be much morning fall even so intraday worst loss be pare final half hour trading dow jone industrial average fall
870,PRGO,stock market be shaky terrible so so great matter be person continue get sick result drug stock be bit defensive play poor market
871,PRGO,drug biom company indeed have figured fairly prominently ibd ranking top stock late volatile time market
872,PRGO,fact medical related stock count fully ibd week oct
873,PRGO,let look just top drug stock lead couple company have rank high couple month be list ibd rank
874,PRGO,alexion pharmaceutical alxn stock have hold well expectation more approve used only drug market soliris now soliris be only drug market approve treat rare blood disorder call paroxysmal nocturnal hemoglobinurium pnh be life threaten drug cost patient full treatment report food drug administration approve soliris use treat disease call atypical hemolytic uremic syndrome ahus european committee medical product human use chmp recommend same indication be extend soliris europe alexion expect final eu approval month stock hit new time high next day close friday stock hit buy point last day august so extend latest earning report be due thursday oct open
875,PRGO,perrigo prgo alexion be medical biotech biom group rank group track ibd perrigo be medical generic drug group perrigo have lead stock group month aug hit buy point have be close friday sell store brand generic drug chain such cvs cvs target tgt next year expect release generic such counter drug johnson johnson jnj prevacid mucinex last week deutsche bank initiate coverage perrigo only hold rating
876,PRGO,celgene celg maker cancer drug recently get good news revlimid successor thalidomide report european regulatory panel put rest concern risk drug cause secondary cancer be step possible big approval drug next year celgene have make thalidomide drug choice treat blood cancer multiple myeloma terrible reputation drug gain use morning sickness treatment lead rash birth defect last year company greatly expand cancer drug effort acquisition abraxis bioscience report time analyst say deal mean celgene be build franchise cancer drug stock hit buy point last month close friday
877,PRGO,watson pharmaceutical wpi maker generic drug range painkiller blood pressure medicine smoking cessation product have perrigo generally do well economic downturn person turn lower cost drug stock be more less steady roll start friday company confirm challenge patent pfizer pfe embeda watson say ask fda approve low cost generic version embeda extend release drug treat moderate severe pain watson say pfizer be sue patent infringement suit mean fda approve watson drug least month suit be settle stock fall friday news
878,PRGO,shire shpgy company be member ibd medical ethical drug group company group rank ireland base shire have be leader group hit time high july fall mean hold fairly well rough week period hold very week line now fall key level much past month specialize treatment rare disease such angiodema hereditary condition cause swell body be life threaten top seller be vyvanse attention deficit hyperactivity disorder adhd
879,PRGO,follow michael krey twitter stock market be shaky terrible so so great matter be person continue get sick result drug stock be bit defensive play poor market drug biom company indeed have figured fairly prominently ibd ranking top stock late volatile time market fact medical related stock count fully ibd week oct let look just top drug stock lead couple company have rank high couple month be list ibd rank alexion pharmaceutical alxn stock have hold well expectation more approve used only drug market soliris now soliris be only drug market approve treat rare blood disorder call paroxysmal nocturnal hemoglobinurium pnh be life threaten drug cost patient full treatment report food drug administration approve soliris use treat disease call atypical hemolytic uremic syndrome ahus european committee medical product human use chmp recommend same indication be extend soliris europe alexion expect final eu approval month stock hit new time high next day close friday stock hit buy point last day august so extend latest earning report be due thursday oct open perrigo prgo alexion be medical biotech biom group rank group track ibd perrigo be medical generic drug group perrigo have lead stock group month aug hit buy point have be close friday sell store brand generic drug chain such cvs cvs target tgt next year expect release generic such counter drug johnson johnson jnj prevacid mucinex last week deutsche bank initiate coverage perrigo only hold rating celgene celg maker cancer drug recently get good news revlimid successor thalidomide report european regulatory panel put rest concern risk drug cause secondary cancer be step possible big approval drug next year celgene have make thalidomide drug choice treat blood cancer multiple myeloma terrible reputation drug gain use morning sickness treatment lead rash birth defect last year company greatly expand cancer drug effort acquisition abraxis bioscience report time analyst say deal mean celgene be build franchise cancer drug stock hit buy point last month close friday watson pharmaceutical wpi maker generic drug range painkiller blood pressure medicine smoking cessation product have perrigo generally do well economic downturn person turn lower cost drug stock be more less steady roll start friday company confirm challenge patent pfizer pfe embeda watson say ask fda approve low cost generic version embeda extend release drug treat moderate severe pain watson say pfizer be sue patent infringement suit mean fda approve watson drug least month suit be settle stock fall friday news shire shpgy company be member ibd medical ethical drug group company group rank ireland base shire have be leader group hit time high july fall mean hold fairly well rough week period hold very week line now fall key level much past month specialize treatment rare disease such angiodema hereditary condition cause swell body be life threaten top seller be vyvanse attention deficit hyperactivity disorder adhd follow michael krey twitter
880,PRGO,chris bonavico ken broad be not afraid be wrong have enough confidence best investment idea place delaware cap growth fund just stock don want dilute mileage get weigh portfolio backup idea ve be
881,PRGO,stock take drubbing wednesday hit double whammy post election blue bad news europe
882,PRGO,nasdaq swoon dow jone industrial average tumble index have lose much low day volume soar major exchange
883,PRGO,diving new lows correction market lose have be attempt rally worry loom fiscal cliff warning eu economy take toll
884,PRGO,overnight trading december contract trade point discount spot index show thing go wrong contract peaked et london put spot index close tuesday regular session moderate gain be roughly line advance score benchmark tokyo hong kong sydney
885,PRGO,future contract start back rout didn begin noon london et contract steep loss didn bottom hour market open december contract sank low reflect spot value hair low see wednesday regular session
886,PRGO,agrium agu dive badly miss view earlier morning gap move draw monster volume cost stock week line fertilizer maker earning drop share cent view sale fall just vs view agrium also guide profit well analyst expectation
887,PRGO,vitamin shoppe vsi fall pull back tuesday earning inspire pop retreat put stock buy point flat base larger consolidation
888,PRGO,perrigo prgo shave large chunk loss be still blister trade open drugmaker post disappointing fiscal sale perrigo report revenue year first single digit percentage gain quarters miss more
889,PRGO,upside nationstar mortgage nsm end day lose streak rise few penny heavy trade small gain be dramatic come stock have drop much claw back tuesday mortgage servicer report earning miss view penny
890,PRGO,middleby midd reversed higher rise bounce support day line late tuesday maker commercial cook equipment beat expectation earning grow share sale rise edge view upside reversal also put thinly trade stock back buy point flat base
891,PRGO,hospital stock rally president obama victory affirm status quo health care reform tenet healthcare thc jump hca holding hca climb community health system cyh gap gain huge trade heavy volume move power operator acute care hospital buy point stock take drubbing wednesday hit double whammy post election blue bad news europe nasdaq swoon dow jone industrial average tumble index have lose much low day volume soar major exchange diving new lows correction market lose have be attempt rally worry loom fiscal cliff warning eu economy take toll overnight trading december contract trade point discount spot index show thing go wrong contract peaked et london put spot index close tuesday regular session moderate gain be roughly line advance score benchmark tokyo hong kong sydney future contract start back rout didn begin noon london et contract steep loss didn bottom hour market open december contract sank low reflect spot value hair low see wednesday regular session agrium agu dive badly miss view earlier morning gap move draw monster volume cost stock week line fertilizer maker earning drop share cent view sale fall just vs view agrium also guide profit well analyst expectation vitamin shoppe vsi fall pull back tuesday earning inspire pop retreat put stock buy point flat base larger consolidation perrigo prgo shave large chunk loss be still blister trade open drugmaker post disappointing fiscal sale perrigo report revenue year first single digit percentage gain quarters miss more upside nationstar mortgage nsm end day lose streak rise few penny heavy trade small gain be dramatic come stock have drop much claw back tuesday mortgage servicer report earning miss view penny middleby midd reversed higher rise bounce support day line late tuesday maker commercial cook equipment beat expectation earning grow share sale rise edge view upside reversal also put thinly trade stock back buy point flat base hospital stock rally president obama victory affirm status quo health care reform tenet healthcare thc jump hca holding hca climb community health system cyh gap gain huge trade heavy volume move power operator acute care hospital buy point
892,PRGO,stock future pare loss tuesday trading just shade red investor pore heavy docket earning report
893,PRGO,dow future trim point loss just point future be point lower nasdaq future be point
894,PRGO,commodity trader glencore mining heavyweight xstrata agree merger value combine firm base switzerland be largest exporter coal used power plant largest producer copper
895,PRGO,oil price continue ease hold just barrel gold slip fraction ounce
896,PRGO,perrigo prgo hustle ahead open counter generic drug maker report fourth quarter earning share cent analyst expectation revenue jump well analyst view company lift full year earning guidance forecast
897,PRGO,perrigo share be week possible flat base buy point
898,PRGO,colfax clfx tumble premarket trade fourth quarter earning rise fraction cent share cent short analyst view revenue growth fall well short expectation
899,PRGO,stock have be work second rebound week move average follow november
900,PRGO,european stock sag euro pare loss comment dutch vice president european commission say eu monetary union withstand greek exit currency stock china dip shanghai composite
901,PRGO,heavy roster earning report be due close include report netgear ntgr panera bread pnra walt disney cerner cern other stock future pare loss tuesday trading just shade red investor pore heavy docket earning report dow future trim point loss just point future be point lower nasdaq future be point commodity trader glencore mining heavyweight xstrata agree merger value combine firm base switzerland be largest exporter coal used power plant largest producer copper oil price continue ease hold just barrel gold slip fraction ounce perrigo prgo hustle ahead open counter generic drug maker report fourth quarter earning share cent analyst expectation revenue jump well analyst view company lift full year earning guidance forecast perrigo share be week possible flat base buy point colfax clfx tumble premarket trade fourth quarter earning rise fraction cent share cent short analyst view revenue growth fall well short expectation stock have be work second rebound week move average follow november european stock sag euro pare loss comment dutch vice president european commission say eu monetary union withstand greek exit currency stock china dip shanghai composite heavy roster earning report be due close include report netgear ntgr panera bread pnra walt disney cerner cern other
902,PRGO,fidelity contrafund have stay nose ahead broad market aug low barely diversify stock fund have manage process manager have stick knit still believe stock price follow earning say so look company generate average growth pullback
903,PRGO,market be bad shape financial be crash direct indirect exposure european debt crisis industrial be skid global economic wo consumer focuse company be less buffet international shock scare consumer mind firm be thick top ibd list elite stock top lululemon athletica lulu ulta salon
904,PRGO,tight economy be winner loser winner often save consumer money consumer do math often opt store brand counter medication rather pricier name brand desire cut rate drug have spark sale perrigo prgo world largest maker generic perrigo product save consumer
905,PRGO,stock drive lower heavy trade wednesday earning report election result power most action dow jone industrial average dive nasdaq fall volume swell nasdaq nyse compare same time tuesday swarm health care stock buck riptide
906,PRGO,stock be session lows late trading tuesday appear track distribution day nyse composite fall dow nasdaq turnover continue track sharply higher major exchange zhongpin hog gap tumble report result estimate open chinese pork producer say earning fall cent share miss view penny sale grow view zhongpin reversed lower record high thursday global hunter security downgrade share neutral buy perrigo prgo erased earlier gain tumble slice day move average have already trade more time normal daily volume generic drug maker fall sympathy teva pharmaceutical teva court block teva selling generic version brain cancer treatment temodar be make merck mrk mercadolibre meli fall fast trade wipe bulk monday gain mercadolibre have be trading roughly sideway day move average more month job job reversed lower hit year high share fall ahead result close analyst see chinese provider human resource service earn cent share
907,PRGO,stock push new session high snap back day retreat nasdaq rally dow jone industrial average rise component bank america bac gap announce management shake tuesday volume be tracking lower board especially nyse nearly industry group
908,PRGO,stock stage big comeback friday essentially erased thursday large lose european union say most member country be open join new treaty solve financial crisis tune make money stock ibd saturday pm pm pst see listen nasdaq jump
909,PRGO,nothing separate leader laggard market correction even stock appear elite list such ibd true star show worth build basis bearish time drugmaker perrigo prgo be hold fine score gain week see nasdaq fall perrigo advance push new
910,PRGO,delaware select growth fund have biggest chunk asset tech fund buoyancy recent market downtrend come stock several sector stock be still week move average line go tuesday hold solid year date gain include mastercard visa perrigo prgo core laboratory clb
911,PRGO,not think country child only policy be boom market infant formula china have become hottest market supplier be respond step production price
912,PRGO,abbott laboratory say aug investing build new powdered milk plant jiax call largest investment china date abbott spokesman pete paradossi say even child policy baby be born middle kingdom year capture consume more attention resource ever
913,PRGO,grow middle class be really demand higher quality product afford premium price product well paradossi tell ibd child ve get parent ve get set grandparent many time ve get great grandparent want do best child
914,PRGO,player jockey position be perrigo prgo abbott perrigo be better know drugmaker mostly private label counter medicine last year moved infant nutrition business buyout pbm holding
915,PRGO,make label sell
916,PRGO,same day abbott announce new plant perrigo ceo joe papa tell investor conference call asia represent major opportunity infant formula especially company
917,PRGO,believe ve get quality product perrigo say be very important person asia make believe make be important quality advantage vs concern have occur asia infant formula
918,PRGO,papa comment hint darker reason company be do well scandal erupt late melamine be discover chinese powdered milk supply more infant wound hospitalize die july more contaminate powder be seize qinghai
919,PRGO,paradossi say china be begin move right direction quality standard say local supplier still have serious trust problem point milk abbott used chinese formula be import
920,PRGO,melamine scandal hasn prod chinese parent give infant formula accord euromonitor market grow compound annual rate last year morningstar analyst damien conover estimate asia represent infant child nutrition market now
921,PRGO,global market leader be mead johnson nutrition mjn maker enfamil brand rival mead be see much growth come east asia most recent quarter north american sale rise year year sale china hong kong rise
922,PRGO,bristol myer squibb bmy spun mead then mead share have nearly triple even parent have stay roughly flat success spinoff be pfizer pfe say july think selling infant nutrition business
923,PRGO,pfizer have own business just october buy fellow drug giant wyeth unit sell entirely outside be china
924,PRGO,speculation have fly wall street potential buyer include nestle nsrgy swiss food titan have struggle china taint milk scandal own cause withdraw product line
925,PRGO,pfizer weigh spin
926,PRGO,analyst conover say stand alone route be more appeal pfizer
927,PRGO,be just split wouldn have pay much tax hit say sell discrepancy have be offset buyer extent
928,PRGO,euromonitor estimate market keep grow year field be get more crowd establish player know keep rely scandal recall keep rival
929,PRGO,china market be intensely competitive say mead johnson ceo stephen golsby firm conference call yes re investing advertising promotion salesforce expansion re not alone be unexpected continue grow share rate re currently grow not think country child only policy be boom market infant formula china have become hottest market supplier be respond step production price abbott laboratory say aug investing build new powdered milk plant jiax call largest investment china date abbott spokesman pete paradossi say even child policy baby be born middle kingdom year capture consume more attention resource ever grow middle class be really demand higher quality product afford premium price product well paradossi tell ibd child ve get parent ve get set grandparent many time ve get great grandparent want do best child player jockey position be perrigo prgo abbott perrigo be better know drugmaker mostly private label counter medicine last year moved infant nutrition business buyout pbm holding make label sellson same day abbott announce new plant perrigo ceo joe papa tell investor conference call asia represent major opportunity infant formula especially company believe ve get quality product perrigo say be very important person asia make believe make be important quality advantage vs concern have occur asia infant formula papa comment hint darker reason company be do well scandal erupt late melamine be discover chinese powdered milk supply more infant wound hospitalize die july more contaminate powder be seize qinghai paradossi say china be begin move right direction quality standard say local supplier still have serious trust problem point milk abbott used chinese formula be import melamine scandal hasn prod chinese parent give infant formula accord euromonitor market grow compound annual rate last year morningstar analyst damien conover estimate asia represent infant child nutrition market now global market leader be mead johnson nutrition mjn maker enfamil brand rival mead be see much growth come east asia most recent quarter north american sale rise year year sale china hong kong rise bristol myer squibb bmy spun mead then mead share have nearly triple even parent have stay roughly flat success spinoff be pfizer pfe say july think selling infant nutrition business pfizer have own business just october buy fellow drug giant wyeth unit sell entirely outside be china speculation have fly wall street potential buyer include nestle nsrgy swiss food titan have struggle china taint milk scandal own cause withdraw product line pfizer weigh spin offanalyst conover say stand alone route be more appeal pfizer be just split wouldn have pay much tax hit say sell discrepancy have be offset buyer extent euromonitor estimate market keep grow year field be get more crowd establish player know keep rely scandal recall keep rival china market be intensely competitive say mead johnson ceo stephen golsby firm conference call yes re investing advertising promotion salesforce expansion re not alone be unexpected continue grow share rate re currently grow
930,PRGO,election result baked stock market yawned open wednesday perked fed layer new treasury purchasing plan want hear ibd analysis today market emerge stock click here watch latest market wrap video ibd lead pop rise nasdaq
931,PRGO,index open weaker thursday then stage positive reversal want hear ibd analysis today market emerge stock click here watch latest market wrap video most session be spend red stock rally afternoon dow add nasdaq be fractionally lower
932,PRGO,everyone like survivor count ibd tracker high group hit dog day summer let take look ibd tech company be second dog day season not easy typical stock be list year later look back
933,PRGO,market get blanket indiscriminate selling thursday highly rate stock make new high understandably suffer reversal stock hold earning share rating higher make new high hailed medical sector perrigo prgo fall end day winning streak volume be just average
934,PRGO,stock future hold steady healthy gain ahead monday open market look short week preholiday trade dow future be level trading point fair market value
935,PRGO,nasdaq future future be also steady point respectively
936,PRGO,stock market today have work cut christmas week trade generally tend be light young uptrend run heavy distribution friday raise question long last
937,PRGO,economic news isn likely have much impact chicago federal reserve national activity index most prominent piece economic news prior open show slip november accelerate october contraction be not economist consensus have expect increase
938,PRGO,international market also appear have negligible effect stock europe trade modestly higher midday china market rise include jump shanghai composite tokyo nikkei japan slip
939,PRGO,dollar rise bond edge oil price slip west texas intermediate bob barrel brent crude just most metal trade higher big gain
940,PRGO,be star war effect early trade walt disney be stock lead dow better gain premarket trade goldman sachs gs apple aapl also gain more
941,PRGO,disney star war force awaken gross estimate canada weekend be expectation beating prior record holder jurassic world gross premier june avenger pull premier
942,PRGO,disney share briefly clear buy point cup handle base november then drop undercut buy point more trigger sell rule
943,PRGO,huge screen savvy imax imax jump new star war film reportedly premier imax screen weekend pull set imax record top open weekend take jurassic world accord box office figure deadline hollywood imax ibd stock end friday buy point cup handle base
944,PRGO,also ibd list arm armh perked ahead open share cambridge england base chip designer tumble last week end stock converge week line support stock future hold steady healthy gain ahead monday open market look short week preholiday trade dow future be level trading point fair market value nasdaq future future be also steady point respectively stock market today have work cut christmas week trade generally tend be light young uptrend run heavy distribution friday raise question long last economic news isn likely have much impact chicago federal reserve national activity index most prominent piece economic news prior open show slip november accelerate october contraction be not economist consensus have expect increase international market also appear have negligible effect stock europe trade modestly higher midday china market rise include jump shanghai composite tokyo nikkei japan slip dollar rise bond edge oil price slip west texas intermediate bob barrel brent crude just most metal trade higher big gain be star war effect early trade walt disney be stock lead dow better gain premarket trade goldman sachs gs apple aapl also gain more disney star war force awaken gross estimate canada weekend be expectation beating prior record holder jurassic world gross premier june avenger pull premier disney share briefly clear buy point cup handle base november then drop undercut buy point more trigger sell rule huge screen savvy imax imax jump new star war film reportedly premier imax screen weekend pull set imax record top open weekend take jurassic world accord box office figure deadline hollywood imax ibd stock end friday buy point cup handle base also ibd list arm armh perked ahead open share cambridge england base chip designer tumble last week end stock converge week line support
945,PRGO,whoa boy gonna be ibd earning party thursday well maybe be party maybe be funeral likelihood be mishmash investor don need be remind earning day be hold hat day investor do be be guard be ready sell thing go badly be ready celebrate thing go grandly earning be always mixed bag already shaky market confirm uptrend start last week thing get dicey ibd company usually have pretty high expectation expect top stock so even quarterly number be very good result disappoint analyst investor apple aapl example so ibd follower be hang edge pcs smartphone tablet thursday oct less tech biom ibd ers be set report be ibd ranking perrigo prgo perrigo have lead ibd stock medical generic drug group month fellow ibd watson pharmaceutical wpi maker generic drug carry brand name store sell such cvs cvs target tgt hit time high have hung pretty close level ever perrigo ceo joseph papa have say see company market share store brand product top point vs today perrigo enter infant formula biz last year purchase pbm last week say supply infant formula manufacture facility sale distribution founder pharma china thursday analyst expect perrigo report open ep sale percentage gain solid be precede quarter trading less buy point hit last month cerner cern maker electronic health record ehr software tend beat ep view penny quarter face test thursday analyst expect ep ex item cent sale match previous quarter biggest sale jump ep be most least year percentagewise be tad previous quarters federal rule encourage electronic health record have help cerner rival here latest story subject stock be trading just tad buy point hit last month be hang pretty close week line celgene celg maker cancer drug be med stock trading bit past buy point hit buy point last month now trade more higher year high report european regulatory panel earlier month make favorable ruling company revlimid successor thalidomide drug choice treat blood cancer multiple myeloma ruling pave way big approval next year investment bank rodman renshaw initiate coverage celgene oct rating market outperform buy analyst expect celgene perrigo report open report ep cent sale percentage be previous quarters celgene have beaten ep view cent past quarters solarwind swi oct report class do not consist solely medical stock maker software help manage computer network other information technology system report open day analyst expect ep ex item rise cent be smallest percentage increase year company have be grow solidly sale be expect come stock be pretty steadily stay week line be trading more time high set june report recently company be expand productwise regionwise kla tencor klac maker equipment used manufacture computer chip return ibd week oct long absence stock be early september stock be also more year high hit early march chip gear field be notoriously cyclical ibd company electronic semiconductor equipment group rank just group track ibd week week analyst poll thomson reuter expect kla report close thursday fiscal ep rise sale rise company have more double year year ep previous quarters sale rise smallest percentage quarters kla have beaten profit view least cent past quarters include beating cent previous quarter follow mike krey twitter
946,PRGO,sector leader close higher volatile session friday volume be unimpressive nearly winner gold producer again rise gold rebound picked steam barrick gold abx gold field gfi goldcorp gg rise volume be average royal gold rgld climb brand new
947,PRGO,person love pet strong earning pet product retailer petsmart petm raise outlook rest year push share close new high also help spot elite ibd list top company petsmart surge week be firm join
948,PRGO,luxury electric car maker tesla motor tsla touch new week high stock market today mark milestone monday tesla join nasdaq index morning july replace oracle orcl roster biggest company market capitalization oracle be move nasdaq nyse
949,PRGO,earning season be wind slew highly rate company be still deck here be company ibd list report result week tuesday michael kor kor rank ibd list be expect report first quarter earning tuesday kor sell high end clothing accessory design fashion designer
950,PRGO,ibd stock play part surprisingly good week market ibd index crank gain outpace major index show constructive action many leader chart more few ibd issue push new high week netease com nte dollar tree dltr scripps network interactive sni be
951,PRGO,lot drugmaker large small report quarterly result week many strong number keep biotech ethical drug ibd top industry group always company hit unexpected turbulence here day day recap drugmaker earning week news top drug company tuesday swiss pharma giant novartis nvs start thing
952,PRGO,global have launch pair etfs hold largest nasdaq trade stock financial global nasdaq etf qqqv nasdaq mid cap etf qqqm past year company index have demonstrated strong earning growth be mature profitable company global say financial have lag broader market
953,PRGO,give jason weiner credit manager fidelity growth discovery fund be not only ahead market year broad market be negative territory also do hard way
954,PRGO,health biotech utility be top perform fund category oct yet weiner fund have look leader elsewhere mostly growthier segment
955,PRGO,health care stock account modest fund asset be aug less half march weighting utility weighting be
956,PRGO,june report shareholder weiner say be cautious health care due ongoing war cost loom patent cliff face big drugmaker
957,PRGO,still fund have be help hold perrigo prgo be ibd leaderboard maker store brand generic drug be year
958,PRGO,recent fail share re-cover be past buy point
959,PRGO,return equity have climb year row earning share grow past quarters announce quarterly result oct bell
960,PRGO,be weiner make most bet information technology industrial consumer discretionary be fund biggest sector latest monthly report
961,PRGO,recent top hold apple aapl be year recent fail friday stock rebound new close high
962,PRGO,dial dollar
963,PRGO,pre order new iphone top company expectation
964,PRGO,quarterly earning be accelerate rise past stanzas analyst poll thomson reuter see year ep vs last year
965,PRGO,goodrich gr industrial focuse aerospace gap news takeover unite technology utx
966,PRGO,stock have ibd composite rating be year
967,PRGO,consumer discretionary amazon amzn be year
968,PRGO,stock fall trigger set time high find support week line stock set new time high friday
969,PRGO,sale have grow past quarters still stock be pace show third straight quarterly earning decline
970,PRGO,go monday fidelity growth discovery be vs large cap growth rival track morningstar inc top peer
971,PRGO,past year fund average annual return be vs peer group big cap bogey
972,PRGO,june shareholder update weiner say technology advance energy drill have spark spending area
973,PRGO,have be build position several quarters oil service name halliburton hal baker hughe bhi latest disclosure
974,PRGO,also say like commercial aerospace too generally be build stake such name unite technology honeywell hon transdigm tdg esterline technology esl precision castpart pcp goodrich give jason weiner credit manager fidelity growth discovery fund be not only ahead market year broad market be negative territory also do hard way health biotech utility be top perform fund category oct yet weiner fund have look leader elsewhere mostly growthier segment health care stock account modest fund asset be aug less half march weighting utility weighting be june report shareholder weiner say be cautious health care due ongoing war cost loom patent cliff face big drugmaker still fund have be help hold perrigo prgo be ibd leaderboard maker store brand generic drug be year recent fail share re-cover be past buy point return equity have climb year row earning share grow past quarters announce quarterly result oct bell be weiner make most bet information technology industrial consumer discretionary be fund biggest sector latest monthly report recent top hold apple aapl be year recent fail friday stock rebound new close high dial dollarspre order new iphone top company expectation quarterly earning be accelerate rise past stanzas analyst poll thomson reuter see year ep vs last year goodrich gr industrial focuse aerospace gap news takeover unite technology utx stock have ibd composite rating be year consumer discretionary amazon amzn be year stock fall trigger set time high find support week line stock set new time high friday sale have grow past quarters still stock be pace show third straight quarterly earning decline go monday fidelity growth discovery be vs large cap growth rival track morningstar inc top peer past year fund average annual return be vs peer group big cap bogey june shareholder update weiner say technology advance energy drill have spark spending area have be build position several quarters oil service name halliburton hal baker hughe bhi latest disclosure also say like commercial aerospace too generally be build stake such name unite technology honeywell hon transdigm tdg esterline technology esl precision castpart pcp goodrich
975,PRGO,large cap growth opportunity be top echelon portfolio seek resume winning way have hit rough patch
976,PRGO,fund average annual gain year go thursday rank top large cap growth rival track morningstar inc calendar loss meant trail peer
977,PRGO,year fund be vs category
978,PRGO,hal goldstein year old be co lead manager scott mullinix james diedrich be co manager goldstein discuss approach office minneapoli
979,PRGO,ibd be do differently year
980,PRGO,goldstein be challenged particularly fourth quarter be rapid turn stock benefit economic recovery lower quality more cyclical name environment do least well
981,PRGO,year be sort respectable be middle pack
982,PRGO,ibd year
983,PRGO,goldstein win do anything differently stay true process be occasion approach be completely favor even underperform tough quarter long term performance remain strong
984,PRGO,ibd have fish bargain
985,PRGO,goldstein yes favorite growth company earning prospect have stay strong valuation have be compress so ve add repurchase name not have own bit
986,PRGO,ibd such
987,PRGO,goldstein citrix system ctxs re involved desktop virtualization much way vmware vmw provider software virtualization server help client enterprise efficiency cost reduction citrix let enterprise purchase less powerful desktop computer employee manage software more centrally much less expensive maintain software desktop
988,PRGO,sell citrix last year feel cycle desktop virtualization be advance slower pace anticipate growth thesis be not come true even sell company keep monitoring get point want buy back then ve see more evidence desktop virtualization be advance so add back
989,PRGO,ibd example
990,PRGO,goldstein amazon amzn add hold year reason be have not be controversial revenue growth have be strong believe amazon be gain share online sale same time online be gain share brick mortar
991,PRGO,many investor be concern amazon profitability be permanently impair make significant infrastructure investment shipping cost percent sale have go quite bit
992,PRGO,believe be sign margin be least stabilize perhaps show early sign improve
993,PRGO,ibd be bargain bin aspect
994,PRGO,goldstein hard argue amazon be super cheap feel be attractively value growth continue margin stabilize improve example shipping cost percent sale decline first time year
995,PRGO,yes do add more stable company challenge economic environment
996,PRGO,ibd example please
997,PRGO,goldstein consumer space petsmart petm have merchandize initiative allow accelerate growth store same store comp improve already happen degree so earning upside surprise opportunity well sale be better expectation lead profit expectation
998,PRGO,health care idexx laboratory idxx provide veterinary lab testing product benefit rise trend pet adoption
999,PRGO,think rise pet adoption be sign economy be little better employment trend be little better housing be bottom improve residential rental activity be more person be move parent home start household
1000,PRGO,ibd general approach
1001,PRGO,goldstein first buy subset highly selective universe call exceptional growth company subset be company expectation most exceed consensus expectation
1002,PRGO,second develop proprietary growth thesis hold
1003,PRGO,hold investment vast majority opportunity opportunity longer exist sell critically important sell be appropriate
1004,PRGO,last thing do be construct balanced portfolio objective be dampen volatility
1005,PRGO,ibd do diversification right
1006,PRGO,goldstein yes diversify sector market capitalization style
1007,PRGO,ibd be style diversification
1008,PRGO,goldstein have cyclical growth name more stable growth name high growth company
1009,PRGO,don own many company domicile outside have meaningful number holding have revenue exposure outside
1010,PRGO,way don diversify be relative weighting don allow have more percentage point more less sector weighting russell growth index re typically closer benchmark weighting
1011,PRGO,allow much basis point overweight individual security again practice largest overweight tend average basis point
1012,PRGO,ibd do diversification sector reflect style diversification
1013,PRGO,goldstein right health care holding example be not same type
1014,PRGO,own alexion pharmaceutical alxn fast grow high multiple pharmaceutical company company be involved ultrarare disease pharmaceutical also own gilead science gild be involved hepatitis vaccine own vertex vrtx be also involved hepatitis next opportunity be drug kalydeco treatment cystic fibrosis biotech company be develop tomorrow cure
1015,PRGO,also own perrigo prgo be more stable company be lead maker store brand counter medicine
1016,PRGO,ibd describe diversification sector such consumer discretionary please
1017,PRGO,goldstein hand own dollar tree dltr tjx co tjx course benefit reality more person be economically challenged be trading dollar store discount store
1018,PRGO,other hand own lululemon athletica lulu coach coh be focuse much higher end demographic more luxury end
1019,PRGO,ibd do approach show largest sector technology asset
1020,PRGO,goldstein hand have apple aapl lululemon be gain meaningful profitable market share tend sell higher price product more affluent demographic
1021,PRGO,other hand own accenture acn be consult outsource company serve global fortune company apple be consumer focuse accenture be enterprise focuse help client cut cost
1022,PRGO,also have visa mastercard fall tech sector aren tech do use lot technology do re really increase use plastic globally method payment terrific profitability accrue visa mastercard more person swipe card incremental cost visa mastercard be way incremental revenue terrific margin opportunity
1023,PRGO,ibd apple recent quarterly earning report disappoint do see long term problem
1024,PRGO,goldstein don believe sign long term crack thesis be gain profitable global market share consumer electronic first buy apple meant be mac computer now have mobile phone new category invented tablet be still intact
1025,PRGO,reason be pause apple stock performance be many consumer be wait next iteration iphone update pent demand iphone be large not only exist iphone user also consumer don own iphone so temporary pause sale bigger ramp later year next year
1026,PRGO,ibd teradata tdc have quarters higher earning share growth thesis
1027,PRGO,goldstein benefit proliferation datum sell hard software combination let very large enterprise collect analyze large amount datum turn use make strategic decision
1028,PRGO,demand datum analytic other service be very strong so love top line growth look company top line growth not just margin improvement
1029,PRGO,ibd netsuite ep growth jump past quarters take
1030,PRGO,goldstein be emerge high growth high valuation company
1031,PRGO,re software service so cloud play salesforce com crm benefit enterprise want get business critical software cloud delivery software buy need basis rather own old fashion house suite software
1032,PRGO,ibd be cerner cern story basically shift electronic health care record
1033,PRGO,goldstein cerner be lead public company health care information technology have strong backlog due government regulatory change merely reflection economic encourage hospital automate digitize be really well run lead health care company
1034,PRGO,ibd monster beverage mnst have quarters accelerate ep growth view
1035,PRGO,goldstein monster have do well be still attractive be gain share energy drink market international opportunity be sizable mature internationally nice margin improvement opportunity well own reason other get purchase example coke ko re not bet
1036,PRGO,ibd whole food wfm have explode recession trough much more specialty market grow
1037,PRGO,goldstein believe be still lot room run same store sale tough economy suggest deliver american consumer want comp be fiscal rise store level operate margin show great discipline expect continue grow store base combine same store growth get meaningful profit growth
1038,PRGO,ibd gnc gnc ep growth have slow quarters do need shot geritol
1039,PRGO,goldstein most recent quarter same store sale be almost be higher most retailer
1040,PRGO,secondly opportunity grow internationally attract
1041,PRGO,think earning estimate rise rest year most next year collectively factor point attractive opportunity large cap growth opportunity be top echelon portfolio seek resume winning way have hit rough patch fund average annual gain year go thursday rank top large cap growth rival track morningstar inc calendar loss meant trail peer year fund be vs category hal goldstein year old be co lead manager scott mullinix james diedrich be co manager goldstein discuss approach office minneapoli ibd be do differently year goldstein be challenged particularly fourth quarter be rapid turn stock benefit economic recovery lower quality more cyclical name environment do least well year be sort respectable be middle pack ibd year goldstein win do anything differently stay true process be occasion approach be completely favor even underperform tough quarter long term performance remain strong ibd have fish bargain goldstein yes favorite growth company earning prospect have stay strong valuation have be compress so ve add repurchase name not have own bit ibd such goldstein citrix system ctxs re involved desktop virtualization much way vmware vmw provider software virtualization server help client enterprise efficiency cost reduction citrix let enterprise purchase less powerful desktop computer employee manage software more centrally much less expensive maintain software desktop sell citrix last year feel cycle desktop virtualization be advance slower pace anticipate growth thesis be not come true even sell company keep monitoring get point want buy back then ve see more evidence desktop virtualization be advance so add back ibd example goldstein amazon amzn add hold year reason be have not be controversial revenue growth have be strong believe amazon be gain share online sale same time online be gain share brick mortar many investor be concern amazon profitability be permanently impair make significant infrastructure investment shipping cost percent sale have go quite bit believe be sign margin be least stabilize perhaps show early sign improve ibd be bargain bin aspect goldstein hard argue amazon be super cheap feel be attractively value growth continue margin stabilize improve example shipping cost percent sale decline first time year yes do add more stable company challenge economic environment ibd example please goldstein consumer space petsmart petm have merchandize initiative allow accelerate growth store same store comp improve already happen degree so earning upside surprise opportunity well sale be better expectation lead profit expectation health care idexx laboratory idxx provide veterinary lab testing product benefit rise trend pet adoption think rise pet adoption be sign economy be little better employment trend be little better housing be bottom improve residential rental activity be more person be move parent home start household ibd general approach goldstein first buy subset highly selective universe call exceptional growth company subset be company expectation most exceed consensus expectation second develop proprietary growth thesis hold hold investment vast majority opportunity opportunity longer exist sell critically important sell be appropriate last thing do be construct balanced portfolio objective be dampen volatility ibd do diversification right goldstein yes diversify sector market capitalization style ibd be style diversification goldstein have cyclical growth name more stable growth name high growth company don own many company domicile outside have meaningful number holding have revenue exposure outside way don diversify be relative weighting don allow have more percentage point more less sector weighting russell growth index re typically closer benchmark weighting allow much basis point overweight individual security again practice largest overweight tend average basis point ibd do diversification sector reflect style diversification goldstein right health care holding example be not same type own alexion pharmaceutical alxn fast grow high multiple pharmaceutical company company be involved ultrarare disease pharmaceutical also own gilead science gild be involved hepatitis vaccine own vertex vrtx be also involved hepatitis next opportunity be drug kalydeco treatment cystic fibrosis biotech company be develop tomorrow cure also own perrigo prgo be more stable company be lead maker store brand counter medicine ibd describe diversification sector such consumer discretionary please goldstein hand own dollar tree dltr tjx co tjx course benefit reality more person be economically challenged be trading dollar store discount store other hand own lululemon athletica lulu coach coh be focuse much higher end demographic more luxury end ibd do approach show largest sector technology asset goldstein hand have apple aapl lululemon be gain meaningful profitable market share tend sell higher price product more affluent demographic other hand own accenture acn be consult outsource company serve global fortune company apple be consumer focuse accenture be enterprise focuse help client cut cost also have visa mastercard fall tech sector aren tech do use lot technology do re really increase use plastic globally method payment terrific profitability accrue visa mastercard more person swipe card incremental cost visa mastercard be way incremental revenue terrific margin opportunity ibd apple recent quarterly earning report disappoint do see long term problem goldstein don believe sign long term crack thesis be gain profitable global market share consumer electronic first buy apple meant be mac computer now have mobile phone new category invented tablet be still intact reason be pause apple stock performance be many consumer be wait next iteration iphone update pent demand iphone be large not only exist iphone user also consumer don own iphone so temporary pause sale bigger ramp later year next year ibd teradata tdc have quarters higher earning share growth thesis goldstein benefit proliferation datum sell hard software combination let very large enterprise collect analyze large amount datum turn use make strategic decision demand datum analytic other service be very strong so love top line growth look company top line growth not just margin improvement ibd netsuite ep growth jump past quarters take goldstein be emerge high growth high valuation company re software service so cloud play salesforce com crm benefit enterprise want get business critical software cloud delivery software buy need basis rather own old fashion house suite software ibd be cerner cern story basically shift electronic health care record goldstein cerner be lead public company health care information technology have strong backlog due government regulatory change merely reflection economic encourage hospital automate digitize be really well run lead health care company ibd monster beverage mnst have quarters accelerate ep growth view goldstein monster have do well be still attractive be gain share energy drink market international opportunity be sizable mature internationally nice margin improvement opportunity well own reason other get purchase example coke ko re not bet ibd whole food wfm have explode recession trough much more specialty market grow goldstein believe be still lot room run same store sale tough economy suggest deliver american consumer want comp be fiscal rise store level operate margin show great discipline expect continue grow store base combine same store growth get meaningful profit growth ibd gnc gnc ep growth have slow quarters do need shot geritol goldstein most recent quarter same store sale be almost be higher most retailer secondly opportunity grow internationally attract think earning estimate rise rest year most next year collectively factor point attractive opportunity
1042,PRGO,stock bent higher trade remain mixed investor look january auto sale datum due afternoon
1043,PRGO,nasdaq climb stretched do dow jone industrial average lead bank america bac
1044,PRGO,trade continue strengthen nyse remain nasdaq compare action same time thursday
1045,PRGO,ibd stock moved generally higher lead ixia xxia jump more weak trade maker network testing gear system be buy point cup handle base still jan high
1046,PRGO,celgene celg add nearly take new high strong trade maker cancer treatment revlimid rise more week early january past buy point move trigger week hold rule investor buy close buy point
1047,PRGO,commvault system cvlt climb almost grab new high datum backup recovery specialist be past buy point ascend base
1048,PRGO,ibd stock opentable open polyone pol climb more
1049,PRGO,eastman chemical emn spark better double average trade put share ahead more week mark straight weekly gain stock be still buy range buy point week tight pattern
1050,PRGO,generic drugmaker perrigo prgo gap gain heavy trade michigan base company say fiscal earning rise share vs analyst consensus revenue rise clear expectation wide margin company also announce acquisition velcera maker flea tick treatment petarmor
1051,PRGO,stock have be correct mid november friday move put share back day move average day line
1052,PRGO,carbo ceramic crr zoom report deliver late thursday maker proppant use oil natural gas production say earning slip quarter not quite far analyst estimate earning dip better expectation dive
1053,PRGO,be enough point share gain week stock continue recovery begin november
1054,PRGO,downside lifetime fitness ltm collapse startling trade update fourth quarter sale earning guidance leave well analyst consensus view company cite anticipate impact timing new center opening pre sale expense center open early stock bent higher trade remain mixed investor look january auto sale datum due afternoon nasdaq climb stretched do dow jone industrial average lead bank america bac trade continue strengthen nyse remain nasdaq compare action same time thursday ibd stock moved generally higher lead ixia xxia jump more weak trade maker network testing gear system be buy point cup handle base still jan high celgene celg add nearly take new high strong trade maker cancer treatment revlimid rise more week early january past buy point move trigger week hold rule investor buy close buy point commvault system cvlt climb almost grab new high datum backup recovery specialist be past buy point ascend base ibd stock opentable open polyone pol climb more eastman chemical emn spark better double average trade put share ahead more week mark straight weekly gain stock be still buy range buy point week tight pattern generic drugmaker perrigo prgo gap gain heavy trade michigan base company say fiscal earning rise share vs analyst consensus revenue rise clear expectation wide margin company also announce acquisition velcera maker flea tick treatment petarmor stock have be correct mid november friday move put share back day move average day line carbo ceramic crr zoom report deliver late thursday maker proppant use oil natural gas production say earning slip quarter not quite far analyst estimate earning dip better expectation dive be enough point share gain week stock continue recovery begin november downside lifetime fitness ltm collapse startling trade update fourth quarter sale earning guidance leave well analyst consensus view company cite anticipate impact timing new center opening pre sale expense center open early
1055,PRGO,top spot tuesday unusual option volume ibd questor pharmaceutical qcor be flash time daily average option share imbue bull bear action headline don yield much clue risk create opportunity marketwatch stock potential new year courtesy forbe try tease cajole bull more offensive frame mind
1056,PRGO,today pressure share qcor be breaking key day simple move average support action have also damage prior attempt week flat base trigger back early december stock be now more proper buy point
1057,PRGO,most active option side intent purpose only decisive action day nearly slightly money january put multiple varied print have trade compare almost existent open interest contract
1058,PRGO,price mid market long put purchase require maximum move expiration order double value guesstimate base fast deteriorate technical picture see put purchase most likely beneficiary today open activity trader
1059,PRGO,know side trade tuesday initiate trader also gather be result newsletter recommendation be used target purchase strategy more commonly be know put sale less acknowledge risk equivalent buy
1060,PRGO,state just last week come option fact stock always complicate just side trade party be fact be remiss not mention possibility married put less likely synthetic short call position part share married put long synthetic call afford bull protection strike price premium paid add really know add expiration risk contract used put price
1061,PRGO,do think feel free share opinion comment section top spot tuesday unusual option volume ibd questor pharmaceutical qcor be flash time daily average option share imbue bull bear action headline don yield much clue risk create opportunity marketwatch stock potential new year courtesy forbe try tease cajole bull more offensive frame mind today pressure share qcor be breaking key day simple move average support action have also damage prior attempt week flat base trigger back early december stock be now more proper buy point most active option side intent purpose only decisive action day nearly slightly money january put multiple varied print have trade compare almost existent open interest contract price mid market long put purchase require maximum move expiration order double value guesstimate base fast deteriorate technical picture see put purchase most likely beneficiary today open activity trader know side trade tuesday initiate trader also gather be result newsletter recommendation be used target purchase strategy more commonly be know put sale less acknowledge risk equivalent buy state just last week come option fact stock always complicate just side trade party be fact be remiss not mention possibility married put less likely synthetic short call position part share married put long synthetic call afford bull protection strike price premium paid add really know add expiration risk contract used put price do think feel free share opinion comment section
1062,PRGO,perrigo prgo lead maker store brand counter drug report fiscal fourth quarter earning share vs year earlier cent wall street forecast sale rise just shy analyst view perrigo expect fiscal earning vs just end fy midpoint be slightly consensus company also announce plan issue note private placement perrigo be part ibd list top stock base fundamental technical factor share fall premarket trading et trading sharply lower open bell share rise less et
1063,PRGO,stock advanced thursday index continue find support recent battleground area nasdaq take smallest step rise nyse composite gain respectively ibd add volume rise major exchange appear have establish support area knife
1064,PRGO,stock score strong gain monday nasdaq snap session lose streak
1065,PRGO,stock score strong gain monday nasdaq snap session lose streak
1066,PRGO,want hear ibd analysis today market emerge stock click here watch market wrap video
1067,PRGO,nasdaq today jump dow jone industrial average volume increase board friday half session level
1068,PRGO,hour fitch cut outlook debt negative stable
1069,PRGO,also hour copart cprt be slate report quarterly result hadn do so immediately close bell analyst be expect ep cent sale represent gain respectively copart conduct salvage vehicle auction be second stage cup handle base buy point
1070,PRGO,monday regular session market get lift news euro zone leader be close far reach agreement address debt crisis well report indicate strong start holiday shopping season preliminary datum show record level buy mall online black friday cyber monday
1071,PRGO,highly rate stock panera bread pnra jump average turnover bakery cafe chain clear buy point week tight pattern touch new time high
1072,PRGO,tuesday tif ralcorp rah be company slate report quarterly earning day economic news include fresh datum home price consumer confidence
1073,PRGO,want hear ibd analysis today market emerge stock click here watch market wrap video
1074,PRGO,nasdaq today jump dow jone industrial average volume increase board friday half session level
1075,PRGO,hour fitch cut outlook debt negative stable
1076,PRGO,also hour copart cprt be slate report quarterly result hadn do so immediately close bell analyst be expect ep cent sale represent gain respectively copart conduct salvage vehicle auction be second stage cup handle base buy point
1077,PRGO,monday regular session market get lift news euro zone leader be close far reach agreement address debt crisis well report indicate strong start holiday shopping season preliminary datum show record level buy mall online black friday cyber monday
1078,PRGO,highly rate stock panera bread pnra jump average turnover bakery cafe chain clear buy point week tight pattern touch new time high
1079,PRGO,tuesday tif ralcorp rah be company slate report quarterly earning day economic news include fresh datum home price consumer confidence nasdaq today jump dow jone industrial average volume increase board friday half session level hour fitch cut outlook debt negative stable also hour copart cprt be slate report quarterly result hadn do so immediately close bell analyst be expect ep cent sale represent gain respectively copart conduct salvage vehicle auction be second stage cup handle base buy point monday regular session market get lift news euro zone leader be close far reach agreement address debt crisis well report indicate strong start holiday shopping season preliminary datum show record level buy mall online black friday cyber monday highly rate stock panera bread pnra jump average turnover bakery cafe chain clear buy point week tight pattern touch new time high tuesday tif ralcorp rah be company slate report quarterly earning day economic news include fresh datum home price consumer confidence
1080,PRGO,share ibd constituent perrigo prgo be mostly flat tight trade friday didn stop couple option trader initiate rather large position pharmaceutical upstart
1081,PRGO,compare daily average volume perrigo see bit more contract fairly even trade split call put activity be concentrated february contract notice nearly feb call be put represent contract net volume
1082,PRGO,compare open interest be sure trader be open close give earning be not too far february wager action be open activity money doesn appear have be directly stock implied bid session speculative buy front report seem likely
1083,PRGO,slightly more interesting less clear way also appear have be establish base smaller exist open interest follow print occur
1084,PRGO,feb call feb put feb put
1085,PRGO,check attach stock neutralize delta label quirky spread such unorthodox risk reversal similarly oddly position strangle teaser option synthetic bull call spread come empty handed
1086,PRGO,also be look simpler still odd bear bull put spread couple smaller size still large call say not have firm grip situation honestly hear reader have clearer take action
1087,PRGO,do think feel free share opinion comment section share ibd constituent perrigo prgo be mostly flat tight trade friday didn stop couple option trader initiate rather large position pharmaceutical upstart compare daily average volume perrigo see bit more contract fairly even trade split call put activity be concentrated february contract notice nearly feb call be put represent contract net volume compare open interest be sure trader be open close give earning be not too far february wager action be open activity money doesn appear have be directly stock implied bid session speculative buy front report seem likely slightly more interesting less clear way also appear have be establish base smaller exist open interest follow print occur feb call feb put feb put check attach stock neutralize delta label quirky spread such unorthodox risk reversal similarly oddly position strangle teaser option synthetic bull call spread come empty handed also be look simpler still odd bear bull put spread couple smaller size still large call say not have firm grip situation honestly hear reader have clearer take action do think feel free share opinion comment section
1088,PRGO,stock have cut more loss turn mixed afternoon trading wednesday dow rise have be much ibm ibm lead blue chip gauge hit time high johnson johnson jnj jpmorgan chase jpm also boost dow broader average such nasdaq be fractionally lower turnover
1089,PRGO,stock dive early trading monday tracking overseas loss concern flare euro zone debt crisis jone industrial average plunge nasdaq fall so far volume be tracking far option expiration fuel level friday confidence builder single family home drop point september national association home builder housing market index confidence have hold straight month access construction credit appraisal value foreclose property continue stymie market dollar soar euro crude oil price turn sharply lower open diving barrel gold give early gain pull back ounce long list heavyweight include metlife meet freeport mcmoran copper gold fcx schlumberger slb drop ibd stock priceline com pcln perrigo prgo ancestry com acom post loss jazz pharmaceutical jazz also drop diving just day move average maker specialty pharmaceutical be buy point july
1090,PRGO,stock be bounce back midday thursday pare gain earlier news deal help europe send equity charge gate rally earlier touch day move average have be much dow jone industrial average rise issue higher caterpillar cat ibm ibm
1091,PRGO,sure follow day week be encourage couple day ibd style investor have only small field promising stock work tuesday follow shift ibd outlook market correction thursday action shift outlook uptrend pressure many highly rate stock have only just begin build new basis endure
1092,PRGO,stock sank early trading concern inflation china meet mixed economic datum earning report nasdaq nyse fall respectively lose dow be volume figure be not immediately available exist home sale climb december november well economist expectation mid atlantic manufacturing activity dip philadelphia fed index january december expectation cloud compute stock be be hit hard weak report outlook late wednesday network ffiv plummet massive trade rackspace host rax tumble salesforce com crm crumple upside perrigo prgo climb busy trade announce acquire minneapoli base generic drugmaker paddock laboratory cash deal gap bump stock new high just resistance perrigo have rebound week move average morgan stanley ms climb big volume jump fourth quarter earning cent share cent expectation revenue climb also view
1093,PRGO,be tough year market
1094,PRGO,volatility broader major average end little change leader outshone market huge margin few even manage triple digit gain
1095,PRGO,questcor pharmaceutical qcor wrapped gain stock be good example watch strength market be weak
1096,PRGO,nasdaq top questcor trade sideway market sell intensified august questcor again go sideway trading stock break third stage base base oct have rac gain least be debate clear buy point stock be now testing week move average
1097,PRGO,surplus salvage good auctioneer liquidity service lqdt rac gain year name liquidity service isn most liquid stock make easy stock pass stock average daily volume have grow just share day low start
1098,PRGO,stock last break irregular third stage base dec clear buy point huge upside reversal liquidity be still buy range
1099,PRGO,intuitive surgical isrg have big year leader robotic surgical system rally be also third biggest winner
1100,PRGO,stock be institutional favorite end third quarter nearly mutual fund own stock intuitive surgical be own lead growth fund such columbia marsico st century fidelity balanced stock hasn see sign distribution almost month
1101,PRGO,intuitive surgical last clear buy point base base dec light trade be still buy range
1102,PRGO,leader be modestly lower final week average change stock ibd be
1103,PRGO,perrigo prgo mercadolibre meli royal gold rgld be biggest decliner
1104,PRGO,commvault system cvlt rise nearly bounce back week slide
1105,PRGO,ebix ebix rally almost extend streak week be tough year market volatility broader major average end little change leader outshone market huge margin few even manage triple digit gain questcor pharmaceutical qcor wrapped gain stock be good example watch strength market be weak nasdaq top questcor trade sideway market sell intensified august questcor again go sideway trading stock break third stage base base oct have rac gain least be debate clear buy point stock be now testing week move average surplus salvage good auctioneer liquidity service lqdt rac gain year name liquidity service isn most liquid stock make easy stock pass stock average daily volume have grow just share day low start stock last break irregular third stage base dec clear buy point huge upside reversal liquidity be still buy range intuitive surgical isrg have big year leader robotic surgical system rally be also third biggest winner stock be institutional favorite end third quarter nearly mutual fund own stock intuitive surgical be own lead growth fund such columbia marsico st century fidelity balanced stock hasn see sign distribution almost month intuitive surgical last clear buy point base base dec light trade be still buy range leader be modestly lower final week average change stock ibd be perrigo prgo mercadolibre meli royal gold rgld be biggest decliner commvault system cvlt rise nearly bounce back week slide ebix ebix rally almost extend streak week
1106,PRGO,most part market lead stock have continue show improvement so far week more highly rate stock manage break new high ambev abv dollar general dg dollar tree dltr clear basis past week monro muffler brake mnro nu skin enterprise nus perrigo prgo be also same
1107,PRGO,lead stock act better past week main index bounce back nicely big week note friday weekly review column almost late november slide just serve opportunity ibd stock test support week move average red hat rht tjx tjx have
1108,PRGO,ibd special report mutual fund monthly stock gyrate several sharp sell day november european credit hope market rebound late month recover most loss nasdaq be just thanksgiving month fall recent market turmoil hasn keep top perform mutual fund
1109,PRGO,major index finished modestly lower monday give early gain come news osama bin laden death
1110,PRGO,major index finished modestly lower monday give early gain come news osama bin laden death
1111,PRGO,want hear ibd analysis today market emerge stock click here watch market wrap video
1112,PRGO,nasdaq nyse shed lose volume be friday level board accord preliminary datum
1113,PRGO,hour netlogic microsystem netl trade lower chip designer report ep beat view revenue miss forecast netlogic be week ibd have be rebound third later stage test week move average follow january
1114,PRGO,also close bell herbalife hlf rise late trading post ep sale beat view marketer nutritional supplement weight loss product hike ep guidance too herbalife be well extend february monday regular session hit new high fast trade give most gain herbalife be ibd world stock screen monday
1115,PRGO,accretive health be top rate stock gain ground strong volume monday accretive ibd rise leave extend proper buy range follow first pullback week line first stage accretive offer back office service health care provider focuse revenue cycle management
1116,PRGO,tuesday green mountain coffee gmcr perrigo prgo cognizant ctsh be top rate firm expect post quarterly earning day economic news include fresh datum auto sale factory order
1117,PRGO,want hear ibd analysis today market emerge stock click here watch market wrap video
1118,PRGO,nasdaq nyse shed lose volume be friday level board accord preliminary datum
1119,PRGO,hour netlogic microsystem netl trade lower chip designer report ep beat view revenue miss forecast netlogic be week ibd have be rebound third later stage test week move average follow january
1120,PRGO,also close bell herbalife hlf rise late trading post ep sale beat view marketer nutritional supplement weight loss product hike ep guidance too herbalife be well extend february monday regular session hit new high fast trade give most gain herbalife be ibd world stock screen monday
1121,PRGO,accretive health be top rate stock gain ground strong volume monday accretive ibd rise leave extend proper buy range follow first pullback week line first stage accretive offer back office service health care provider focuse revenue cycle management
1122,PRGO,tuesday green mountain coffee gmcr perrigo prgo cognizant ctsh be top rate firm expect post quarterly earning day economic news include fresh datum auto sale factory order nasdaq nyse shed lose volume be friday level board accord preliminary datum hour netlogic microsystem netl trade lower chip designer report ep beat view revenue miss forecast netlogic be week ibd have be rebound third later stage test week move average follow january also close bell herbalife hlf rise late trading post ep sale beat view marketer nutritional supplement weight loss product hike ep guidance too herbalife be well extend february monday regular session hit new high fast trade give most gain herbalife be ibd world stock screen monday accretive health be top rate stock gain ground strong volume monday accretive ibd rise leave extend proper buy range follow first pullback week line first stage accretive offer back office service health care provider focuse revenue cycle management tuesday green mountain coffee gmcr perrigo prgo cognizant ctsh be top rate firm expect post quarterly earning day economic news include fresh datum auto sale factory order
1123,PRGO,scan list market best rate stock ll find few be well poise basis do not make last market uptrend more likely re build watch list ll have quality name ibd look alexion pharmaceutical alxn drug target cancer autoimmune disorder transplant rejection
1124,PRGO,picture improve stock weekly review last week market firm
1125,PRGO,uptrend year have be short indefinite difficult play profit column note week
1126,PRGO,still remain case least current market rally have picked offer more breakout highly rate stock
1127,PRGO,armour ua jump past buy point big trade monday power strong earning report sport apparel retailer be now past meaning outside proper buy zone watch see pull back range
1128,PRGO,stock have already break fall more buy point find support day line
1129,PRGO,polaris industry pii motor entry cup shape base wednesday remain buy range thursday close
1130,PRGO,maker terrain vehicle snowmobile top earlier buy point soft trade then stage rebound week move average
1131,PRGO,panera bread pnra gap trigger wednesday also get lift upbeat earning report
1132,PRGO,restaurant bakery chain close just thursday so still range
1133,PRGO,triumph group tgi aerospace part maker stand past buy point clear monday
1134,PRGO,armour watch see pull back range
1135,PRGO,red hat rht be stock extend week software maker move so far hasn draw huge volume prefer see
1136,PRGO,leader break last week be hold well intuitive surgical isrg tractor supply tsco fall category
1137,PRGO,few weekly review stock have flash sell signal slice week line week be hansen natural han have fall lineup perrigo prgo picture improve stock weekly review last week market firm uptrend year have be short indefinite difficult play profit column note week still remain case least current market rally have picked offer more breakout highly rate stock armour ua jump past buy point big trade monday power strong earning report sport apparel retailer be now past meaning outside proper buy zone watch see pull back range stock have already break fall more buy point find support day line polaris industry pii motor entry cup shape base wednesday remain buy range thursday close maker terrain vehicle snowmobile top earlier buy point soft trade then stage rebound week move average panera bread pnra gap trigger wednesday also get lift upbeat earning report restaurant bakery chain close just thursday so still range triumph group tgi aerospace part maker stand past buy point clear monday armour watch see pull back range red hat rht be stock extend week software maker move so far hasn draw huge volume prefer see leader break last week be hold well intuitive surgical isrg tractor supply tsco fall category few weekly review stock have flash sell signal slice week line week be hansen natural han have fall lineup perrigo prgo
1138,PRGO,major index climb monday help better expect economic datum activity
1139,PRGO,major index climb monday help better expect economic datum activity
1140,PRGO,want hear ibd analysis today market emerge stock click here watch market wrap video
1141,PRGO,nyse rise nearly add nasdaq gain volume decline major exchange friday hefty level accord preliminary datum
1142,PRGO,close baidu bidu report ep cent ex item beating expectation stock be sharply late trading gain regular session revenue come also estimate chinese web search engine see sale expectation stock have be add handle buy point later stage base
1143,PRGO,stock get additional lift last hour trade news federal judge florida have strike key part health care overhaul
1144,PRGO,stronger anticipate economic report include december consumer spending well chicago pmi result top forecast activity include coal producer alpha natural resource anr move acquire massey energy
1145,PRGO,canadian oil gas producer be monday top performer unrest egypt fuel sharp rise oil price gulfport energy gpor concho resource cxo northern oil gas nog be top rate name space
1146,PRGO,gulfport jump monday clear flat base buy point remain possible buy zone concho northern oil advanced continue rebound day move average
1147,PRGO,notable company slate post earning tuesday include acme packet apkt cummin cmi perrigo prgo up up economic datum expect tuesday include ism manufacturing index january well result december auto sale construction spending
1148,PRGO,want hear ibd analysis today market emerge stock click here watch market wrap video
1149,PRGO,nyse rise nearly add nasdaq gain volume decline major exchange friday hefty level accord preliminary datum
1150,PRGO,close baidu bidu report ep cent ex item beating expectation stock be sharply late trading gain regular session revenue come also estimate chinese web search engine see sale expectation stock have be add handle buy point later stage base
1151,PRGO,stock get additional lift last hour trade news federal judge florida have strike key part health care overhaul
1152,PRGO,stronger anticipate economic report include december consumer spending well chicago pmi result top forecast activity include coal producer alpha natural resource anr move acquire massey energy
1153,PRGO,canadian oil gas producer be monday top performer unrest egypt fuel sharp rise oil price gulfport energy gpor concho resource cxo northern oil gas nog be top rate name space
1154,PRGO,gulfport jump monday clear flat base buy point remain possible buy zone concho northern oil advanced continue rebound day move average
1155,PRGO,notable company slate post earning tuesday include acme packet apkt cummin cmi perrigo prgo up up economic datum expect tuesday include ism manufacturing index january well result december auto sale construction spending nyse rise nearly add nasdaq gain volume decline major exchange friday hefty level accord preliminary datum close baidu bidu report ep cent ex item beating expectation stock be sharply late trading gain regular session revenue come also estimate chinese web search engine see sale expectation stock have be add handle buy point later stage base stock get additional lift last hour trade news federal judge florida have strike key part health care overhaul stronger anticipate economic report include december consumer spending well chicago pmi result top forecast activity include coal producer alpha natural resource anr move acquire massey energy canadian oil gas producer be monday top performer unrest egypt fuel sharp rise oil price gulfport energy gpor concho resource cxo northern oil gas nog be top rate name space gulfport jump monday clear flat base buy point remain possible buy zone concho northern oil advanced continue rebound day move average notable company slate post earning tuesday include acme packet apkt cummin cmi perrigo prgo up up economic datum expect tuesday include ism manufacturing index january well result december auto sale construction spending
1156,PRGO,stock fade more have turn mixed early afternoon trading thursday dow rise session peak turn flat meanwhile nyse composite fall nasdaq turnover be again mixed nyse tracking lower nasdaq higher china yuchai international cyd bolt year high news stock have already trade more twice average daily volume company make diesel engine truck bus china yuchai earning growth accelerate past quarters fossil fosl rise new record high put stock past handle buy point have yet test week line follow aug downside recent ipo china new borun born reversed open gain dive big volume seek alpha article criticize chinese alcohol producer child place plce gap day move average tumble cut profit forecast cite weak fall sale retailer now expect earning share prior outlook share currently analyst be expect share sterne agee cut stock neutral buy child place come close potential support day move average caterpillar cat reversed lower hit year high strong earning cash america csh up up also turn lower
1157,PRGO,major market average storm higher thursday thank deal help europe agreement call bank insurance company haircut greek debt bolster europe bailout fund want hear ibd analysis today market emerge stock click here watch market wrap video nasdaq rally
1158,PRGO,manager best perform fund have remain cautious buy recent month market sell
1159,PRGO,tempting pick top rate stock low price unpredictable volatile market condition often drag good stock lower wise market follow diving lead stock breaking sound basis
1160,PRGO,meantime lead fund recent buy sell provide idea keep watch list fresh
1161,PRGO,lead fund buy precious metal issue such randgold resource gold eldorado gold ego newmont mining nem latest report period
1162,PRGO,new buy new buy top perform stock fund
1163,PRGO,slow growth economy greece debt wo have have investor diving gold be often see safe haven
1164,PRGO,latest sell top perform stock fund latest sell
1165,PRGO,gold price hit high ounce then gold have sell investor take profit
1166,PRGO,ibd industry group mining gold silver group be rank monday group be rank week
1167,PRGO,ibd find lead fund add newmont mining investing estimate american fund growth fund america add share latest report period
1168,PRGO,colorado base firm be world biggest gold producer significant operation australia peru indonesia ghana canada new mexico
1169,PRGO,dec newmont have ounce proven gold reserve
1170,PRGO,stock clear month long base mid august run week high newmont have pull back high find support week move average
1171,PRGO,newmont earning growth have slow past quarters manage
1172,PRGO,sell side
1173,PRGO,country top perform fund have be selling medical stock such biotech firm gilead science gild manage care company humana hum generic drug maker perrigo prgo latest report period
1174,PRGO,top fund have also be get rid retailer such wholesale discount chain costco cost athletic footwear seller finish line finl ugg boot maker decker outdoor deck
1175,PRGO,manager best perform fund have remain cautious buy recent month market sell tempting pick top rate stock low price unpredictable volatile market condition often drag good stock lower wise market follow diving lead stock breaking sound basis meantime lead fund recent buy sell provide idea keep watch list fresh lead fund buy precious metal issue such randgold resource gold eldorado gold ego newmont mining nem latest report period
1176,PRGO,new buy new buy top perform stock fund
1177,PRGO,slow growth economy greece debt wo have have investor diving gold be often see safe haven
1178,PRGO,latest sell top perform stock fund latest sell
1179,PRGO,gold price hit high ounce then gold have sell investor take profit
1180,PRGO,ibd industry group mining gold silver group be rank monday group be rank week
1181,PRGO,ibd find lead fund add newmont mining investing estimate american fund growth fund america add share latest report period
1182,PRGO,colorado base firm be world biggest gold producer significant operation australia peru indonesia ghana canada new mexico
1183,PRGO,dec newmont have ounce proven gold reserve
1184,PRGO,stock clear month long base mid august run week high newmont have pull back high find support week move average
1185,PRGO,newmont earning growth have slow past quarters manage
1186,PRGO,sell side
1187,PRGO,country top perform fund have be selling medical stock such biotech firm gilead science gild manage care company humana hum generic drug maker perrigo prgo latest report period
1188,PRGO,top fund have also be get rid retailer such wholesale discount chain costco cost athletic footwear seller finish line finl ugg boot maker decker outdoor deck
1189,PRGO,slow growth economy greece debt wo have have investor diving gold be often see safe haven
1190,PRGO,latest sell top perform stock fund latest sell
1191,PRGO,gold price hit high ounce then gold have sell investor take profit
1192,PRGO,ibd industry group mining gold silver group be rank monday group be rank week
1193,PRGO,ibd find lead fund add newmont mining investing estimate american fund growth fund america add share latest report period
1194,PRGO,colorado base firm be world biggest gold producer significant operation australia peru indonesia ghana canada new mexico
1195,PRGO,dec newmont have ounce proven gold reserve
1196,PRGO,stock clear month long base mid august run week high newmont have pull back high find support week move average
1197,PRGO,newmont earning growth have slow past quarters manage
1198,PRGO,sell side
1199,PRGO,country top perform fund have be selling medical stock such biotech firm gilead science gild manage care company humana hum generic drug maker perrigo prgo latest report period
1200,PRGO,top fund have also be get rid retailer such wholesale discount chain costco cost athletic footwear seller finish line finl ugg boot maker decker outdoor deck gold price hit high ounce then gold have sell investor take profit ibd industry group mining gold silver group be rank monday group be rank week ibd find lead fund add newmont mining investing estimate american fund growth fund america add share latest report period colorado base firm be world biggest gold producer significant operation australia peru indonesia ghana canada new mexico dec newmont have ounce proven gold reserve stock clear month long base mid august run week high newmont have pull back high find support week move average newmont earning growth have slow past quarters manage sell country top perform fund have be selling medical stock such biotech firm gilead science gild manage care company humana hum generic drug maker perrigo prgo latest report period top fund have also be get rid retailer such wholesale discount chain costco cost athletic footwear seller finish line finl ugg boot maker decker outdoor deck
1201,PRGO,stock take beating monday more bad news europe trump positive economic news want hear ibd analysis today market emerge stock click here watch market wrap video nasdaq swoon lowest close come close undercut aug low nyse composite
1202,PRGO,side more breakout be see last week lead stock
1203,PRGO,unfortunately leader drop back buy point friday broad tumble
1204,PRGO,retreat come major index give most gain week market snap session winning streak thursday then slump further friday discourage job report
1205,PRGO,week ibd stock gain average meanwhile nyse composite advanced week nasdaq rise fraction lose
1206,PRGO,priceline pclr reversed lower friday thursday cup handle pattern be week too short handle be day too short volume didn surge quite much priceline still have lowly accumulation distribution rating break cup handle stock now stand trigger friday decline be lure speedy trade
1207,PRGO,ibd name break hold buy point last week end include dollar general dg dollar tree dltr mcdonald franchisee arco dorado arco
1208,PRGO,dollar general get lift strong quarterly earning report decision get commerce
1209,PRGO,clear basis finished trigger include perrigo prgo ambev abv also know companhia bebida da americas note perrigo latest base be flaw
1210,PRGO,nu skin enterprise nus finished last week buy point have regain trigger wednesday
1211,PRGO,ibd stock hansen natural han struggle bit last week follow aug be day market follow confirm new rally attempt
1212,PRGO,advance much past buy point hansen briefly trade level wednesday friday
1213,PRGO,still producer monster energy drink manage end week
1214,PRGO,longtime leader netflix nflx be last week notable loser web base movie service have now drop ibd shed week be hurt news lose right stream content provide cable network starz
1215,PRGO,ibd issue continue work possible basis hold week line be athenahealth athn mastercard
1216,PRGO,mastercard appear be shape square box pattern best see daily stock chart try break week faltered athenahealth surge new high base be too short be sound side more breakout be see last week lead stock unfortunately leader drop back buy point friday broad tumble retreat come major index give most gain week market snap session winning streak thursday then slump further friday discourage job report week ibd stock gain average meanwhile nyse composite advanced week nasdaq rise fraction lose priceline pclr reversed lower friday thursday cup handle pattern be week too short handle be day too short volume didn surge quite much priceline still have lowly accumulation distribution rating break cup handle stock now stand trigger friday decline be lure speedy trade ibd name break hold buy point last week end include dollar general dg dollar tree dltr mcdonald franchisee arco dorado arco dollar general get lift strong quarterly earning report decision get commerce clear basis finished trigger include perrigo prgo ambev abv also know companhia bebida da americas note perrigo latest base be flaw nu skin enterprise nus finished last week buy point have regain trigger wednesday ibd stock hansen natural han struggle bit last week follow aug be day market follow confirm new rally attempt advance much past buy point hansen briefly trade level wednesday friday still producer monster energy drink manage end week longtime leader netflix nflx be last week notable loser web base movie service have now drop ibd shed week be hurt news lose right stream content provide cable network starz ibd issue continue work possible basis hold week line be athenahealth athn mastercard mastercard appear be shape square box pattern best see daily stock chart try break week faltered athenahealth surge new high base be too short be sound
1217,PRGO,stock fall third straight session tuesday late day bounce shave large chunk market loss want hear ibd analysis today market emerge stock click here watch market wrap video nyse composite drop be much respectively
1218,PRGO,stock take beating friday labor department say net job be add august economist have expect gain job
1219,PRGO,stock take beating friday labor department say net job be add august economist have expect gain job
1220,PRGO,want hear ibd analysis today market emerge stock click here watch market wrap video
1221,PRGO,nasdaq tumble dow jone industrial average
1222,PRGO,volume drop board save market distribution day turnover tend be soft ahead long weekend
1223,PRGO,week dow jone industrial fall nasdaq finished fractionally higher
1224,PRGO,financial be hardest hit friday federal housing finance agency be sue major bank include bank america bac barclay bcs nomura mortgage security financial sector spdr xlf slump
1225,PRGO,netflix nflx gap day move average stumble heavy trading late thursday netflix unveil end talk liberty medium linta renew distribution content starz channel netflix current deal end april
1226,PRGO,perrigo prgo gap lose heavy trading stock fall much buy point flaw base clear tuesday perrigo pattern be too deep flat base too short cup stock find support day move average
1227,PRGO,recent breakout monro muffler brake mnro autonation ambev abv close latest buy point
1228,PRGO,gold producer buck sell gold rally almost
1229,PRGO,royal gold rgld climb record high fast trade now past buy point square box base
1230,PRGO,newmont mining nem rise week high turnover climb average
1231,PRGO,barrick gold abx gap gain brisk trade clear cup handle base close penny buy point
1232,PRGO,ism service index august be tuesday
1233,PRGO,want hear ibd analysis today market emerge stock click here watch market wrap video
1234,PRGO,nasdaq tumble dow jone industrial average
1235,PRGO,volume drop board save market distribution day turnover tend be soft ahead long weekend
1236,PRGO,week dow jone industrial fall nasdaq finished fractionally higher
1237,PRGO,financial be hardest hit friday federal housing finance agency be sue major bank include bank america bac barclay bcs nomura mortgage security financial sector spdr xlf slump
1238,PRGO,netflix nflx gap day move average stumble heavy trading late thursday netflix unveil end talk liberty medium linta renew distribution content starz channel netflix current deal end april
1239,PRGO,perrigo prgo gap lose heavy trading stock fall much buy point flaw base clear tuesday perrigo pattern be too deep flat base too short cup stock find support day move average
1240,PRGO,recent breakout monro muffler brake mnro autonation ambev abv close latest buy point
1241,PRGO,gold producer buck sell gold rally almost
1242,PRGO,royal gold rgld climb record high fast trade now past buy point square box base
1243,PRGO,newmont mining nem rise week high turnover climb average
1244,PRGO,barrick gold abx gap gain brisk trade clear cup handle base close penny buy point
1245,PRGO,ism service index august be tuesday nasdaq tumble dow jone industrial average volume drop board save market distribution day turnover tend be soft ahead long weekend week dow jone industrial fall nasdaq finished fractionally higher financial be hardest hit friday federal housing finance agency be sue major bank include bank america bac barclay bcs nomura mortgage security financial sector spdr xlf slump netflix nflx gap day move average stumble heavy trading late thursday netflix unveil end talk liberty medium linta renew distribution content starz channel netflix current deal end april perrigo prgo gap lose heavy trading stock fall much buy point flaw base clear tuesday perrigo pattern be too deep flat base too short cup stock find support day move average recent breakout monro muffler brake mnro autonation ambev abv close latest buy point gold producer buck sell gold rally almost royal gold rgld climb record high fast trade now past buy point square box base newmont mining nem rise week high turnover climb average barrick gold abx gap gain brisk trade clear cup handle base close penny buy point ism service index august be tuesday
1246,PRGO,stock take step mend wound monday make moderate gain nasdaq advanced nyse composite add want hear ibd analysis today market emerge stock click here watch market wrap video continue climb support day move average have quietly put
1247,PRGO,economic worry here abroad batter stock wednesday recent day index do not trim loss
1248,PRGO,want hear ibd analysis today market emerge stock
1249,PRGO,click here watch latest market wrap video
1250,PRGO,major index suffer biggest hit week nyse composite plunge dow slice day move average benchmark index close just day line nasdaq drop close day day line
1251,PRGO,volume climb major exchange major index add distribution day
1252,PRGO,many leader get hit hard
1253,PRGO,cree cree gap day day move average dive time average trade late tuesday maker lead chip guide fiscal sale vs view early wednesday ub cut share neutral buy
1254,PRGO,lead related firm veeco instrument veco aixtron aixg tumble respectively
1255,PRGO,industrial service america idsa gap drop more twice average trade stock clear buy point cup base july have give back bulk gain
1256,PRGO,str holding stri lose more twice average trade stock snap session streak share get slam firm solid result outlook give late tuesday solar component maker profit surge cent share cent view
1257,PRGO,jinko solar hold jks also end session streak drop more triple average volume stock be more intraday
1258,PRGO,elsewhere green mountain coffee roaster gmcr reversed record high lose more twice average trade stock close handle buy point clear monday
1259,PRGO,upside netflix nflx seesaw gain heavy trading stock clear buy point double bottom base tuesday
1260,PRGO,close networking giant cisco system csco tumble report fiscal sale slightly view
1261,PRGO,earning thursday include gildan activewear gil china agritech cagc perrigo prgo
1262,PRGO,weekly jobless claim import export price also be thursday economic worry here abroad batter stock wednesday recent day index do not trim loss want hear ibd analysis today market emerge stock
1263,PRGO,click here watch latest market wrap video
1264,PRGO,major index suffer biggest hit week nyse composite plunge dow slice day move average benchmark index close just day line nasdaq drop close day day line volume climb major exchange major index add distribution day many leader get hit hard cree cree gap day day move average dive time average trade late tuesday maker lead chip guide fiscal sale vs view early wednesday ub cut share neutral buy lead related firm veeco instrument veco aixtron aixg tumble respectively industrial service america idsa gap drop more twice average trade stock clear buy point cup base july have give back bulk gain str holding stri lose more twice average trade stock snap session streak share get slam firm solid result outlook give late tuesday solar component maker profit surge cent share cent view jinko solar hold jks also end session streak drop more triple average volume stock be more intraday elsewhere green mountain coffee roaster gmcr reversed record high lose more twice average trade stock close handle buy point clear monday upside netflix nflx seesaw gain heavy trading stock clear buy point double bottom base tuesday close networking giant cisco system csco tumble report fiscal sale slightly view earning thursday include gildan activewear gil china agritech cagc perrigo prgo weekly jobless claim import export price also be thursday
1265,PRGO,better expect job service datum lift stock wednesday upbeat earning report also help
1266,PRGO,want hear ibd analysis today market emerge stock
1267,PRGO,click here watch latest market wrap video
1268,PRGO,nasdaq outshined gain gain priceline pcln google goog amazon com amzn help index close best level june
1269,PRGO,meanwhile rise nyse dow volume fall nyse rise tad nasdaq
1270,PRGO,opentable open rally new time high triple average volume late tuesday provider restaurant reservation service serve surge earning beating view sale grow fourth straight quarter acceleration stock come public have more double
1271,PRGO,acme packet apkt gap day move average climb more twice average volume stock have recoup more half recent loss
1272,PRGO,thinly trade jinkosolar hold jks climb new record high ipo clear first base early july have surge more jinkosolar make solar cell wafer report earning aug analyst be expect cent share cent share year earlier period
1273,PRGO,iconix brand group icon rise nearly twice average volume stock clear buy point cup handle base structure be part base base pattern
1274,PRGO,downside whole food market wfmi gap lose almost time average trade late tuesday organic grocer deliver fiscal earning match view boost full year profit outlook company expect same store sale slow current quarter
1275,PRGO,dg fastchannel dgit stage big downside reversal stock turn gain loss stock manage close day move average earlier wednesday provider digital advertising service deliver earning sale blow past view
1276,PRGO,close mercadolibre meli report earning sale view share fall extend trading
1277,PRGO,cent only store ndn deliver fiscal profit view revenue miss estimate still share rise hour trading
1278,PRGO,earning thursday autodesk adsk gildan activewear gil perrigo prgo sara lee sle
1279,PRGO,datum weekly jobless claim also be thursday better expect job service datum lift stock wednesday upbeat earning report also help want hear ibd analysis today market emerge stock
1280,PRGO,click here watch latest market wrap video
1281,PRGO,nasdaq outshined gain gain priceline pcln google goog amazon com amzn help index close best level june meanwhile rise nyse dow volume fall nyse rise tad nasdaq opentable open rally new time high triple average volume late tuesday provider restaurant reservation service serve surge earning beating view sale grow fourth straight quarter acceleration stock come public have more double acme packet apkt gap day move average climb more twice average volume stock have recoup more half recent loss thinly trade jinkosolar hold jks climb new record high ipo clear first base early july have surge more jinkosolar make solar cell wafer report earning aug analyst be expect cent share cent share year earlier period iconix brand group icon rise nearly twice average volume stock clear buy point cup handle base structure be part base base pattern downside whole food market wfmi gap lose almost time average trade late tuesday organic grocer deliver fiscal earning match view boost full year profit outlook company expect same store sale slow current quarter dg fastchannel dgit stage big downside reversal stock turn gain loss stock manage close day move average earlier wednesday provider digital advertising service deliver earning sale blow past view close mercadolibre meli report earning sale view share fall extend trading cent only store ndn deliver fiscal profit view revenue miss estimate still share rise hour trading earning thursday autodesk adsk gildan activewear gil perrigo prgo sara lee sle datum weekly jobless claim also be thursday
1282,PRGO,stock marched higher second straight day tuesday round mixed earning dip dollar mostly upbeat housing datum climb close back short term resistance level nyse also picked dow nasdaq gain respectively remain
1283,PRGO,most ibd stock find week high few be form sound basis many stock today list be still trend downward haven correct enough chart reader view price decline proper basis other be extend most recent buy point not offer good buy area medical sector provide
1284,PRGO,day big gain stock putter mixed finish tuesday nyse composite tack edge nasdaq lose want hear ibd analysis today market emerge stock click here watch market wrap video volume come mixed well decrease slightly
1285,PRGO,market saw moderate gain monday dollar slide stock get boost earning report few merger want hear ibd analysis today market emerge stock click here watch latest market wrap video nasdaq lead rise dow edge higher nyse crawl ahead
1286,PRGO,stock climb early thursday afternoon new claim jobless benefit fall greece make progress bailout keep government default debt
1287,PRGO,nasdaq be dow jone industrial average volume rise nasdaq be slightly higher nyse compare same time wednesday
1288,PRGO,greek politician creditor appear have reach agreement allow further financial assistance athen european union country overdue agreement be consider crucial meeting european union minister schedule evening
1289,PRGO,meanwhile new claim jobless benefit fall greater expect last week labor department say latest sign job market be heal
1290,PRGO,network solution provider akamai technology akam gap report earning rise cent share nickel consensus view revenue be vs year quarter analyst have expect
1291,PRGO,stock have be climb october build right side month consolidation
1292,PRGO,lorillard lit more clear buy point flat base also be part base base cigarette producer turn earning share quarter consensus estimate revenue jump be also better expect
1293,PRGO,drugmaker alexion pharmaceutical alxn rise release better expect fourth quarter result revenue forecast be also high side estimate company say strong demand soliris used treat rare blood disease drive earning
1294,PRGO,meanwhile visa world largest credit card processor climb fiscal first quarter profit sale top forecast company also announce plan buy back share year
1295,PRGO,visa alexion be top performer ibd stock
1296,PRGO,nuance communication nuan be ahead fiscal first quarter result profit maker speech recognition software believe be used apple aapl siri voice command system mobile phone be expect rise vs year earlier
1297,PRGO,stock be extend past buy point cup handle base
1298,PRGO,apple jump strong volume follow report announce next generation ipad tablet first week march year debut current model ipad new tablet be expect have faster processor higher resolution display accord thing
1299,PRGO,downside groupon grpn gap earning trail analyst estimate stock go public november stock climb early thursday afternoon new claim jobless benefit fall greece make progress bailout keep government default debt nasdaq be dow jone industrial average volume rise nasdaq be slightly higher nyse compare same time wednesday greek politician creditor appear have reach agreement allow further financial assistance athen european union country overdue agreement be consider crucial meeting european union minister schedule evening meanwhile new claim jobless benefit fall greater expect last week labor department say latest sign job market be heal network solution provider akamai technology akam gap report earning rise cent share nickel consensus view revenue be vs year quarter analyst have expect stock have be climb october build right side month consolidation lorillard lit more clear buy point flat base also be part base base cigarette producer turn earning share quarter consensus estimate revenue jump be also better expect drugmaker alexion pharmaceutical alxn rise release better expect fourth quarter result revenue forecast be also high side estimate company say strong demand soliris used treat rare blood disease drive earning meanwhile visa world largest credit card processor climb fiscal first quarter profit sale top forecast company also announce plan buy back share year visa alexion be top performer ibd stock nuance communication nuan be ahead fiscal first quarter result profit maker speech recognition software believe be used apple aapl siri voice command system mobile phone be expect rise vs year earlier stock be extend past buy point cup handle base apple jump strong volume follow report announce next generation ipad tablet first week march year debut current model ipad new tablet be expect have faster processor higher resolution display accord thing downside groupon grpn gap earning trail analyst estimate stock go public november
1300,PRGO,stock end confuse session monday moderate gain lower volume dow rise nyse composite nasdaq edge volume fall board indicate institutional investor remain reluctant buy stock economic news staggering bankruptcy grip market get go later come
1301,PRGO,lead stock be few refer such way behaved decently wednesday major index rise third straight day want hear ibd analysis today market emerge stock click here watch market wrap video nasdaq rally finished almost day high
1302,PRGO,stock stroll moderately higher friday show calmer action index do past week want hear ibd analysis today market emerge stock click here watch latest market wrap video nasdaq nyse composite add rise ibd component average gain volume slide
1303,PRGO,round good news stock give modest early gain lose ground third straight session monday want hear ibd analysis today market emerge stock click here watch market wrap video hurt energy stock nyse composite fall nasdaq lose continue back
1304,PRGO,stock take well need break tuesday post biggest loss week volume climb leader sell hard other take selling largely stride want hear ibd analysis today market emerge stock click here watch latest market wrap video nyse composite suffer day biggest decline mild
1305,PRGO,update stock gain higher volume tuesday be encourage sign monday low volume advance
1306,PRGO,index be strong housing datum market day streak be best nearly month tuesday dow gain nasdaq nyse composite volume rise board
1307,PRGO,today market action include verisign vrsn internet infrastructure company say earning be cent share loss cent share year analyst estimate cent
1308,PRGO,ctrip com ctrp be also expect report close
1309,PRGO,deck wednesday be several economic report include challenger job datum adp employment change consensus forecast adp report be loss
1310,PRGO,also tomorrow be ism service sector index crude inventory forecast ism index be
1311,PRGO,tomorrow visa yum brand yum report close
1312,PRGO,stock end higher so do volume
1313,PRGO,patrick
1314,PRGO,update stock finished higher tuesday second straight day time higher volume
1315,PRGO,dow gain nasdaq nyse composite
1316,PRGO,top stock day be pegasystem pega maker business management software jump double usual volume pegasystem have see earning grow triple digit past quarters analyst see profit rise cent share
1317,PRGO,perrigo prgo gain stock erased morning loss finish time high open drugmaker beat view jump fiscal earning sale grow miss view
1318,PRGO,ctrip com international ctrp advanced average volume ahead company earning close analyst see chinese provider travel service earning cent share year
1319,PRGO,stock ease late trade
1320,PRGO,vincent mao
1321,PRGO,update major stock index pull back late trading tuesday
1322,PRGO,nyse composite gain session peak rise dip back level meanwhile dow nasdaq tack respectively
1323,PRGO,tupperware tup gap rally regain day move average late monday houseware maker report increase earning rise sale also raise profit outlook boost stock buyback addition food container company make beauty personal care product
1324,PRGO,netlogic microsystem netl be session high still ahead result close chipmaker earning be expect rise cent share sale be slate double
1325,PRGO,downside toyota tm fall extend earlier loss hurt sale freeze several best selling model japanese auto giant say january sale tumble earlier ford report spike january vehicle sale
1326,PRGO,stock index extend gain
1327,PRGO,vincent mao
1328,PRGO,update major stock index charge ahead afternoon trading tuesday
1329,PRGO,gain moved further north mark touch highest level jan index have yet close jan
1330,PRGO,meanwhile nyse composite climb dow nasdaq
1331,PRGO,turnover be again tracking higher board especially nyse
1332,PRGO,seagate technology stx reversed earlier loss climb fast trade fiscal hard drive maker report loss share analyst be expect earning share fiscal
1333,PRGO,warner chilcott wcrx rally upgrade caris co raise drugmaker buy average lift price target
1334,PRGO,downside longtop financial technology lft reversed earlier gain fall heavy trading stock have take beating past week accumulation distribution rating have slump last month
1335,PRGO,longtop provide service china fast grow financial sector report fiscal earning feb profit be slate rise cent share
1336,PRGO,stock extend gain flirt
1337,PRGO,vincent mao
1338,PRGO,update stock add gain hover new session high early afternoon trading tuesday
1339,PRGO,climb trade hair resistance level nyse composite rally dow nasdaq
1340,PRGO,turnover be again tracking higher board
1341,PRGO,pegasystem pega reversed earlier loss run fast trade stock be continue rebound last week fail pegasystem manage find support day move average friday maker business process software have deliver triple digit earning growth past quarters analyst see profit rise cent share
1342,PRGO,perrigo prgo erased morning loss rise time high open drugmaker beat view jump fiscal earning sale grow miss view
1343,PRGO,ctrip com international ctrp rally ahead fourth quarter result close analyst see chinese provider travel service earning cent share year
1344,PRGO,downside american superconductor amsc gap drop slice day move average electrical system maker get hit report fiscal result easily beat view also raise full year outlook earning sale
1345,PRGO,elsewhere dollar come pressure second straight session boost commodity price oil climb more gold add
1346,PRGO,stock retain gain nyse index lead
1347,PRGO,jonah keri
1348,PRGO,update market remain higher board midday tuesday mostly positive earning news latest housing figure give stock lift
1349,PRGO,climb dow nyse composite nasdaq volume picked nyse nasdaq compare same period monday
1350,PRGO,northern oil gas nog advanced more triple normal trade oil natural gas exploration production firm stock have rebound day move average
1351,PRGO,jda software jdas rise double average volume maker business process management software retail industry complete acquisition technology last week
1352,PRGO,downside amazon com amzn shed more time usual turnover online retail giant be add monday loss amazon stock now sit week high day move average
1353,PRGO,stock gain steam housing result stoke rally
1354,PRGO,update stock gain higher volume tuesday be encourage sign monday low volume advance index be strong housing datum market day streak be best nearly month tuesday dow gain nasdaq nyse composite volume rise board today market action include verisign vrsn internet infrastructure company say earning be cent share loss cent share year analyst estimate cent ctrip com ctrp be also expect report close deck wednesday be several economic report include challenger job datum adp employment change consensus forecast adp report be loss also tomorrow be ism service sector index crude inventory forecast ism index be tomorrow visa yum brand yum report close stock end higher so do volume patrick update stock finished higher tuesday second straight day time higher volume dow gain nasdaq nyse composite top stock day be pegasystem pega maker business management software jump double usual volume pegasystem have see earning grow triple digit past quarters analyst see profit rise cent share perrigo prgo gain stock erased morning loss finish time high open drugmaker beat view jump fiscal earning sale grow miss view ctrip com international ctrp advanced average volume ahead company earning close analyst see chinese provider travel service earning cent share year stock ease late tradeby vincent mao update major stock index pull back late trading tuesday nyse composite gain session peak rise dip back level meanwhile dow nasdaq tack respectively tupperware tup gap rally regain day move average late monday houseware maker report increase earning rise sale also raise profit outlook boost stock buyback addition food container company make beauty personal care product netlogic microsystem netl be session high still ahead result close chipmaker earning be expect rise cent share sale be slate double downside toyota tm fall extend earlier loss hurt sale freeze several best selling model japanese auto giant say january sale tumble earlier ford report spike january vehicle sale stock index extend gainsby vincent mao update major stock index charge ahead afternoon trading tuesday gain moved further north mark touch highest level jan index have yet close jan meanwhile nyse composite climb dow nasdaq turnover be again tracking higher board especially nyse seagate technology stx reversed earlier loss climb fast trade fiscal hard drive maker report loss share analyst be expect earning share fiscal warner chilcott wcrx rally upgrade caris co raise drugmaker buy average lift price target downside longtop financial technology lft reversed earlier gain fall heavy trading stock have take beating past week accumulation distribution rating have slump last month longtop provide service china fast grow financial sector report fiscal earning feb profit be slate rise cent share stock extend gain flirt vincent mao update stock add gain hover new session high early afternoon trading tuesday climb trade hair resistance level nyse composite rally dow nasdaq turnover be again tracking higher board pegasystem pega reversed earlier loss run fast trade stock be continue rebound last week fail pegasystem manage find support day move average friday maker business process software have deliver triple digit earning growth past quarters analyst see profit rise cent share perrigo prgo erased morning loss rise time high open drugmaker beat view jump fiscal earning sale grow miss view ctrip com international ctrp rally ahead fourth quarter result close analyst see chinese provider travel service earning cent share year downside american superconductor amsc gap drop slice day move average electrical system maker get hit report fiscal result easily beat view also raise full year outlook earning sale elsewhere dollar come pressure second straight session boost commodity price oil climb more gold add stock retain gain nyse index leadby jonah keri update market remain higher board midday tuesday mostly positive earning news latest housing figure give stock lift climb dow nyse composite nasdaq volume picked nyse nasdaq compare same period monday northern oil gas nog advanced more triple normal trade oil natural gas exploration production firm stock have rebound day move average jda software jdas rise double average volume maker business process management software retail industry complete acquisition technology last week downside amazon com amzn shed more time usual turnover online retail giant be add monday loss amazon stock now sit week high day move average stock gain steam housing result stoke rally
1355,PRGO,stock tick higher wednesday snap recent lose streak abbreviated pre holiday trading nasdaq edge nyse composite climb dow industrial smaller cap stock also gain ground small cap rise midcap volume slide board trading end volume
1356,PRGO,june get gloomy start stock stumble seesaw session tuesday worry europe debt crisis china economic growth tension israel lebanon offset better expect domestic economic datum
1357,PRGO,want hear ibd analysis today market emerge stock
1358,PRGO,click here watch latest market wrap video
1359,PRGO,nyse composite drop hurt oil steel issue dow lose respectively meanwhile nasdaq fall close back day move average volume fall exchange
1360,PRGO,acme packet apkt reversed new record high drop twice average trade stock have be hold tough correction
1361,PRGO,sirona dental system siro shed heavy trading stock ease worst level support day move average
1362,PRGO,perrigo prgo drop brisk volume close back day move average stock be work new base recent price action have be wide loose
1363,PRGO,upside ev evvv gap bolt takeover news covidien cov agree buy medical gear maker cash share mark premium nearly friday close
1364,PRGO,close collective brand pss tumble report sale analyst estimate
1365,PRGO,datum pending home sale vehicle sale be wednesday medical action mdci also report earning wednesday
1366,PRGO,stock close lows
1367,PRGO,vincent mao
1368,PRGO,stock sway loss gain ultimately finishing lower late sell tuesday
1369,PRGO,nyse composite drop nasdaq dow accord preliminary datum volume rise major exchange
1370,PRGO,late selling come report say israeli warplane have come fire lebanon
1371,PRGO,energy steel related industry group be worst performer defensive industry such food beverage company rise
1372,PRGO,stock waver late trade
1373,PRGO,vincent mao
1374,PRGO,stock continue trade much direction late tuesday
1375,PRGO,dow nasdaq rise respectively nyse composite fall volume be tracking higher nyse tad lower nasdaq
1376,PRGO,apple aapl climb news sale ipad have top unit hit store shelve april tablet device go sale number overseas market friday
1377,PRGO,boston beer sam erased early loss rise fresh time high stock recently find support day move average earlier month brewer beat expectation pop earning
1378,PRGO,concho resource cxo erased morning loss climb regain day move average heavy trading stock buck weakness other oil issue early oil gas producer smash view
1379,PRGO,collective brand pss be intraday low still ahead result close shoe retailer be expect deliver earning cent share sale be slate rise
1380,PRGO,stock improve blue chip lead
1381,PRGO,vincent mao
1382,PRGO,stock improve afternoon trading dow lead pack
1383,PRGO,blue chip index climb new session high be only index do so component trade higher ibm ibm johnson johnson jnj be biggest point gainer
1384,PRGO,meanwhile nasdaq gain nyse composite lose fraction hurt loss oil energy steel stock volume turn lower exchange
1385,PRGO,august gold settle ounce july crude slip cent barrel
1386,PRGO,universal display panl surge fast trade earlier tuesday canaccord adam raise stock buy hold universal display make light emit flat panel display firm have lose money number quarters sale growth ramp recent period composite rating be
1387,PRGO,edward lifescience ew reversed earlier loss climb fast trade stock regain day move average be work new base
1388,PRGO,stock seesaw early afternoon trading
1389,PRGO,vincent mao
1390,PRGO,stock waver mixed territory early afternoon trade major index have have trouble hold gain today turn positive
1391,PRGO,dow rise boost gain ibm ibm johnson johnson jnj earlier blue chip index have be much much
1392,PRGO,meanwhile nyse composite fall nasdaq be flat volume be tracking higher exchange
1393,PRGO,china agritech cagc erased earlier gain skid put stock week high composite rating however be consider leader
1394,PRGO,yanzhou coal yzc gap fall fast trade erased chunk gain past session earlier report say chinese factory activity slow
1395,PRGO,xryatex xrtx turn lower briefly turn positive shed fast trade last month datum storage firm swung better expect profit report first quarter revenue growth year have composite rating
1396,PRGO,august gold climb ounce boost gold producer
1397,PRGO,randgold resource gold rally near record high barrick gold abx iamgold iag gain apiece
1398,PRGO,stock turn mostly lower midday
1399,PRGO,jonah keri
1400,PRGO,major index give most brief intraday gain midday tuesday stock continue trade narrowly mixed
1401,PRGO,dow be downside nasdaq fall nyse composite lose volume swell nyse nasdaq compare pre holiday trading friday
1402,PRGO,acme packet apkt fall more time usual turnover maker technology other interactive communication reversed lower hit time high
1403,PRGO,perrigo prgo slip rapid volume drugmaker stock duck day move average
1404,PRGO,upside concho resource cxo advanced nearly triple normal trade oil natural gas exploration development firm stock rebound day move average
1405,PRGO,stock turn higher construction manufacturing report
1406,PRGO,june get gloomy start stock stumble seesaw session tuesday worry europe debt crisis china economic growth tension israel lebanon offset better expect domestic economic datum want hear ibd analysis today market emerge stock
1407,PRGO,click here watch latest market wrap video
1408,PRGO,nyse composite drop hurt oil steel issue dow lose respectively meanwhile nasdaq fall close back day move average volume fall exchange acme packet apkt reversed new record high drop twice average trade stock have be hold tough correction sirona dental system siro shed heavy trading stock ease worst level support day move average perrigo prgo drop brisk volume close back day move average stock be work new base recent price action have be wide loose upside ev evvv gap bolt takeover news covidien cov agree buy medical gear maker cash share mark premium nearly friday close close collective brand pss tumble report sale analyst estimate datum pending home sale vehicle sale be wednesday medical action mdci also report earning wednesday stock close lowsby vincent maostock sway loss gain ultimately finishing lower late sell tuesday nyse composite drop nasdaq dow accord preliminary datum volume rise major exchange late selling come report say israeli warplane have come fire lebanon energy steel related industry group be worst performer defensive industry such food beverage company rise stock waver late tradeby vincent maostock continue trade much direction late tuesday dow nasdaq rise respectively nyse composite fall volume be tracking higher nyse tad lower nasdaq apple aapl climb news sale ipad have top unit hit store shelve april tablet device go sale number overseas market friday boston beer sam erased early loss rise fresh time high stock recently find support day move average earlier month brewer beat expectation pop earning concho resource cxo erased morning loss climb regain day move average heavy trading stock buck weakness other oil issue early oil gas producer smash view collective brand pss be intraday low still ahead result close shoe retailer be expect deliver earning cent share sale be slate rise stock improve blue chip leadby vincent maostock improve afternoon trading dow lead pack blue chip index climb new session high be only index do so component trade higher ibm ibm johnson johnson jnj be biggest point gainer meanwhile nasdaq gain nyse composite lose fraction hurt loss oil energy steel stock volume turn lower exchange august gold settle ounce july crude slip cent barrel universal display panl surge fast trade earlier tuesday canaccord adam raise stock buy hold universal display make light emit flat panel display firm have lose money number quarters sale growth ramp recent period composite rating be edward lifescience ew reversed earlier loss climb fast trade stock regain day move average be work new base stock seesaw early afternoon tradingby vincent maostock waver mixed territory early afternoon trade major index have have trouble hold gain today turn positive dow rise boost gain ibm ibm johnson johnson jnj earlier blue chip index have be much much meanwhile nyse composite fall nasdaq be flat volume be tracking higher exchange china agritech cagc erased earlier gain skid put stock week high composite rating however be consider leader yanzhou coal yzc gap fall fast trade erased chunk gain past session earlier report say chinese factory activity slow xryatex xrtx turn lower briefly turn positive shed fast trade last month datum storage firm swung better expect profit report first quarter revenue growth year have composite rating august gold climb ounce boost gold producer randgold resource gold rally near record high barrick gold abx iamgold iag gain apiece stock turn mostly lower middayby jonah major index give most brief intraday gain midday tuesday stock continue trade narrowly mixed dow be downside nasdaq fall nyse composite lose volume swell nyse nasdaq compare pre holiday trading friday acme packet apkt fall more time usual turnover maker technology other interactive communication reversed lower hit time high perrigo prgo slip rapid volume drugmaker stock duck day move average upside concho resource cxo advanced nearly triple normal trade oil natural gas exploration development firm stock rebound day move average stock turn higher construction manufacturing report
1409,PRGO,stock surge round upbeat earning report thursday
1410,PRGO,nasdaq outshined gain jump nyse composite dow major index have re-trace bulk tuesday sharp drop
1411,PRGO,volume fall nyse nasdaq volume rise due increase trading trade etfc palm palm baidu bidu
1412,PRGO,baidu gap sky-rocket new record high late wednesday chinese internet search firm trounce view pop earning sale jump also view also guide sale well ahead view
1413,PRGO,valassis communication vci gap vault more best level november provider direct mail service blow past view surge earning valassis be now past buy point flat base
1414,PRGO,perrigo prgo run nearly new record high drugmaker beat view rise fiscal earning sale grow miss view perrigo boost full year profit outlook range share vs view perrigo break january have yet test week move average
1415,PRGO,encore capital group ecpg gap rally heavy trading stock hit year high now sit past buy point cup handle base analyst see debt buyer earning rise year
1416,PRGO,downside green mountain coffee roaster gmcr gap shed more time average trade late wednesday company give weak profit outlook stock close slightly day move average level be trading january
1417,PRGO,close acme packet apkt bolt deliver result view also raise full year outlook earning sale
1418,PRGO,dolby laboratory dlb rise report fiscal earning view
1419,PRGO,netlogic microsystem netl fall deliver earning sale ahead analyst estimate
1420,PRGO,vistaprint vprt drop report disappointing sale guide earning view
1421,PRGO,casino operator wynn resort wynn report earning view rise extend trading
1422,PRGO,earning friday chevron cvx hms holding hmsy first quarter gdp employment cost chicago pmi michigan sentiment index be also be friday
1423,PRGO,stock surge nasdaq retake key level
1424,PRGO,vincent mao
1425,PRGO,stock stage broad rally thursday close session high
1426,PRGO,nasdaq rally close level climb retake mark meanwhile nyse composite dow gain respectively volume be lower nyse higher nasdaq
1427,PRGO,internet be top industry group thank huge pop baidu bidu hotel operator automotive equipment maker also gain school operator tumble
1428,PRGO,stock hold strong gain late trading
1429,PRGO,vincent mao
1430,PRGO,stock remain sharply higher late trading equity have nearly recoup loss tuesday sell
1431,PRGO,nasdaq climb dow nyse composite rise volume be again mixed nyse lower nasdaq higher
1432,PRGO,acme packet apkt reversed earlier loss climb ahead result close analyst see company earn cent share year sale be expect climb
1433,PRGO,netlogic microsystem netl also bounce back earlier loss climb ahead earning close chipmaker be expect earn cent share stock have gain clear buy point week consolidation
1434,PRGO,dolby laboratory dlb rise seesaw trading audio technology firm also report earning close bell analyst be expect cent share
1435,PRGO,elsewhere bj restaurant bjri bounce back earlier loss rise fast trade stock turn find support day move average
1436,PRGO,stock hold high
1437,PRGO,vincent mao
1438,PRGO,major index hover session high hour left thursday session
1439,PRGO,nasdaq rally dow nyse composite gain turnover continue track mixed lower nyse higher nasdaq
1440,PRGO,akamai technology akam gap soar near year high late wednesday provider content delivery service report smaller expect drop earning earlier thursday wedbush morgan raise earning estimate stock akamai clear buy point week tight pattern april
1441,PRGO,ev evvv gap surge approach year high blow away estimate medical product company report earning cent share lift full year outlook earning sale stock find support day move average several session
1442,PRGO,downside green mountain coffee roaster gmcr gap shed huge volume late wednesday company report fiscal earning view give weak outlook share be nearly session low
1443,PRGO,stock strengthen nasdaq retake
1444,PRGO,vincent mao
1445,PRGO,stock add gain hit new session early afternoon trading thursday
1446,PRGO,climb back level nasdaq rally retake mark meanwhile dow nyse composite gain
1447,PRGO,volume be again mixed nyse tracking lower nasdaq higher nasdaq turnover spiked due heighten trading trade etfc palm palm
1448,PRGO,perrigo prgo bolt almost new record high drugmaker beat view rise fiscal earning sale grow miss view perrigo boost full year profit outlook range share vs view perrigo break january have yet test week move average
1449,PRGO,encore capital group ecpg gap rally heavy trading stock hit year high now sit past buy point cup handle base analyst see debt buyer earning rise year
1450,PRGO,lubrizol lz be session peak still strong quarterly result open chemical maker easily beat view surge earning marked third straight period triple digit growth lubrizol also boost full year profit outlook range share vs view
1451,PRGO,downside power integration powi gap day move average dump huge volume late wednesday chipmaker deliver pop earning yet still miss view sale jump also analyst estimate
1452,PRGO,aixtron aixg slump slice day move average stock accumulation distribution rating have drop just week
1453,PRGO,stock retain broad base gain
1454,PRGO,jonah keri
1455,PRGO,major index continue trade broadly higher mixed volume midday thursday
1456,PRGO,dow nasdaq jump nyse composite volume fall nyse rise nasdaq compare same period wednesday
1457,PRGO,china yuchai cyd rise average trade car part maker have push sharply higher gapping march stock sit recent week high
1458,PRGO,chip stock continue recent hot streak cirrus logic crus climb isilon system isln gain
1459,PRGO,chipotle grill cmg also advanced brisk volume fast food chain gap new high april
1460,PRGO,stock expand gain school stock tumble
1461,PRGO,stock surge round upbeat earning report thursday nasdaq outshined gain jump nyse composite dow major index have re-trace bulk tuesday sharp drop volume fall nyse nasdaq volume rise due increase trading trade etfc palm palm baidu bidu baidu gap sky-rocket new record high late wednesday chinese internet search firm trounce view pop earning sale jump also view also guide sale well ahead view valassis communication vci gap vault more best level november provider direct mail service blow past view surge earning valassis be now past buy point flat base perrigo prgo run nearly new record high drugmaker beat view rise fiscal earning sale grow miss view perrigo boost full year profit outlook range share vs view perrigo break january have yet test week move average encore capital group ecpg gap rally heavy trading stock hit year high now sit past buy point cup handle base analyst see debt buyer earning rise year downside green mountain coffee roaster gmcr gap shed more time average trade late wednesday company give weak profit outlook stock close slightly day move average level be trading january close acme packet apkt bolt deliver result view also raise full year outlook earning sale dolby laboratory dlb rise report fiscal earning view netlogic microsystem netl fall deliver earning sale ahead analyst estimate vistaprint vprt drop report disappointing sale guide earning view casino operator wynn resort wynn report earning view rise extend trading earning friday chevron cvx hms holding hmsy first quarter gdp employment cost chicago pmi michigan sentiment index be also be friday stock surge nasdaq retake key levelsby vincent maostock stage broad rally thursday close session high nasdaq rally close level climb retake mark meanwhile nyse composite dow gain respectively volume be lower nyse higher nasdaq internet be top industry group thank huge pop baidu bidu hotel operator automotive equipment maker also gain school operator tumble stock hold strong gain late tradingby vincent maostock remain sharply higher late trading equity have nearly recoup loss tuesday sell nasdaq climb dow nyse composite rise volume be again mixed nyse lower nasdaq higher acme packet apkt reversed earlier loss climb ahead result close analyst see company earn cent share year sale be expect climb netlogic microsystem netl also bounce back earlier loss climb ahead earning close chipmaker be expect earn cent share stock have gain clear buy point week consolidation dolby laboratory dlb rise seesaw trading audio technology firm also report earning close bell analyst be expect cent share elsewhere bj restaurant bjri bounce back earlier loss rise fast trade stock turn find support day move average stock hold highsby vincent maothe major index hover session high hour left thursday session nasdaq rally dow nyse composite gain turnover continue track mixed lower nyse higher nasdaq akamai technology akam gap soar near year high late wednesday provider content delivery service report smaller expect drop earning earlier thursday wedbush morgan raise earning estimate stock akamai clear buy point week tight pattern april ev evvv gap surge approach year high blow away estimate medical product company report earning cent share lift full year outlook earning sale stock find support day move average several session downside green mountain coffee roaster gmcr gap shed huge volume late wednesday company report fiscal earning view give weak outlook share be nearly session low stock strengthen nasdaq retake vincent maostock add gain hit new session early afternoon trading thursday climb back level nasdaq rally retake mark meanwhile dow nyse composite gain volume be again mixed nyse tracking lower nasdaq higher nasdaq turnover spiked due heighten trading trade etfc palm palm perrigo prgo bolt almost new record high drugmaker beat view rise fiscal earning sale grow miss view perrigo boost full year profit outlook range share vs view perrigo break january have yet test week move average encore capital group ecpg gap rally heavy trading stock hit year high now sit past buy point cup handle base analyst see debt buyer earning rise year lubrizol lz be session peak still strong quarterly result open chemical maker easily beat view surge earning marked third straight period triple digit growth lubrizol also boost full year profit outlook range share vs view downside power integration powi gap day move average dump huge volume late wednesday chipmaker deliver pop earning yet still miss view sale jump also analyst estimate aixtron aixg slump slice day move average stock accumulation distribution rating have drop just week stock retain broad base gainsby jonah major index continue trade broadly higher mixed volume midday thursday dow nasdaq jump nyse composite volume fall nyse rise nasdaq compare same period wednesday china yuchai cyd rise average trade car part maker have push sharply higher gapping march stock sit recent week high chip stock continue recent hot streak cirrus logic crus climb isilon system isln gain chipotle grill cmg also advanced brisk volume fast food chain gap new high april stock expand gain school stock tumble
1462,PRGO,couple notable company beat earning expectation close add day positive tone
1463,PRGO,adobe system adbe report earning be cent share top view cent revenue also top estimate go forward digital publish firm see revenue wall street estimate share be hour
1464,PRGO,darden restaurant dri also beat view darden earn cent share top estimate cent share be slightly higher
1465,PRGO,trading open tomorrow general mill gis be expect report result analyst forecast earning growth cent share also bell durable good datum february be expect be release economist estimate be increase
1466,PRGO,stock close session high
1467,PRGO,couple notable company beat earning expectation close add day positive tone adobe system adbe report earning be cent share top view cent revenue also top estimate go forward digital publish firm see revenue wall street estimate share be hour darden restaurant dri also beat view darden earn cent share top estimate cent share be slightly higher trading open tomorrow general mill gis be expect report result analyst forecast earning growth cent share also bell durable good datum february be expect be release economist estimate be increase stock close session high
1468,PRGO,update china raise bank reserve requirement slam stock early equity bounce back close mixed friday
1469,PRGO,nasdaq rise be much big cap techs such research motion rimm boost index chip also help philadelphia semiconductor index rise
1470,PRGO,meanwhile dow lose nyse composite fall
1471,PRGO,volume climb sharply nyse rise tad nasdaq
1472,PRGO,major index close first time week
1473,PRGO,nasdaq rally nyse composite dow gain
1474,PRGO,riverb technology rvbd appear be fizzling monday rally nearly time average trade friday now past buy point cup handle base
1475,PRGO,telestone technology tstc erased early loss run regain day move average stock be bounce back plunge telestone be chinese maker wireless telecom equipment firm sale growth accelerate latest quarters
1476,PRGO,perrigo prgo reversed loss climb new time high generic drug maker win favorable court ruling perrigo close fourth straight week be now past buy point flat base
1477,PRGO,downside buffalo wild wing bwld gap tumble huge volume report disappointing result late thursday stock be much
1478,PRGO,earning tuesday abercrombie fitch anf capella education cpla dg fastchannel dgit kraft food kft merck mrk teva pharmaceutical teva unite therapeutic uthr
1479,PRGO,empire manufacturing index treasury budget be tuesday
1480,PRGO,stock end mixed techs buck sell
1481,PRGO,vincent mao
1482,PRGO,update techs outshined broader market step back friday
1483,PRGO,nasdaq climb thank gain research motion rimm qualcomm qcom intel intc dow give nyse composite fall
1484,PRGO,accord preliminary datum volume rise nyse slip nasdaq
1485,PRGO,datum storage energy group fared worst office supply chain genetic security software group climb
1486,PRGO,stock pace first weekly gain week
1487,PRGO,vincent mao
1488,PRGO,update stock firm dollar pull back late trade friday major index be track snap week lose streak
1489,PRGO,nasdaq again push positive territory rise dow nyse composite fall lose
1490,PRGO,volume be again tracking higher exchange pace slow
1491,PRGO,kinetic concept kci reversed morning loss rise heavy trading stock have find support day move average recent session kinetic develop wound care system latest report quarter earning growth accelerate period analyst be expect gain current quarter
1492,PRGO,athero communication athr shed early loss climb fast trade earlier friday benchmark start coverage chipmaker buy rating athero be work new base stock be still week high relative strength line be already new high
1493,PRGO,perrigo prgo turn positive add trade time high generic drug maker win favorable ruling patent suit perrigo clear buy point cup base jan have gain
1494,PRGO,stock afternoon trading
1495,PRGO,vincent mao
1496,PRGO,update comeback effort wane afternoon trading dollar firm
1497,PRGO,nasdaq fall back negative territory lose chip weaken remain higher philadelphia semiconductor index rise session peak
1498,PRGO,meanwhile dow nyse composite drop lose
1499,PRGO,turnover continue track slightly higher exchange
1500,PRGO,compellent technology cml extend loss slice day move average late thursday datum storage firm report earning view earlier friday william blair cut share underperform market perform
1501,PRGO,ehealth ehth pare loss late thursday insurance firm beat view rise earning sale grow miss view friday morning jeffery co cut share hold buy
1502,PRGO,side altisource portfolio solution asps erased morning loss rise new high heavy trading stock follow clear square box base thursday altisource provide real estate mortgage related service company be featured monday daily stock analysis
1503,PRGO,stock step rebound effort nasdaq turn green
1504,PRGO,vincent mao
1505,PRGO,update stock greatly improve early afternoon trading friday
1506,PRGO,nasdaq rebound deficit turn fractionally higher chip issue show strength second session philadelphia semiconductor index rise
1507,PRGO,meanwhile nyse composite fall dow be much respectively dip
1508,PRGO,volume be tracking slightly higher exchange
1509,PRGO,blue nile nile gap tumble huge trade deficit late thursday jewelry retailer report earning view give soft first quarter outlook earlier friday morning benchmark downgrade share sell hold
1510,PRGO,upside restaurant operator bounce positive territory
1511,PRGO,cheesecake factory cake turn loss gain also hit year high late thursday company report hot earning sale be flat miss view
1512,PRGO,panera bread pnra bounce back nearly loss rise bakery cafe operator report mixed quarterly earning sale late thursday guide full year earning view
1513,PRGO,elsewhere volterra semiconductor vltr reversed morning loss run fast trade chipmaker hit best level december
1514,PRGO,stock continue trim loss midday
1515,PRGO,jonah keri
1516,PRGO,update major index remain broadly lower midday friday market do pare few more loss china decision force bank increase reserve level rocked stock early
1517,PRGO,nasdaq drop nyse composite dow volume remain higher board rise nyse nasdaq compare same period thursday
1518,PRGO,western digital wdc slip nearly twice normal trade hard disk drive maker have be consolidate past week now sit week high
1519,PRGO,upside telestone technology tstc rise rapid volume maker repeater antenna radio frequency peripheral rebound day move average complete fifth week shape consolidation
1520,PRGO,riverb technology rvbd advanced more triple usual turnover provider product service improve application accessibility datum wide area network try break cup handle base monday give most day gain stock clear buy point second time today
1521,PRGO,stock pare loss slightly leader pressure
1522,PRGO,update china raise bank reserve requirement slam stock early equity bounce back close mixed friday nasdaq rise be much big cap techs such research motion rimm boost index chip also help philadelphia semiconductor index rise meanwhile dow lose nyse composite fall volume climb sharply nyse rise tad nasdaq major index close first time week nasdaq rally nyse composite dow gain riverb technology rvbd appear be fizzling monday rally nearly time average trade friday now past buy point cup handle base telestone technology tstc erased early loss run regain day move average stock be bounce back plunge telestone be chinese maker wireless telecom equipment firm sale growth accelerate latest quarters perrigo prgo reversed loss climb new time high generic drug maker win favorable court ruling perrigo close fourth straight week be now past buy point flat base downside buffalo wild wing bwld gap tumble huge volume report disappointing result late thursday stock be much earning tuesday abercrombie fitch anf capella education cpla dg fastchannel dgit kraft food kft merck mrk teva pharmaceutical teva unite therapeutic uthr empire manufacturing index treasury budget be tuesday stock end mixed techs buck sell offby vincent mao update techs outshined broader market step back friday nasdaq climb thank gain research motion rimm qualcomm qcom intel intc dow give nyse composite fall accord preliminary datum volume rise nyse slip nasdaq datum storage energy group fared worst office supply chain genetic security software group climb stock pace first weekly gain weeksby vincent mao update stock firm dollar pull back late trade friday major index be track snap week lose streak nasdaq again push positive territory rise dow nyse composite fall lose volume be again tracking higher exchange pace slow kinetic concept kci reversed morning loss rise heavy trading stock have find support day move average recent session kinetic develop wound care system latest report quarter earning growth accelerate period analyst be expect gain current quarter athero communication athr shed early loss climb fast trade earlier friday benchmark start coverage chipmaker buy rating athero be work new base stock be still week high relative strength line be already new high perrigo prgo turn positive add trade time high generic drug maker win favorable ruling patent suit perrigo clear buy point cup base jan have gain stock afternoon tradingby vincent mao update comeback effort wane afternoon trading dollar firm nasdaq fall back negative territory lose chip weaken remain higher philadelphia semiconductor index rise session peak meanwhile dow nyse composite drop lose turnover continue track slightly higher exchange compellent technology cml extend loss slice day move average late thursday datum storage firm report earning view earlier friday william blair cut share underperform market perform ehealth ehth pare loss late thursday insurance firm beat view rise earning sale grow miss view friday morning jeffery co cut share hold buy side altisource portfolio solution asps erased morning loss rise new high heavy trading stock follow clear square box base thursday altisource provide real estate mortgage related service company be featured monday daily stock analysis stock step rebound effort nasdaq turn greenby vincent mao update stock greatly improve early afternoon trading friday nasdaq rebound deficit turn fractionally higher chip issue show strength second session philadelphia semiconductor index rise meanwhile nyse composite fall dow be much respectively dip volume be tracking slightly higher exchange blue nile nile gap tumble huge trade deficit late thursday jewelry retailer report earning view give soft first quarter outlook earlier friday morning benchmark downgrade share sell hold upside restaurant operator bounce positive territory cheesecake factory cake turn loss gain also hit year high late thursday company report hot earning sale be flat miss view panera bread pnra bounce back nearly loss rise bakery cafe operator report mixed quarterly earning sale late thursday guide full year earning view elsewhere volterra semiconductor vltr reversed morning loss run fast trade chipmaker hit best level december stock continue trim loss middayby jonah keri update major index remain broadly lower midday friday market do pare few more loss china decision force bank increase reserve level rocked stock early nasdaq drop nyse composite dow volume remain higher board rise nyse nasdaq compare same period thursday western digital wdc slip nearly twice normal trade hard disk drive maker have be consolidate past week now sit week high upside telestone technology tstc rise rapid volume maker repeater antenna radio frequency peripheral rebound day move average complete fifth week shape consolidation riverb technology rvbd advanced more triple usual turnover provider product service improve application accessibility datum wide area network try break cup handle base monday give most day gain stock clear buy point second time today stock pare loss slightly leader pressure
1523,PRGO,update stock shrug round mixed economic datum finished higher holiday abbreviated session wednesday
1524,PRGO,dow snap session lose streak rise general motor gm be biggest percentage winner blue chip index
1525,PRGO,bank america bac citigroup jpmorgan chase jpm follow suit gain respectively
1526,PRGO,rise nyse composite gain nasdaq
1527,PRGO,volume finished sharply lower board day half session
1528,PRGO,flir system flir gap gain nearly maker thermal imaging system be replace national city corp ncc
1529,PRGO,electricity generator scana scg climb news replace lynch mer
1530,PRGO,lead stock have quiet day ibd firm heico hei rally regain day move average aircraft equipment maker be top percentage gainer ibd
1531,PRGO,economic earning report be schedule friday
1532,PRGO,update index trim gain drift holiday break
1533,PRGO,alan elliott
1534,PRGO,investor wrapped christmas eve session light touch index erase early loss close modest gain
1535,PRGO,dow add nyse composite nasdaq be lower early end higher respectively
1536,PRGO,expect volume lag pre holiday session slumping third lower vs tuesday light trading
1537,PRGO,advance issue lead decliner nyse be essentially even nasdaq
1538,PRGO,third ibd industry group gain ground
1539,PRGO,houseware rise gain lifetime brand lcut newell rubbermaid nwl
1540,PRGO,airline rise broadly lead jetblue airway jblu jump
1541,PRGO,update stock ease morning high
1542,PRGO,vincent mao
1543,PRGO,stock pare gain just hour remain wednesday shorten session
1544,PRGO,dow rise lead gain procter gamble pg caterpillar cat exxon mobil xom index have be much
1545,PRGO,nyse composite climb nasdaq edge
1546,PRGO,volume be tracking sharply lower board
1547,PRGO,supertex supx gap day move average surge follow upgrade lazard capital raise chipmaker buy hold set price target broker note microchip technology mchp buy stake supertex
1548,PRGO,resm rmd reversed early loss rise brisk volume medical equipment maker have change heart touch day move average
1549,PRGO,downside apple aapl fall slip further south day line ipod maker be head test november trough
1550,PRGO,elsewhere crude oil fall barrel session low
1551,PRGO,update nyse nasdaq reverse gain airline climb
1552,PRGO,alan elliott
1553,PRGO,index crawl break even line spindly trading action transportation issue moved higher soft oil price
1554,PRGO,dow nose gain nyse composite reversed early loss advance nasdaq composite also reversed move higher
1555,PRGO,trading level hold far tuesday average action advance issue be lead decliner nyse run even nasdaq
1556,PRGO,flir system flir teva pharmaceutical teva be only nasdaq stock move average volume general motor gm general electric ge post dow biggest price percentage gain decline respectively
1557,PRGO,crude future remain more keep oil barrel datum show last week oil inventory slip barrel analyst have expect barrel increase refinery activity slip low end recent range total capacity use refiner work lower output closer level demand gasoline stockpile nevertheless rise barrel
1558,PRGO,stock airline rac morning best gain southwest airline luv amr amr continental airline cal jump jetblue airway jblu throttle
1559,PRGO,biotech central lab service provider covance cvd add slightly average trading share have advanced recent session possibly start right side month correction
1560,PRGO,downside generic drug maker perrigo prgo tumble trading have begin tighten stock week move average sharp sell october
1561,PRGO,overseas market asia close generally lower japan nikkei tokyo take biggest slip automaker sell hard toyota project first annual operate loss
1562,PRGO,stock europe also trade mildly red london ftse lag late trading
1563,PRGO,update stock fade higher open
1564,PRGO,vincent mao
1565,PRGO,stock open higher wednesday have quickly turn mixed
1566,PRGO,dow rise respectively nyse composite decline nasdaq fall
1567,PRGO,volume be tracking sharply lower many trader be take day
1568,PRGO,owen illinois oi gap rally news be add maker glass container replace wb be be acquire well fargo wfc
1569,PRGO,flir system flir gap gain near day move average also be add thermal imaging system maker replace national city corp ncc
1570,PRGO,google goog rise climb back level stock have resistance just ahead day move average
1571,PRGO,downside astrazeneca azn slip food drug administration ask more information drugmaker seroquel depression treatment
1572,PRGO,update stock set slightly better start
1573,PRGO,vincent mao
1574,PRGO,stock future signale modestly higher open wednesday mixed batch economic datum
1575,PRGO,nasdaq future rise fraction point vs fair value future be mostly unchanged dow future climb point
1576,PRGO,economic news initial jobless claim rise highest total november economist estimate
1577,PRGO,order durable good fall november vs expectation decline october durable order be revise exclude transportation order big ticket item rise
1578,PRGO,personal income slip november vs expectation flat read personal spending fall slightly better forecast decline
1579,PRGO,corporate news micron technology mu drop pre market follow latest quarterly result late tuesday chipmaker report loss loss widen cent share cent prior year be much wall street estimate cent shortfall sale fall view
1580,PRGO,late tuesday fitch rating cut rating textron txt textron financial unit cite worsening operate performance tuesday regular session textron plunge diversify manufacturer cut outlook announce round layoff
1581,PRGO,wal mart wmt say settle lawsuit employee wage hour violation world largest retailer take fourth quarter charge cent share
1582,PRGO,defense contractor lockheed martin lmt agree buy universal system technology provide training simulation international government agency term be not disclose
1583,PRGO,elsewhere crude oil decline barrel ahead weekly energy inventory report
1584,PRGO,stock market close ahead thursday christmas holiday update stock shrug round mixed economic datum finished higher holiday abbreviated session wednesday dow snap session lose streak rise general motor gm be biggest percentage winner blue chip index bank america bac citigroup jpmorgan chase jpm follow suit gain respectively rise nyse composite gain nasdaq volume finished sharply lower board day half session flir system flir gap gain nearly maker thermal imaging system be replace national city corp ncc electricity generator scana scg climb news replace lynch mer lead stock have quiet day ibd firm heico hei rally regain day move average aircraft equipment maker be top percentage gainer ibd economic earning report be schedule friday update index trim gain drift holiday break alan elliottinvestor wrapped christmas eve session light touch index erase early loss close modest gain dow add nyse composite nasdaq be lower early end higher respectively expect volume lag pre holiday session slumping third lower vs tuesday light trading advance issue lead decliner nyse be essentially even nasdaq third ibd industry group gain ground houseware rise gain lifetime brand lcut newell rubbermaid nwl airline rise broadly lead jetblue airway jblu jump update stock ease morning highsby vincent maostock pare gain just hour remain wednesday shorten session dow rise lead gain procter gamble pg caterpillar cat exxon mobil xom index have be much nyse composite climb nasdaq edge volume be tracking sharply lower board supertex supx gap day move average surge follow upgrade lazard capital raise chipmaker buy hold set price target broker note microchip technology mchp buy stake supertex resm rmd reversed early loss rise brisk volume medical equipment maker have change heart touch day move average downside apple aapl fall slip further south day line ipod maker be head test november trough elsewhere crude oil fall barrel session low update nyse nasdaq reverse gain airline climb alan elliottindex crawl break even line spindly trading action transportation issue moved higher soft oil price dow nose gain nyse composite reversed early loss advance nasdaq composite also reversed move higher trading level hold far tuesday average action advance issue be lead decliner nyse run even nasdaq flir system flir teva pharmaceutical teva be only nasdaq stock move average volume general motor gm general electric ge post dow biggest price percentage gain decline respectively crude future remain more keep oil barrel datum show last week oil inventory slip barrel analyst have expect barrel increase refinery activity slip low end recent range total capacity use refiner work lower output closer level demand gasoline stockpile nevertheless rise barrel stock airline rac morning best gain southwest airline luv amr amr continental airline cal jump jetblue airway jblu throttle biotech central lab service provider covance cvd add slightly average trading share have advanced recent session possibly start right side month correction downside generic drug maker perrigo prgo tumble trading have begin tighten stock week move average sharp sell october overseas market asia close generally lower japan nikkei tokyo take biggest slip automaker sell hard toyota project first annual operate loss stock europe also trade mildly red london ftse lag late trading update stock fade higher openby vincent maostock open higher wednesday have quickly turn mixed dow rise respectively nyse composite decline nasdaq fall volume be tracking sharply lower many trader be take day owen illinois oi gap rally news be add maker glass container replace wb be be acquire well fargo wfc flir system flir gap gain near day move average also be add thermal imaging system maker replace national city corp ncc google goog rise climb back level stock have resistance just ahead day move average downside astrazeneca azn slip food drug administration ask more information drugmaker seroquel depression treatment update stock set slightly better startby vincent maostock future signale modestly higher open wednesday mixed batch economic datum nasdaq future rise fraction point vs fair value future be mostly unchanged dow future climb point economic news initial jobless claim rise highest total november economist estimate order durable good fall november vs expectation decline october durable order be revise exclude transportation order big ticket item rise personal income slip november vs expectation flat read personal spending fall slightly better forecast decline corporate news micron technology mu drop pre market follow latest quarterly result late tuesday chipmaker report loss loss widen cent share cent prior year be much wall street estimate cent shortfall sale fall view late tuesday fitch rating cut rating textron txt textron financial unit cite worsening operate performance tuesday regular session textron plunge diversify manufacturer cut outlook announce round layoff wal mart wmt say settle lawsuit employee wage hour violation world largest retailer take fourth quarter charge cent share defense contractor lockheed martin lmt agree buy universal system technology provide training simulation international government agency term be not disclose elsewhere crude oil decline barrel ahead weekly energy inventory report stock market close ahead thursday christmas holiday
1585,PRGO,stock recoup prior session heavy loss wednesday market shake downgrade spain extend gain fed again stand pat interest rate
1586,PRGO,rise dow nyse composite climb nasdaq manage tiny gain volume fall board
1587,PRGO,valeant pharmaceutical vrx rally drugmaker agree buy dermatology firm vital science canadian valeant nearly test day move average wednesday tuesday
1588,PRGO,gildan activewear gil rise more twice average turnover rbc capital market raise shirt maker outperform sector perform gildan be past buy point double bottom base
1589,PRGO,downside lead retail stock get hit hard
1590,PRGO,dineequity din shed nearly heavy trading erased gain last week company run ihop applebee chain report earning cheesecake factory cake tumble more double average volume stock close slightly day move average
1591,PRGO,round restaurant loser panera bread pnra shed bj restaurant bjri texas roadhouse txrh drop
1592,PRGO,close hewlett packard hpq announce buy smart phone maker palm palm deal stock fall extend trading
1593,PRGO,green mountain coffee roaster gmcr dive guide fiscal earn view
1594,PRGO,earning thursday include acme packet apkt expedia expe imax imax lubrizol lz netlogic microsystem netl perrigo prgo strayer education stra wynn resort wynn
1595,PRGO,stock gain choppy session
1596,PRGO,vincent mao
1597,PRGO,stock climb choppy trading session wednesday
1598,PRGO,rise dow nyse composite gain nasdaq eke fractional gain accord preliminary datum nyse volume fall nasdaq trade tick
1599,PRGO,gold producer be session best performer yellow metal climb fourth straight session medical related group also gain restaurant other retail group be session worst performer
1600,PRGO,stock high late trade
1601,PRGO,vincent mao
1602,PRGO,major stock average strengthen late trading wednesday
1603,PRGO,climb nyse composite dow gain nasdaq edge turnover continue track lower exchange
1604,PRGO,encore capital group ecpg rise heavy trading late tuesday debt collector report quarterly earning view sale miss stock clear buy point cup handle base last week
1605,PRGO,green mountain coffee roaster gmcr shed earlier loss edge ahead fiscal result close coffee distributor be expect post earning cent share year sale be slate climb
1606,PRGO,express script esrx visa visa also report quarterly result close
1607,PRGO,dsw dsw erased open gain drop heavy trading tuesday dsw surge clear cup base boost full year profit outlook
1608,PRGO,fed leave rate unchanged stock steady
1609,PRGO,scott stoddard
1610,PRGO,economy be strengthen job market be improve federal reserve say wednesday reiterate longstanding vow keep interest rate low extend period expectation moderate growth low inflation
1611,PRGO,stock find strength news
1612,PRGO,policymaker vote keep benchmark fed fund rate record low range most analyst expect fed late year early raise rate
1613,PRGO,datum fed last meeting march suggest economic activity have continue strengthen labor market be begin improve central bank say post meeting statement
1614,PRGO,add growth household spending have picked recently remain constrain high unemployment modest income growth lower housing wealth tight credit
1615,PRGO,meanwhile fed say business spending equipment software have rise significantly
1616,PRGO,kansa city fed president thomas hoenig dissent third straight meeting say condition have improve enough end vow keep rate low extend period inflation hawk fear huge fed cash infusion cause price soar economy accelerate
1617,PRGO,fed expect moderate economic growth time inflation remain subdue tight credit expectation unemployment remain high
1618,PRGO,fed say investment nonresidential structure be decline housing start edge remain depress level
1619,PRGO,market return session high fed announcement dow be nyse composite nasdaq volume remain lower board
1620,PRGO,stock stay mixed ahead fed
1621,PRGO,stock recoup prior session heavy loss wednesday market shake downgrade spain extend gain fed again stand pat interest rate rise dow nyse composite climb nasdaq manage tiny gain volume fall board valeant pharmaceutical vrx rally drugmaker agree buy dermatology firm vital science canadian valeant nearly test day move average wednesday tuesday gildan activewear gil rise more twice average turnover rbc capital market raise shirt maker outperform sector perform gildan be past buy point double bottom base downside lead retail stock get hit hard dineequity din shed nearly heavy trading erased gain last week company run ihop applebee chain report earning cheesecake factory cake tumble more double average volume stock close slightly day move average round restaurant loser panera bread pnra shed bj restaurant bjri texas roadhouse txrh drop close hewlett packard hpq announce buy smart phone maker palm palm deal stock fall extend trading green mountain coffee roaster gmcr dive guide fiscal earn view earning thursday include acme packet apkt expedia expe imax imax lubrizol lz netlogic microsystem netl perrigo prgo strayer education stra wynn resort wynn stock gain choppy sessionby vincent maostock climb choppy trading session wednesday rise dow nyse composite gain nasdaq eke fractional gain accord preliminary datum nyse volume fall nasdaq trade tick gold producer be session best performer yellow metal climb fourth straight session medical related group also gain restaurant other retail group be session worst performer stock high late tradeby vincent maothe major stock average strengthen late trading wednesday climb nyse composite dow gain nasdaq edge turnover continue track lower exchange encore capital group ecpg rise heavy trading late tuesday debt collector report quarterly earning view sale miss stock clear buy point cup handle base last week green mountain coffee roaster gmcr shed earlier loss edge ahead fiscal result close coffee distributor be expect post earning cent share year sale be slate climb express script esrx visa visa also report quarterly result close dsw dsw erased open gain drop heavy trading tuesday dsw surge clear cup base boost full year profit outlook fed leave rate unchanged stock steadyby scott economy be strengthen job market be improve federal reserve say wednesday reiterate longstanding vow keep interest rate low extend period expectation moderate growth low inflation stock find strength news policymaker vote keep benchmark fed fund rate record low range most analyst expect fed late year early raise rate datum fed last meeting march suggest economic activity have continue strengthen labor market be begin improve central bank say post meeting statement add growth household spending have picked recently remain constrain high unemployment modest income growth lower housing wealth tight credit meanwhile fed say business spending equipment software have rise significantly kansa city fed president thomas hoenig dissent third straight meeting say condition have improve enough end vow keep rate low extend period inflation hawk fear huge fed cash infusion cause price soar economy accelerate fed expect moderate economic growth time inflation remain subdue tight credit expectation unemployment remain high fed say investment nonresidential structure be decline housing start edge remain depress level market return session high fed announcement dow be nyse composite nasdaq volume remain lower board stock stay mixed ahead fed
1622,PRGO,strong late rally tuesday spare stock ugly loss
1623,PRGO,index have be neighborhood earlier session late surge wipe virtually intraday loss index undercut recent lows rebound
1624,PRGO,want hear ibd analysis today market emerge stock
1625,PRGO,click here watch latest market wrap video
1626,PRGO,finished fractionally higher nyse composite end barely nasdaq step back dow ease volume be sharply higher major exchange
1627,PRGO,ibd industry group best performer be steel retail gold miner worst performer be temporary staffing group
1628,PRGO,economic report due wednesday include durable good order new home sale april
1629,PRGO,lead stock report earning include rue rue dress barn dbrn netapp ntap
1630,PRGO,stock erase most loss close narrowly lower
1631,PRGO,juan carlos arancibia
1632,PRGO,market close session high tuesday erase nearly steep sell early today
1633,PRGO,index be left minor loss dow be nasdaq nyse close flat volume swell
1634,PRGO,financial stock be strongest afternoon rally retail material sector also be lead sector be day best perform
1635,PRGO,wall street plunge early more worry euro zone financial problem threat war north south korea
1636,PRGO,rebound effort step late trade
1637,PRGO,strong late rally tuesday spare stock ugly loss index have be neighborhood earlier session late surge wipe virtually intraday loss index undercut recent lows rebound want hear ibd analysis today market emerge stock
1638,PRGO,click here watch latest market wrap video
1639,PRGO,finished fractionally higher nyse composite end barely nasdaq step back dow ease volume be sharply higher major exchange ibd industry group best performer be steel retail gold miner worst performer be temporary staffing group economic report due wednesday include durable good order new home sale april lead stock report earning include rue rue dress barn dbrn netapp ntap stock erase most loss close narrowly lowerby juan carlos market close session high tuesday erase nearly steep sell early today index be left minor loss dow be nasdaq nyse close flat volume swell financial stock be strongest afternoon rally retail material sector also be lead sector be day best perform wall street plunge early more worry euro zone financial problem threat war north south korea rebound effort step late trade
1640,PRGO,stock rebound recent loss score first gain day monday dow jone industrial average lead rise rise recoup most friday loss nasdaq lag gain still tech laden index close back level continue weakness biotech stock medical biom biotech industry group
1641,PRGO,update greek debt wo expect economic datum slam stock thursday equity finished well worst level session
1642,PRGO,dow pare shortfall nyse composite dip meanwhile nasdaq slip bellwether apple aapl baidu bidu finished slightly higher
1643,PRGO,volume climb board
1644,PRGO,stock tumble gate moody investor service threaten downgrade greece debt rating standard poor warn downgrade late wednesday weekly jobless claim come expect durable good order ex transportation unexpectedly fall
1645,PRGO,overall leader heavy volume be few aegean marine petroleum anw erased early gain lose heavy trading stock also slice day move average late wednesday marine fuel logistic firm beat view rise earning jump sale
1646,PRGO,upside big lot big reversed higher gain nearly best level september earlier thursday jpmorgan raise discount retailer overweight neutral raise price target
1647,PRGO,other retailer fared well tjx co tjx add new record high limit brand ltd gap also gain
1648,PRGO,china agritech cagc stage big upside reversal climb have be more
1649,PRGO,perrigo prgo reversed early loss rise brisk trade snap session decline
1650,PRGO,economic report friday include revise gdp chicago pmi michigan sentiment index exist home sale
1651,PRGO,stock finish worst level
1652,PRGO,vincent mao
1653,PRGO,update stock take beating early close well thursday session lows
1654,PRGO,nasdaq slip deficit nasdaq exclude financial tick fraction
1655,PRGO,meanwhile nyse composite fall dow lose
1656,PRGO,volume jump exchange
1657,PRGO,metal distributor daily food producer energy related be thursday worst group retail related gold producer be session best beverage maker also gain thank activity dr pepper snapple group dps earning report
1658,PRGO,stock lows late trade
1659,PRGO,vincent mao
1660,PRGO,update stock remain lower have shave good chunk loss late trading thursday
1661,PRGO,dow lose shortfall nyse composite shed apiece be much respectively meanwhile nasdaq fall
1662,PRGO,volume continue track higher board pace have increase exchange
1663,PRGO,dollar turn slightly lower euro
1664,PRGO,insituform technology insu fall just day move average pipe maker report earning close analyst see earn cent share year insituform sale have accelerate recent quarters
1665,PRGO,salesforce com crm pare loss software maker be nearly earlier upbeat result late wednesday
1666,PRGO,upside china agritech cagc stage big upside reversal climb have be
1667,PRGO,trina solar limit tsl also stage big comeback turn loss gain earlier deutsche bank upgrade solar module maker buy hold
1668,PRGO,stock cut loss further
1669,PRGO,vincent mao
1670,PRGO,update stock pare more loss afternoon trading thursday dollar rally wane
1671,PRGO,dow shed component red nyse composite lose nasdaq fall
1672,PRGO,turnover be tracking higher exchange gold rise settle ounce oil fall barrel
1673,PRGO,green plain renewable energy gpre gap slump news secondary stock offer late wednesday ethanol producer propose sell share share be nearly session low green plain clear cup base monday
1674,PRGO,almost family afam come pressure fifth straight session reversed loss shed heavy volume stock accumulation distribution rating have drop last month
1675,PRGO,aegean marine petroleum anw erased early gain lose active trading stock also slice day move average late wednesday marine fuel logistic firm beat view rise earning jump sale
1676,PRGO,side dr pepper snapple group dps gap pop record high open beverage maker beat view gain earning sale slip slightly estimate
1677,PRGO,big lot big shed morning loss rise brisk trade earlier thursday jpmorgan raise discount retailer overweight neutral cite prospect continue robust sale
1678,PRGO,stock ease lows
1679,PRGO,vincent mao
1680,PRGO,update stock remain sharply lower early afternoon trading thursday have crawl worst level session
1681,PRGO,dow drop deficit nasdaq nyse composite fall
1682,PRGO,volume be again tracking higher exchange
1683,PRGO,dollar rally euro pound oil slide more barrel gold gain ounce
1684,PRGO,revlon rev gap drop ugly month low heavy trading open cosmetic maker report earning sale view
1685,PRGO,ansys anss shed fast trade earlier thursday engineering software maker beat view rise earning gain sale give weak outlook profit be expect range cent cent share vs view cent revenue be peg vs view
1686,PRGO,upside true religion apparel trlg gap day move average surge brisk trade late wednesday high price jean maker top view gain earning jump sale guide full year revenue view earning view
1687,PRGO,vanceinfo technology vit reversed earlier loss gain fast trade open chinese service firm deliver result view give upbeat first quarter sale outlook
1688,PRGO,stock tumble higher volume midday
1689,PRGO,jonah keri
1690,PRGO,update stock remain sharply lower midday thursday follow morning stuffed economic worry
1691,PRGO,dow swoon nasdaq nyse composite volume swell board rise nyse nasdaq compare same period wednesday
1692,PRGO,salesforce com crm skid more time normal trade maker customer relationship management software report earning penny estimate salesforce full year earning forecast fall far short analyst view company cite cash charge link debt sale plan expand sale force
1693,PRGO,conceptus cpt lose nearly double usual turnover maker birth control product woman add wednesday loss company report quarterly earning late tuesday match view weak forecast
1694,PRGO,citrix system ctxs give more twice average volume maker networking performance management software slice day move average intraday have pare loss rebound line
1695,PRGO,stock retain loss global domestic economic concern
1696,PRGO,update greek debt wo expect economic datum slam stock thursday equity finished well worst level session dow pare shortfall nyse composite dip meanwhile nasdaq slip bellwether apple aapl baidu bidu finished slightly higher volume climb board stock tumble gate moody investor service threaten downgrade greece debt rating standard poor warn downgrade late wednesday weekly jobless claim come expect durable good order ex transportation unexpectedly fall overall leader heavy volume be few aegean marine petroleum anw erased early gain lose heavy trading stock also slice day move average late wednesday marine fuel logistic firm beat view rise earning jump sale upside big lot big reversed higher gain nearly best level september earlier thursday jpmorgan raise discount retailer overweight neutral raise price target other retailer fared well tjx co tjx add new record high limit brand ltd gap also gain china agritech cagc stage big upside reversal climb have be more perrigo prgo reversed early loss rise brisk trade snap session decline economic report friday include revise gdp chicago pmi michigan sentiment index exist home sale stock finish worst levelsby vincent mao update stock take beating early close well thursday session lows nasdaq slip deficit nasdaq exclude financial tick fraction meanwhile nyse composite fall dow lose volume jump exchange metal distributor daily food producer energy related be thursday worst group retail related gold producer be session best beverage maker also gain thank activity dr pepper snapple group dps earning report stock lows late tradeby vincent mao update stock remain lower have shave good chunk loss late trading thursday dow lose shortfall nyse composite shed apiece be much respectively meanwhile nasdaq fall volume continue track higher board pace have increase exchange dollar turn slightly lower euro insituform technology insu fall just day move average pipe maker report earning close analyst see earn cent share year insituform sale have accelerate recent quarters salesforce com crm pare loss software maker be nearly earlier upbeat result late wednesday upside china agritech cagc stage big upside reversal climb have be trina solar limit tsl also stage big comeback turn loss gain earlier deutsche bank upgrade solar module maker buy hold stock cut loss furtherby vincent mao update stock pare more loss afternoon trading thursday dollar rally wane dow shed component red nyse composite lose nasdaq fall turnover be tracking higher exchange gold rise settle ounce oil fall barrel green plain renewable energy gpre gap slump news secondary stock offer late wednesday ethanol producer propose sell share share be nearly session low green plain clear cup base monday almost family afam come pressure fifth straight session reversed loss shed heavy volume stock accumulation distribution rating have drop last month aegean marine petroleum anw erased early gain lose active trading stock also slice day move average late wednesday marine fuel logistic firm beat view rise earning jump sale side dr pepper snapple group dps gap pop record high open beverage maker beat view gain earning sale slip slightly estimate big lot big shed morning loss rise brisk trade earlier thursday jpmorgan raise discount retailer overweight neutral cite prospect continue robust sale stock ease lowsby vincent mao update stock remain sharply lower early afternoon trading thursday have crawl worst level session dow drop deficit nasdaq nyse composite fall volume be again tracking higher exchange dollar rally euro pound oil slide more barrel gold gain ounce revlon rev gap drop ugly month low heavy trading open cosmetic maker report earning sale view ansys anss shed fast trade earlier thursday engineering software maker beat view rise earning gain sale give weak outlook profit be expect range cent cent share vs view cent revenue be peg vs view upside true religion apparel trlg gap day move average surge brisk trade late wednesday high price jean maker top view gain earning jump sale guide full year revenue view earning view vanceinfo technology vit reversed earlier loss gain fast trade open chinese service firm deliver result view give upbeat first quarter sale outlook stock tumble higher volume middayby jonah keri update stock remain sharply lower midday thursday follow morning stuffed economic worry dow swoon nasdaq nyse composite volume swell board rise nyse nasdaq compare same period wednesday salesforce com crm skid more time normal trade maker customer relationship management software report earning penny estimate salesforce full year earning forecast fall far short analyst view company cite cash charge link debt sale plan expand sale force conceptus cpt lose nearly double usual turnover maker birth control product woman add wednesday loss company report quarterly earning late tuesday match view weak forecast citrix system ctxs give more twice average volume maker networking performance management software slice day move average intraday have pare loss rebound line stock retain loss global domestic economic concern
1697,PRGO,wednesday start well finished badly
1698,PRGO,jump durable order big increase new home sale fuel gain financial time report say china be review european debt holding help send market lower
1699,PRGO,want hear ibd analysis today market emerge stock
1700,PRGO,click here watch latest market wrap video
1701,PRGO,stock have reversed sharply past session signale market uncertainty
1702,PRGO,nasdaq turn gain decline dow fall nyse composite volume rise board
1703,PRGO,tech pharmacal hitk erased early gain slide heavy volume stock close day move average first time more year
1704,PRGO,start well finished badly jump durable order big increase new home sale fuel gain financial time report say china be review european debt holding help send market lower want hear ibd analysis today market emerge stock
1705,PRGO,click here watch latest market wrap video
1706,PRGO,stock have reversed sharply past session signale market uncertainty nasdaq turn gain decline dow fall nyse composite volume rise board tech pharmacal hitk erased early gain slide heavy volume stock close day move average first time more year aeropostale
1707,PRGO,update greek bailout hope activity bigger expect rise consumer spending boost stock monday
1708,PRGO,techs lead pack nasdaq rally turn positive year chip datum storage commerce biotechs boost nasdaq
1709,PRGO,meanwhile dow rise respectively regain day move average nyse composite gain close just shy day line
1710,PRGO,turnover jump nasdaq fall nyse
1711,PRGO,many leader show positive action
1712,PRGO,power integration powi rally more triple average volume stock clear cup base hit best level october earlier month integrate circuit maker beat view surge earning best performance year analyst see pop quarter
1713,PRGO,group mate sandisk sndk also clear base gap bolt best level nearly year friday company boost sale outlook earlier monday wedbush morgan raise share neutral underperform
1714,PRGO,fellow chipmaker volterra semiconductor vltr netlogic microsystem netl rise respectively rally huge volume
1715,PRGO,philadelphia semiconductor index run regain day line
1716,PRGO,elsewhere cognizant technology solution ctsh climb nearly twice average trade clear cup base stock handle vacillate sideway rather drift lower
1717,PRGO,downside perfect world pwrd gap day move average tumble month low open chinese online gamer report earning cent share miss view cent
1718,PRGO,hour news dress barn dbrn report fiscal earning view give rosy full year outlook share rise extend trading
1719,PRGO,stock finish high
1720,PRGO,vincent mao
1721,PRGO,update stock start march strong note close session high
1722,PRGO,nasdaq rally nyse composite dow accord preliminary datum nasdaq volume surge nyse volume fall
1723,PRGO,commerce datum storage biotechs be monday top group build related bank be day worst group
1724,PRGO,stock maintain gain
1725,PRGO,vincent mao
1726,PRGO,update stock again hover session high just hour left monday trade
1727,PRGO,nasdaq climb session peak chip continue boost nasdaq philadelphia semiconductor jump sandisk sndk extend gain friday company boost sale outlook earlier monday wedbush morgan raise share neutral underperform
1728,PRGO,meanwhile gain nyse composite dow
1729,PRGO,turnover be again tracking sharply higher nasdaq touch higher nyse
1730,PRGO,seagate technology stx gain best level nearly year last year hard drive maker lose share analyst see earn share year
1731,PRGO,dress barn dbrn rise come penny jan high apparel retailer report fiscal result close analyst be expect cent share sale
1732,PRGO,mindray medical international mr pare earlier gain just too report quarterly result close chinese maker patient monitoring device be slate earn cent share sale
1733,PRGO,stock hold high
1734,PRGO,vincent mao
1735,PRGO,update stock continue hold session best level afternoon trading monday
1736,PRGO,tech heavy nasdaq again lead gain chipmaker commerce datum storage network solution provider be session top group meanwhile rise nyse composite dow turnover remain higher board especially nasdaq
1737,PRGO,amazon com amzn reversed earlier loss rally attempt retake day move average privately hold freescale semiconductor say have chip drive price electronic book reader amazon com make popular kindle book reader
1738,PRGO,insituform technology insu add year high stock rise more friday cup base friday trenchless pipe maker beat view jump profit revenue climb third straight quarter acceleration
1739,PRGO,perrigo prgo gap gain new record high open drugmaker agree buy australia orion laboratory counter drugmaker cash deal be expect add more annual sale boost earning first year perrigo clear buy point flat base jan have gain
1740,PRGO,downside warner chilcott wcrx turn lower poke day move average open drugmaker easily top view rise earning jump sale result be boost last year buyout prescription drug unit procter gamble pg
1741,PRGO,stock ease early afternoon trade
1742,PRGO,vincent mao
1743,PRGO,update stock ease session high early afternoon trading monday equity have be positive session boost report relief greece merger activity
1744,PRGO,nasdaq climb rise further north day move average chip continue show strength philadelphia semiconductor index rally regain day line
1745,PRGO,meanwhile dow be respectively regain day move average nyse composite rise
1746,PRGO,volume be tracking sharply higher nasdaq bit higher nyse
1747,PRGO,power integration powi rally highest october stock clear cup base earlier month integrate circuit maker beat view surge earning best performance year analyst see pop quarter
1748,PRGO,group mate netlogic microsystem netl add trade time high clear week consolidation earlier month
1749,PRGO,riverb technology rvbd rise month high put stock past buy point cup handle base company provide network optimization solution earning grow analyst see growth pick year
1750,PRGO,downside perfect world pwrd gap day move average tumble month low open chinese online gamer report earning cent share miss view cent
1751,PRGO,fellow online gaming firm shanda interactive entertainment snda also fall too report earning view
1752,PRGO,techs lead stock rally midday
1753,PRGO,jonah keri
1754,PRGO,update major index continue move higher midday monday buoy strong show tech sector
1755,PRGO,nasdaq lead way gain rise dow nyse composite volume swell board rise nyse nasdaq compare same period friday
1756,PRGO,china automotive system caas jump nearly triple normal trade chinese auto part maker be form right side shape consolidation stock sit week high deep correction
1757,PRGO,ual corp uaua ramp close double average turnover operator unite airline be several airline stock mark robust gain monday
1758,PRGO,acme packet apkt rise brisk volume maker internet border controller security gateway other product marked latest recent string week high
1759,PRGO,stock expand gain spending manufacturing report
1760,PRGO,update greek bailout hope activity bigger expect rise consumer spending boost stock monday techs lead pack nasdaq rally turn positive year chip datum storage commerce biotechs boost nasdaq meanwhile dow rise respectively regain day move average nyse composite gain close just shy day line turnover jump nasdaq fall nyse many leader show positive action power integration powi rally more triple average volume stock clear cup base hit best level october earlier month integrate circuit maker beat view surge earning best performance year analyst see pop quarter group mate sandisk sndk also clear base gap bolt best level nearly year friday company boost sale outlook earlier monday wedbush morgan raise share neutral underperform fellow chipmaker volterra semiconductor vltr netlogic microsystem netl rise respectively rally huge volume philadelphia semiconductor index run regain day line elsewhere cognizant technology solution ctsh climb nearly twice average trade clear cup base stock handle vacillate sideway rather drift lower downside perfect world pwrd gap day move average tumble month low open chinese online gamer report earning cent share miss view cent hour news dress barn dbrn report fiscal earning view give rosy full year outlook share rise extend trading stock finish highsby vincent mao update stock start march strong note close session high nasdaq rally nyse composite dow accord preliminary datum nasdaq volume surge nyse volume fall commerce datum storage biotechs be monday top group build related bank be day worst group stock maintain gainsby vincent mao update stock again hover session high just hour left monday trade nasdaq climb session peak chip continue boost nasdaq philadelphia semiconductor jump sandisk sndk extend gain friday company boost sale outlook earlier monday wedbush morgan raise share neutral underperform meanwhile gain nyse composite dow turnover be again tracking sharply higher nasdaq touch higher nyse seagate technology stx gain best level nearly year last year hard drive maker lose share analyst see earn share year dress barn dbrn rise come penny jan high apparel retailer report fiscal result close analyst be expect cent share sale mindray medical international mr pare earlier gain just too report quarterly result close chinese maker patient monitoring device be slate earn cent share sale stock hold highsby vincent mao update stock continue hold session best level afternoon trading monday tech heavy nasdaq again lead gain chipmaker commerce datum storage network solution provider be session top group meanwhile rise nyse composite dow turnover remain higher board especially nasdaq amazon com amzn reversed earlier loss rally attempt retake day move average privately hold freescale semiconductor say have chip drive price electronic book reader amazon com make popular kindle book reader insituform technology insu add year high stock rise more friday cup base friday trenchless pipe maker beat view jump profit revenue climb third straight quarter acceleration perrigo prgo gap gain new record high open drugmaker agree buy australia orion laboratory counter drugmaker cash deal be expect add more annual sale boost earning first year perrigo clear buy point flat base jan have gain downside warner chilcott wcrx turn lower poke day move average open drugmaker easily top view rise earning jump sale result be boost last year buyout prescription drug unit procter gamble pg stock ease early afternoon tradeby vincent mao update stock ease session high early afternoon trading monday equity have be positive session boost report relief greece merger activity nasdaq climb rise further north day move average chip continue show strength philadelphia semiconductor index rally regain day line meanwhile dow be respectively regain day move average nyse composite rise volume be tracking sharply higher nasdaq bit higher nyse power integration powi rally highest october stock clear cup base earlier month integrate circuit maker beat view surge earning best performance year analyst see pop quarter group mate netlogic microsystem netl add trade time high clear week consolidation earlier month riverb technology rvbd rise month high put stock past buy point cup handle base company provide network optimization solution earning grow analyst see growth pick year downside perfect world pwrd gap day move average tumble month low open chinese online gamer report earning cent share miss view cent fellow online gaming firm shanda interactive entertainment snda also fall too report earning view techs lead stock rally middayby jonah keri update major index continue move higher midday monday buoy strong show tech sector nasdaq lead way gain rise dow nyse composite volume swell board rise nyse nasdaq compare same period friday china automotive system caas jump nearly triple normal trade chinese auto part maker be form right side shape consolidation stock sit week high deep correction ual corp uaua ramp close double average turnover operator unite airline be several airline stock mark robust gain monday acme packet apkt rise brisk volume maker internet border controller security gateway other product marked latest recent string week high stock expand gain spending manufacturing report
1761,PRGO,update complex day economic datum earning result left major index higher so far week
1762,PRGO,industry group genetic drugmaker post biggest gain lead myriad genetic mygn jump steel specialty alloy group be next line rti international metal rti graftech international gti post top gain
1763,PRGO,close walt disney share tank company report fiscal earning slide weak theme park receipt dvd sale ad revenue share have add regular session
1764,PRGO,netlogic microsystem netl rise extend trading ep cent top analyst view cent revenue slide just consensus view share have add just fraction regular trading
1765,PRGO,heavyweight life insurer metlife meet spark hour trading earning cent share outpaced analyst view nickel revenue climb well forecast share have slump regular hour
1766,PRGO,wednesday adp employment number arrive market open institute supply management service index be due energy information administration american petroleum institute plan release weekly crude inventory datum
1767,PRGO,wednesday earning calendar include alcatel lucent alu brink co bco market open akamai technology akam cisco system csco visa plan report close
1768,PRGO,update late rally cement market gain
1769,PRGO,juan carlos arancibia
1770,PRGO,stock second straight day mount late rally time assure market gain
1771,PRGO,nyse composite surge dow nasdaq
1772,PRGO,volume rise nasdaq fall nyse accord early calculation
1773,PRGO,lead stock make strong move green mountain coffee roaster gmcr break myriad genetic mygn corinthian college coco surge earning report
1774,PRGO,surprising rise pending home sale send housing market stock higher include homebuilder home furnishing
1775,PRGO,update home sale earning win bump index higher
1776,PRGO,alan elliott
1777,PRGO,strong pending home sale december better expect earning report supersede weak auto sale datum manufacturer push index new high enter final hour trade
1778,PRGO,nyse composite lead run dow gain run just ahead advance nasdaq bring rear add
1779,PRGO,volume remain mixed slightly nasdaq lower nyse
1780,PRGO,air freight operator logistic firm rise hard pull transport index dow nasdaq higher financial continue slump
1781,PRGO,merck mrk alcoa aa boee ba head dow upside bank america boa top decliner list
1782,PRGO,up up surge double normal trading report expect drop ep company say slow global economy bit package freight volume company say be freeze management salary freeze match contribution shut select package handle operation order cut cost company also say be still talk germany base dhl manage shipping talk be make difficult current economic condition
1783,PRGO,peer fedex fdx power similarly strong tail wind
1784,PRGO,downside wynn resort wynn topple strong trading casino operator have be general downtrend month sharp decline august
1785,PRGO,update index move higher volume lag
1786,PRGO,patrick
1787,PRGO,index rally back positive territory hour selling
1788,PRGO,dow be nasdaq gain nyse composite rise volume be tracking lower
1789,PRGO,general motor gm report january sale plunge announcement have little impact dow general market
1790,PRGO,brink home security cfl rise recent ipo hit new high pullback week line be third straight day gain average volume relative strength line be time high brink be rank industry group
1791,PRGO,downside techne corp tech dive biotech maker hematology product report earning cent share miss view cent revenue be also consensus estimate
1792,PRGO,comic creator marvel entertainment mvl be need hero stock slip tuesday be fourth straight high volume sell stock
1793,PRGO,update index hold positive territory
1794,PRGO,alan elliott
1795,PRGO,market hem haw head afternoon trading dollar slip automaker begin report january sale
1796,PRGO,nyse composite maintain advance dow hold gain nasdaq composite hover just water line hold back financial telecom
1797,PRGO,nyse industry sector index outside financial have post gain health care international sector lead advance respectively nyse financial index sunk trading action picked move positive territory nasdaq edge nearer break even line nyse advance issue run nearly dead even decliner exchange
1798,PRGO,crude future most oil related product remain little change natural gas hold early loss cent gold slip ounce dollar slip euro yen
1799,PRGO,stock wholesale coffee distributor green mountain coffee roaster gmcr climb average volume stock be duel resistance right level
1800,PRGO,bj wholesale club bj ride higher strong trading ub analyst upgrade stock buy neutral lower price target share have be primarily decline august be well key level support
1801,PRGO,downside automaker ford slump weak trading report wider expect drop january vehicle sale ford say fall fleet sale be main driver loss truck sale component also backed
1802,PRGO,alliance datum system ad dump heavy trading provider retail transaction credit service be schedule report earning analyst consensus call ep gain share be attempt build bottom month correction
1803,PRGO,update stock retreat session halftime
1804,PRGO,vincent mao
1805,PRGO,stock pull back climb new session high tuesday halftime
1806,PRGO,nyse composite tack dow gain retreat briefly top mark meanwhile nasdaq rise respectively
1807,PRGO,volume turn mixed nyse tracking slightly higher nasdaq slightly lower
1808,PRGO,corinthian college coco gap rally follow solid earning report outlook
1809,PRGO,group mate devry dv apollo group apol strayer education stra edge higher
1810,PRGO,aaron rent rnt jump continue bounce back recent sell electronic furniture retailer report earning feb analyst see profit rise cent share
1811,PRGO,downside pnc financial service pnc tumble huge volume badly miss view bank hold company post fourth quarter loss cent share exclude item company earn cent share vs view profit cent follow last year purchase national city slash job
1812,PRGO,liz claiborne liz rockwell collin col huntington bank hban king pharmaceutical kg also announce job cut
1813,PRGO,update index pull higher sag volume
1814,PRGO,alan elliott
1815,PRGO,better expect december pending home sale number cut morning choppy earning report lift index mixed trade positive ground
1816,PRGO,nyse composite muster gain dow nasdaq composite reversed early loss rise respectively
1817,PRGO,alcoa aa merck mrk verizon communication vz wal mart wmt pull higher dow homebuilder dr horton dhi tyco international tyc notch best gain
1818,PRGO,volume sag lower exchange more half industry group track ibd moved lower morning trading genetic drug maker see biggest gain super regional bank be bottom list
1819,PRGO,pending home sale index national association realtor be december more november number be well analyst consensus call index remain flat decline slightly association say gain be spur buyer respond lower home price mortgage interest rate
1820,PRGO,rest market commodity be choppy oil remain largely unchanged barrel natural gas slip cent gold rise slightly remain ounce
1821,PRGO,dollar slip vs euro be unchanged yen bank japan overnight announcement tighten supply buy yen share hold japanese bank
1822,PRGO,stock nitrogen tnh skip heavy trade sioux city iowa base fertilizer maker be climb left side high month cup
1823,PRGO,downside daniel adm dump busy trading food product process heavyweight easily top consensus ep view cent share analyst consensus call cent share revenue however be less expectation company cite decrease sale volume impact shift foreign currency
1824,PRGO,update stock fade higher open
1825,PRGO,vincent mao
1826,PRGO,stock be mostly lower early tuesday squander higher open barrage mixed earning report
1827,PRGO,nasdaq lose erase most monday advance dow shed nyse composite be mostly unchanged
1828,PRGO,volume be tracking mixed nyse sharply lower nasdaq slightly higher
1829,PRGO,earning news sandisk sndk gap dive badly miss view late monday
1830,PRGO,perrigo prgo gap tumble post mixed quarterly result give weak outlook open generic drugmaker deliver fiscal earning cent share cent prior year cent estimate sale grow view perrigo lower full year profit forecast range share vs view
1831,PRGO,upside transdigm tdg gap surge top view raise guidance open aircraft component maker report fiscal earning cent share year earlier cent view sale grow also view transdigm lift full year revenue forecast range prior guidance profit be expect be share previously
1832,PRGO,myriad genetic mygn gap rally year high follow stellar fiscal report company swung profit cent share reverse loss cent share prior year top view cent revenue gain also view
1833,PRGO,update stock head mostly flat open
1834,PRGO,vincent mao
1835,PRGO,stock future signale mostly flat open follow round mixed corporate earning report
1836,PRGO,nasdaq future fall point vs fair value future slip fraction point dow future rise point
1837,PRGO,corinthian college coco climb pre market beat fiscal profit view give strong outlook profit educator grow earning cent share cent estimate sale rise also view company guide current quarter earning range cent cent share vs view cent peg fiscal sale view
1838,PRGO,merck mrk rally pre open post fourth quarter profit surprisingly cent share cent ahead view revenue fall also beat view
1839,PRGO,group mate schering plough sgp rise turn earning expectation exclude item maker nasonex vytorin other drug report income cent share cent year period cent estimate revenue climb miss view
1840,PRGO,not earning news be rosy
1841,PRGO,motorola shed pre open report fourth quarter loss penny share exclude item analyst expect break even quarter sale tumble view
1842,PRGO,current quarter motorola expect loss cent share vs analyst expectation cent shortfall company also suspend quarterly dividend announce chief financial officer step undisclosed reason
1843,PRGO,share dow chemical dow decline pre market post loss cent share much cent profit forecast analyst sale fall miss view
1844,PRGO,elsewhere citigroup pressure boost lend say deploy issue mortgage buy mortgage backed security provide other loan fund come government trouble asset relief program
1845,PRGO,economic front datum december pending home sale be economist expect flat sale
1846,PRGO,january auto sale be release session update complex day economic datum earning result left major index higher so far week industry group genetic drugmaker post biggest gain lead myriad genetic mygn jump steel specialty alloy group be next line rti international metal rti graftech international gti post top gain close walt disney share tank company report fiscal earning slide weak theme park receipt dvd sale ad revenue share have add regular session netlogic microsystem netl rise extend trading ep cent top analyst view cent revenue slide just consensus view share have add just fraction regular trading heavyweight life insurer metlife meet spark hour trading earning cent share outpaced analyst view nickel revenue climb well forecast share have slump regular hour wednesday adp employment number arrive market open institute supply management service index be due energy information administration american petroleum institute plan release weekly crude inventory datum wednesday earning calendar include alcatel lucent alu brink co bco market open akamai technology akam cisco system csco visa plan report close update late rally cement market gainsby juan carlos arancibiastock second straight day mount late rally time assure market gain nyse composite surge dow nasdaq volume rise nasdaq fall nyse accord early calculation lead stock make strong move green mountain coffee roaster gmcr break myriad genetic mygn corinthian college coco surge earning report surprising rise pending home sale send housing market stock higher include homebuilder home furnishing update home sale earning win bump index higher alan elliottstrong pending home sale december better expect earning report supersede weak auto sale datum manufacturer push index new high enter final hour trade nyse composite lead run dow gain run just ahead advance nasdaq bring rear add volume remain mixed slightly nasdaq lower nyse air freight operator logistic firm rise hard pull transport index dow nasdaq higher financial continue slump merck mrk alcoa aa boee ba head dow upside bank america boa top decliner list up up surge double normal trading report expect drop ep company say slow global economy bit package freight volume company say be freeze management salary freeze match contribution shut select package handle operation order cut cost company also say be still talk germany base dhl manage shipping talk be make difficult current economic condition peer fedex fdx power similarly strong tail wind downside wynn resort wynn topple strong trading casino operator have be general downtrend month sharp decline august update index move higher volume lag patrick cainindex rally back positive territory hour selling dow be nasdaq gain nyse composite rise volume be tracking lower general motor gm report january sale plunge announcement have little impact dow general market brink home security cfl rise recent ipo hit new high pullback week line be third straight day gain average volume relative strength line be time high brink be rank industry group downside techne corp tech dive biotech maker hematology product report earning cent share miss view cent revenue be also consensus estimate comic creator marvel entertainment mvl be need hero stock slip tuesday be fourth straight high volume sell stock update index hold positive territoryby alan elliottmarket hem haw head afternoon trading dollar slip automaker begin report january sale nyse composite maintain advance dow hold gain nasdaq composite hover just water line hold back financial telecom nyse industry sector index outside financial have post gain health care international sector lead advance respectively nyse financial index sunk trading action picked move positive territory nasdaq edge nearer break even line nyse advance issue run nearly dead even decliner exchange crude future most oil related product remain little change natural gas hold early loss cent gold slip ounce dollar slip euro yen stock wholesale coffee distributor green mountain coffee roaster gmcr climb average volume stock be duel resistance right level bj wholesale club bj ride higher strong trading ub analyst upgrade stock buy neutral lower price target share have be primarily decline august be well key level support downside automaker ford slump weak trading report wider expect drop january vehicle sale ford say fall fleet sale be main driver loss truck sale component also backed alliance datum system ad dump heavy trading provider retail transaction credit service be schedule report earning analyst consensus call ep gain share be attempt build bottom month correction update stock retreat session halftimeby vincent maostock pull back climb new session high tuesday halftime nyse composite tack dow gain retreat briefly top mark meanwhile nasdaq rise respectively volume turn mixed nyse tracking slightly higher nasdaq slightly lower corinthian college coco gap rally follow solid earning report outlook group mate devry dv apollo group apol strayer education stra edge higher aaron rent rnt jump continue bounce back recent sell electronic furniture retailer report earning feb analyst see profit rise cent share downside pnc financial service pnc tumble huge volume badly miss view bank hold company post fourth quarter loss cent share exclude item company earn cent share vs view profit cent follow last year purchase national city slash job liz claiborne liz rockwell collin col huntington bank hban king pharmaceutical kg also announce job cut update index pull higher sag volume alan elliottbetter expect december pending home sale number cut morning choppy earning report lift index mixed trade positive ground nyse composite muster gain dow nasdaq composite reversed early loss rise respectively alcoa aa merck mrk verizon communication vz wal mart wmt pull higher dow homebuilder dr horton dhi tyco international tyc notch best gain volume sag lower exchange more half industry group track ibd moved lower morning trading genetic drug maker see biggest gain super regional bank be bottom list pending home sale index national association realtor be december more november number be well analyst consensus call index remain flat decline slightly association say gain be spur buyer respond lower home price mortgage interest rate rest market commodity be choppy oil remain largely unchanged barrel natural gas slip cent gold rise slightly remain ounce dollar slip vs euro be unchanged yen bank japan overnight announcement tighten supply buy yen share hold japanese bank stock nitrogen tnh skip heavy trade sioux city iowa base fertilizer maker be climb left side high month cup downside daniel adm dump busy trading food product process heavyweight easily top consensus ep view cent share analyst consensus call cent share revenue however be less expectation company cite decrease sale volume impact shift foreign currency update stock fade higher openby vincent maostock be mostly lower early tuesday squander higher open barrage mixed earning report nasdaq lose erase most monday advance dow shed nyse composite be mostly unchanged volume be tracking mixed nyse sharply lower nasdaq slightly higher earning news sandisk sndk gap dive badly miss view late monday perrigo prgo gap tumble post mixed quarterly result give weak outlook open generic drugmaker deliver fiscal earning cent share cent prior year cent estimate sale grow view perrigo lower full year profit forecast range share vs view upside transdigm tdg gap surge top view raise guidance open aircraft component maker report fiscal earning cent share year earlier cent view sale grow also view transdigm lift full year revenue forecast range prior guidance profit be expect be share previously myriad genetic mygn gap rally year high follow stellar fiscal report company swung profit cent share reverse loss cent share prior year top view cent revenue gain also view update stock head mostly flat openby vincent maostock future signale mostly flat open follow round mixed corporate earning report nasdaq future fall point vs fair value future slip fraction point dow future rise point corinthian college coco climb pre market beat fiscal profit view give strong outlook profit educator grow earning cent share cent estimate sale rise also view company guide current quarter earning range cent cent share vs view cent peg fiscal sale view merck mrk rally pre open post fourth quarter profit surprisingly cent share cent ahead view revenue fall also beat view group mate schering plough sgp rise turn earning expectation exclude item maker nasonex vytorin other drug report income cent share cent year period cent estimate revenue climb miss view not earning news be rosy motorola shed pre open report fourth quarter loss penny share exclude item analyst expect break even quarter sale tumble view current quarter motorola expect loss cent share vs analyst expectation cent shortfall company also suspend quarterly dividend announce chief financial officer step undisclosed reason share dow chemical dow decline pre market post loss cent share much cent profit forecast analyst sale fall miss view elsewhere citigroup pressure boost lend say deploy issue mortgage buy mortgage backed security provide other loan fund come government trouble asset relief program economic front datum december pending home sale be economist expect flat sale january auto sale be release session
1847,PRGO,perrigo company plc prgo free report be expect report second quarter result open bell aug overall company have average trail quarter positive earning surprise last quarter company deliver positive surprise perrigo company price ep surprise perrigo company price ep surprise perrigo company quoteperrigo share have lose so far year industry witness increase let see thing be shape company quarter factor influence quarterprice erosion change market dynamic perrigo prescription pharmaceutical rx segment be likely continue hurt company performance company continue expect tough drug pricing environment impact segment performance anticipate price erosion approximately rx segment come quarters brand consumer healthcare bch business part consumer health care international chci segment be still be impact unfavorable market dynamic country belgium france germany italy bch segment be project underperform yet be report quarter due lower expect revenue certain high margin product department justice antitrust division have be conduct investigation perrigo seek information latter drug pricing practice company announce search warrant be execute corporate office associate ongoing investigation hence company pricing strategy get affected such probe however perrigo constant focus pursue additional brand otc opportunity market well product acquisition new product launch rx segment be expect boost sale future quarters ongoing restructure initiative operate expense discipline be expect support bottom line earning whispersour proven model do not conclusively show perrigo be likely beat estimate quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp earning esp perrigo be most accurate estimate be peg cent share zack consensus estimate stand cent uncover best stock buy sell re report earning esp filter zack rank perrigo zack rank hold increase predictive power esp negative earning esp leave earning surprise prediction inconclusive caution sell rate stock go earning announcement especially company be see negative estimate revision stock warrant lookhere be other company consider model show have right combination element come earning beat quarter zoetis inc zts free report be schedule release result aug earning esp zack rank see complete list today zack rank stock here tesaro inc tsro free report be schedule release result aug company have earning esp zack rank esperion therapeutic inc espr free report be schedule release result aug company have earning esp zack rank trade profit big league trump policy stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
1848,PRGO,be tough week generic drugmaker see share tumble follow release disappointing second quarter result israel base teva pharmaceutical industry limit teva free report teva not only miss earning revenue expectation company also slash outlook announce cut dividend teva share plunge trading session follow release second quarter result reflect concern company business debt burden trigger few analyst downgrade year date ytd teva have lose value versus decline generic pricing environmenta key reason teva dismal performance be generic pricing erosion sharp decline generic drug price blessing patient be prove be major challenge generic drugmaker well drug distributor second quarter conference call teva say ongoing consolidation customer have lead increase price erosion decrease volume consolidation industry have increase ability negotiate lower price generic drug moreover fda be speeding approval generic drug mean more competition increase price cut decrease volume generic drug be basically cheaper version brand drug have go patent teva say price erosion be second quarter be expect increase high single digit remainder year not just teva be affected tough generic pricing environment corporation abc free report report mixed quarter see share decline trading session follow release third quarter fiscal result company mentioned generic deflation remain headwind be yet ease high single digit be quarters generic deflation be expect remain headwind remainder fiscal range situation continue fiscal well cardinal health inc cah free report too mentioned generic drug pricing be material headwind company pharma distribution business fourth quarter fiscal company expect generic deflation mid single digit fiscal stock focusfollow release teva second quarter result company presence generic market see share decline concern company too be affected generic drug pricing environment company mylan nv myl free report lannett company inc lci free report perrigo company plc prgo free report impax laboratory inc be last trading session week investor be focuse mylan second quarter result include company take generic pricing situation impax perrigo also be report result week mylan perrigo impax be zack rank hold stock lannett be zack rank buy stock see complete list today zack rank strong buy stock here medical generic drug industry yr return medical generic drug industry yr returnin view generic price erosion remain headwind remainder year affect margin generic player fda focuse speeding generic drug approval process market continue witness additional competition escalate generic price erosion trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
1849,PRGO,perrigo company plc prgo free report announce have receive final approval fda ab rate generic version abbvie inc abbv free report androgel topical gel drug be indicated replacement therapy male condition associate deficiency absence endogenous testosterone annual market sale androgel topical gel packet month end be share perrigo have significantly underperform zack classify medical product industry so far year stock have decline broader industry gain simultaneously perrigo also declare subsidiary have file paragraph iv abbreviated new drug application anda fda generic version galderma soolantra ivermectin cream indicated treatment inflammatory lesion rosacea soolantra annual market sale month end be however same date perrigo settle litigation related meda pharmaceutical inc cipla ltd generic version dymista azelastine hydrochloride fluticasone propionate nasal spray dymista be indicated relief symptom seasonal allergic rhinitis patient year age older require treatment azelastine hydrochloride fluticasone propionate symptomatic relief approval generic version drug bode well company help boost revenue anda once approve also lead increase revenue meanwhile company have be constantly make acquisition expand business drive growth fact be impressed perrigo growth acquisition strategy perrigo have also undertake certain restructure initiative be expect support bottom line go forward perrigo company price consensus perrigo company price consensus perrigo company quotezack rank stock considerperrigo currently carry zack rank hold better rank health care stock same space include enzo inc sanofi sny free report enzo sport zack rank strong buy sanofi hold zack rank buy see complete list today zack rank stock here enzo loss share estimate narrow cent cent cent cent last day company deliver positive earning surprise trail quarters average beat share price company have increase year date sanofi earning share estimate increase last day company come positive earning surprise trail quarters average beat share price company have increase year date trade profit big league trump policy stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
1850,PRGO,merger acquisition continue play major role pharma sector be not show sign slow last few month have bring tax inversion deal focus consider number agreement sign ex company
1851,PRGO,tax inversion focuse deal involve creation more efficient tax structure deal be earlier popular mid size company be pick even large cap company prime example be pfizer pfe free report unsuccessful attempt acquire uk base astrazeneca azn abbvie abbv agreement acquire shire shpg shire acquisition abbvie not only boost product portfolio be also be able cut tax rate
1852,PRGO,other such move have be make company mylan myl free report salix slxp actavis act perrigo prgo free report auxilium auxl jazz jazz free report
1853,PRGO,effort be bring more stringent inversion rule such deal continue term fact expectation be high pfizer resume talk acquire astrazeneca later year
1854,PRGO,meanwhile expect small bolt acquisition continue licensing activity collaboration development pipeline candidate have also increase significantly several pharma company be focuse licensing mid late stage pipeline candidate look promising instead develop product scratch involve lot fund time
1855,PRGO,small biotech company be open licensing activity collaboration most company find challenge raise cash thereby make difficult survive continue development promising pipeline candidate therefore make sense seek deal pharma company be sit huge pile cash
1856,PRGO,recommend biotech stock have attractive pipeline candidate technology be used development novel therapeutic therapeutic area see lot licensing activity include immuno oncology oncology central nervous system disorder diabetes immunology inflammation hepatitis virus hcv market be also attract lot attention merck mrk deal acquire idenix idix boost hcv portfolio
1857,PRGO,recent acquisition deal include actavis acquisition forest salix agreement acquire cosmo meanwhile valeant vrx free report be pursue allergan agn
1858,PRGO,trend be see past few quarters be divestment core business segment company pfizer glaxosmithkline gsk free report astrazeneca have be part trend
1859,PRGO,monetization core asset allow pharma biotech company focus area expertise abbott lab recently sign deal mylan sale develop market specialty brand generic business johnson johnson jnj free report divest ortho clinical diagnostic business vertex vrtx monetized incivo related royalty company use cash generate deal cystic fibrosis program theravance thrx also split company
1860,PRGO,restructure activity be also gain momentum large pharma company be look cut cost streamline operation most company be re evaluate pipeline discontinue program do not have favorable risk benefit profile company announce restructure plan include allergan merck novartis nvs free report eli lilly lly free report shire sanofi sny free report new product hold promise
1861,PRGO,worst patent cliff be pharmaceutical sector be slowly steadily recover impact genericization many company have be struggle post growth face genericization past few year be now recovery path new product start contribute significantly result increase pipeline visibility appropriate utilization cash increase confidence sector
1862,PRGO,see fda approve novel medicine third be identify fda first class meaning use new unique mechanism action treat medical condition include drug invokana type ii diabetes kadcyla positive late stage breast cancer sovaldi interferon free oral treatment patient chronic hepatitis mekinist metastatic melanoma
1863,PRGO,yet third approve drug fall rare orphan disease category affect fewer person include imbruvica mantle cell lymphoma gazyva chronic lymphocytic leukemia kynamro homozygous familial adempas opsumit pulmonary arterial hypertension approve drug gazyva imbruvica sovaldi have breakthrough therapy designation breakthrough status new designation become effective jul be design cut short development time promising new treatment
1864,PRGO,important product approve include
1865,PRGO,drug tecfidera sovaldi olysio imbruvica be strong start represent significant commercial potential
1866,PRGO,so far drug have gain approval include astrazeneca myalept complication leptin deficiency farxiga type ii diabetes chelsea therapeutic chtp northera treat neurogenic orthostatic hypotension biomarin bmrn vimizim morquio syndrome vanda vnda hetlioz hour sleep wake disorder mannkind mnkd free report afrezza
1867,PRGO,immuno oncology be area have be limelight especially good show annual meeting american society clinical oncology asco immuno oncology therapy have potential change treatment paradigm cancer basically use natural capability patient own immune system fight cancer
1868,PRGO,major player field include bristol myer squibb bmy astrazeneca merck roche company come datum immuno oncology candidate asco deal target immuno oncology be be inked company bristol myer astrazeneca incyte incy emerge market biosimilar
1869,PRGO,trend see pharmaceutical sector be focus emerge market company mylan pfizer merck eli lilly glaxo sanofi be look expand presence india china brazil other emerge market
1870,PRGO,recently most effort be focuse largest pharmaceutical market europe japan emerge market be slowly steadily gain more importance several company be now shift focus area
1871,PRGO,however higher demand medicine government initiative healthcare new patient population increase use generic help drive demand point emerge market be also not immune genericization moreover investigation bribery charge china put lid term growth
1872,PRGO,meanwhile growth europe continue be pressurize austerity cost containment measure
1873,PRGO,be also see several company enter deal development biosimilar generic version biologic company merck amgen biogen actavis be target highly lucrative biosimilar market earning trend jul
1874,PRGO,earning season have just start only medical company release financial result so far earning beat ratio percentage company come positive surprise be revenue beat ratio be total earning be total revenue improve quarter
1875,PRGO,major part medical sector yet report result earning revenue forecast stand respectively compare earning revenue growth respectively factor negative currency movement few patent expiry affect second quarter growth
1876,PRGO,picture become brighter second half year earning growth expect be respectively revenue be expect grow third fourth quarters respectively new product sale pick significantly second half year
1877,PRGO,overall earning be expect grow detailed look earning outlook medical other sector please check zack earning trend report
1878,PRGO,nyse arca pharmaceutical index drg be last year so far year sector benefit ongoing activity encourage show asco zack industry rank
1879,PRGO,zack industry classification pharma biotech be broadly group medical sector zack sector further sub divide industry expand level large cap pharma med biom gene med drug med generic drug
1880,PRGO,rank industry zack sector base earning outlook fundamental strength constituent company industry learn more visit zack industry rank
1881,PRGO,point reference outlook industry zack industry rank lower be positive be neutral higher be negative
1882,PRGO,zack industry rank large cap pharma be med biom gene be med drug be med generic drug be analyze zack industry rank different medical segment be obvious outlook be positive med generic drug neutral med drug med biom gene large cap pharma stock opportunity
1883,PRGO,several company continue face challenge eu austerity measure genericization pharma industry be worst genericization phase many company have face generic headwind last couple year continue see sustain improvement result year
1884,PRGO,cost cut downsize streamline pipeline growth emerge market new product launch support growth
1885,PRGO,pharma stock allergan zack rank strong buy stock look well position growth company be currently news thank strong second quarter result restructure initiative ongoing effort valeant acquire company
1886,PRGO,specialty pharma company salix boost portfolio strengthen position market santarus acquisition earlier year look well poise growth company upcoming merger cosmo allow enjoy tax efficient corporate structure further strengthen position disease market salix be also zack rank stock
1887,PRGO,other well rank pharma company include astrazeneca pfizer be zack rank buy stock
1888,PRGO,biotech space be positive abbvie zack rank company recently announce intention acquire shire upcoming acquisition not only lead more efficient tax structure abbvie also benefit shire strong product portfolio pipeline
1889,PRGO,biogen zack rank stock also look well position tecfidera company recently launch oral multiple sclerosis drug be strong start product deliver sale dec launch early april tecfidera have gain top spot oral multiple sclerosis market avonex tysabri continue contribute significantly sale tecfidera gain eu approval recently biogen be also progress hemophilia drug
1890,PRGO,other well rank biotech stock include biomarin medicine co mdco celgene pharmacyclic aegerion aegr theravance incyte incy biomarin medicine co be zack rank stock other carry zack rank
1891,PRGO,generic company teva teva dr reddy laboratory rdy akorn akrx carry zack rank weakness
1892,PRGO,recommend avoid name offer little growth opportunity take include company be develop drug be likely face regulatory hurdle
1893,PRGO,large cap pharma company currently carry zack rank sell include nordisk nvo sanofi biotech stock auxilium be go challenge time zack rank strong sell stock cut revenue guidance primarily due lower expect testim revenue company cubist nektar nktr nps pharma npsp also carry zack rank
1894,PRGO,pharmaceutical sector have be slowly steadily recover impact patent cliff be face several company past few year worst patent cliff be nyse arca pharmaceutical index drg be last year so far index be
1895,PRGO,several company have be struggle post growth face genericization past few year be now recovery path new product start contribute significantly result increase pipeline visibility appropriate utilization cash increase confidence sector
1896,PRGO,product lose exclusivity recently include eli lilly lly cymbalta evista astrazeneca azn nexium also start face generic sale be collaboration acquisition restructure
1897,PRGO,pharma sector witness major merger acquisition activity last couple year go forward expect small bolt acquisition continue licensing activity collaboration development pipeline candidate have also increase significantly several pharma company be focuse licensing mid late stage pipeline candidate look promising instead develop product scratch involve lot fund time
1898,PRGO,small biotech company be open licensing activity collaboration most company find challenge raise cash thereby make difficult survive continue development promising pipeline candidate therefore make sense seek deal pharma company be sit huge pile cash
1899,PRGO,recommend biotech stock have attractive pipeline candidate technology be used development novel therapeutic therapeutic area see lot licensing activity include immuno oncology oncology central nervous system disorder diabetes immunology inflammation hepatitis virus hcv market be also attract lot attention
1900,PRGO,recent acquisition deal include shire shpg acquisition viropharma salix slxp acquisition santarus well acquisition optimer pharmaceutical trius therapeutic cubist pharmaceutical cbst elan perrigo company prgo free report major acquisition agreement be announce recently forest lab frx actavis act deal show intention generic company establish strong position brand market significant deal be sign celgene celg oncomed pharmaceutical omed free report joint development cancer stem cell candidate oncomed biologic pipeline
1901,PRGO,trend be see recent month be divestment core business segment pfizer pfe free report sell capsugel unit nutrition business aug nov respectively pfizer then spun animal health business new company zoetis zts free report
1902,PRGO,meanwhile glaxosmithkline gsk divest certain core brand consumer healthcare segment aug astrazeneca sell astra tech business dentsply xray free report monetization core asset allow pharma biotech company focus area expertise abbott lab split separate publicly trade company company deal diversify medical product other abbvie abbv be focuse research base pharmaceutical johnson johnson jnj be also look divest ortho clinical diagnostic business vertex vrtx free report monetized incivo related royalty company use cash generate deal cystic fibrosis program
1903,PRGO,restructure activity be also gain momentum large pharma company be look cut cost streamline operation most company be re evaluate pipeline discontinue program do not have favorable risk benefit profile company announce restructure plan include merck mrk free report novartis nvs free report eli lilly shire sanofi sny free report destination ireland
1904,PRGO,late several company have be look ireland acquisition latest company join irish club be horizon pharma hznp be do reverse merger dublin base vidara tax benefit be major attraction such deal other such recent acquisition include warner chilcott actavis elan perrigo emerge market biosimilar
1905,PRGO,trend see pharmaceutical sector be focus emerge market company mylan myl free report pfizer merck eli lilly glaxo sanofi be look expand presence india china brazil other emerge market
1906,PRGO,recently most effort be focuse largest pharmaceutical market europe japan emerge market be slowly steadily gain more importance several company be now shift focus area
1907,PRGO,however higher demand medicine government initiative healthcare new patient population increase use generic help drive demand point emerge market be also not immune genericization moreover investigation bribery charge china put lid term growth
1908,PRGO,meanwhile growth europe continue be pressurize austerity cost containment measure
1909,PRGO,be also see several company enter deal development biosimilar generic version biologic company merck amgen biogen biib actavis be target highly lucrative biosimilar market earning
1910,PRGO,company fall medical sector have report fourth quarter full year result earning beat revenue beat ratio percentage company come positive surprise be pretty impressive growth ratio be modest fourth quarter result be characterize currency headwind well impact generic
1911,PRGO,fourth quarter earning beat ratio be revenue beat ratio be total earning sector be compare record third quarter total revenue moved quarter versus growth third quarter
1912,PRGO,look consensus earning expectation first quarter earning be expect decline tough challenge company negative currency movement few patent expiree affect first quarter growth however growth pick second quarter earning growth be expect
1913,PRGO,overall earning be expect grow detailed look earning outlook medical other sector please check zack earning trend report focus new product
1914,PRGO,see fda approve novel medicine third be identify fda first class meaning use new unique mechanism action treat medical condition include drug invokana type ii diabetes kadcyla positive late stage breast cancer sovaldi interferon free oral treatment patient chronic hepatitis mekinist metastatic melanoma
1915,PRGO,yet third approve drug fall rare orphan disease category affect fewer american include imbruvica mantle cell lymphoma gazyva chronic lymphocytic leukemia kynamro homozygous familial adempas opsumit pulmonary arterial hypertension approve drug gazyva imbruvica sovaldi have breakthrough therapy designation breakthrough status new designation become effective jul be design cut short development time promising new treatment
1916,PRGO,important product approve include
1917,PRGO,drug tecfidera sovaldi imbruvica represent strong commercial potential
1918,PRGO,so far drug have gain approval include astrazeneca myalept complication leptin deficiency farxiga type ii diabetes chelsea therapeutic chtp northera treat neurogenic orthostatic hypotension biomarin bmrn vimizim morquio syndrome vanda pharma vnda free report hetlioz hour sleep wake disorder
1919,PRGO,upcoming event include fda advisory panel review regulatory application mannkind mnkd experimental diabetes treatment afrezza april be active month agency expect deliver response approvability several experimental drug include afrezza glaxo eperzan type ii diabetes arzerra cll zack industry rank
1920,PRGO,zack industry classification pharma biotech be broadly group medical sector zack sector further sub divide industry expand level large cap pharma med biom gene med drug med generic drug
1921,PRGO,rank industry zack sector base earning outlook fundamental strength constituent company industry learn more visit zack industry rank
1922,PRGO,point reference outlook industry zack industry rank lower be positive be neutral higher be negative
1923,PRGO,zack industry rank large cap pharma be med biom gene be med drug be med generic drug be analyze zack industry rank different medical segment be obvious outlook be positive med drug med biom gene med generic drug negative large cap pharma stock opportunity
1924,PRGO,several company continue face challenge eu austerity measure genericization pharma industry be worst genericization phase many company have face generic headwind last couple year continue see sustain improvement result year cost cut downsize streamline pipeline growth emerge market new product launch support growth
1925,PRGO,pharma stock shire zack rank strong buy stock look well position growth company expand product portfolio pipeline acquisition viropharma horizon pharma zack rank buy stock also seem right path company announce plan acquire ireland base vidara
1926,PRGO,biotech space be positive biogen tecfidera company recently launch oral multiple sclerosis drug be strong start product deliver sale dec launch early april tecfidera have gain top spot oral multiple sclerosis market avonex tysabri continue contribute significantly sale tecfidera gain eu approval recently biogen be also progress hemophilia pipeline
1927,PRGO,be also positive amgen amgn amgen be able deliver long term strategy base expansion key market launch new manufacturing technology pipeline development enbrel continue perform well amgen late stage pipeline be also move amgen be zack rank stock biogen be zack rank hold stock
1928,PRGO,gilead zack rank stock continue do well hiv segment have potential blockbuster portfolio form hcv treatment sovaldi
1929,PRGO,generic company actavis look well position actavis be slowly steadily build position brand market acquisition actavis group warner chilcott upcoming acquisition forest fewer major patent expiry slate occur next few year be encourage actavis focus build brand biosimilar pipeline company carry zack rank weakness
1930,PRGO,recommend avoid name offer little growth opportunity take include company be develop drug be likely face regulatory hurdle
1931,PRGO,large cap pharma company eli lilly be gear round patent expiry cymbalta dec evista year prefer wait sideline company be able emerge impact genericization
1932,PRGO,company currently carry zack rank sell include bayer bayry sanofi glaxo other sanofi be face currency headwind be news recently related development pcsk inhibitor alirocumab fda have ask sanofi partner regeneron regn free report evaluate potential neurocognitive adverse event global development program alirocumab especially long term study result pcsk inhibitor development have be encourage so far be first time serious safety concern have be raise
1933,PRGO,come end worst patent cliff face pharmaceutical sector be major blockbuster drug merck mrk singulair pfizer pfe free report lipitor forest laboratory frx lexapro sanofi bristol myer squibbs sny free report bmy plavix eli lilly lly zyprexa represent combine brand sale worth more lose patent protection last couple year
1934,PRGO,however effect genericization product be feel mostly industry win be completely free genericization major patent expiry be do
1935,PRGO,several company have be struggle post growth face genericization past few year see accelerate growth new product start contribute significantly result increase pipeline visibility appropriate utilization cash increase confidence sector
1936,PRGO,product be slate lose patent protection later year next year include astrazeneca azn nexium also start face generic sale be collaboration acquisition restructure
1937,PRGO,pharma sector witness major merger acquisition activity last couple year trend continue year go forward expect small bolt acquisition continue licensing activity collaboration development pipeline candidate have also increase significantly several pharma company be focuse licensing mid late stage pipeline candidate look promising instead develop product scratch involve lot fund time
1938,PRGO,small biotech company be open licensing activity collaboration most company find challenge raise cash thereby make difficult survive continue development promising pipeline candidate therefore make sense seek deal pharma company be sit huge pile cash
1939,PRGO,recommend biotech stock have attractive pipeline candidate technology be used development novel therapeutic therapeutic area see lot licensing activity include oncology central nervous system disorder diabetes immunology inflammation hepatitis virus hcv market be also attract lot attention
1940,PRGO,recent acquisition deal include shire shpg free report upcoming acquisition viropharma vphm salix slxp upcoming acquisition santarus snt well acquisition optimer pharmaceutical trius therapeutic cubist pharmaceutical cbst elan eln be also track be acquire perrigo company prgo free report year end
1941,PRGO,trend be see recent month be divestment core business segment pfizer sell capsugel unit nutrition business aug nov respectively pfizer then spun animal health business new company zoetis zts free report meanwhile glaxosmithkline gsk divest certain core brand consumer healthcare segment aug astrazeneca sell astra tech business dentsply xray free report
1942,PRGO,monetization core asset allow pharma biotech company focus area expertise abbott lab split separate publicly trade company company deal diversify medical product other abbvie abbv be focuse research base pharmaceutical johnson johnson jnj also announce plan explore strategic alternative ortho clinical diagnostic business include possible divestiture vertex vrtx free report monetized incivo related royalty vertex use cash generate deal cystic fibrosis program
1943,PRGO,restructure activity be also gain momentum large pharma company be look cut cost streamline operation most company be re evaluate pipeline discontinue program do not have favorable risk benefit profile company announce restructure plan include merck novartis nvs free report eli lilly shire sanofi emerge market biosimilar
1944,PRGO,trend see pharmaceutical sector be focus emerge market company mylan myl free report pfizer merck eli lilly glaxo sanofi be look expand presence india china brazil other emerge market recently most effort be focuse market largest pharmaceutical market europe japan emerge market be slowly steadily gain more importance several company be now shift focus area
1945,PRGO,however higher demand medicine government initiative healthcare new patient population increase use generic help drive demand point emerge market be also not immune genericization moreover investigation bribery charge china put lid term growth
1946,PRGO,meanwhile growth europe continue be pressurize austerity cost containment measure
1947,PRGO,be also see several company enter deal development biosimilar generic version biologic company merck amgen biogen biib actavis act be target highly lucrative biosimilar market earning
1948,PRGO,company fall medical sector have report third quarter result earning beat revenue beat ratio percentage company come positive surprise be pretty impressive growth ratio be modest third quarter result be characterize currency headwind especially japan well slowdown china bribery investigation remain headline
1949,PRGO,third quarter earning beat ratio be revenue beat ratio be total earning sector be compare decline record second quarter total revenue moved quarter versus growth second quarter
1950,PRGO,look consensus earning expectation fourth quarter earning be expect decline tough challenge company negative currency movement few patent expiry affect fourth quarter growth year come end several company maintain narrow guidance range
1951,PRGO,overall earning be expect grow focus new product
1952,PRGO,see fda approve novel medicine include follow
1953,PRGO,most product have be perform well so far stivarga kalydeco xtandi kyproli especially represent strong commercial potential
1954,PRGO,so far quite few important product have gain approval include biogen oral multiple sclerosis drug tecfidera johnson johnson type ii diabetes drug invokana merck liptruzet cholesterol forest fetzima major depressive disorder pharmacyclic pcyc johnson johnson imbruvica mantle cell lymphoma roche rhhby free report gazyva chronic lymphocytic leukemia biogen tecfidera be strong start sale surpass expectation wide margin
1955,PRGO,upcoming event include fda advisory panel reviews biologic licensing application bla bristol myer squibbs metreleptin rare form lipodystrophy dapagliflozin type ii diabetes merck grastek timothy grass pollen extract tablet sublingual use reviews be schedule take place dec timeframe
1956,PRGO,response approval status auxilium pharma auxl xiaflex peyronie gilead sofosbuvir chronic hcv infection also be december zack industry rank
1957,PRGO,zack industry classification pharma biotech be broadly group medical sector zack sector further sub divide industry expand level large cap pharma med biom gene med drug med generic drug
1958,PRGO,rank industry zack sector base earning outlook fundamental strength constituent company industry learn more visit zack industry rank
1959,PRGO,point reference outlook industry zack industry rank lower be positive be neutral higher be negative
1960,PRGO,zack industry rank large cap pharma be med biom gene be med drug be med generic drug be analyze zack industry rank different medical segment be obvious outlook be positive med drug med biom gene med generic drug neutral large cap pharma stock opportunity
1961,PRGO,outlook pharma sector have improve significantly zack industry rank move past few month several company continue face challenge eu austerity measure genericization pharma industry be worst genericization phase
1962,PRGO,many company have face generic headwind last couple year continue see sustain improvement result move cost cut downsize streamline pipeline growth emerge market new product launch support growth
1963,PRGO,large cap pharma stock bayer bayry zack rank buy stock look well position several new product eylea stivarga xarelto portfolio product represent significant commercial potential forest lab frx zack rank stock be do well first half fiscal result beating expectation company have launch several new product past few quarters continue work expand pipeline company also raise earn guidance fiscal shire shpg free report zack rank strong buy stock look well position growth company expand product portfolio pipeline upcoming acquisition viropharma
1964,PRGO,be positive johnson johnson jnj even company currently hold zack rank hold company have perform well so far year momentum continue johnson johnson up earning guidance again announce third quarter result
1965,PRGO,company have be try offset decline sale important product bring new product licensing deal acquisition believe diversity strength company underlie business continue provide strong growth future
1966,PRGO,biotech space be positive biogen biib tecfidera company recently launch oral multiple sclerosis drug be strong start product deliver sale launch early april tecfidera have gain top spot oral multiple sclerosis market avonex tysabri continue contribute significantly sale tecfidera gain eu approval shortly biogen be also progress hemophilia pipeline biogen be company raise guidance again year
1967,PRGO,be also positive amgen amgn amgen be able deliver long term strategy base expansion key market launch new manufacturing technology pipeline development enbrel continue perform well amgen late stage pipeline be also move amgen be zack rank stock biogen be zack rank hold stock gilead zack rank stock continue do well hiv segment be also progress hcv pipeline medivation mdvn zack rank company continue deliver prostate cancer therapy xtandi perform well base datum have see so far believe xtandi have blockbuster potential be currently several study include pre chemo set expansion pre chemo set be major positive medivation vanda pharmaceutical inc vnda free report also look well position company receive positive feedback fda regard insomnia candidate tasimelteon fda advisory panel vote resoundingly favor approve candidate treatment hour disorder totally blind fda be not require follow advice advisory panel usually do so response agency be jan vanda be zack rank stock
1968,PRGO,generic company actavis act look well position view acquisition actavis group smart strategic move believe company be able achieve guidance easily be also positive recent acquisition warner chilcott make strategic financial sense fewer major patent expiry slate occur next few year be encourage actavis focus build brand biosimilar pipeline company carry zack rank weakness
1969,PRGO,recommend avoid name offer little growth opportunity take include company be develop drug be likely face regulatory hurdle fda have be exercise more caution grant approval new product several candidate be face delay receive final approval
1970,PRGO,large cap pharma company eli lilly lly be gear round patent expiry cymbalta dec evista next year prefer wait sideline company be able emerge impact genericization
1971,PRGO,company currently carry zack rank sell include alk biolinerx ltd blrx xoma corporation xoma free report other
1972,PRGO,week back offer view new year article title outlook
1973,PRGO,topic today be same line minor twist focus today be specifically investment lesson learn last year market behavior be rocket science here pay learn re learn lesson new year likely bring back same situation
1974,PRGO,start very positive note expectation gdp growth north overall international backdrop appear favorable europe expect struggle result debt overhang emerge market expect continue grow economic outlook soured significantly oil price rise follow so call arab spring euro zone issue expand greece other country
1975,PRGO,noisy debt ceiling debate rating downgrade add double dip recession fear summer month fear ease only economic reading turn second half year help erase loss first half europe remain dark cloud new year appear finally track put arm issue come month pay be tactical
1976,PRGO,distinct feature stock market last year have be very high level correlation stock price stock moved sync other upside downside little differentiate performance
1977,PRGO,behavior high correlation be not unusual time macro uncertainty economy be enter recession be major stock market obsession summer month then stock suffer ditto contagion risk europe debt wo
1978,PRGO,shift macro backdrop be very unhelpful say least buy hold type investment strategy have be nimble tactical navigate such market be not advocate market timing excessive trading action here have stay ready promptly make change portfolio macro outlook start shift
1979,PRGO,speed market move have increase substantially recent past arrival etfs algorithmic trading most likely be late party critical piece information fall place new outlook become completely clear likely remain highly correlated state linger issue continue exert influence first few month new year expect volatility ebb later year macro environment stabilize putt premium discipline stock pick ability keep eye bond market
1980,PRGO,stock guy never concede bond market be smarter stock market have hesitation acknowledge bond market be lot less sentimental have lot better read macro picture stock market do bond investor employ classic top approach investing conditioning get big picture right order get reward stock market be expose same macro force primarily employ bottom approach investing
1981,PRGO,think back last summer stock market be respond development debt ceiling debate fear rating downgrade know market respond own way subsequent rating downgrade grant contribute factor lower treasury yield be flight safety trade due european turmoil be doubtful bond yield be materially higher absent variable many argue lower bond yield try invest theme be fruitless exercise everyone include pimco bill gross
1982,PRGO,more pertinent new year take cue evolve euro zone picture not stock market be respond day day basis yield government bond market be behave stock market appear have be deal europe lot more optimism last few week be show bond market don forget yield year italian government bond be still flirt level putt together
1983,PRGO,market start new year positive note host favorable domestic international report help push higher most legacy issue weigh stock latter part be still don be surprised concern make comeback come day explain market outlook week expect macro backdrop shift stage first half year have be ready make tactical switch time come
1984,PRGO,rely more bond market give cue macro picture move herd be phenomenon common market asset class include bond nothing be infallible net net bond market be lot less emotional sentimental stock market portfolio update
1985,PRGO,make change focus list week delete add stock deletion moneygram international mgi free report perrigo company prgo free report result zack rank downgrade function downward earning estimation revision
1986,PRGO,replace stock spectra energy ps business park psb free report pick be line strategy investing domestic oriented business lower risk profile ps business park be reit own operate low rise suburban multus tenant office business park other asset company have strongest balance sheet space currently pay very attractive dividend
1987,PRGO,spectra energy be houston base natural gas utility have stable low risk business profile also pay attractive dividend currently yielding
1988,PRGO,time year again have look ahead new year have store be exactly goal today piece want share outlook reason outlook
1989,PRGO,market struggle meaningfully break host fear way fear range recession euro zone implode weight fiscal problem concern extent ongoing slowdown china have also become recur theme lately
1990,PRGO,regular reader know positive outlook economy market be look much better stock market performance new year see many issue keep market check be still likely remain first half year expect visibility improve significantly second half year drive most gain
1991,PRGO,recessionary worry economy have ease report start show pronounce improve trend underlie datum current expectation be economy grow little be hard get excited level growth relative growth prospect other major develop economy growth outlook start look very attractive look ahead
1992,PRGO,earning recovery corporate sector didn miss beat rollercoaster ride still have more quarter go close book be say do earning be close year current expectation be further gain
1993,PRGO,addition typical growth deceleration stage earning cycle weak economic growth europe china also weigh earning growth margin effectively peak level top line gain get hard come due relatively softer global economic backdrop be downside risk current earning expectation assume fairly conservative ep current expectation used historical multiple take index index close today be look gain excess year end
1994,PRGO,say be not look nice straight move fact explain today roundtable review video envision distinct phase stock market next year require set own set investment strategy phase more same
1995,PRGO,first phase be look continuation current market concern carry likely last spring period market essentially behave way have last few month worry europe chinese growth key headwind
1996,PRGO,europe be track greater fiscal union confirm recent eu agreement expect come month bring more clarity next step process european central bank ecb become lender last resort fed meaningful progress get make issuance euro bond europe still go recession weight tough austerity measure put place fear union implode ease
1997,PRGO,have fairly sanguine view ongoing chinese slowdown feel strongly current fear hard landing chinese economy be overblown recent monetary ease chinese central bank be confirmation long run fight inflation have be successful combination fiscal monetary ease chinese authority ensure steady economic growth country start see evidence middle year phase increase visibility
1998,PRGO,increase visibility european chinese situation roughly middle part year help remove cloud have be weigh market first phase situation be analogous cyclical recovery stock market favorable macro backdrop putt stock meaningful uptrend
1999,PRGO,bottom line be not look much stock market momentum first phase most gain expect come second phase be hard not altogether impossible be overly precise timeframe phase depiction first phase last spring mere approximation say be reasonably confident idea distinct phase market risk outlook
2000,PRGO,fiscal imbalance economy remain long term problem don represent danger outlook deficit debt be clearly unsustainable current level be need be roadmap future failure congressional super committee have push issue squarely election overall don consider fiscal imbalance risk factor investment outlook
2001,PRGO,relevant risk factor investment outlook remain europe china expect europe resolve fiscal problem continue strengthen fiscal union come month risk inaction miscalculation be entirely rule
2002,PRGO,china have assume role growth engine world economy largely export centric economy growth profile have be critical positive performance thus far commodity basic material industrial sector economy market have adjust ongoing slowdown chinese economy significant slowdown come negative shock
2003,PRGO,don envision scenario unfold represent risk factor outlook have put odd come fruition put less portfolio update
2004,PRGO,phase outlined have distinct investment implication explain investment strategy top pick video first phase be not much different have experience lately market
2005,PRGO,best investment posture market environment be go quality name relatively mid large cap size preferably steadily grow dividend give concern europe china also help pick have more domestic focus phase be not particularly conducive buy hold type investment style tactical investing bring better result second phase be more investing cyclically upturn market traditional cyclical sector industrial basic material commodity come back favor
2006,PRGO,best perform stock zack focus list have attribute key attribute common kansa city southern ksu free report chipotle grill cmg free report tractor supply company tsco free report top focus list performer present be centric business come distinct industry see same trend play other top perform focus list name well irrespective industry be company broader healthcare sector pharmaceutical sector such humana hum free report perrigo prgo free report master limit partnership such oneok partner ok plain american paa free report be primarily focuse economy
2007,PRGO,perrigo co prgo free report recently deliver record result prompt upward revision zack consensus estimate current earning estimate share be last week fiscal year end june follow year forecast climb past week
2008,PRGO,company description
2009,PRGO,perrigo co develop manufacture distribute counter otc prescription rx pharmaceutical nutritional product active pharmaceutical ingredient api medical diagnostic product worldwide
2010,PRGO,record result
2011,PRGO,perrigo second quarter earning cent share eclipse zack consensus estimate revenue be year year
2012,PRGO,management say company deliver time record quarterly revenue earning well record second quarter cash flow add consumer healthcare rx api segment contribute strong performance
2013,PRGO,upward revision
2014,PRGO,company hike fiscal adjust earning guidance range share range share
2015,PRGO,analyst poll zack be peg earning share year end june increase last week follow year zack consensus estimate share be up last week
2016,PRGO,reward shareholder
2017,PRGO,perrigo also recently declare quarterly dividend share note be payable mar shareholder record feb company pay industry lead dividend yield
2018,PRGO,strong momentum
2019,PRGO,share prgo spiked record quarter add more lead perrigo have accumulate past year
2020,PRGO,alex kolb be growth income stock strategist zack com also write popular daily commentary column zackselite com service
2021,PRGO,bear continue roam wall street monday relatively slow news day grow debt europe particularly greece portugal spain weigh market spark jitter global economy
2022,PRGO,addition european debt impact monday slide also be attribute investor move money sideline recent string day
2023,PRGO,dow lose point close dip point nasdaq give point end session
2024,PRGO,oil climb cent set barrel new york mercantile exchange
2025,PRGO,dollar decline other major currency gold be
2026,PRGO,focus list group inc rhb also gain market add day trading lower most last week estimate have be hold steady company march result current year peg next year peg growth projection
2027,PRGO,gafisa continue see minor rebound share last thursday big sell stock finished session zack have schedule report earning today sometimes foreign company date get change keep eye earning day now analyst be look cent share monro muffler mnro free report analyst continue raise estimate follow company recent earning release unanimous estimate board be rise consensus current year end march be cent next year estimate be average also cent
2028,PRGO,lincoln educational linc free report see uptick full year consensus estimate past few day average analyst be expect penny recently cent past month
2029,PRGO,perrigo co prgo free report be top performer monday model portfolio be major development fuel gain day however company recently deliver record result prompt upward revision zack consensus estimate earning estimate share be last week fiscal year end june follow year forecast climb past week
2030,PRGO,mednax inc md free report see recent upward earning estimate revision solid fourth quarter full year zack consensus estimate share be lift past week analyst poll zack boost forecast last week share
2031,PRGO,growth income updatesbuckeye partner int bpl free report bounce higher weak market add day rebound friday selloff gain come little jump crude close day nutrisystem ntri free report buck negative market trend finished session stock have re-cover last week sharper loss be zack rank buy stock
2032,PRGO,perrigo co prgo free report be week top performer focus list company have be hit recent week high be subject upgrade caris company deliver record result fiscal second quarter
2033,PRGO,company develop manufacture distribute counter otc prescription rx pharmaceutical nutritional product active pharmaceutical ingredient api medical diagnostic product worldwide
2034,PRGO,perrigo second quarter earning cent share eclipse zack consensus estimate revenue be year year
2035,PRGO,company hike fiscal adjust earning guidance range share range share
2036,PRGO,analyst poll zack be peg earning share year end june increase last week follow year zack consensus estimate share be up last week
2037,PRGO,perrigo also recently declare quarterly dividend share note be payable mar shareholder record feb company pay industry lead dividend yield
2038,PRGO,company ticker weekreturn
2039,PRGO,perrigo company prgo free report
2040,PRGO,invacare corp ivc
2041,PRGO,cisco system csco
2042,PRGO,western digital wdc
2043,PRGO,visa inc
2044,PRGO,wall street see modest dip straight day rally ism service survey come little expectation get whole story wednesday ism datum analyst blog title ism service slightly positive
2045,PRGO,other economic datum hit street wednesday be automatic datum process adp free report report show country lose private sector job january be slightly better consensus expectation job drop receive detail adp see job drop analyst blog
2046,PRGO,dow slip point give point close nasdaq be point less end session
2047,PRGO,learn company report recently link follow
2048,PRGO,honda profit jump billioncomcast outperform outlook flattime warner top zack estimatepfizer line guidance paper beat centhubbell beat look murkyfocus list inc blk free report trade higher weak market add day see upward revision estimate last few day current year add cent next year add cent bullish growth projection blackrock have beat last quarters average
2049,PRGO,bristow group brs free report report earning bell look earning share be cent zack consensus call cent revenue rise company see strong activity europe nigeria risk rebel gulf mexico continue see weakness company doesn believe have be impact greatly other service company company conference call be tomorrow so await more guidance stock rise session be higher hour trade news dr pepper snapple dps declare quarterly dividend be cent payable shareholder record march fund hit account april share be unchanged day
2050,PRGO,china green gain light trading share have be time be estimate revision be get stale become day old do not factor zack rank so see good stock slip rank time time negative revision value growth be still be look good report
2051,PRGO,focus list additionscpfl energia be add focus list close feb cpl be brazilian utility company provide electricity several state company be privately run not only have large dividend yield also solid growth be rare utility company analyst expect earning growth zack rank buy stock have attractive valuation be trading forward just
2052,PRGO,gafisa inc be add focus list today feb close brazilian home builder have see estimate shoot higher last month ahead early march result current year estimate be cent next year estimate have add cent bullish growth projection zack rank stock also look reasonably value trading forward multiple discount overall market nice growth projection boot
2053,PRGO,perrigo co prgo free report be upgrade caris company earlier trading share hit week high close tuesday company report record result fiscal second quarter earning cent share eclipse zack consensus estimate revenue year year
2054,PRGO,growth income updateaflac inc afl free report shot most stock lose ground wednesday advance follow company release fourth quarter result tuesday earning share eclipse previous year cent outpaced zack consensus estimate revenue be last year share jump day
2055,PRGO,company also announce wednesday be name training magazine training top list be consecutive year aflac appear magazine esteem list
2056,PRGO,market be again bullish camp tuesday react solid corporate earning report be horton dhi free report fiscal first quarter number show profitability first time get whole story read analyst blog title dhi return profitability
2057,PRGO,economic datum front housing news be mixed learn more check homeownership rate fall again analyst blog
2058,PRGO,tuesday dow climb point picked point close nasdaq advanced point
2059,PRGO,oil see biggest day jump month spiking settle barrel new york mercantile exchange
2060,PRGO,checkout other report recently release link follow
2061,PRGO,beat raise dividendup top outlook positivebp miss refine narrow losswisconsin energy profit riselower loss array biofocus list updatesscott miracle gro co smg free report close nice gain report better expect result bell earning come loss cent cent ahead zack consensus estimate call loss sale be
2062,PRGO,newmarket fall zack rank buy stock today many month zack rank come less spectacular earning last week beat zack consensus estimate only cent estimate have weaken quarter be higher now be watch hold closely feel most sell earning have be price perrigo co prgo free report see share spike report record result fiscal second quarter earning cent share surpass last year cent exceed zack consensus estimate cent revenue come ahead year prior management note company deliver time record quarterly revenue earning record second quarter cash flow add consumer healthcare rx api segment contribute strong performance stock be tuesday strongest performer model portfolio
2063,PRGO,smucker co sjm free report gain be just week high trading such high level stock remain great value share be go just time forward earning company be expect grow steadily fiscal year fiscal
2064,PRGO,growth income updatesaflac inc afl free report post fourth quarter earning share eclipse previous year cent outpace zack consensus estimate revenue be last year share jump day
2065,PRGO,herbalife ltd hlf free report jump higher strong market add day rebound friday sharp loss fundamental picture be hold steady ahead company feb earning release
2066,PRGO,kellogg free report rise high volume be also pressure week high share eclipse high hour trading today so see open go tomorrow smucker share be trading time forward earning trading high
2067,PRGO,growth income lz be delete growth income portfolio close company be due report earning feb however past several quarters have be preannounce better expect preliminary earning result company have not do quarter maybe mean nothing give newmarket result last week seem ominous estimate be also weaken slightly give large profit stock re go lock gain add stock portfolio be remove close feb
2068,PRGO,market see bearish trading most session later stock advanced positive territory upbeat assessment fed expect rate be left unchanged get whole story analyst blog title fed keep rate unchanged
2069,PRGO,other economic news include weak read new home sale new home sale fall december november seasonally adjust annual rate be well consensus estimate annual rate even year rate receive detail new home sale weak analyst blog
2070,PRGO,wednesday dow be point close gain point end session nasdaq climb point
2071,PRGO,click follow link recent earning report
2072,PRGO,caterpillar beat disappointsboee fly high consensusconoco beat hurtsutx beat pennywellpoint beat zack beat sale dipfocus list updatesvisa inc free report jump higher resurgent market add trend higher most afternoon estimate have be mostly flat last few month visa company feb result provide new insight strength business
2073,PRGO,lincoln educational linc free report gain solid day education stock devry post great number reaffirm have thought time profit play be not
2074,PRGO,perrigo company prgo free report declare quarterly dividend share note be payable mar shareholder record feb company pay industry lead dividend yield
2075,PRGO,focus list additionalpha natural resource anr largest coal producer unite state be add focus list close today jan alpha be zack rank stock very bullish estimate share translate earning growth company produce solid earning surprise last quarter beating zack consensus estimate average surprise last year alpha operate zack industry rank
2076,PRGO,focus list deletionwms industry wm be remove focus list close jan company recently surprised estimate penny report solid earning stock have now fall zack rank strong sell follow zack methodology sell stock
2077,PRGO,growth income updatestrayer education inc stra free report enjoy healthy gain day devry dv strong fiscal second quarter keep eye strayer fourth quarter report schedule release feb devry quarterly result be indication strayer post stellar number
2078,PRGO,growth income additionsnew york community bancorp inc nyb be add growth income portfolio close jan nyb be commercial bank location new york several other state estimate full year slide past few month still project modest growth rate however forecast be analyst be expect increase share nyb carry zack rank pay dividend yield roughly stock be trading time forward earning price book time
2079,PRGO,nutrisystem inc ntri free report be add growth income portfolio close jan weight loss management company have surprised estimate last quarters analyst be bullish expect earning growth zack rank strong buy stock be attractively value trading forward earning ntri also reward shareholder solid dividend currently yielding
2080,PRGO,stock dip early trading china moved forward plan slow growth curtail bank lend investor fear country initiative slow growth adversely affect global economy
2081,PRGO,then market rebound advance most session upbeat earning report reassure economic news include conference board state index consumer confidence climb january versus december marked third consecutive increase hit highest level more year
2082,PRGO,however late trading financial tumble rest market follow ahead president state union wednesday investor again become jittery plan place limit trading big bank
2083,PRGO,dow lose point less close give point end session nasdaq decline point
2084,PRGO,click follow link detail recent earning report
2085,PRGO,yahoo top expectationsj beat guidance swing profitbaker hughe top net sinksu steel earning penny shyti beat lead time stretchapple beat frontsfocus list updatesscott miracle gro co smg free report jump higher weak session add day hit new high report better expect result mid january haven see much upward movement estimate next year be still project growth
2086,PRGO,wm industry inc wm be trading lower bell spite report better expect result earning come cent share penny ahead zack consensus estimate gain revenue last year
2087,PRGO,plexus corp plxs free report hit yet week high rise share end session pop day company have also be subject recent brokerage upgrade
2088,PRGO,stock be last week top performer focus list share surge strong fiscal first quarter report plexus see first quarter earning cent be lower last year cent zack consensus estimate cent sale come slightly lower last year top previous quarter
2089,PRGO,perrigo co prgo free report be strongest focus list performer tuesday gain market be little news volume be slightly average company most likely see momentum expectation earning announce drug maker
2090,PRGO,growth income abc free report do not disappoint easily beat zack consensus estimate earning share be cent compare zack consensus cent revenue jump record half growth be new business acquisition last year generic drug be also hot segment company raise fiscal guidance
2091,PRGO,abc stock have be hot go number continue be so today stock hit new week high pull back bit close corning glw free report report fourth quarter result bell beat zack consensus cent sale rise company see especially strong lcd glass demand second half year propel fourth quarter stock however didn get much love investor fall session
2092,PRGO,perrigo company prgo free report be nation largest manufacturer store brand counter prescription pharmaceutical product manufacture store brand nutritional product store brand product be sell national regional supermarket
2093,PRGO,drugstore mass merchandise chain own label compete nationally advertised brand company
2094,PRGO,product include analgesic cough cold remedy antacid laxative feminine hygiene smoking cessation product
2095,PRGO,vitamin nutritional supplement nutritional drink
2096,PRGO,company be hold relatively well light recent market meltdown recent performance have outpaced broader market past month prgo share price be even major average sunk red
2097,PRGO,perrigo recently announce acquisition laboratorio diba approximately cash prgo note privately hold laboratorio diba be base guadalajara mexico be store brand manufacturer counter otc prescription pharmaceutical include antibiotic hormonal opthalmic prgo add acquisition be expect add nearly annual sale
2098,PRGO,mid september company announce acquire drug nutritional product maker jb laboratory cash prgo mentioned acquisition be expect add more annual sale
2099,PRGO,prgo announce record fiscal fourth quarter result mid august company profit increase thank hike see demand consumer health care product
2100,PRGO,record net sale jump year year net income climb last year
2101,PRGO,
2102,PRGO,management note be third consecutive quarter year year record sale earning add
2103,PRGO,company also generate cash operation year
2104,PRGO,perrigo chairman ceo joseph papa say team be execute well grow market share manage supply chain deliver strong return bring innovative new product market continue make quality healthcare more affordable time consumer need save money more ever continue invest research development build pipeline future innovation well
2105,PRGO,company earning outlook full fiscal year stand share wall street have be hike fiscal year projection strong quarterly result current forecast share be last month
2106,PRGO,perrigo co prgo free report have be perform well market analyst have be boost forecast fiscal full year earning estimate be just past week company announce record fiscal fourth quarter result mid august
2107,PRGO,company description
2108,PRGO,perrigo be nation largest manufacturer store brand counter prescription pharmaceutical product manufacture store brand nutritional product store brand product be sell national regional supermarket drugstore mass merchandise chain own label compete nationally advertised brand company product include analgesic cough cold remedy antacid laxative feminine hygiene smoking cessation product vitamin nutritional supplement nutritional drink
2109,PRGO,recent event
2110,PRGO,company recently announce be dismiss patent infringement lawsuit earlier johnson johnson jnj mcneil unit try sue perrigo
2111,PRGO,prgo also recently acquire drug nutritional product maker jb laboratory cash prgo mentioned acquisition be expect add more annual sale
2112,PRGO,record result
2113,PRGO,company announce record fiscal fourth quarter result mid august company profit increase thank hike see demand consumer health care product
2114,PRGO,record net sale jump year year net income climb last year
2115,PRGO,management note be third consecutive quarter year year record sale earning add company also generate cash operation year
2116,PRGO,perrigo chairman ceo joseph papa say team be execute well grow market share manage supply chain deliver strong return bring innovative new product market continue make quality healthcare more affordable time consumer need save money more ever continue invest research development build pipeline future innovation well
2117,PRGO,higher estimate
2118,PRGO,company earning outlook full fiscal year stand share
2119,PRGO,wall street hike fiscal year projection strong quarterly result current forecast share be just past week
2120,PRGO,stock come roar back life today session market once again begin anticipate approval pending financial bailout plan dow finished point close
2121,PRGO,congress take day recognition rosh hashanah holiday reconvene tomorrow attempt hammer deal get rescue plan clear be pretty clear market be search direction proposal be square unusual volatility be expect segment market
2122,PRGO,federal deposit insurance corp fdic chairman sheila bair be process pitch proposal federal banking official raise limit federally insure deposit regular bank attempt shore public confidence banking system proposal be add term pending bailout deal approve function temporary basis
2123,PRGO,dollar find traction anticipation bailout approval euro post largest day decline greenback inception euro drop be also fuel france belgium orchestrate rescue distressed financial company dexia sa indication financial crisis cause hyper leverage be not just domestic issue
2124,PRGO,more lousy news come housing sector morning very negative read standard poor case shiller housing report city index show housing price be july july almost high water mark set summer city index show decline fourth consecutive month
2125,PRGO,zack elite portfoliosfocus list holding gain ground market rally portfolio advance be narrower broader market however slimmer gain follow yesterday performance focus list see loss be not large slide experience major average
2126,PRGO,yesterday perrigo co prgo free report manage move higher market see record drop unfortunately company be few portfolio decliner today however company be positive territory be add focus list remain strong fundamentally analyst be upbeat earning fiscal full year earning estimate be just past week
2127,PRGO,growth income portfoliooge energy corp oge declare dividend share today note be paid october shareowner record october oge offer dividend yield be industry average share oge close higher tuesday
2128,PRGO,take look senior market analyst charle rotblut cfa be suggest turbulent time
2129,PRGO,stock react violently rejection financial bailout cause widespread uncertainty volatility sector market dow plunge point largest day point drop ever close
2130,PRGO,long weekend negotiation partisan compromise financial rescue plan be reject congress vote today decision do not mean deal be dead table do require party involved negotiation process once again walk necessary step bring bill back vote
2131,PRGO,hour financial rescue bill be reject fed go ahead flooded global financial system additional liquidity attempt provide bank more cash order relax constricted credit market be tactic fed have be used past couple month be single largest injection point
2132,PRGO,pressure continue build financial sector citigroup inc free report biggest bank asset announce acquire banking operation corp wb be many large financial institution be suffering bad mortgage related bet
2133,PRGO,oil price drop news fail bailout shedding close barrel number global economy show sign slow gdp growth energy market be begin forecast weaker demand have be anticipate only month way much welcome development consumer have be pinch higher energy price
2134,PRGO,focus list
2135,PRGO,day see dow deliver largest day point plunge focus list be diversify enough keep loss smaller major average portfolio be day
2136,PRGO,freefall experience most stock perrigo co prgo free report end monday note gain major news
2137,PRGO,remain focus list holding decrease overall bearishness stock see double digit decline however be not go sell panic right now be stay put today assess unprecedented situation day day basis
2138,PRGO,perrigo co prgo free report analyst be steadily increase estimate drug company fuel latest earning surprise
2139,PRGO,company description
2140,PRGO,perrigo co make otc generic prescription drug nutritional product pharmaceutical ingredient other consumer product currently be biggest manufacturer store brand otc pharmaceutical operation be north america europe
2141,PRGO,revenue spike
2142,PRGO,nov report company announce first quarter result include revenue be year year net income come cent share
2143,PRGO,zack consensus estimate be cent make beat third consecutive earning surprise
2144,PRGO,estimate climb
2145,PRGO,follow announcement full year estimate jump zack consensus estimate next year be now
2146,PRGO,year project growth rate be solid additional next fiscal year
2147,PRGO,valuation
2148,PRGO,share prgo be trading great value share cost just time forward earning also peg ratio be time meaning project growth be price fairly company also maintain dividend cent year
2149,PRGO,chart
2150,PRGO,see gradual increase earning perrigo analyst have be raise full year estimate consistently past few year currently level be highest year
2151,PRGO,bill wilton be growth stock strategist zack com be also editor charge market beating zack growth trader service
2152,PRGO,last few week have find screening stock best relative price change effort determine stock be good not
2153,PRGO,course earning growth valuation be important stock be simply not respond go market something wrong very least just simply not ready move higher
2154,PRGO,ve talk kind stuff past investor best stock be one be perform best other word one be move higher
2155,PRGO,same here
2156,PRGO,stock move higher have tendency move even higher
2157,PRGO,stock ve be look recently be indeed one move higher especially good volume overall market volume have be kind weak
2158,PRGO,be move higher likely good reason be move higher else probably wouldn be
2159,PRGO,course doesn mean only look price change
2160,PRGO,include kind thing screening very interesting stock come
2161,PRGO,have just miss normal fundamental screening put radar screen thru other measure price performance example find be just kind company ve be look
2162,PRGO,once again ll also notice say relative price strength be period course virtually everything be go so screening absolute positive price change often time come result period just need most
2163,PRGO,also market be do nothing go want get pacesetter outperformer not laggard be go only rise tide be raise ship
2164,PRGO,so used relative price strength always put outperformer list good time bad
2165,PRGO,week screen look relative price change winner also have fundamental potentially make gain last continue future
2166,PRGO,screen start relative price change week relative price change week relative price change week
2167,PRGO,look stock be outperform last week week week project growth rate median growth rate
2168,PRGO,not only do want price be respond better market also want growth rate be better market well zack rank
2169,PRGO,only zack strong buy current price
2170,PRGO,have be trading minimum higher average day volume share
2171,PRGO,have enough volume allow easy trading
2172,PRGO,here be stock make thru week screen
2173,PRGO,nelnet inc nus free report nu skin enterprise inc prgo free report perrigo company tecd free report tech datum corp wpz william partner
2174,PRGO,be fundamentally strong stock be move outperform market
2175,PRGO,learn pick winning stock market test screen other build own strategy test be do research wizard click here learn more begin week free trial research wizard disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance
2176,PRGO,dreary day dow give first session week industrial fall steadily open afternoon selling hard bell blue chip index close friday close information be trickle washington regard term government bailout foreclosure prevention democrat have be push be agree lawmaker bush urge congress finalize historic plan investor unease bailout plan lead dollar slide oil spiking gold surge investor race get hard asset dollar continue close eur usd early last friday dollar be trading eur usd just driver be hope feel relief pump crude spiked fourth consecutive session contract next month delivery expire today rise much barrel eventually settle crude be trading mid just last week gold also roar back gain day close dollar continue get pummeled gold be climb flight quality wall street change drastically weekend goldman sachs gs free report morgan stanley ms free report converted bank hold company investment banking giant now be able open commercial bank bolster resource take deposit change give new hold company eligibility receive emergency aid fed focus list
2177,PRGO,focus list dip well monday bearish trading however portfolio loss be narrower decline produce major average
2178,PRGO,experience nice run last week perrigo co prgo free report be today biggest focus list decliner be major news healthcare company however monday drop be most likely reaction general market trend also profit take have occur last week stock outpaced other focus list holding gain
2179,PRGO,prgo remain positive territory be add portfolio strong fundamental be not signale removal focus list time
2180,PRGO,deletion
2181,PRGO,conversely be determine stop loss be execute gamestop corp gme free report therefore be delete focus list timely buy list stock have be pressure concern weak holiday shopping season fundamental remain strong however earning estimate be revise higher recent week
2182,PRGO,addition
2183,PRGO,update portfolio also come strong candidate addition
2184,PRGO,international inc sii be be add focus list sii provide complete range oilfield drill product service rig floor drill bit sizeable portion business be tie long term project eastern hemisphere historically have provide less volatile revenue stream international be also shareholder friendly company have raise dividend repurchase stock
2185,PRGO,sohu com inc sohu free report be be add focus list timely buy list sohu com be lead internet search engine web portal china company have be experience rapid growth revenue earning recent weakness chinese stock market have make share company bargain
2186,PRGO,renesola ltd sol free report be be add focus list timely buy list company manufacture solar wafer supply many major manufacturer solar cell module many other alternative energy company renesola have be profitable equally important company earning be project rise approximately next year share
2187,PRGO,perrigo company prgo free report be nation largest manufacturer store brand counter prescription pharmaceutical product manufacture store brand nutritional product store brand product be sell national regional supermarket
2188,PRGO,drugstore mass merchandise chain own label compete nationally advertised brand company
2189,PRGO,product include analgesic cough cold remedy antacid laxative feminine hygiene smoking cessation product
2190,PRGO,vitamin nutritional supplement nutritional drink
2191,PRGO,company recently announce acquire drug nutritional product maker jb laboratory cash prgo mentioned acquisition be expect add more annual sale
2192,PRGO,company announce record fiscal fourth quarter result mid august company profit increase thank hike see demand consumer health care product
2193,PRGO,record net sale jump year year net income climb last year
2194,PRGO,
2195,PRGO,management note be third consecutive quarter year year record sale earning add
2196,PRGO,company also generate cash operation year
2197,PRGO,perrigo chairman ceo joseph papa say team be execute well grow market share manage supply chain deliver strong return bring innovative new product market continue make quality healthcare more affordable time consumer need save money more ever continue invest research development build pipeline future innovation well
2198,PRGO,company earning outlook full fiscal year stand share wall street hike fiscal year projection strong quarterly result current forecast share be last month
2199,PRGO,perrigo company prgo free report manufacture distribute counter otc prescription pharmaceutical nutritional product consumer product be expand consumer switch more expensive brand name product cheaper item slow economy
2200,PRGO,prgo headquarter allegan mi have manufacturing logistic facility unite state israel unite kingdom mexico germany china
2201,PRGO,company be largest supplier brand product retailer perrigo supply product more category formula offer analgesic cough cold remedy feminine hygiene product well vitamin dietary supplement nutritional drink
2202,PRGO,product be manufacture compare national brand product such tylenol advil day example tylenol have acetaminophen active ingredient be available drug store
2203,PRGO,perrigo acetaminophen be locate right next national brand acetaminophen offer same active ingredient acetaminophen same relief store brand be market own label such walgreen wal mart perrigo expand michigan operation
2204,PRGO,july perrigo announce spend expand facility headquarters allegan mi company say expansion add approximately job next year
2205,PRGO,tough economic time perrigo continue help consumer provide quality affordable healthcare product say joseph papa perrigo president chairman ceo
2206,PRGO,see many new opportunity further reduce consumer healthcare cost many brand product exclusivity right expire soon allow develop additional high quality store brand version affordable price
2207,PRGO,state michigan be provide company worth tax credit year city allegan also intend approve real property tax abatement worth estimate perrigo report record sale third quarter
2208,PRGO,perrigo report third quarter earning beat wall street estimate cent share net income jump cent share cent share third quarter analyst expect cent share
2209,PRGO,sale climb record company launch largest product history omeprazole cetirizine quarter perrigo fundamental
2210,PRGO,perrigo zack rank strong buy have year average return equity roe forward be prgo have price book company also pay dividend current yield
2211,PRGO,prgo report fourth quarter earning aug
2212,PRGO,best perform stock zack rank list last week be perrigo company prgo free report coca cola femsa kof free report calgon carbon corporation ccc netflix inc nflx free report western digital corporation wdc free report perrigo company prgo free report raise earning share guidance full year feb make healthcare supplier top perform zack rank last week ep be now expect mark growth previous year prgo say new outlook reflect continue strong performance exist portfolio additional volume gain ongoing quality issue competitor earning estimate year end june be past session
2213,PRGO,perrigo raise guidance come strong fiscal second quarter report ep reach cent net sale earning result advanced easily previous year marked positive surprise almost consensus revenue jump prgo be also featured aggressive growth stock day zack com feb
2214,PRGO,coca cola femsa kof free report be top perform zack rank company last week gain more company be also highlighted momentum stock day zack com feb share bottler coca cola trademark beverage latin america go strong run recently break long standing trading range
2215,PRGO,kof report fourth quarter result feb third quarter company report earning share cent better consensus almost total revenue advanced
2216,PRGO,calgon carbon corporation ccc reach fresh week high last week also make top performer list gain earning estimate year end december moved forward approximately past session company provide service product solution purify water air have excellent record meeting surpass wall street quarterly earning expectation fact first quarters ccc have average ep surprise more
2217,PRGO,most recently report quarter ccc announce earning share cent reversed year loss top consensus much revenue advanced other recent news include contract huntsman textile effect co ltd supply wastewater treatment equipment service facility china
2218,PRGO,netflix inc nflx free report gain almost week end feb be enough put online movie rental service top perform zack rank list fourth quarter report company announce earning share surprise more revenue growth netflix have now better wall street quarterly expectation consecutive quarters average surprise more nflx gain customer quarter expect bring approximately more subscriber year
2219,PRGO,more recently nflx announce stock high def dvds exclusively blu ray format company have be stocking blu ray hd dvd now phase latter roughly year end decision be make major movie studio decide publish high def dvd title blu ray format western digital corporation wdc free report be not only top perform zack rank period end feb be also timely buy week zack com hard disk drive maker make list more gain share wdc be get help strong demand consumer gadget include notebook computer past month earning estimate year end june be approximately
2220,PRGO,fiscal second quarter western digital report earning share beat consensus almost easily surpass prior year performance revenue increase year year company also raise outlook third quarter
2221,PRGO,fuel system solution inc fsys just hit new week high surge short term level resistance big jump come heel big upgrade earning estimate current year add cent share next year estimate also add cent climb solid growth projection company have beat last quarters average
2222,PRGO,perrigo co prgo free report have also gain rise estimate share recently hit new week high current year estimate be cent last month next year estimate be cent growth projection
2223,PRGO,perrigo company prgo free report be global healthcare supplier develop manufacture distribute otc generic prescription rx pharmaceutical nutritional product active pharmaceutical ingredient api pharmaceutical medical diagnostic product company be world largest manufacturer otc pharmaceutical product store brand market perrigo primary market location manufacturing logistic operation be unite state israel mexico unite kingdom
2224,PRGO,company recently report record fiscal first quarter earning cent share top last year cent exceed zack consensus estimate cent revenue jump year year
2225,PRGO,management say perrigo deliver record earning quarter strong performance business segment cash flow operation continue be strong company generate record period be prepare cough cold flu season
2226,PRGO,company hike fiscal year guidance range share previous range
2227,PRGO,past month zack consensus estimate soar year end june follow year analyst poll zack be call earning share past month
2228,PRGO,share prgo soar record quarter outpace more past month
2229,PRGO,perrigo declare quarterly dividend share note be payable december shareholder record november dividend represent boost
2230,PRGO,perrigo pay industry lead dividend yield
2231,PRGO,company offer return equity roe surpass industry average perrigo net profit margin top industry average earning share be expect grow next year beating industry average
2232,PRGO,perrigo company prgo free report recently report record fiscal first quarter earning cent share top last year cent exceed zack consensus estimate cent revenue jump year year company hike fiscal year guidance range share previous range
2233,PRGO,company description
2234,PRGO,perrigo company be global healthcare supplier develop manufacture distribute otc generic prescription rx pharmaceutical nutritional product active pharmaceutical ingredient api pharmaceutical medical diagnostic product company be world largest manufacturer otc pharmaceutical product store brand market perrigo primary market location manufacturing logistic operation be unite state israel mexico unite kingdom
2235,PRGO,record result
2236,PRGO,company recently report record fiscal first quarter earning cent share top last year cent exceed zack consensus estimate cent revenue jump year year
2237,PRGO,management say perrigo deliver record earning quarter strong performance business segment cash flow operation continue be strong company generate record period be prepare cough cold flu season
2238,PRGO,bullish forecast
2239,PRGO,company hike fiscal year guidance range share previous range
2240,PRGO,past week zack consensus estimate soar year end june follow year analyst poll zack be call earning share past week
2241,PRGO,higher income
2242,PRGO,perrigo declare quarterly dividend share note be payable december shareholder record november dividend represent boost
2243,PRGO,perrigo pay industry lead dividend yield
2244,PRGO,lead industry
2245,PRGO,company offer return equity roe surpass industry average perrigo net profit margin top industry average earning share be expect grow next year beating industry average
2246,PRGO,stock see modest gain volatile day investor receive datum manufacturing housing
2247,PRGO,institute supply management factory index hit year high follow september economist be look read signal expansion meanwhile national association realtor report pending home sale be september eighth consecutive month advance result exceed expectation
2248,PRGO,monday dow climb point index rise point nasdaq picked point close
2249,PRGO,volatility be high major average trend repeat week several economic report schedule release week
2250,PRGO,focus list updatesdollar tree inc dltr free report gain impressive volatile market twice normal volume share dltr have be trend lower most last few week spiking higher today session
2251,PRGO,goldman sachs gs free report gain just fraction percent today continue trade great valuation share cost just time forward earning peg ratio be just time premier investment bank continue maintain zack rank
2252,PRGO,perrigo company prgo free report just report record earning cent fiscal first quarter result top last year cent exceed zack consensus estimate cent first quarter revenue jump year year company hike fiscal year guidance range share previous range
2253,PRGO,jda software jdas rise heavy volume news company be zack rank hold stock haemonetic hae free report gain report fiscal second quarter result see revenue rise compare second quarter fiscal year date revenue be same period fiscal earning share be cent
2254,PRGO,plasma disposable boost quarter revenue rise segment haemonetic reaffirm full year ep guidance range revenue growth mednax inc md free report deliver record quarter include earning share result surpass previous year cent eclipse zack consensus estimate cent revenue be year year
2255,PRGO,growth income updatestjx cox inc tjx free report gain retailer await monthly sale figure thursday estimate be average increase compare decline october last year
2256,PRGO,buckeye partner ltd bpl free report close marginal loss day report better expect third quarter result bell earning come cent share cent ahead zack consensus estimate revenue decline
2257,PRGO,investor be buy mode thursday respond gdp read come expectation get detail third quarter gdp read analyst blog title gdp note depth contribution gdp growth
2258,PRGO,other economic news include dip initial unemployment claim learn more analyst blog title continue jobless claim fall
2259,PRGO,dow spiked point best day dow july jump point nasdaq advanced point
2260,PRGO,focus list updatesdresser rand group drc rally today ahead third quarter earning announcement oct zack rank hold stock have surprised last quarters zack consensus estimate third quarter have be hold cent last day fuel system solution fsys surge today new development excellent day come rise crude strong gdp number just make yesterday debacle company be set announce quarterly result next week
2261,PRGO,schweitzer mauduit international inc swm free report gain solid market regain loss earlier week maker paper product tobacco industry be set report third quarter result next week nov zack consensus estimate be look earning cent share
2262,PRGO,netflix inc nflx free report also post solid gain strong market add day estimate be company recent better expect third quarter result current year add cent now stand share next year estimate be bullish peg growth projection
2263,PRGO,perrigo company prgo free report declare quarterly dividend share note be payable december shareholder record november dividend represent boost previous dividend share
2264,PRGO,growth income updateslubrizol lz report third quarter earning share include cent charge company have already preannounce preliminary earning revenue fall year period volume continue be weak cost saving initiative discipline margin management boost result
2265,PRGO,company also raise full year earning forecast range exclude charge zack consensus estimate currently call share company be also bullish anticipate year earning growth kellog free report beat zack consensus estimate announce earning share cent additionally company raise full year expectation now see growth earning share
2266,PRGO,strayer education inc stra free report deliver record third quarter earning share top year prior cent outpaced zack consensus estimate revenue totale increase year year fall enrollment jump
2267,PRGO,company note expect full year earning come share analyst poll zack respond hike forecast
2268,PRGO,strayer also announce annual dividend increase share declare quarterly dividend cent dividend be payable december shareholder record november
2269,PRGO,perrigo co prgo free report be just add focus list company be head quarterly report come record financial result
2270,PRGO,company description
2271,PRGO,perrigo co make otc generic prescription drug nutritional product pharmaceutical ingredient other consumer product currently be biggest manufacturer store brand otc pharmaceutical operation be north america europe
2272,PRGO,upcoming report
2273,PRGO,perrigo announce release first quarter result fiscal nov open bell last quarter company report record level sale earning cash flow operation
2274,PRGO,past month zack consensus estimate have be climb upward revision past month average forecast be cent past quarter next year consensus be
2275,PRGO,meet level produce year year growth rate respectively
2276,PRGO,valuation
2277,PRGO,share prgo be trading decent valuation time forward earning stock also have peg ratio time perrigo be top rate company industry generate roe more net profit margin just
2278,PRGO,generic rogaine
2279,PRGO,perrigo announce have file generic formula man rogaine be sell counter sale rogaine be estimate annually
2280,PRGO,chart
2281,PRGO,share prgo be trading time high see estimate be higher ever
2282,PRGO,dow close today first time last october investor receive upbeat earning news
2283,PRGO,financial soar jpmorgan chase company jpm report better expect result read full story jpm check analyst blog title jpmorgan beat profit surge
2284,PRGO,techs also jump strong earning intel corp intc intel story read analyst blog title intel look strong ever
2285,PRGO,dow gain totale point close blue chip index widest advance aug highest close oct last year
2286,PRGO,index climb point nasdaq picked point close
2287,PRGO,retail number come today commerce department announce retailer see sale climb last month exclude motor vehicle part take look analyst blog title retailer register be ring whole story include zack industry rank analysis video charle rotblut cfa senior market analyst zack com
2288,PRGO,oil see nice bounce weaker dollar again crude spiked settle barrel new york mercantile exchange
2289,PRGO,focus list updatesambev abv trade market today set week high quarterly estimate be hold steady cent head nov earning report
2290,PRGO,cgi group inc gib free report post impressive gain market hit new week high technology continue be hot cisco csco acquisition wireless software developer starent network estimate meanwhile have hold steady current year sit tight cent share
2291,PRGO,netflix inc nflx free report rally market close day pressure key short term level resistance just have keep share contain mid july move level place week time high just striking distance
2292,PRGO,focus list inc blk free report be add portfolio today close company operate investment bank have market cap financial sector economy general rebound last month estimate blk have be surge current year have add cent last month climb share next year estimate be cent bullish growth projection blackrock have also be produce steady earning last month have beaten match zack consensus estimate last quarters
2293,PRGO,invacare corporation ivc free report be add focus list close today company make acute home health care related medical product share be trading just time forward earning continue see upward estimate revision follow company earning surprise last quarter steady growth projection solid earning history make invacare great focus list addition
2294,PRGO,perrigo company prgo free report be add focus list close today perrigo manufacture counter prescription pharmaceutical nutritional product other consumer product august company report record sale fiscal revenue rise consumer flocked cheaper store brand product recession perrigo be grow have peg ratio just company be zack rank strong buy stock
2295,PRGO,growth income updatest rowe price group inc trow be biggest gainer today portfolio gain overall strength financial expect more gain go forward
2296,PRGO,baxter international inc bax free report slip today ahead report thursday morning stock be positive portfolio be watch closely continue anticipate advance go forward
2297,PRGO,perrigo company prgo free report have surprised estimate last quarters report record sale fiscal prgo have peg ratio just company description
2298,PRGO,perrigo manufacture counter prescription pharmaceutical nutritional product other consumer product also provide counter otc product various store store brand name instance manufacture acetaminophen product similar tylenol brand record sale
2299,PRGO,aug perrigo report fiscal fourth quarter full year result see record sale earning year be first year company report sale be rise be also second year row record sale increase be drive new product sale
2300,PRGO,fourth quarter sale grow fourth quarter best perform sector be consumer healthcare segment rise rx pharmaceutical segment climb year year
2301,PRGO,earning share fourth quarter jump cent cent year period also beat zack consensus estimate cent growth expect continue fiscal
2302,PRGO,perrigo be bullish fiscal forecasting year year earning share growth expect earning share
2303,PRGO,analyst expect earning growth fiscal zack consensus estimate have rise last month be higher end company guidance range cover analyst raise time period
2304,PRGO,perrigo be expect report first quarter earning nov income
2305,PRGO,shareholder be currently be reward dividend yielding be well industry average be actually fundamental
2306,PRGO,perrigo be zack rank strong buy stock have forward company also have stellar year return equity
2307,PRGO,perrigo co prgo free report have return equity roe more double industry average company earning share be expect grow next year industry average expectation stand
2308,PRGO,company description
2309,PRGO,perrigo be nation largest manufacturer store brand counter prescription pharmaceutical product manufacture store brand nutritional product store brand product be sell national regional supermarket drugstore mass merchandise chain own label compete nationally advertised brand company product include analgesic cough cold remedy antacid laxative feminine hygiene smoking cessation product vitamin nutritional supplement nutritional drink
2310,PRGO,recent event
2311,PRGO,company recently announce receive final approval food drug administration abbreviated new drug application anda counter otc ibuprofen diphenhydramine citrate tablet perrigo say expect begin product shipment retailer first quarter calendar year
2312,PRGO,record result
2313,PRGO,early november company announce record fiscal first quarter adjust earning cent share beatin previous year cent net sale jump year year
2314,PRGO,perrigo chairman ceo joseph papa state fiscal be strong start have anticipate first quarter achieve record sale record earning new product contribute top line growth past quarter counter otc category grow more versus first quarter last year same period store brand grow nearly believe store brand offering continue perform well consumer realize value perrigo product offer challenge economy
2315,PRGO,street estimate
2316,PRGO,analyst earning forecast year end june have hold steady share follow year projection share be past month
2317,PRGO,industry lead fundamental
2318,PRGO,perrigo have return equity roe more double industry average company earning share be expect grow next year industry average expectation stand
2319,PRGO,perrigo company prgo free report
2320,PRGO,company description
2321,PRGO,perrigo be nation largest manufacturer store brand counter pharmaceutical product also manufacture store brand nutritional product store brand product be sell national regional supermarket drugstore mass merchandise chain own label compete nationally advertised brand
2322,PRGO,company product include analgesic cough cold remedy antacid laxative feminine hygiene smoking cessation product vitamin nutritional supplement nutritional drink
2323,PRGO,raise guidance
2324,PRGO,perrigo announce first quarter fiscal earning result nov first quarter revenue rise year year management increase fiscal earning guidance expect earning year be now
2325,PRGO,earning share come cent increase cent last year however analyst be expect cent make second consecutive negative surprise
2326,PRGO,tentative fda approval
2327,PRGO,oct perrigo announce tentative approval fda counter ibuprofen diphenhydramine citrate tablet pill be sell store brand be similar advil pm
2328,PRGO,read oct feature herelast week aggressive growth zack rank buy stocksallegiant travel co algt have report fantastic third quarter stock be climb estimate be dramatically point growth next year
2329,PRGO,read full article varian medical system inc var just report earning surprise increase revenue company also release newest technology cancer treatment
2330,PRGO,read full article itt educational service inc esi report excellent third quarter result oct stock price consensus estimate be rise
2331,PRGO,read full article stantec inc stn be expand active mining sector current growth rate be very strong company present solid value well
2332,PRGO,read full article
2333,PRGO,market open rally news chinese stimulus package quickly turn lower concern economy especially light government give american international group aig free report more money part rescue package share general motor corp gm plunge lowest level see more year
2334,PRGO,investor interpreted news china stimulus package reassure sign global level however most market participant do not see chinese stimulus have significant impact domestic economic wo
2335,PRGO,stock close lows remain mostly red major average turn loss day dow jone industrial average close point lower standard poor index lose point close nasdaq dip point
2336,PRGO,receive initial bailout package government september aig receive more assistance government today bring total aid package share aig advanced news however most financial tumble development translate more anxiety wall street
2337,PRGO,share gm slide monday couple analyst issue bearish forecast automaker year next cite concern company burn cash
2338,PRGO,also news be circuit city cc bankruptcy protection filing electronic retailer have see tough time consumer cut back spending credit become tighter cc end monday session decline
2339,PRGO,oil stage marginal advance see mostly week last week barrel light sweet crude be settle new york mercantile exchange
2340,PRGO,zack elite portfolio
2341,PRGO,most stock see red today focus list deliver gain
2342,PRGO,perrigo co prgo free report be monday biggest winner soar nearly major development
2343,PRGO,growth income portfolio end monday session red be still ahead broader market
2344,PRGO,make news portfolio be mcdonald corp mcd free report climb almost upbeat october sale
2345,PRGO,company global same store sale jump sale be particularly robust europe asia africa middle east result be solid well domestic same store sale increase thank new menu item southern style chicken sandwich continue demand breakfast item popular dollar menu item
2346,PRGO,profit forecast continue be cut large number positive revision have be cut ratio be roughly same sample group be larger zack rank universe contain stock
2347,PRGO,be also quite bit difference analyst be forecasting last night calculate project earning growth base lowest consensus highest estimate here be result base bottom calculation
2348,PRGO,lowest estimate
2349,PRGO,consensus estimate
2350,PRGO,highest estimate
2351,PRGO,bottom estimate be calculate used individual earning estimate company then apply index weight lowest estimate used lowest profit forecast company highest estimate used highest forecast company
2352,PRGO,be possible highest forecast be close day old meaning analyst have yet adjust credit crunch
2353,PRGO,top forecast be consensus estimate make whole show tighter range
2354,PRGO,lowest estimate
2355,PRGO,consensus estimate
2356,PRGO,highest estimate
2357,PRGO,have say previously profit forecast need be take grain salt brokerage analyst be do best make educate guess assumption used model end be very wrong not analyst fault rather just current reality
2358,PRGO,credit market
2359,PRGO,credit freeze be continue show sign thaw positive
2360,PRGO,month london interbank offer rate aka libor be friday morning height credit crunch rate have reach rate be used basis many loan term include interest rate credit card
2361,PRGO,ted spread be difference libor rate month treasury bill rate have also narrow friday spread be well recent peak
2362,PRGO,higher ted spread imply greater credit risk prior current credit crunch ted spread be
2363,PRGO,election portfolio
2364,PRGO,campaign president elect obama say healthcare be top priority focus list presently have heavy weighting medical sector want address not concern
2365,PRGO,healthcare be major battle be too many player high power lobbyist allow true change occur fight
2366,PRGO,furthermore even move national health care much exist system be keep place switzerland have universal coverage powerful insurance pharmaceutical company
2367,PRGO,other word expect most company medical sector remain profitable long president elect obama leave white house say monitor progress make change portfolio legislation dictate
2368,PRGO,market
2369,PRGO,volatility be still big trading range post election pullback occure dow be just resistance overbought short term basis
2370,PRGO,be big rally head election so sell news reaction be not surprising
2371,PRGO,monthly column sfo magazine web site describe dow range see intraday swing slightly outside number think close approximation
2372,PRGO,be big range dow start see more day double digit move opposed triple digit move then investor confidence be more fully restore
2373,PRGO,here weekly chart nothing much have change last week
2374,PRGO,volatility remain exceptionally high even vix record high
2375,PRGO,focus list
2376,PRGO,do not make change week be few company be look closely target be add company week
2377,PRGO,perrigo prgo free report earning be penny expectation guidance seem be okay re look estimate revision come
2378,PRGO,mcdonald mcd free report say stronger dollar hurt fourth quarter earning do think company benefit more frugal consumer however re go monitor estimate revision
2379,PRGO,charle rotblut cfa be senior market analyst zack com
2380,PRGO,perrigo co prgo free report recently announce have receive final approval fda sell generic version mcneil consumer healthcare zyrtec allergy medicine counter early december zack rank strong buy company state fda grant final approval partner dexcel pharma technology ltd counter generic heartburn drug tablet company guidance wall street estimate advanced higher news heartburn drug prgo share start reach week high current share price trading slightly week high perrigo roe sit industry average
2381,PRGO,full analysis
2382,PRGO,perrigo company be lead global healthcare supplier develop manufacture distribute counter otc prescription pharmaceutical nutritional product active pharmaceutical ingredient api consumer product company be world largest manufacturer otc pharmaceutical product store brand market company primary market location manufacturing facility be unite state israel mexico unite kingdom
2383,PRGO,company recently announce have receive final approval food drug administration abbreviated new drug application anda counter otc cetirizine hydrochloride tablet mg perrigo note product be market store brand label be comparable mcneil consumer healthcare cetirizine hydrochloride tablet mg be market zyrtec tablet indicated allergy hive relief
2384,PRGO,early december zack rank strong buy company state food drug administration fda have grant final approval dexcel pharma technology ltd mg omeprazole delay release tablet exclusive marketer distributor product store brand counter otc market unite state perrigo expect begin shipping product first quarter calendar year full year annual sale be range
2385,PRGO,prgo note due omeprazole launch full year earning fiscal year be now expect be range share wall street lift forecast match new outlook year end june cover analyst increase estimate last month share month consensus estimate be
2386,PRGO,analyst also up projection follow year share last month most accurate earning expectation year end june be currently company earning share expect grow next year industry average stand
2387,PRGO,perrigo share price have be advance quite nicely omeprazole launch increase earning forecast hit week high late december company share be currently trading just slightly week high
2388,PRGO,dividend yield prgo be be better industry average company roe be industry average
2389,PRGO,wall street be batter second session row jitter additional gloomy economic news send stock tumble largest day session loss
2390,PRGO,dow fall point nasdaq decline point fall point have now lose half rally begin oct hit year low
2391,PRGO,even aggressive rate cut several european bank weren enough appease investor european central bank cut half point second cut recent week ecb president jean claude trichet say be more reduction come central bank denmark follow ecb lead cut point
2392,PRGO,bank england cut surprising point largest single reduction be grant independence swiss national bank emergency action cut half point
2393,PRGO,retail sector report october sale today be even lower expectation only bright spot be wal mart wmt discount giant see sale actually rise estimate expect november same store sale be
2394,PRGO,retailer discretionary apparel segment be hit hard target tgt be heavier apparel wal mart see sale fall
2395,PRGO,initial jobless claim last week be slightly higher analyst expectation however number person receive unemployment rise highest level tomorrow labor department high anticipate october employment report be release
2396,PRGO,job cut announcement accelerate citigroup fall new multus year low report be layer additional worker next month mattel mat announce job cut worldwide
2397,PRGO,crude continue slide demand worry fall settle month low crude price be july crude hit record high barrel zack elite portfolio
2398,PRGO,focus list perform well broader market today bearishness portfolio be day
2399,PRGO,perrigo co prgo free report report record result today fiscal first quarter company net sale total represent year year increase net income jump same time period
2400,PRGO,company note achieve record sale record earning new product contribute top line growth chairman ceo joseph papa say past quarter counter otc category grow more versus first quarter last year same period store brand grow nearly believe store brand offering continue perform well consumer realize value perrigo product offer challenge economy
2401,PRGO,couple day prgo boost quarterly dividend half penny share company state dividend be payable dec shareholder record nov
2402,PRGO,mcdonald corp mcd free report announce expect revenue operate income be hurt foreign currency translation current fourth quarter due fact dollar have gain strength
2403,PRGO,mcd be currently most profitable focus list hold ll be watch closely become necessary remove lock gain light development however be not yet rush judgment
2404,PRGO,growth income portfolio also fared well market lose today
2405,PRGO,stock stage large election day rally credit concern ease libor rate fall straight session dow gain point finish nasdaq climb point close
2406,PRGO,commodity lead charge dollar be crushed largest day decline euro euro debut dollar fall euro
2407,PRGO,dollar weakness gsci index commodity spiked largest gain august reuter jeffry crb index surge second largest gain
2408,PRGO,crude lead commodity charge gain natural gas also jump british thermal unit concern likelihood fall temperature winter inventory
2409,PRGO,metal complex get action gold jump silver gain cent zack elite portfolio
2410,PRGO,focus list lag market tuesday turn gain
2411,PRGO,be slow news day focus list stock however perrigo co prgo free report do announce dividend increase new quarterly dividend share be bump half penny prgo note dividend be payable dec shareholder record nov
2412,PRGO,growth income portfolio advanced day
2413,PRGO,other general dynamic corp gd free report announce couple contract be little news report growth income holding
2414,PRGO,contract be deal navy communication network link sea land program
2415,PRGO,other be infrastructure design engineering architecture integration ideai contract patent trademark office uspto contract be award general dynamic information technology unit
2416,PRGO,have hold add stock portfolio ahead election result due post election uncertainty depend market react be new president intend beef portfolio more holding
2417,PRGO,ambev abv just hit new week high jump short term level resistance push month gain stock share abv have be lock very trend higher most last month bottom overall market march just macd signal momentum indicator be reinforce trend short term move average trading ahead long term counterpart take look
2418,PRGO,perrigo company prgo free report recently rebound long term trend line just surge past short term level resistance hit new week high also have strong macd signal here short term move average recently turn higher take look
2419,PRGO,stock be wednesday lead financial bank executive testify part financial meltdown
2420,PRGO,also help put gain be fed beige book report paint somewhat more upbeat picture economy do report last month get detail report read beige book better analyst blog
2421,PRGO,dow advanced point rise point nasdaq gain point close
2422,PRGO,crude dip supply increase settle barrel new york mercantile exchange gold climb ounce dollar be most other major currency
2423,PRGO,focus list updatesnetflix inc nflx free report announce morning have strike deal nintendo stream online video gaming company wii platform netflix already have deal stream online video content microsoft xbox live new channel make easier company distribute grow digital catalogue share nflx close day
2424,PRGO,conagra cag free report hit new week high today news stock gain session conagra be zack rank buy stock correction corporation america cxw free report announce contract award cibola county correction center milan new mexico correction corporation america continue manage roughly prisoner cibola county correction center cxw say contract have anticipate effective date october have initial year term year renewal option largest prison operator also announce contract manage prisoner california city correctional center be not renew expire september
2425,PRGO,dr pepper snapple dps rise light trading share be recently lower zack rank hold estimate be split past day so be debate delete position beverage company have be quite stable find better gain somewhere else keep post
2426,PRGO,steven madden shoo free report be upgrade zack rank today estimate have be trickle past month be positive share be today session
2427,PRGO,growth income updateslubrizol lz have resume strong upward momentum break hit new week high be several month lubrizol attempt set new high company be expect report earning feb have be preannounce early so investor be anticipate check month chart buckeye partner lp bpl free report drop day pull back recent week high crude dip mark first time week estimate be hold elevated territory current year next year estimate project growth
2428,PRGO,perrigo co prgo free report continue surge hit new week high close day be major development trading volume be average
2429,PRGO,tuesday pessimistic sentiment be response alcoa aa disappointing report show earning revenue be expectation china move slow growth possibility government tax bank receive bailout
2430,PRGO,share aa be release company report post monday close bell market find result be discourage indicator first big company report often be consider sign overall corporate earning
2431,PRGO,also weigh alcoa other raw material producer well overall market be china tighten monetary policy country want contain growth translate slower recovery other country adversely impact company sell china
2432,PRGO,financial take hit news government tax bank learn more move read analyst blog title obama mull bailout tax bank
2433,PRGO,tuesday dow slip point nasdaq give point close
2434,PRGO,decline point index be first day year first time
2435,PRGO,focus list group rhb pull back recent week high drop day surge last few day come response share breaking short term level resistance just have develop last few week
2436,PRGO,western digital corp wdc free report also drop weak market fall day hit new week high last week see slight upward movement estimate week current year add cent next year estimate be also cent peg growth projection
2437,PRGO,china green get pummeled china government send signal be lookout runaway growth economy selling higher yield bond raise reserve requirement bank country have not hide fact be worry inflation speculative bubble today hit home investor today loss be also exacerbate profit take estimate remain unchanged be company specific news here far be concern be still mouth feed global community be push green movement
2438,PRGO,china auto caas free report be
2439,PRGO,enterprise product partner lp epd free report announce increase quarterly cash distribution rate paid partner cent cent common unit unit annualize basis
2440,PRGO,perrigo co prgo free report have be surge lately climb share earlier hit week high have be major news prgo
2441,PRGO,growth income updatesibm ibm free report gain company news however fame value investor bill miller legg mason trust be cnbc morning talk stock excellent value play comment not be surprise ve discuss company strong fundamental repeatedly elite stock day article commentary last add growth income portfolio coach coh gain session sympathy tif free report report strong holiday season raise full year guidance luxury retailer be gain momentum business appear be strengthen coach be expect report earning jan
2442,PRGO,perrigo company prgo free report be sector investor have be flock market downturn health care
2443,PRGO,company zack rank strong buy manufacture distribute counter otc prescription pharmaceutical nutritional product consumer product be expand consumer switch more expensive brand name product cheaper item slow economy
2444,PRGO,perrigo be largest supplier brand product retailer supply product more category formula offer analgesic cough cold remedy feminine hygiene product well vitamin dietary supplement nutritional drink perrigo get tentative approval ibuprofen pm
2445,PRGO,perrigo continue invest new generic product oct prgo announce receive tentative approval fda counter ibuprofen diphenhydramine citrate tablet mg be pain reliever nighttime sleep aid
2446,PRGO,company estimate brand sale product prior month end be perrigo be value stock
2447,PRGO,analyst continue be bullish perrigo future year year growth be expect be
2448,PRGO,full year estimate be cent last day estimate first quarter be cent cent last day
2449,PRGO,perrigo have forward price book be prgo have stellar year return equity roe
2450,PRGO,company have surprised earning quarters average report first quarter earning nov
2451,PRGO,texas instrument inc txn free report be expect earn share accord zack consensus estimate mark year year profit growth nearly
2452,PRGO,response mid quarter update dec earning estimate have moved forward past day zack consensus estimate have advanced respectively update texas instrument raise fourth quarter earning share guidance cent cent compare prior range cent cent revenue be now expect instead
2453,PRGO,zack consensus estimate fourth quarter stand cent cent day
2454,PRGO,third quarter texas instrument beat fourth straight positive surprise
2455,PRGO,generic drug developer perrigo company prgo free report find sweet spot health care be big news country even health care reform isn comprehensive hope industry be good position person search lower cost alternative
2456,PRGO,perrigo have put together consecutive quarters better expect ep most recently fiscal first quarter end september company surpass zack consensus estimate nearly
2457,PRGO,perrigo fiscal year end june year end june zack consensus estimate be share month likewise zack consensus estimate fiscal year end june have advanced month suggest year year profit growth next fiscal year fiscal year
2458,PRGO,here be top fastest grow stock focus list company ticker ep gr current year ep gr curr next yrwestern digital wdc texas instrs txn free report blackrock inc blk rehabcare group rhb mc cop fcx dollar tree inc dltr perrigo company prgo free report cantel med corp cmn scott mircl gr smg apple inc aapl
2459,PRGO,almost family inc afam be relatively new focus list be portfolio top performer straight week make rd consecutive appearance top
2460,PRGO,company recently announce forbe rank forbe list best small company america advance afam ranking
2461,PRGO,almost family also recently deliver record second quarter earning share cent jump ahead previous year cent exceed consensus estimate
2462,PRGO,net service revenue grow year prior
2463,PRGO,company announce release result third quarter nov
2464,PRGO,bristol myer squibb co bmy free report perrigo co prgo free report psychiatric solution inc psys continue outperform show top focus list performer second straight week
2465,PRGO,colgate palmolive cl free report strong performance week arrived heel favorable third quarter report company see earning growth prior year worldwide sale jump year year
2466,PRGO,company ticker weekreturn
2467,PRGO,almost family afam
2468,PRGO,bristol myr sqb bmy free report
2469,PRGO,perrigo company prgo free report
2470,PRGO,colgate palmoli cl free report
2471,PRGO,psychiatric sol psys
2472,PRGO,perrigo company prgo free report be sector investor have be flock market downturn health care
2473,PRGO,company zack rank strong buy manufacture distribute counter otc prescription pharmaceutical nutritional product consumer product be expand consumer switch more expensive brand name product cheaper item slow economy
2474,PRGO,perrigo be largest supplier brand product retailer supply product more category formula offer analgesic cough cold remedy feminine hygiene product well vitamin dietary supplement nutritional drink perrigo get tentative approval ibuprofen pm
2475,PRGO,perrigo continue invest new generic product oct prgo announce receive tentative approval fda counter ibuprofen diphenhydramine citrate tablet mg be pain reliever nighttime sleep aid
2476,PRGO,company estimate brand sale product prior month end be perrigo be value stock
2477,PRGO,analyst continue be bullish perrigo future year year growth be expect be
2478,PRGO,full year estimate be cent last day estimate first quarter be cent cent last day
2479,PRGO,perrigo have forward price book be prgo have stellar year return equity roe
2480,PRGO,company have surprised earning quarters average report first quarter earning nov
2481,PRGO,volatility continue stock fed rate cut throw market disarray last hour session dow close point finish
2482,PRGO,biggest story day be fed announcement once again cut key fed fund lend rate time half point benchmark rate now stand level not see cut be attempt fed unlock tightly wound credit market facilitate more lend commercial institution
2483,PRGO,fed also release statement say intensification financial market turmoil be likely exert additional restraint spending partly further reduce ability household business obtain credit
2484,PRGO,not surprisingly effect rate cut quickly reverberate different segment market
2485,PRGO,dollar logged biggest day trading lower number international currency include euro be greenback dollar also fall japanese yen
2486,PRGO,crude other hand have much more intense reaction news rally close barrel reduce lend rate drive value dollar lower investor frequently seek shelter hard asset inflationary hedge oil have be popular destination folk last few year
2487,PRGO,finally bright side commerce department report morning order durable good rise last month ahead analyst estimate biggest month gain june zack elite portfolio
2488,PRGO,focus list outpaced today broader market gain be major news release portfolio holding follow be note worthy
2489,PRGO,colgate palmolive co cl free report be set report third quarter result tomorrow market open
2490,PRGO,perrigo co prgo free report announce today receive tentative approval fda food drug administration abbreviated new drug application counter ibuprofen diphenhydramine citrate tablet mg national brand exclusivity end prior end calendar year
2491,PRGO,prgo note estimate brand sale product last month end september be
2492,PRGO,growth income portfolio be today be ahead dow slightly nasdaq advance major development be announce growth income holding
2493,PRGO,highlighted stock include perrigo co prgo free report abbott laboratory harris corp hrs csx corp csx sherwin william co shw
2494,PRGO,perrigo co prgo free report be see upward estimate revision ahead fiscal first quarter report analyst be forecasting earning share year end june last month analyst be project wall street expectation company first quarter earning be cent share versus last month cent
2495,PRGO,company offer return equity roe more double industry average perrigo earning share be expect grow next year beating industry average company be yielding industry offer income
2496,PRGO,prgo announce record fiscal fourth quarter result mid august company profit increase thank hike see demand consumer health care product
2497,PRGO,prgo be schedule release fiscal first quarter result nov
2498,PRGO,read oct analysis last week growth income zack rank buy stocksabbott laboratory recently post strong result third quarter earning share cent surpass year prior cent exceed consensus estimate worldwide sale jump year year basis company hike full year guidance analyst follow suit read full analysis harris corp hrs boast excellent track record beating analyst estimate company miss consensus earning expectation penny last quarter turn only other miss past year hrs be schedule report fiscal first quarter result october read full analysis hrs csx corp csx recently post record third quarter result note resilient business portfolio discipline operation continue generate substantial earning growth company offer dividend yield be line industry average read full analysis csx sherwin william co shw recently post third quarter earning share exceed consensus estimate sale climb record company hike full year earning guidance analyst follow suit boost forecast just past week read full analysis shw
2499,PRGO,perrigo company prgo free report report third straight quarter record year year sale earning august sale rise compare fiscal company generate cash flow
2500,PRGO,analyst continue be bullish perrigo future year year growth be expect be full year estimate be cent last day estimate first quarter be penny cent last month
2501,PRGO,perrigo have forward price book be have stellar year return equity roe
2502,PRGO,company have surprised earning quarters average report first quarter earning nov
2503,PRGO,perrigo co prgo free report have see consensus earning estimate rise company approach first quarter earning announcement fiscal nov
2504,PRGO,current consensus estimate full year be estimate be average just few week current quarter estimate have also rise marginally cent cent same time period include latest past day
2505,PRGO,estimate creep announcement loom be very bullish sign company be look turn thing narrowly miss estimate last quarter
2506,PRGO,perrigo have announce positive surprise prior cent miss last quarter
2507,PRGO,current projection ep growth be be fairly price peg ratio perrigo year growth rate be strong easily outpace industry average just
2508,PRGO,company ticker ep gr current year ep gr curr next yr mcdonald corp mcd psychiatric sol psys healthspr hs almost family afam perrigo company prgo free report
2509,PRGO,dow flirted positive territory twice ultimately selling close unable overcome several gloomy earning announcement blue chip index give point day close broader market suffer same fate finished nasdaq slide
2510,PRGO,fed announce provide half ease pressure money market fund cause surge redemption fall lehman brother trigger fear money fail institution not be re-cover send weary investor get asset plan hopefully alleviate bank run exacerbate ongoing credit crisis
2511,PRGO,texas instrument txn free report meet analyst expectation earning give bearish outlook future company forecast lower order result quarterly earning cent share announcement consensus estimate be cent next quarter semiconductor giant also say plan further reduce inventory expense capital spending
2512,PRGO,preliminary announcement sun microsystem java warn first quarter loss cent share stock be crushed analyst be expect gain cent
2513,PRGO,tracinda corp run billionaire kirk kerkorian divest nearly stake ford motor co free report watch investment slide roughly news cause struggle automaker slide day ford remain confident current strategy turn company
2514,PRGO,positive note libor overnight loan loosen basis point rate bank loan other be indicator thaw credit market be now fed target first time nearly week
2515,PRGO,precious metal finished mixed silver gain settle gold drop just nearly settle
2516,PRGO,crude pull back settle barrel
2517,PRGO,zack special coverageclick here take look part part video special coverage segment customer receive answer common question
2518,PRGO,zack elite portfolio
2519,PRGO,focus list be pretty much line dow tuesday post loss versus dow drop however portfolio outpaced nasdaq
2520,PRGO,lockheed martin corporation lmt free report report third quarter result today earning share top consensus estimate exceed year prior result however lmt provide soft outlook
2521,PRGO,share lmt respond selloff determine be best remove company focus list wednesday
2522,PRGO,also focus list news perrigo co prgo free report be upgrade zack rank buy zack rank strong buy
2523,PRGO,focus list company soon report be follow
2524,PRGO,bristol myer squibb co bmy free report be schedule report oct
2525,PRGO,kimberly clark corporation kmb free report report oct
2526,PRGO,mcdonald corp mcd free report announce quarterly result oct
2527,PRGO,air brake technology corp wab free report be slate report oct
2528,PRGO,growth income portfolio decline day
2529,PRGO,portfolio holding be schedule report week mcd date be reference computer program system inc cpsi free report be schedule announce oct
2530,PRGO,have narrow shopping list growth income candidate handful stock be be strongly consider addition week couple company be post quarterly result week be wait report add stock
2531,PRGO,healthspr inc hs recent addition turn best performance focus list portfolio past week company operate manage care organization unite state focus primarily medicare hs own operate medicare advantage plan alabama florida illinois mississippi tennessee texas company also offer national stand alone medicare prescription drug plan consensus estimate full year have climb share past day full year estimate be also rise nearly same period time healthspr third quarter report be schedule release october healthcare playerperrigo co prgo free report repeat appearance list focus list top performer third straight week wall street have be hike fiscal year earning projection prgo strong quarterly result current forecast share be last month prgo announce record fiscal fourth quarter result mid august company profit increase thank hike see demand consumer health care product company plan report first quarter november week outperformance lockheed martin corporation lmt free report come top focus list outperformer second straight week full year consensus forecast share edge penny just past week lmt be schedule report october company ticker weekreturn
2532,PRGO,healthspr hs
2533,PRGO,perrigo company prgo free report
2534,PRGO,kimberly clark kmb
2535,PRGO,lockheed martin lmt free report
2536,PRGO,psychiatric sol psys
2537,PRGO,friday capped week wild swing react several economic report continue economic uncertainty friday report news story lead modest loss however week wall street see gain first time week
2538,PRGO,dow jone industrial average decline point standard poor index slip point nasdaq fall point
2539,PRGO,different datum release friday be not rosy side however optimism be infuse market bank bank loan rate ease make day only moderate loss especially present day standard
2540,PRGO,right friday open bell president bush speak wall street main street state government unprecedented rescue effort benefit economy effect not be immediate explain economy didn overnight take time credit system thaw
2541,PRGO,report hit street today include biggest monthly consumer confidence drop record october reuter university michigan survey consumer note index confidence sunk october september economist be expect read
2542,PRGO,bring index lowest level june year report indicated only other survey deliver monthly slide index point more
2543,PRGO,commerce department report today construction new home apartment dip october analyst be expect decrease only result be seasonally adjust annual rate unit lowest january
2544,PRGO,application build permit good indicator future hold real estate tank september decline annual rate unit total translate lowest level november
2545,PRGO,oil price rebound level be barrel opec call special meeting next friday vienna austria analyst be indicate opec cut much barrel day slow oil fall
2546,PRGO,light sweet crude jump settle barrel new york mercantile exchange
2547,PRGO,gold dip ounce
2548,PRGO,warren buffet take away doom gloom surround stock cause market upside action friday oracle omaha state new york time op ed piece long term stock market be place be cash be trash
2549,PRGO,zack elite portfolio
2550,PRGO,focus list fared better dow friday dip none position be signale removal right now however holding be closely analyze next week determine add drop be necessary
2551,PRGO,week healthspr inc hs recent addition turn best performance focus list portfolio
2552,PRGO,consensus estimate full year have climb share past day full year estimate be also rise nearly same period time
2553,PRGO,healthspr third quarter report be schedule release october
2554,PRGO,perrigo co prgo free report repeat appearance list focus list top performer third straight week
2555,PRGO,wall street have be hike fiscal year earning projection prgo strong quarterly result current forecast share be last month
2556,PRGO,company plan report first quarter november
2557,PRGO,lockheed martin corporation lmt free report come top focus list outperformer second straight week
2558,PRGO,full year consensus forecast share edge penny just past week
2559,PRGO,lmt be schedule report october
2560,PRGO,take look past week top focus list performer click here
2561,PRGO,growth income portfolio lose friday
2562,PRGO,continue evaluate list growth income candidate intend beef portfolio next week
2563,PRGO,perrigo company prgo free report have see stock hold pretty well recent stock market sell
2564,PRGO,company zack rank strong buy manufacture distribute counter otc prescription pharmaceutical nutritional product consumer product be expand consumer switch more expensive brand name product cheaper item slow economy
2565,PRGO,perrigo be largest supplier brand product retailer company supply product more category formula offer analgesic cough cold remedy feminine hygiene product well vitamin dietary supplement nutritional drink
2566,PRGO,stock investor have be flee quality health drug company name include perrigo market downturn perrigo have solid fundamental
2567,PRGO,company recently paid cash laboratorio diba privately hold store brand manufacturer otc prescription pharmaceutical perrigo expect acquisition add annual sale sale grow
2568,PRGO,august perrigo report third straight quarter record year year sale earning sale rise compare fiscal company generate cash flow
2569,PRGO,analyst continue be bullish perrigo future year year growth be expect be full year estimate be cent last day estimate first quarter be penny cent last month
2570,PRGO,perrigo have forward price book be have stellar year return equity roe
2571,PRGO,company have surprised earning quarters average report first quarter earning nov
2572,PRGO,perrigo company prgo free report have acquire more laboratory quarter focuse effort growth exist market company be also come record quarterly earning report
2573,PRGO,company description
2574,PRGO,perrigo be nation largest manufacturer store brand counter pharmaceutical product also manufacture store brand nutritional product store brand product be sell national regional supermarket drugstore mass merchandise chain own label compete nationally advertised brand
2575,PRGO,company product include analgesic cough cold remedy antacid laxative feminine hygiene smoking cessation product vitamin nutritional supplement nutritional drink
2576,PRGO,acquire manufacturer
2577,PRGO,oct perrigo announce acquire laboratorio diba cash transaction manufacturer be expect add sale year
2578,PRGO,perrigo have be mexico year deal provide company new formula new trademark
2579,PRGO,company also acquire jb laboratory cash transaction michigan base lab be expect produce sale
2580,PRGO,lawsuit drop
2581,PRGO,patent infringement lawsuit bring johnson johnson be dismiss sep perrigo now pursue fda approval cream be sell generic form monistat once shelve be store brand name
2582,PRGO,record annual result
2583,PRGO,perrigo announce record annual result aug fourth quarter earning announcement revenue full year be record level increase net income be share increase
2584,PRGO,management project earning be
2585,PRGO,chart
2586,PRGO,share prgo have develop level support past month stock have struggle maintain share have strong support just take look chart
2587,PRGO,perrigo company prgo free report have see stock hold pretty well recent stock market sell
2588,PRGO,company zack rank strong buy manufacture distribute counter otc prescription pharmaceutical nutritional product consumer product be expand consumer switch more expensive brand name product cheaper item slow economy
2589,PRGO,perrigo be largest supplier brand product retailer supply product more category formula offer analgesic cough cold remedy feminine hygiene product well vitamin dietary supplement nutritional drink
2590,PRGO,stock investor have be flee quality health drug company name include perrigo market downturn perrigo have solid fundamental
2591,PRGO,company recently paid cash laboratorio diba privately hold store brand manufacturer otc prescription pharmaceutical perrigo expect acquisition add annual sale sale grow
2592,PRGO,august perrigo report third straight quarter record year year sale earning sale rise compare fiscal company generate cash flow
2593,PRGO,analyst continue be bullish perrigo future year year growth be expect be full year estimate be cent last day estimate first quarter be penny cent last month
2594,PRGO,perrigo have forward price book be have stellar year return equity roe
2595,PRGO,company have surprised earning quarters average report first quarter earning nov
2596,PRGO,perrigo company prgo free report share price have show lot resilience last week overall market have weaken drop lower recent price strength come analyst have push company earning estimate higher something be very unique environment current year estimate be share day next year estimate be peg share earning growth projection
2597,PRGO,market experience worst week ever be surprise none focus list holding turn positive performance past week
2598,PRGO,turmoil communication lll free report come top performer week outperform major average
2599,PRGO,wall street be bullish aerospace defense communication company analyst increase full year earning forecast communication share just past week consensus estimate moved same time period
2600,PRGO,company recently declare quarterly dividend cent share note be payable december shareholder record close business november
2601,PRGO,be definitely keep eye analyst keep boost expectation lll be schedule release result third quarter october
2602,PRGO,watch be perrigo co prgo free report healthcare name repeat appearance list focus list top performer week recent performance have also outpaced broader market
2603,PRGO,wall street have be hike fiscal year earning projection prgo strong quarterly result current forecast share be last month
2604,PRGO,prgo announce record fiscal fourth quarter result mid august company profit increase thank hike see demand consumer health care product
2605,PRGO,company plan report first quarter november
2606,PRGO,company ticker weekreturn
2607,PRGO,comm hldgs lll free report
2608,PRGO,almost family afam
2609,PRGO,wabtech wab
2610,PRGO,lockheed martin lmt
2611,PRGO,perrigo company prgo free report
2612,PRGO,click here investment idea current market turmoil
2613,PRGO,dow stage fierce rally late afternoon avoid largest day point plunge panic world market dow jone manage finish only point crash point early day even rally be dow lowest close year
2614,PRGO,nasdaq composite fared slightly dow fall point
2615,PRGO,bad be only stock hit new high nyse only do same nasdaq
2616,PRGO,market however hung better many counterpart russia brazil halter trading loss mount msci emerge market index suffer biggest day loss year uk market have worst day crash
2617,PRGO,investor sell equity financial crisis appear deepen europe germany agree rescue hypo real estate second largest commercial property lender uk also say do be necessary help bank
2618,PRGO,response chaos european market dollar extend last week record gain euro euro fall friday close month low
2619,PRGO,commodity sell fear demand slow economy cool crude fall barrel first time february close crude have decline july high
2620,PRGO,bright spot investor be gold yellow metal rise investor seek safe haven today gain come heel last week loss anticipation passage rescue package temporarily calm market focus listfocus list holding be not spare bear today portfolio turn loss monday
2621,PRGO,be certainly rough market be do best contain loss lock profit accordance strategy fpl group inc fpl praxair inc px free report be remove portfolio fpl become necessary contain loss however regard px be locking profit
2622,PRGO,remain focus list stock be hold position today decline follow broader market real news serve impetus
2623,PRGO,be take day day now exercise more stop loss become necessary same be search good stock appeal valuation none be add today market uncertainty continue unprecedented time however be several good candidate radar be add soon see opportune entry point
2624,PRGO,recent development focus list company include lockheed martin corporation lmt free report announce contract transportation command ustranscom extend sustainment global transportation network gtn command control system lmt explain sustainment contract bring total value gtn contract award lockheed martin
2625,PRGO,perrigo co prgo free report announce acquisition laboratorio diba approximately cash prgo note privately hold laboratorio diba be base guadalajara mexico be store brand manufacturer counter otc prescription pharmaceutical include antibiotic hormonal opthalmic prgo add acquisition be expect add nearly annual sale
2626,PRGO,healthcare related stock stand focus list rough week market top strongest portfolio performer past week be healthcare company company operate segment offer healthcare related product focus list top performer week be company be also part top last week psychiatric solution inc psys company report strong second quarter include record revenue result recently see share price spike reaffirmation analyst buy rating analyst note psys be trading discount full year analyst be forecasting earning share be increase past trading day earning share be project grow year versus
2627,PRGO,analyst be expect third quarter earning share come cent third quarter result be schedule release november psychiatric solution provide inpatient behavioral health care service unite state company offer service child adolescent adult acute inpatient behavioral health care facility residential treatment center service include nursing observation care daily intervention oversight psychiatrist coordinate treatment physician lead team mental health professional second place go colgate palmolive co cl free report be week second strongest focus list performer company oral personal home care segment offer healthcare related product toothpaste toothbrush oral rinse dental floss pharmaceutical product dentist cl recently declare quarterly dividend share note be payable november shareholder record october company add have paid uninterrupted dividend common stock healthcare co prgo free report round list week top portfolio performer company have be perform well market analyst have be boost forecast fiscal full year earning estimate be just past week company announce record fiscal fourth quarter result mid august perrigo be nation largest manufacturer store brand counter prescription pharmaceutical product manufacture store brand nutritional product store brand product be sell national regional supermarket drugstore mass merchandise chain own label compete nationally advertised brand company product include analgesic cough cold remedy antacid laxative feminine hygiene smoking cessation product vitamin nutritional supplement nutritional drink company ticker sol psys colgate palmoli cl free report mcdonald corp mcd edison intl eix perrigo company prgo free report
2628,PRGO,so be say decide put together screen look company solid cash position
2629,PRGO,let note not do hope company initiate repurchase program own even be benefit do credit market tighten company strongest cash position couple low debt reduce inventory be best position weather financial crisis
2630,PRGO,today eye pop number make think spite turmoil ve see stock market company do just fine due healthy balance sheet
2631,PRGO,so here go
2632,PRGO,first look company cash marketable security be higher now be last year time have strong cash position mean company not have depend bank finance operation especially tight credit market
2633,PRGO,also want debt total capital be less year average debt total capital company able reduce debt position historical ratio be sign strength healthy balance sheet
2634,PRGO,want cash flow be greater cash flow last year too be sign financial health
2635,PRGO,also want see inventory last year level turnover inventory raw material unfinished good finished good be primary way company make money high level inventory long period time be usually not good sign
2636,PRGO,also want stock show annual ep growth rate be greater median respective industry let focus top half company peer group
2637,PRGO,lastly want next year ep growth rate be better last year company expect growth current economy be one favor
2638,PRGO,criterium be apply stock trading have average daily trade volume least share more
2639,PRGO,here be few stock list tuesday
2640,PRGO,ayi acuity brand inc
2641,PRGO,dmnd diamond food inc
2642,PRGO,dv devry inc
2643,PRGO,lvb steinway musical instrument inc
2644,PRGO,seac seachange international inc
2645,PRGO,sign now free trial today start pick better stock immediately backtesting feature test most idea see improve trading market market don market get better decide do better start learn be better trader today
2646,PRGO,click here free trial research wizard
2647,PRGO,disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material
2648,PRGO,so be say decide put together screen look company solid cash position
2649,PRGO,let note not do hope company initiate repurchase program own even be benefit do credit market tighten company strongest cash position couple low debt reduce inventory be best position weather financial crisis
2650,PRGO,today eye pop number make think spite turmoil ve see stock market company do just fine due healthy balance sheet
2651,PRGO,so here go
2652,PRGO,first look company cash marketable security be higher now be last year time have strong cash position mean company not have depend bank finance operation especially tight credit market
2653,PRGO,also want debt total capital be less year average debt total capital company able reduce debt position historical ratio be sign strength healthy balance sheet
2654,PRGO,want cash flow be greater cash flow last year too be sign financial health
2655,PRGO,also want see inventory last year level turnover inventory raw material unfinished good finished good be primary way company make money high level inventory long period time be usually not good sign
2656,PRGO,also want stock show annual ep growth rate be greater median respective industry let focus top half company peer group
2657,PRGO,lastly want next year ep growth rate be better last year company expect growth current economy be one favor
2658,PRGO,criterium be apply stock trading have average daily trade volume least share more
2659,PRGO,here be few stock list tuesday
2660,PRGO,ayi acuity brand inc
2661,PRGO,dmnd diamond food inc
2662,PRGO,dv devry inc
2663,PRGO,lvb steinway musical instrument inc
2664,PRGO,seac seachange international inc
2665,PRGO,sign now free trial today start pick better stock immediately backtesting feature test most idea see improve trading market market don market get better decide do better start learn be better trader today
2666,PRGO,click here free trial research wizard
2667,PRGO,disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material
2668,PRGO,perrigo company prgo free report be nation largest manufacturer store brand counter prescription pharmaceutical product manufacture store brand nutritional product
2669,PRGO,perrigo enjoy strong upward momentum week ascend thursday wednesday gain increase tuesday company be subject analyst upgrade few day
2670,PRGO,prior upgrade prgo announce acquire drug nutritional product maker jb laboratory cash company mentioned acquisition be expect add more annual sale perrigo announce record fiscal fourth quarter result mid august company profit increase thank hike see demand consumer health care product record net sale jump year year net income climb last year management note be third consecutive quarter year year record sale earning add company also generate cash operation year perrigo chairman ceo joseph papa say team be execute well grow market share manage supply chain deliver strong return bring innovative new product market continue make quality healthcare more affordable time consumer need save money more ever continue invest research development build pipeline future innovation well company earning outlook full fiscal year stand share wall street hike fiscal year projection strong quarterly result current forecast share be last month
2671,PRGO,company ticker weekreturn
2672,PRGO,perrigo company prgo free report
2673,PRGO,psychiatric sol psys
2674,PRGO,columbus mckinn cmco
2675,PRGO,kansa city ksu
2676,PRGO,mcdonald corp mcd
2677,PRGO,keep seatbelt fasten rollercoaster ride be not yet plunge point wednesday
2678,PRGO,dow soar point today such wide move have be norm week unprecedented event fall
2679,PRGO,lehman bank america bac free report purchase
2680,PRGO,lynch mer government bailout
2681,PRGO,american international group inc aig free report
2682,PRGO,unprecedented event drive much today gain be report federal government create
2683,PRGO,entity take bank bad debt entity be similar resolution trust corp be
2684,PRGO,establish saving loan debacle late early
2685,PRGO,earlier today investor awake news fed european central bank bank england bank
2686,PRGO,japan swiss national bank agree infuse much financial structure
2687,PRGO,order help ease calamity be experience financial market worldwide
2688,PRGO,thursday dow close point gain standard poor index jump
2689,PRGO,point nasdaq composite index picked point end
2690,PRGO,session
2691,PRGO,today other market move news include morgan stanley ms free report talk wb possible merger washington mutual
2692,PRGO,inc wm putt auction block
2693,PRGO,price oil moved again yesterday climb oil october delivery increase cent settle
2694,PRGO,barrel new york mercantile exchange advance occur weaker dollar news
2695,PRGO,nigerian militant increase attack oil company cause supply disruption concern
2696,PRGO,gold also stage move forward yesterday record jump precious metal surge today
2697,PRGO,ounce new york mercantile exchange
2698,PRGO,focus list
2699,PRGO,focus list participate today rally gain day
2700,PRGO,perrigo co prgo free report continue bullish run ascend thursday wednesday gain increase tuesday be major development today however yesterday company be subject analyst upgrade
2701,PRGO,prgo also recently announce acquire drug nutritional product maker jb laboratory cash prgo mentioned acquisition be expect add more annual sale
2702,PRGO,lockheed martin corporation lmt free report be big focus list gainer jump day past week analyst boost earning estimate year next penny year forecast be share projection be
2703,PRGO,upward estimate revision recently take place be increase wabtec wab free report see year current earning expectation share be last week
2704,PRGO,government bailout insurer american international group inc aig free report do not ease investor concern financial fact bailout news send financial stock tumble worry more despair financial sector be yet come
2705,PRGO,share morgan stanley ms free report goldman sachs gs free report suffer biggest blow even ms release quarterly result beat expectation gs report profit note produce solid performance tough environment ms lose day gs fall
2706,PRGO,regard aig rescue term deal stipulate fed provide insurer year emergency loan interest rate return government receive stake aig right remove senior management aig be day
2707,PRGO,news come financial arena weigh stock drive dow plunge point blue chip index end wednesday session
2708,PRGO,broader average tank well standard poor index slide point nasdaq composite index decline point close
2709,PRGO,carnage stock lead investor seek refuge other area such commodity gold shine brighter ever today precious metal set day record jump settle trading hour continue soar higher
2710,PRGO,market participant also seek safety oil today light sweet crude october delivery spiked settle barrel new york mercantile exchange be plummet more tuesday
2711,PRGO,zack elite portfolio
2712,PRGO,focus list suffer broader market dip be pretty much line only little wider dow drop
2713,PRGO,wall street bearish action be putt strain focus list holding lead execute deletion flowserve fls company be be remove focus list timely buy list earning estimate be recently cut more importantly stock performance have not be good want contain current loss
2714,PRGO,current environment have also trigger removal nucor nue free report growth income portfolio company stock have be hit hard commodity sell be delete nue contain loss fundamental remain place estimate continue rise analyst raise estimate last week
2715,PRGO,upside perrigo co prgo free report advanced wednesday climb yesterday company be subject analyst upgrade today prgo also recently announce acquire drug nutritional product maker jb laboratory cash prgo mentioned acquisition be expect add more annual sale
2716,PRGO,perrigo co prgo free report be see higher forecast analyst company offer return equity roe more double industry average earning share be expect grow next year outpace industry average
2717,PRGO,company description
2718,PRGO,perrigo company be healthcare supplier develop manufacture distribute counter otc prescription pharmaceutical nutritional product active pharmaceutical ingredient api consumer product company be world largest manufacturer otc pharmaceutical product store brand market prgo primary market location manufacturing facility be unite state israel mexico unite kingdom
2719,PRGO,recent event
2720,PRGO,company recently announce acquire exclusive right sell distribute levocetirizine tablet generic version ucb xyzal tablet synthon pharmaceutical
2721,PRGO,perrigo cite datum describe xyzal medicine indoor outdoor allergy estimate annual sale reflect annual growth
2722,PRGO,perrigo chairman ceo joseph papa say leverage first file opportunity brand product stay pharmacy counter switch counter status likely scenario
2723,PRGO,record result
2724,PRGO,company release fiscal fourth quarter result mid august include record net sale increase previous year
2725,PRGO,perrigo chairman ceo joseph papa comment third quarter row deliver year year record sale earning also generate cash operation year team be execute well grow market share manage supply chain deliver strong return bring innovative new product market continue make quality healthcare more affordable time consumer need save money more ever continue invest research development build pipeline future innovation well
2726,PRGO,favorable comparison
2727,PRGO,perrigo return equity roe more double industry average company net profit margin be ahead industry earning share be expect grow next year outpace industry average
2728,PRGO,yield also beat industry
2729,PRGO,prgo annual income cent share translate dividend yield top industry average virtually none company industry pay dividend
2730,PRGO,be see market work right now be surprisingly bullish be currently bearish ll start bearish market first then give reason optimism
2731,PRGO,fundamental backdrop continue deteriorate business inventory be rise company be shedding job oil be so high fall still trade barrel food price be cause peacekeeper protect haitian presidential palace rioter egypt use military bake bread thailand use soldier guard grain
2732,PRGO,aggregate growth first quarter be negative
2733,PRGO,then be credit crunch general electric ge free report blame poor earning morning business borrow ll spend less
2734,PRGO,ll also engage fewer merger hurt stock keep mind interest yahoo yhoo be come cash rich company other merger be occur be also many deal aren get do lender don trust borrower remain big problem
2735,PRGO,housing crisis be worsening call lender work homebuyer credit standard remain tight furthermore be many person buy more house afford add rise unemployment level term recovery housing market just doesn seem likely
2736,PRGO,then be bank earning estimate multiple large bank be be cut not typo estimate next year be be slash plunge be good way describe expect bank earning year
2737,PRGO,many market observer include anticipate economy slump first quarter so bad news be not real surprise even be have thought big question be recovery start equity market be bet recovery occur sooner later
2738,PRGO,take look chart hoopin hollerin
2739,PRGO,daily volatility major index be essentially same level be mid january
2740,PRGO,overshadowed big trading range be fact many stock be trading week high include focus list member cf industry cf free report perrigo prgo free report
2741,PRGO,bull be wrong possibility case financial sector think be really really wrong other hand bull be right economy do recover second half equity market be not go give advanced notice put money cash upside go occur
2742,PRGO,very least market be hold much better give current backdrop alone be reason be optimistic
2743,PRGO,don think be wood yet do think now be not right time investor be market rather investor need remain smart keep look opportunity be re do focus list beat performance last month result
2744,PRGO,remember investing be process not stock buy make money smart decision be make time return winner far offset loss
2745,PRGO,focus list business machine ibm be add last week big blue have transform shedding lower margin business focuse more enterprise product service addition company customer base be geographically diversify help protect current economic slump recently speak ibm bull bear week feature chuck jaffe marketwatch
2746,PRGO,scansource scsc be remove portfolio company cut quarterly guidance company be incur weakness catalyst telecom unit international pos bar code unit
2747,PRGO,charle rotblut cfa be senior market analyst zack com be reach crotblut zack com
2748,PRGO,best perform stock zack rank list last week be china security surveillance technology inc csr take interactive software inc free report first solar inc fslr free report equipment service inc hee free report perrigo company prgo free report china security surveillance technology inc csr be top performer last week share improve approximately earning estimate year have moved forward just past trading day
2749,PRGO,november company report third quarter result include revenue increase year year addition earning share match consensus csr secure new contract quarter china security surveillance be excited opportunity security service market demand product service continue be strong company expect revenue fourth quarter take interactive software inc free report spend second consecutive week top performer list share gain approximately last week share video game company advanced almost analyst be expect big thing upcoming release grand theft auto iv schedule early anticipation latest release popular series have lead brokerage upgrade take be also benefit favorable trend industry video game sale november be strong suggest space be bright spot otherwise lackluster holiday selling season
2750,PRGO,take interactive be schedule report fiscal fourth quarter result bell dec earning estimate year end october have be trend higher several month include gain past trading day first solar inc fslr free report be manufacturer solar module mean zack rank be growth industry lot potential future earning estimate year surge past month include gain past week expectation next year be month day share company gain week end dec
2751,PRGO,third quarter report announce early november first solar earn cent share trounce consensus much revenue advanced sequentially year year company attribute strong result part complete ramp german production facility ahead schedule company forecast revenue be better many analyst be expect equipment service inc hee free report be largest integrate equipment service company country gain almost hee be top performer week end dec earning estimate year be approximately past month third quarter report november company increase outlook thank favorable trend business
2752,PRGO,equipment third quarter performance include earning share top consensus well revenue increase year year company state result quarter be very solid major business segment highlight quarter be completion burress inc acquisition sep also help third quarter strong performance perrigo company prgo free report announce last week fda grant final approval partner dexcel pharma mg omeprazole delay release tablet be indicated treatment heartburn be expect be largest product company year history news help share global healthcare supplier rise approximately last week putt top perform zack rank list
2753,PRGO,past month earning estimate year be dec perrigo be highlighted aggressive growth stock day zack com first quarter announce early november company earn cent share beat consensus more better year result revenue rise perrigo also raise earning guidance
2754,PRGO,perrigo company prgo free report be nation largest manufacturer store brand counter prescription pharmaceutical product also manufacture store brand nutritional product company stock have have amazing run gap open higher nov report awesome quarter company profit quarter more double same quarter last year also announce revenue increase last day cover analyst have increase current quarter earning projection consensus estimate now stand more bullish cent compare cent last month
2755,PRGO,update previous momentum zack rank buy stocksbunge ltd bg experience small sell nov most market be absorb bigger loss then company stock price have do great job stabilize create foundation build last week share have trade fairly tight range primarily last day cover analyst have raise current quarter projection read oct analysis encore energy partner eac seem have find stabilization point retreat fresh week high just nov share rebound nov logging term low then reverse close higher previous day analyst community have be increase current quarter projection company cover analyst have raise estimate past day consensus estimate now stand cent opposed cent last month read oct analysis last week momentum zack rank buy stocksmaine maritime corporation mam have have wonderful year share holder stock price steadily climb higher more double value company recently report strong quarter come well ahead analyst earning estimate last day current year earning projection have increase cent share read full analysis tim horton inc thi have have very nice run stock price past month much have be fuel continue earning projection upgrade cover analyst company recently report great quarter oct announce board director have approve stock repurchase program read full analysis dolby laboratory dlb have adapt new licensing policy technology enable company save money production cost fuel margin read full analysis
2756,PRGO,perrigo company plc prgo free report report first quarter adjust earning cent share miss zack consensus estimate bottom line however increase year figure cent net sale report quarter increase figure surpass zack consensus estimate company share have underperform industry year date stock have decline industry rally segment jan company report segment be consumer health care americas chca consumer health care international chci prescription pharmaceutical rx other segment chca chca net sale first quarter come year year upside be attribute strong performance infant nutrition analgesic cough cold category compare year quarter new product sale also contribute top line however upside be partially offset lower sale animal health category discontinue product chci chci segment report net sale decline constant currency basis year period exclude exit russian unprofitable distribution business favorable foreign currency movement net revenue grow drive new product sale however be partially offset lower net sale cough cold personal care analgesic category addition discontinue product rx segment net sale slip report basis constant currency basis new product sale be offset lower net revenue exist product primarily due price erosion be line expectation new product sale be lower expect due supply disruption key new product earning outlook perrigo reiterate revenue guidance expect be range company also reaffirm adjust earning guidance expect be band share corporate governance perrigo board director appoint rolf classon serve company board chairman effective zack rank stock considerperrigo be zack rank hold stock few better rank stock same space worth consider be ligand pharmaceutical lgnd free report protagonist therapeutic ptgx free report illumina inc ilmn free report sport zack rank strong buy see complete list today zack rank stock here ligand earning share estimate have moved last day company deliver positive earning surprise trail quarters average beat company share have rally year date protagonist loss estimate narrow cent last day company deliver positive earning surprise trail quarters average beat illumina earning share estimate have moved last day company come positive earning surprise precede quarters average beat stock have rally so far year perrigo company plc price consensus ep surprise perrigo company plc price consensus ep surprise perrigo company plc quotelook stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
2757,PRGO,be last leg first quarter earning season latest earning preview already member have report financial result overall performance reflect many positive sign buoy optimism investor latest earning scorecard highlight increase total earning higher revenue beat ratio have be impressive well company surpass bottom line expectation beating top line mark medical sector zack sector have put stellar show so far be project rise revenue growth earning season await medical product stock broadly speaking latest tax cut job act have have also raise hope stakeholder have slash corporate tax rate earlier many other change medical product space be part broader medical sector have be hog lot limelight back certain favorable development sector have be go strong courtesy encourage demographic change market dynamic artificial intelligence ai big datum application upbeat consumer sentiment increase business investment further senate decision defer implementation industry wide excise tax medical device tax couple year have instilled confidence investor tax be effective jan bill also delay so call cadillac tax tax employer insurance backdrop let take sneak peek major medical product stock schedule release earning report quantitative zack model stock perfect combination solid zack rank strong buy buy hold positive earning esp have higher chance beating estimate uncover best stock buy sell re report earning esp filter henry schein inc hsic free report henry schein strategy globally expand digital dentistry be impressive management also look forward sustainable dental equipment business growth europe other region company bank digital dentistry be line strategic plan furthermore management believe company be well position gain ongoing trend digitalization global dental market be also content well diversify animal health product portfolio feature software diagnostic equipment surgical instrument good news be array solid product offering have be drive growth domestically well globally notably company earning outpaced zack consensus estimate average beat trail quarters moreover consensus mark first quarter earning cent share have remain unchanged last day same company revenue be peg improvement year figure henry schein have earning esp zack rank read more overall growth drive henry schein hsic free report earning henry schein inc price ep surprise henry schein inc price ep surprise henry schein inc quotepenumbra inc pen free report first quarter result be expect gain traction strong product uptake last report quarter company witness better sequential growth higher procedural volume additionally company be actively pursue marketing strategy also management seem cheer internal effort generate awareness domestic region also appear positive heighten cooperation hospital handle stroke case zack consensus estimate be peg loss cent share indicate year year improvement however be difficult conclusively predict earning beat stock last complete quarter penumbra have zack rank earning esp read more store penumbra earning season see complete list today zack rank stock here penumbra inc price ep surprise penumbra inc price ep surprise penumbra inc quotebio rad laboratory inc bio free report be global provider broad range innovative product solution life science research clinical diagnostic market company have net sale exceed consensus estimate earning cent translate surge year quarter however metric outperformed zack consensus estimate average beat last quarters bio rad have earning esp be zack rank player bio rad laboratory inc price ep surprise bio rad laboratory inc price ep surprise bio rad laboratory inc quotehaemonetic corporation hae free report haemonetic have be benefit continue momentum new business generation geographical expansion be happy haemonetic consistent growth plasma franchise strong end market demand plasma derive continue enhance growth company be now focuse development launch nexsys pcs plasmapheresis system additionally strong cash position lift investor trust notably company earning outshined zack consensus estimate average positive surprise precede quarters haemonetic have earning esp carry zack rank sell zack consensus estimate fourth quarter fiscal earning stand cent share depict significant rise prior year tally estimate revision company revenue see decline year year value haemonetic corporation price ep surprise haemonetic corporation price ep surprise haemonetic corporation quotemore stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
2758,PRGO,perrigo company plc prgo free report have announce reschedule fourth quarter full year earning result require more time complete year end tax review procedure result be earlier expect feb however company have provide preliminary unaudited result company say be lie low refrain issue further financial update earning release date get schedule perrigo share fall almost pre market trading feb follow preliminary release share company have underperform industry year time stock have gain compare industry rally preliminary resultsperrigo expect net sale approximately reflect year year decrease sale number be line zack consensus estimate however exclude impact divest european distribution business well israel api business negative impact competitive pressure price erosion company market drug entocort adjust net sale register growth constant currency basis effective jan company new report segment be consumer health care americas chca consumer health care international chci prescription pharmaceutical rx chca preliminary chca net sale come however adjust net sale be expect inch constant currency basis chci company expect net sale chci segment year period exclude contribution divest european distribution business sale be expect increase approximately constant currency prescription pharmaceutical rx prescription pharmaceutical segment be expect report net sale line prior year result exclude year year impact entocort perrigo company plc price perrigo company plc price perrigo company plc quote zack rank key picksperrigo carry zack rank hold better rank stock health care sector be regeneron pharmaceutical inc regn free report exelixis inc exel free report enanta pharmaceutical inc enta free report regeneron sport zack rank strong buy exelixis enanta carry zack rank buy see complete list today zack rank stock here regeneron earning share estimate have moved respectively last day company pull positive earning surprise last quarters average beat exelixis earning share estimate have be revise upward cent cent last day company deliver positive surprise last quarters average beat be share price company have rally year enanta pharma come positive surprise last quarters average beat share price company have sky-rocket year zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
2759,PRGO,expect perrigo company plc prgo free report beat estimate report fourth quarter full year result open bell feb perrigo have average beat last quarter company deliver positive surprise share company have lose year time industry rally let see thing be shape company quarter factor influence quarterperrigo product acquisition launch prescription pharmaceutical rx segment be expect boost sale come quarters company counter version astrazeneca azn free report heart burn drug nexium generate nominal sale third quarter be launch right end period however expect significant sale draw drug fourth quarter release moreover september company announce fda approval exalgo generic version manage moderate severe pain opioid tolerant patient same acanya topical treatment acne vulgaris product introduction agency nod be likely drive sale be report quarter also ongoing restructure initiative operate expense discipline be anticipate support company bottom line however price erosion change market dynamic tough drug pricing environment perrigo rx segment hurt segment performance additionally brand consumer healthcare bch business part consumer health care international segment be still be impact unfavorable market dynamic country belgium france germany italy bch segment be project persist weak performance yet be report quarter lower expect revenue certain high margin product earning whispersour proven model show perrigo be likely beat earning quarter have right combination key ingredient positive earning esp favorable zack rank strong buy buy hold happen zack esp perrigo have earning esp be most accurate estimate be peg share higher zack consensus estimate uncover best stock buy sell re report earning esp filter zack rank perrigo have zack rank increase predictive power esp further combine positive esp stock have significantly higher chance beating estimate caution sell rate stock go earning announcement especially company be see negative estimate revision perrigo company plc price ep surprise perrigo company plc price ep surprise perrigo company plc quote stock warrant lookhere be couple health care stock right combination element beat earning time gemphire therapeutic gemp free report be expect release fourth quarter result mar company have earning esp zack rank see complete list today zack rank stock here puma biotechnology inc pbyi free report be slate release fourth quarter financial number mar company have earning esp zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
2760,PRGO,expectperrigo company plc prgo free report beat estimate report first quarter result open bell perrigo earning history have be quite impressive company surpass expectation last quarters average beat last report quarter company deliver positive surprise share company have lose so far year industry gain let see thing be shape company report cycle factor influence last complete quarterperrigo product acquisition launch prescription pharmaceutical rx segment be expect boost sale be report quarter company counter version astrazeneca azn free report heart burn drug nexium be launch last september same generate significant sale fourth quarter expect positive trend continue first quarter release well moreover january company announce fda approval subsequent launch prolensa generic version treat postoperative inflammation reduction ocular pain patient have undergo cataract surgery additionally same month perrigo receive fda nod generic version epiduo enable topical treatment acne vulgaris patient age year product introduction be likely drive sale be report quarter also ongoing restructure initiative operate expense discipline be anticipate cushion company bottom line however price erosion change market dynamic tough drug pricing environment perrigo rx segment continue hurt segment performance moreover brand consumer healthcare bch business integral consumer health care international segment be still be adversely impact unfavorable market dynamic country belgium france germany italy bch segment sluggish performance be apprehend persist yet be report quarter lower expect revenue certain high margin product earning whispersour proven model show perrigo be likely beat earning earning season have perfect combination key ingredient positive earning esp favorable zack rank strong buy buy hold happen zack esp perrigo have earning esp indicate likely earning surprise zack consensus estimate be peg share uncover best stock buy sell re report earning esp filter zack rank perrigo have zack rank increase predictive power esp further combine positive esp stock have significantly higher chance beating estimate conversely sell rate stock never be consider go earning announcement especially company be see negative estimate revision perrigo company plc price ep surprise perrigo company plc price ep surprise perrigo company plc quote other stock considerhere be couple other health care stock also worth consider right combination element surpass estimate time emergent biosolution inc ebs free report have earning esp be zack rank player company be schedule release first quarter result see complete list today zack rank stock here adverum biotechnology inc advm free report have earning esp zack rank company be expect release first quarter result look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
2761,PRGO,course financial plan execution value investor miss chance bet stock have bright long term prospect growth investor often end investing expensive stock consequently quest mixed investment strategy lead introduction garp growth reasonable price approach garper look be stock be somewhat undervalue have solid sustainable growth potential investopedium price earning growth peg ratio be perfect example garp strategy be categorize value investing strategy follow principle growth value investing peg ratio be defined price earning earning growth rateit relate stock ratio future earning growth rate alone only give idea stock be trading discount peg add growth element help find stock have solid future potential lower peg ratio preferably less be always better garp investor say example stock ratio be expect long term growth rate be company peg come ratio indicate undervaluation future growth potential unfortunately ratio be often neglected due investor limitation calculate future earning growth rate stock be drawback used peg ratio doesn consider very common situation change growth rate such forecast first year very high growth rate follow sustainable lower growth rate long term hence peg base investing turn be even more reward other relevant parameter be also take consideration here be screening criterium winning strategy peg ratio less industry medianp ratio used less industry median more accurate valuation purpose zack rank strong buy buy good market condition bad stock zack rank have proven history success market capitalization greater help focus company have strong liquidity average day volume greater substantial trading volume ensure stock be easily tradable percentage change earning estimate revision week greater upward estimate revision add optimism suggest further bullishness value score less equal research show stock style score combine zack rank hold offer best upside potential here be stock qualify screening perrigo company plc prgo free report company develop manufacture market distribute counter otc consumer good pharmaceutical product worldwide apart zack rank value score stock also have impressive long term expect growth rate dxc technology company dxc free report be independent end end service company primarily provide information technology service solution north america europe asia australia apart discount peg stock have value score hold zack rank kopper holding inc kop free report headquarter pittsburgh pa kopper be integrate global provider treat wood product wood treatment chemical carbon compound company hold zack rank have value score also have impressive expect growth rate next year pbf energy inc pbf free report company operate field refine supply petroleum product company have segment refine logistic stock have impressive expect growth rate next fiscal stock currently have value score zack rank see complete list today zack rank stock here triton international limit trtn free report company be engage acquisition lease re lease sale various intermodal container chassis shipping line freight forwarding company manufacturer company hold zack rank have value score also have impressive expect growth rate next year get rest stock list start putt other idea test be do research wizard stock pick backtesting software research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
2762,PRGO,course strict screening determine intrinsic value company investor often miss chance bet stock have bright long term prospect same way growth investor often end investing expensive stock keenly observe investment track oracle omaha see quest eliminate hazard pure play value investor have gradually shift mixed investment strategy more precisely garp growth reasonable price strategy strategy combine growth value investing principle have proven track record success garper look be stock be somewhat undervalue have solid sustainable growth potential investopedium here lie importance not so popular fundamental metric price earning growth peg ratio be categorize value investing strategy follow principle growth value investing peg ratio be defined price earning earning growth rateit relate stock ratio future earning growth rate alone only give idea stock be trading discount peg add growth element help find stock have solid future potential lower peg ratio preferably less be always better garp investor say example stock ratio be expect long term growth rate be company peg come ratio indicate undervaluation future growth potential unfortunately ratio be often neglected due investor limitation calculate future earning growth rate stock be drawback used peg ratio doesn consider very common situation change growth rate such forecast first year very high growth rate follow sustainable lower growth rate long term hence peg base investing turn be even more reward other relevant parameter be also take consideration here be screening criterium winning strategy peg ratio less industry medianp ratio used less industry median more accurate valuation purpose zack rank strong buy buy good market condition bad stock zack rank have proven history success market capitalization greater help focus company have strong liquidity average day volume greater substantial trading volume ensure stock be easily tradable percentage change earning estimate revision week greater upward estimate revision add optimism suggest further bullishness value score less equal research show stock style score combine zack rank hold offer best upside potential here be stock qualify screening boot barn holding inc boot free report zack rank buy company be lifestyle retail chain operate specialty retail store unite state boot barn holding be impressive value investment pick value style score company long term expect earning growth rate be project be perrigo company plc prgo free report company develop manufacture market distribute counter otc consumer good pharmaceutical product worldwide apart zack rank value style score stock also have impressive long term expect growth rate boise cascade company bcc free report be largest producer engineer wood product plywood north america lead wholesale distributor build product stock have impressive long term expect growth rate stock currently have value score zack rank see complete list today zack rank stock here dxc technology company dxc free report be independent end end service company primarily provide information technology service solution north america europe asia australia apart discount peg stock have value score hold zack rank kopper holding inc kop free report headquarter pittsburgh pa kopper be integrate global provider treat wood product wood treatment chemical carbon compound company hold zack rank have value style score also have impressive expect growth rate next year get rest stock list start putt other idea test be do research wizard stock pick backtesting software research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation inaddition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
2763,PRGO,share roku inc roku free report jump report third quarter loss share narrower zack consensus estimate decline macy inc free report share increase post third quarter adjust earning share beating zack consensus estimate centsshare solaredge technology inc sedg free report advanced report third quarter adjust earning share outpace zack consensus estimate perrigo company plc prgo free report share climb post third quarter adjust earning cent share higher zack consensus estimate
2764,PRGO,share perrigo co prgo free report surge post second quarter earning share beat zack consensus estimate share kohl corp kss free report share decline report second quarter revenue slip year year share brinker international inc eat free report increase post second quarter earning share surpass zack consensus estimate live nation entertainment inc lyv free report share climb report second quarter earning share beat zack consensus estimate
2765,PRGO,have be month last earning report perrigo company plc prgo free report share have add time frame recent positive trend continue lead next earning release be prgo due pullback dive investor analyst have react late let take quick look most recent earning report order get better handle important driver perrigo surpass earning revenue yperrigo company report fourth quarter adjust earning share beat zack consensus estimate bottom line also increase year figure net sale report quarter decline divestiture business hurt top line metric surpass zack consensus estimate moreover exclude impact divestiture sale nudge year year segment discussionchca chca net sale fourth quarter come year year upside be attribute strong performance analgesic category compare year quarter new product sale also contribute top line lead store brand version nexium launch last september smoking cessation product however upside be partially offset lower sale nutritional drink product infant nutrition category well pricing pressure certain otc counter category chci chci segment report net sale decline constant currency basis year period exclude contribution divest european distribution business favorable currency movement organic net sale increase approximately owing higher sale new product company also witness higher new product sale personal care category well store brand business however be partially offset lower net sale parasite category prescription pharmaceutical rx prescription pharmaceutical segment net sale slip report basis constant currency basis sale dip be attribute lower sale entocort due competitive pressure price erosion resultsfull year sale decrease year year metric be however line zack consensus estimate preliminary result earning share be slightly higher zack consensus estimate decline compare year figure earning outlook perrigo expect revenue range revenue company project earning band share also ahead full year adjust earning have estimate be move then past month investor have witness downward trend fresh estimate have be revision lower current quarter past month consensus estimate have shift due change perrigo company plc price consensus perrigo company plc price consensus perrigo company plc quotevgm scoresat time prgo have nice growth score be lag lot momentum front however stock be allocate grade value side putt second quintile investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested zack style score indicate company stock be suitable value growth investor outlookestimate have be broadly trend downward stock magnitude revision indicate downward shift notably prgo have zack rank hold expect line return stock next few month
2766,PRGO,healthy rise healthcare share help nasdaq finish positive territory friday such share rise aren affected trump tariff import steel aluminum however such tariff do have negative impact overall investor sentiment lead major index post weekly loss first time week tariff steel aluminum import hurt corporation well consumer also stir fear trade dispute unite state china benchmark fared dow jone industrial average dji decrease point close gain close tech laden nasdaq composite index close increase cboe volatility index vix wall street so call fear gauge come way higher read most decliner outnumber advancer nyse nasdaq issue rise fall healthcare share risesharp rise healthcare share somewhat help nasdaq finish green be least affected trump tariff foreign steel aluminum health care select sector spdr etf xlv be best perform sector sector gain individually perrigo company plc prgo free report be best performer index increase ishare nasdaq biotechnology etf ibb free report also advanced trump tariff drag market major bourse however end red week dow nasdaq decline respectively trump tariff declaration steel aluminum import prompt steep stock market sell trump say impose tariff steel import tariff aluminum such protectionist trade policy trigger lot concern corporation consumer tariff increase cost company rely heavily aluminum steel auto plane maker fact corporate america have caution trump tariff backfire import make third steel american business house use year higher price steel aluminum furthermore compel company rely such product pass cost consumer increase consumer price long run hamper sale growth affect company lead job loss trump contentious tariff announcement have raise apprehension retaliation china other major trading partner china have caution america abide multilateral trade rule not harm delicate global economy shouldn forget china be world dominant steel producer trump tariff move easily start trade war trump tariff announcement have already receive angry response global leader european union say impose tariff worth import reuter stock make headlineliberty interactive earning sale top interactive corp deliver impressive fourth quarter result bottom top line surpass zack consensus estimate read more hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
2767,PRGO,perrigo company plc prgo free report report fourth quarter adjust earning share beat zack consensus estimate bottom line also increase year figure net sale report quarter decline divestiture business hurt top line metric surpass zack consensus estimate exclude impact divestiture sale nudge back positive execution business segment perrigo be more hour trading mar follow earning release moreover company share have underperform industry year time stock have gain compare industry rally segment jan company report segment be consumer health care americas chca consumer health care international chci prescription pharmaceutical rx other segment chca chca net sale fourth quarter come year year upside be attribute strong performance analgesic category compare year quarter new product sale also contribute top line lead store brand version nexium launch last september smoking cessation product however upside be partially offset lower sale nutritional drink product infant nutrition category well pricing pressure certain otc counter category chci chci segment report net sale decline constant currency basis year period exclude contribution divest european distribution business favorable currency movement organic net sale increase approximately owing higher sale new product company also witness higher new sale personal care category well store brand business however be partially offset lower net sale parasite category prescription pharmaceutical rx prescription pharmaceutical segment net sale slip report basis constant currency basis sale dip be attribute lower sale entocort due competitive pressure price erosion resultsfull year sale decrease year year metric be however line zack consensus estimate preliminary result earning share be slightly higher zack consensus estimate decline compare year figure earning outlook perrigo expect revenue range revenue company project earning band share also ahead full year adjust earning perrigo company plc price consensus ep surprise perrigo company plc price consensus ep surprise perrigo company plc quote zack rank key picksperrigo carry zack rank hold better rank stock health care sector be regeneron pharmaceutical inc regn free report ligand pharmaceutical incorporate lgnd free report enanta pharmaceutical inc enta free report regeneron sport zack rank strong buy ligand enanta carry zack rank buy see complete list today zack rank stock here regeneron earning share estimate have moved respectively last day company pull positive earning surprise last quarters average beat ligand earning share estimate have moved last day company deliver positive surprise trail quarters average beat share price company have surge year enanta pharma come positive surprise last quarters average beat share price company have sky-rocket year don even think buy bitcoin read most popular cryptocurrency sky-rocket last year give investor chance bank return even more gain however come serious volatility risk bitcoin sank more time zack have just release new special report help reader capitalize explosive profit potential bitcoin other cryptocurrency significantly less volatility buy directly see crypto related stock now
2768,PRGO,share perrigo company plc prgo free report hit new week high jan just few day company announce appointment new chief executive officer ceo uwe rohrhoff stock eventually close perrigo share underperform industry stock gain broader industry rally however company have re-cover be already jan company end search new ceo appoint uwe rohrhoff effective jan new ceo succeed john hendrickson have announce retirement plan june john hendrickson resign ceo board member jan continue remain company mar ensure successful transition uwe rohrhoff bring strong record operation global leadership position also have proven track record drive growth profitability manage complex operate platform global healthcare market currently perrigois face challenge pricing environment rx segment due industry competitive pressure generic sector be hurt company top line department justice antitrust division have also be conduct investigation perrigo seek information drug pricing practice meanwhile brand consumer healthcare bch segment continue be impact market dynamic due softness certain lead brand category primarily owing lower sell result re stage launch timing certain product change timing certain advertising promotional campaign however company be make effort overcome challenge march perrigo divest tysabri royalty stream order monetize asset further november company also divest active pharmaceutical ingredient api business sk capital order focus core business february company adopt cost optimization strategy slash workforce approximately global production staff workforce reduction be expect generate annual saving worth mid support effort perrigo raise earning outlook third quarter earning call see continue positive execution business segment now remain be see new ceo continue guide company challenge have be face past couple year perrigo company price perrigo company price perrigo company quotezack rank stock considerperrigo have zack rank hold better rank stock health care space include exelixis inc exel free report xoma corporation xoma free report sucampo pharmaceutical exelixis xoma sport zack rank strong buy sucampo carry zack rank buy see complete list today zack rank stock here exelixis earning share estimate have moved cent cent last day company deliver positive earning surprise last quarters average beat share price company surge xoma loss share estimate have narrow cent last day company pull positive earning surprise last quarters average beat share price company sky-rocket sucampo earning share estimate have moved cent last day company deliver positive earning surprise last quarters average beat share price company have surge zack editor chief go stock full disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
2769,PRGO,second quarter earning season be draw close most major company have report result week company endo mylan myl free report nordisk perrigo prgo free report present second quarter result recap week most important storiesa look earning result mylan second quarter result be disappointing company miss earning revenue cut outlook also read mylan miss earning sale lower view mylan have push back major product launch reflect ongoing challenge uncertain regulatory environment product launch include generic version advair copaxone escalate price erosion generic market remain major challenge meanwhile mylan get subpoena department justice doj late jul seek information relate opioid manufacture market sell company jan dec mylan have lose value year date versus decline industry perrigo second quarter result be better expect company raise outlook also read perrigo earning sale top view raise nordisk also top earning estimate raise outlook meanwhile endo top earning revenue estimate lower outlook also read endo beat earning sale guidance lower endo stock have lose value year date versus decline industry perrigo be zack rank hold stock see complete list today zack rank strong buy stock here esperion positive mid stage datum esperion espr free report share be positive top line datum study evaluate company bempedoic acid zetia ezetimibe combination lipitor versus placebo patient mid stage triplet oral therapy study meet primary endpoint greater ldl lower compare placebo company intend conduct additional study next year expect file fda approval combination first quarter zynerba plunge star fail shine zynerba see share plunge disappointing mid stage datum company experimental cannabinoid treatment zyn result double blind placebo controlled star study adult epilepsy patient focal seizure show dose zyn fail meet endpoint compare placebo focus have now shift couple more study be conduct zyn osteoarthritis top line datum expect aug fragile syndrome top line datum expect sep valeant get crl eye drop valeant vrx free report report second quarter result week also read valeant beat earning sale line trim view get complete response letter crl fda new drug application nda vyzulta latanoprostene bunod ophthalmic solution company be look gain approval use intraocular pressure lower single agent eye drop patient open angle glaucoma ocular hypertension safety efficacy concern be raise fda crl refer current good manufacturing practice cgmp inspection bausch lomb manufacturing facility tampa fl valeant be work resolve manufacturing quality issue tampa plant be work agency determine path forward cap pharmaceutical industry yr return large cap pharmaceutical industry yr nyse arca pharmaceutical index decline last trading session major stock bristol myer bmy free report be glaxo lose last month be merck mrk free report decline see last pharma stock roundup here mixed result pfizer bristol myer announce io deal next pharma world watch usual pipeline regulatory update make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2770,PRGO,perrigo company plc prgo free report report second quarter earning share beat zack consensus estimate cent share however adjust earning decline year figure company however report loss cent share same period include amortization restructure charge other time item figure narrow year year net sale report quarter decline divesture business currency headwind hurt top line revenue surpass zack consensus estimate exclude impact currency divesture sale improve back positive execution business segment share perrigo have rally more pre market hour however company share have significantly underperform industry so far year stock have lose compare broader industry gain segment discussionin january perrigo announce have change report segment follow sale tysabri royalty stream earlier march year effective jan company new report segment be consumer health care americas chca consumer health care international chci prescription pharmaceutical rx other segment chca chca net sale second quarter come due sale vitamin mineral supplement vms business jun have contribute segmental sale prior year company report higher new product sale quarter drive continue strong net sale store brand version flonase however be offset lower sale animal health analgesic cough cold category chci chci segment report net sale decline constant currency basis year period exclude year year contribution divest european distribution business currency headwind organic net sale increase approximately due higher sale new product net sale exist product also rise primarily higher sale allergy analgesic cough cold category prescription pharmaceutical rx prescription pharmaceutical segment also show sluggish performance quarter net sale decline report constant currency basis dip sale be attribute lower sale entocort due competitive pressure price erosion however lower sale be partially offset higher sale exist new product other updatesdure quarter company announce have reach agreement divest israel active pharmaceutical ingredient api business amount cash company have be look strategic alternative api unit february year earning outlook updatedperrigo increase earning outlook due sale api business continue positive execution business segment company now expect adjust earning diluted share range compare project previously perrigo company price consensus ep surpriseperrigo company price consensus ep surprise perrigo company quotezack rank key picksperrigo currently carry zack rank hold better rank stock pharma sector be summit therapeutic plc smmt free report aduro biotech inc adro free report enzo inc carry zack rank buy see complete list today zack rank strong buy stock here summit loss share estimate narrow cent last day company deliver positive earning surprise trail quarters average beat share price surge so far year aduro biotech loss share estimate narrow last day company deliver positive surprise trail quarters average beat stock be last month enzo loss share estimate narrow cent cent cent cent last day company come positive earning surprise trail quarters average beat stock surge so far year simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
2771,PRGO,perrigo company plc prgo free report report third quarter adjust earning share beat zack consensus estimate bottom line increase year figure net sale report quarter decline divestiture business hurt top line revenue surpass zack consensus estimate exclude impact divestiture sale improve back positive execution business segment share perrigo have rally almost hour trading back company raise guidance however company share have significantly underperform industry so far year stock have lose versus broader industry gain segment jan company new report segment be consumer health care americas chca consumer health care international chci prescription pharmaceutical rx chca chca net sale third quarter come due sale vitamin mineral supplement vms business june have contribute segmental sale prior year however exclude year year contribution vms business company witness increase sale report quarter upside be attribute strong performance category animal health mexico business compare year quarter new product sale be lead store brand version nexium launch september chci chci segment report net sale decline constant currency basis year period exclude contribution divest european distribution business favorable currency movement organic net sale increase approximately owing higher sale new product company also witness higher sale allergy analgesic cough cold category prescription pharmaceutical rx prescription pharmaceutical segment net sale slip report basis remain flat constant currency basis dip sale be attribute lower sale entocort due competitive pressure price erosion however lower sale be partially offset higher sale new product earning outlook updatedperrigo increase earning outlook continue positive execution business segment company now expect adjust earning share range compare project previously perrigo company price consensus ep surprise perrigo company price consensus ep surprise perrigo company quotezack rank key picksperrigo carry zack rank hold better rank stock health care sector include emergent biosolution inc ebs free report ligand pharmaceutical inc lgnd free report exelixis inc exel free report ligand sport zack rank strong buy emergent exelixis carry zack rank buy see complete list today zack rank stock here ligand earning share estimate have moved last day company deliver positive earning surprise trail quarters average beat share price company have surge year date emergent earning share estimate have moved last day company come positive earning surprise trail quarters average beat share price company have rally year date exelixis earning share estimate have moved cent cent last day company come positive earning surprise trail quarters average beat share price company have soar year date today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
2772,PRGO,expect perrigo company plc prgo free report beat expectation report third quarter result open bell nov perrigo have average positive surprise last quarter company deliver positive surprise perrigo share have lose so far year industry rally let see thing be shape company quarter factor influence quarterperrigo product acquisition new product launch prescription pharmaceutical rx segment be expect boost sale come quarters september perrigo announce have initiate shipment first market counter store brand equivalent nexium capsule retail customer be indicated treat frequent heartburn same month company also announce fda approval generic version exalgo management moderate severe pain opioid tolerant patient generic version acanya topical treatment acne vulgaris launch approval be expect contribute top line come quarters also ongoing restructure initiative operate expense discipline be expect support bottom line however price erosion change market dynamic tough drug pricing environment perrigo rx segment be likely continue hurt segment performance anticipate price erosion approximately rx segment come quarters brand consumer healthcare bch business part consumer health care international chci segment be still be impact unfavorable market dynamic country belgium france germany italy bch segment be project underperform yet be report quarter due lower expect revenue certain high margin product earning whispersour proven model show perrigo be likely beat earning have right combination key ingredient positive earning esp favorable zack rank strong buy buy hold happen zack esp perrigo have earning esp indicate likely positive earning surprise figure also represent difference most accurate estimate share zack consensus estimate uncover best stock buy sell re report earning esp filter zack rank perrigo have zack rank increase predictive power esp caution sell rate stock go earning announcement especially company be see negative estimate revision other stock warrant looksome other health care stock worth consider right combination element surpass estimate quarter be inc agen free report be schedule release result nov company have earning esp carry zack rank see complete list today zack rank stock here syndax pharmaceutical inc sndx free report be schedule release result nov company have earning esp zack rank acadium pharmaceutical inc acad free report be schedule release result nov zack rank company have earning esp look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
2773,PRGO,political gridlock pullback affordable care act obamacare have be make headline medtech space medtech space receive sudden jolt recently white house pull plug obamacare subsidy reduce health care cost american low income be concern final trump care plan still include medtech tax repeal agenda meanwhile old template plan promise eradicate infamous medical device tax cadillac tax excise tax high cost healthcare plan be not bad deal such uproar question emerge be medical product player gain lose member total company broader medical sector have release third quarter result full picture be reveal latest earning preview suggest stock much seek index witness bottom line expansion report cycle notably be powerful long term tailwind medical space include merger acquisition emerge market expansion positive demographic trend new product innovation have be major drive force sector impressive performance past few quarters even severe socio economic political instability rise interest rate strengthen dollar continue act dampener industry make right pick existence number industry player find right stock have potential beat earning be daunting task proprietary methodology make fairly simple narrow list choice look stock have combination favorable zack rank strong buy buy hold positive earning esp earning esp be proprietary methodology determine stock have best chance surprise next earning announcement show percentage difference most accurate estimate zack consensus estimate research show stock combination have chance positive earning surprise earning beat boost investor confidence stock be reflect rapid price appreciation uncover best stock buy sell report earning esp filter choicesbelow be medical product player have right combination element post earning beat quarter gw pharmaceutical plc gwph free report gw pharmaceutical be company focuse discover develop commercialize therapeutic proprietary cannabinoid product platform broad range disease area company be base salisbury uk note gw pharmaceutical have beaten zack consensus estimate trail quarters average positive earning surprise zack rank stock have earning esp company be anticipate report third quarter result dec see complete list today zack rank stock here macrogenic inc mgnx free report company headquarter rockville md be company be focuse discover develop innovative monoclonal antibody base therapeutic company have diverse portfolio product candidate focuse therapeutic area oncology autoimmune disorder infectious disease company have miss zack consensus estimate precede quarters average negative earning surprise company be set report third quarter result nov currently company have earning esp carry zack rank neurometrix inc neurometrix be medical device company establish new standard care design development sale proprietary product used diagnose neuropathy neuropathy be disease peripheral nerve part spine frequently be cause associate diabetes low back pain carpal tunnel syndrome well other clinical disorder company have beaten zack consensus estimate precede quarters average negative earning surprise zack rank stock have earning esp company be expect report third quarter result oct perrigo company prgo free report perrigo company develop manufacture distribute healthcare product company operate primarily segment consumer healthcare nutritional rx pharmaceutical active pharmaceutical ingredient also provide animal health product company operate primarily unite state unite kingdom mexico israel australia canada china latin america note company have beaten zack consensus estimate precede quarters average positive earning surprise company be set report third quarter result nov currently company have earning esp carry zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
2774,PRGO,perrigo company plc prgo free report share increase almost jeff ceo starboard value new york base investment consult company declare company be top investment option deliver alpha event host cnbc notably perrigo be world largest manufacturer counter otc healthcare product supplier infant formula store brand market be lead provider brand otc product eu unite state company also produce generic standard topical product however perrigo share have underperform industry so far year stock have gain compare broader industry increase conference jeff state perrigo be undervalue present due pricing pressure particularly generic segment change dynamic unite state continue say company hold huge potential much larger business whole compare single brand further add many retailer be face online challenge commerce giant amazon amzn free report perrigo utilize prime distribution outlet generic drug other counter otc product conference jeff also cite altaba inc new york base investment company good option investor put money remind investor jeff have place total member company board include new one come late perrigo company priceperrigo company price perrigo company quotezack rank stock considerperrigo currently carry zack rank hold better rank stock pharma sector be acadium pharmaceutical inc acad free report hold zack rank buy see complete list today zack rank strong buy stock here acadium loss share estimate narrow last day company come positive earning surprise last quarters average beat more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
2775,PRGO,perrigo company plc prgo free report announce fda have grant final approval counter otc version astrazeneca azn free report nexium hr esomeprazole magnesium capsule treat patient frequent heartburn perrigo share have significantly underperform industry so far year stock have lose versus broader industry rally meanwhile perrigo also say have enter settlement agreement astrazeneca regard ongoing patent litigation company settlement perrigo launch generic capsule late september importantly nexium record retail sale last month remind investor perrigo have expand product offering otc market europe slew target acquisition mar acquisition omega pharma purchase portfolio well establish otc brand niquitin coldrex glaxosmithkline plc gsk free report aug expand perrigo market share european otc market meanwhile aug perrigo also acquire scaraway lead otc scar management brand portfolio provide perrigo entry brand otc business unite growth otc market track consumer demographic dynamic drive use otc product perrigo have identify potential rx otc switch worth multibillion dollar nexium launch be expect be key new store brand rx otc switch product perrigo company priceperrigo company price perrigo company quotezack rank key picksperrigo currently carry zack rank hold better rank stock pharma sector be aduro biotech inc adro free report carry zack rank buy see complete list today zack rank strong buy stock here aduro biotech loss share estimate narrow last day company deliver positive surprise trail quarters average beat zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
